PropDefinitions:
  #crdc_id
  crdc_id:
    Desc: The crdc_id is a unique identifier that is generated by Data Hub
    Type: string
  #image
  study_link_id:
    Desc: The study_link_id is a unique numerical identifier for each study listed on the collection information sheet. The sole purpose of the study_link_id is to indicate which participant described on worksheet 2 - Participant information belongs to what study/collection described on worksheet 1 - Collection information.
    Req: true
    Type: string
    Key: true
    Term:
    - Origin: caDSR
      Code: New CDE
      Version: '1.00'
  de_identification_method_type:
    Desc: General description of the de-identification method
    Req: true
    Enum:
    - Manual
    - Semiautomatic
    - Automatic
    - Not applicable
    Term:
    - Origin: caDSR
      Original Source: CDS
      Code: 14607284
      Value: Deidentification Method Type
      Version: '1.00'
  de_identification_method_description:
    Desc: Description of the process of removing potentially identifying data or data elements to render data into a form that does not identify individuals and where identification is not likely to take place.
    Type: string
  de_identification_software:
    Desc: Software that was used to de-identify the images (if used)
    Type: string
  license:
    Desc: Official or legal permission to do or own a specified thing.
    Req: true
    Enum:
    - CC BY 3.0    http://creativecommons.org/licenses/by/3.0/
    - CC BY 4.0    https://creativecommons.org/licenses/by/4.0/
    - CC BY-NC 4.0 https://creativecommons.org/licenses/by-nc/4.0/
    - CC BY-NC 3.0 https://creativecommons.org/licenses/by-nc/3.0/
    - Other
    Term:
    - Origin: caDSR
      Code: Pending
      Version: '1.00'
  citation_or_DOI:
    Desc: Publication and/or digital object identifier of the publication for open access studies
    Req: true
    Type: string
    Term:
    - Origin: caDSR
      Original Source: CDS
      Code: '7787673'
      Version: '1.00'
  species:
    Desc: Use the NCBI Taxonomy ID to identify species. A label provided by NCBI Taxonomy Database (https://www.ncbi.nlm.nih.gov/taxonomy/),  which uniquely identifies group or category, at any level, in a system for classifying plants or animals (including humans) providing ranked categories for the classification of organisms according to their suspected evolutionary relationships.
    Req: true
    Type: string
    Term:
    - Origin: caDSR
      Original Source: DSS
      Code: '10543100'
      Value: NCBI Taxonomy ID
      Version: '2.00'
  image_modality:
    Desc: The method in which the images are generated.
    Req: true
    Enum:
    - AR
    - BI
    - BMD
    - EPS
    - CR
    - CT
    - CFM
    - DMS
    - DG
    - DX
    - ECG
    - EEG
    - EMG
    - EOG
    - ES
    - XC
    - GM
    - HD
    - IO
    - IVOCT
    - IVUS
    - KER
    - LS
    - LEN
    - MR
    - MG
    - NM
    - OAM
    - OPM
    - OP
    - OPT
    - OPTBSV
    - OPTENF
    - OPV
    - OCT
    - OSS
    - PX
    - PA
    - POS
    - PT
    - RF
    - RG
    - RESP
    - RTIMAGE
    - SM
    - SRF
    - TG
    - US
    - BDUS
    - VA
    - XA
    - Not specified in data
    Term:
    - Origin: caDSR
      Original Source: DSS
      Code: '12137353'
      Value: Imaging Technology DICOM Modality Type
      Version: '1.00'
  imaging_equipment_manufacturer:
    Desc: Producer of the imaging equipment that was used to generate the digital image
    Req: true
    Type: string
    Term:
    - Origin: caDSR
      Original Source: NCI Standard
      Code: '2866141'
      Value: Equipment Manufacturer Name Text
      Version: '1.00'
  imaging_equipment_model:
    Desc: The words used to describe the specific model of the instrument used to carry out an imaging experiment.
    Type: string
    Term:
    - Origin: caDSR
      Original Source: NCI Standard
      Code: '2413274'
      Value: Equipment Manufacturer Model Name Text
      Version: '2.10'
  imaging_sofware:
    Desc: The name of the software package that was used to capture, generate, and process the image.
    Type: string
    Term:
    - Origin: caDSR
      Original Source: NCI Standard
      Code: '2413278'
      Value: Equipment Software Version Text
      Version: '1.20'
  imaging_protocol:
    Desc: A rule which guides how an activity should be performed. Protocols.io ID or DOI link to a free/open protocol resource describing in detail the assay protocol (e.g. surface markers used in Smart-seq, dissociation duration, lot/batch numbers for key reagents such as primers, sequencing reagent kits, etc.) or the protocol by which the image was obtained or generated.
    Type: string
    Term:
    - Origin: caDSR
      Original Source: HTAN
      Code: '7787673'
      Value: Raw Data Protocol Or Digital Object Identifier Text
      Version: '1.00'
  organ_or_tissue:
    Desc: Site where images are associated
    Req: true
    Type: string
    Term:
    - Origin: caDSR
      Original Source: CDS
      Code: 6161035
      Value: ICD-O Origin of Disease Anatomic Site
      Version: '1.00'
  performed_imaging_study_description:
    Desc: The textual representation of the certain or salient aspects, characteristics, or features of the imaging study. [Adapted from www.businessdictionary.com]
    Req: true
    Type: string
    Term:
    - Origin: caDSR
      Original Source: DICOM
      Code: '2182389'
      Value: Image Study Description 64 Character Text
      Version: '2.10'
  performed_imaging_study_admittingDiagnosisCode:
    Desc: The identified disease(s) or illness(es) at the time of the admission during which imaging was performed.
    Req: true
    Type: string
    Term:
    - Origin: caDSR
      Original Source: DICOM
      Code: '2902328'
      Value: Image Study Admitting Diagnosis Description 64 Character Text
      Version: '3.00'
  performed_imaging_study_nonAcquisitionModalitiesInStudyCode:
    Desc: A coded value specifying the type of equipment that created the images in this imaging study other than that used to acquire the original data.
    Req: true
    Type: string
    Term:
    - Origin: caDSR
      Original Source: DSS
      Code: '12137353'
      Value: Imaging Technology DICOM Modality Type
      Version: '1.00'
  performed_imaging_study_lossyImageCompressionIndicator:
    Desc: Specifies whether any images in the study are irreversibly altered during encoding at any time during its life.
    Req: true
    Type: string
  performed_imaging_study_summary:
    Desc: A brief statement about the characteristics of this element, which is intended for use by the radiologist, technologist and/or physicist during management of the imaging protocol to understand the characteristics of the element in the protocol.
    Req: true
    Type: string
    Term:
    - Origin: caDSR
      Original Source: CDS
      Code: '14670299'
      Value: Imaging Study Process Protocol Element Summary Text
      Version: '1.00'
  performed_imaging_study_primaryAnatomicSiteCode:
    Desc: A coded value specifying the anatomic location that is the focus of this imaging process protocol element.
    Req: true
    Type: string
    Term:
    - Origin: caDSR
      Original Source: CDS
      Code: '14612662'
      Value: Image Study Primary Anatomic Site Sequence of Items Text
      Version: '1.00'
  performed_imaging_study_acquisitionTypeCode:
    Desc: A coded value specifying spatial aspects of the mechanism of data collection.
    Req: true
    Type: string
    Term:
    - Origin: caDSR
      Original Source: CDS
      Code: '14670301'
      Value: Image Study Spatial Acquisition Type Code
      Version: '1.00'
  performed_imaging_study_imageTypeCode:
    Desc: A coded value that specifies the most important aspect of the images or their derivation.
    Enum:
    - DYNAMIC
    - STRESS
    - RCBV
    Term:
    - Origin: caDSR
      Original Source: CDS
      Code: Pending
      Version: '1.00'
  performed_imaging_study_cardiacSynchronizationTechniqueCode:
    Desc: The means used to coordinate the collection or reconstruction of data with the cardiac cycle.
    Enum:
    - REALTIME
    - PROSPECTIVE
    - RETROSPECTIVE
    - PACED
    - NONE
    Term:
    - Origin: caDSR
      Original Source: CDS
      Code: '14617521'
      Value: Image Study Cardiac Synchronization Technique Code Name
      Version: '1.00'
  performed_imaging_study_dataCollectionDiameter:
    Desc: The diameter of the region over which information is acquired.
    Req: true
    Type: string
    Term:
    - Origin: caDSR
      Original Source: CDS
      Code: '14612665'
      Value: Image Acquisition Data Collection Location Diameter Number
      Version: '1.00'
  performed_imaging_study_respiratoryMotionTechniqueCode:
    Desc: The means to be used to coordinate the collection or reconstruction of data with breathing.
    Req: true
    Enum:
    - BREATH-HOLD
    - REALTIME
    - GATING
    - TRACKING
    - RETROSPECTIVE
    - CORRECTION
    - NONE
    Term:
    - Origin: caDSR
      Original Source: CDS
      Code: '14617522'
      Value: Image Study Respiratory Motion Technique Code Name
      Version: '1.00'
  performed_imaging_study_bodyPositionCode:
    Desc: A coded value specifying the 3-dimensional spatial orientation of a subject during this imaging acquisition protocol element.
    Enum:
    - Supine
    - Trendelenburg
    - Standing
    Term:
    - Origin: caDSR
      Original Source: CDS
      Code: '14617523'
      Value: Image Study Body Position Name
      Version: '1.00'
  performed_imaging_study_typeCode:
    Desc: A coded value specifying the kind of algorithm used when reconstructing the image from the data acquired during the acquisition process.
    Req: true
    Type: string
    Term:
    - Origin: caDSR
      Code: Pending
      Version: '1.00'
  performed_imaging_study_algorithmCode:
    Desc: A coded value specifying the algorithm to use when reconstructing the image from the data acquired during the acquisition process
    Req: true
    Type: string
    Term:
    - Origin: caDSR
      Code: '14617557'
      Value: Imaging Reconstruction Protocol Algorithm Code Text
      Version: '1.00'
  performed_imaging_study_reconstructionFieldOfViewHeight:
    Desc: The vertical dimension of the rectangular region from which data is used in creating the reconstruction of the image.
    Req: true
    Type: string
    Term:
    - Origin: caDSR
      Code: '14612672'
      Value: Imaging Reconstruction Protocol Field of View Height Number
      Version: '1.00'
  performed_imaging_study_reconstructionFieldOfViewWidth:
    Desc: The horizontal dimension of the rectangular region from which data is used in creating the reconstruction of the image.
    Req: true
    Type: string
    Term:
    - Origin: caDSR
      Code: '14612674'
      Value: Imaging Reconstruction Protocol Field of View Width Number
      Version: '1.00'
  performed_imaging_study_reconstructionDiameter:
    Desc: The diameter of the region from which data is used in creating the reconstruction of the image.
    Req: true
    Type: string
    Term:
    - Origin: caDSR
      Code: '2182085'
      Value: Reconstruction Diameter in Millimeter(s)
      Version: '1.00'
  performed_imaging_study_sliceThickness:
    Desc: The cross plane dimension of the reconstructed image.
    Req: true
    Type: string
    Term:
    - Origin: caDSR
      Code: '3113185'
      Value: Image Plane Slice Thickness Float or Fixed-point Millimeter Number
      Version: '2.00'
  performed_imaging_study_reconstructionInterval:
    Desc: The cross plane distance between the centers of adjacent, parallel reconstructed images.
    Req: true
    Type: string
    Term:
    - Origin: caDSR
      Code: '14612682'
      Value: Imaging Reconstruction Protocol Reconstruction Interval Millimeter Number
      Version: '1.00'
  longitudinal_temporal_event_type:
    Desc: The type of event to which Longitudinal Temporal Offset from Event is relative.
    Type: number
    Term:
    - Origin: caDSR
      Original Source: CDS
      Code: '14670294'
      Value: Longitudinal Study Temporal Event Type
      Version: '1.00'
  longitudinal_temporal_event_offset:
    Desc: An offset in days from a particular event of significance. May be fractional. In the context of a clinical trial, this is often the days since enrollment, or the baseline imaging Study.
    Type: number
    Term:
    - Origin: caDSR
      Original Source: CDS
      Code: '14612661'
      Value: Longitudinal Study Temporal Offset Number
      Version: '1.00'
  CTAquisitionProtocolElement_singleCollimationWidth:
    Desc: The width of a single row of acquired data. The units are of linear distince, e.g. mm.
    Type: string
    Term:
    - Origin: caDSR
      Code: '2903347'
      Value: Image Single Collimation Width 8 Byte Millimeter Number
      Version: '1.00'
  CTAquisitionProtocolElement_totalCollimationWidth:
    Desc: The width of the total collimation over the area of active x-ray detection. The units are of linear distince, e.g. mm.
    Req: true
    Type: string
    Term:
    - Origin: caDSR
      Code: '2903328'
      Value: Image Total Collimation Width 8 Byte Millimeter Number
      Version: '1.00'
  CTAquisitionProtocolElement_gantryDetectorTilt:
    Desc: Nominal angle of tilt in degrees of the scanning gantry. The units are of plane angle , e.g. degrees.  Zero degrees means the gantry is not tilted, negative degrees are when the top of the gantry is tilted away from where the table enters the gantry.
    Req: true
    Type: string
    Term:
    - Origin: caDSR
      Original Source: caDSR
      Code: '2656117'
      Value: Image Gantry Detector Tilt 16 Character Number
      Version: '1.00'
  CTAquisitionProtocolElement_tableSpeed:
    Desc: The distance that the table moves per unit of time during the gathering of data. The units are of linear distance divided by time.
    Req: true
    Type: string
    Term:
    - Origin: caDSR
      Code: Pending
      Version: '1.00'
  CTAquisitionProtocolElement_spiralPitchFactor:
    Desc: Ratio of the distance that the table moves during a complete revolution of the source around the gantry orbit, to the width of the total collimation over the area of active x-ray detection. The units are of unity.
    Req: true
    Type: string
    Term:
    - Origin: caDSR
      Code: '2414556'
      Value: Computed Tomography Pitch Factor Number
      Version: '1.00'
  CTAquisitionProtocolElement_ctdiVol:
    Desc: The average dose over the total volume scanned for the selected CT conditions of operation (calculated according to IEC 60601-2-44, Ed.2.1 (Clause 29.1.103.4)). The units are energy dose, e.g. mGy.
    Req: true
    Type: string
    Term:
    - Origin: caDSR
      Code: '3882991'
      Value: Computed Tomography Dose Index Volume Quantity 8 Byte Number
      Version: '1.00'
  CTAquisitionProtocolElement_ctdiPhantomTypeCode:
    Desc: The type of phantom to use for CTDI measurement according to IEC 60601-2-44
    Req: true
    Type: string
    Term:
    - Origin: caDSR
      Code: '14612683'
      Value: Imaging Technique CTDI Phantom Type Sequence of Items Text
      Version: '1.00'
  CTAquisitionProtocolElement_kVp:
    Desc: Peak kilovoltage output of the x-ray generator. The units are of electrical potential.
    Req: true
    Type: string
    Term:
    - Origin: caDSR
      Code: '2904496'
      Value: Image Kilovolt Peak Float 16 Number
      Version: '1.00'
  CTAquisitionProtocolElement_exposureModulationType_Code:
    Desc: The manner in which tube current is varied in order to limit the dose.
    Enum:
    - NONE
    - ANGULAR
    - LONGITUDINAL
    - ECG-BASED
    - ORGAN-BASED
  CTImageReconstructionProtocolElement_convolutionKernel:
    Desc: A label describing the mathematical operations used to reconstruct images from the acquired data. The values for this attribute are vendor specific and not coded.
    Type: string
    Term:
    - Origin: caDSR
      Code: '2656119'
      Value: Image Convolution Kernel 16 Character Text
      Version: '1.00'
  CTImageReconstructionProtocolElement_convolutionKernelGroupCode:
    Desc: A coded value specifying the family of mathematical operations to use to reconstruct images from the acquired data
    Type: string
    Term:
    - Origin: caDSR
      Code: '14617525'
      Value: Imaging Technique Convolution Kernel Group Name
      Version: '1.00'
  MRImageAcquisitionProtocolElement_echoPulseSequenceCategoryCode:
    Desc: A coded value specifying an echo category of pulse sequences.
    Enum:
    - SPIN
    - GRADIENT
    - BOTH
    Term:
    - Origin: caDSR
      Original Source: CDS
      Code: '14645641'
      Value: Image Acquisition Spin-Echo Pulse Sequence Code Category
      Version: '1.00'
  MRImageAcquisitionProtocolElement_diffusionBValue:
    Desc: The factor by which the acquisition is sensitized to the Brownian motion of water molecules. The units are of time/area, e.g. s/mm2
    Type: string
    Term:
    - Origin: caDSR
      Code: '14607706'
      Value: Imaging Technique MR Diffusion B Value Number
      Version: '1.00'
  MRImageAcquisitionProtocolElement_diffusionDirectionalityCode:
    Desc: A coded value specifying whether diffusion conditions for the frame are directional, or isotropic with respect to direction
    Enum:
    - DIRECTIONAL
    - BMATRIX
    - ISOTROPIC
    - NONE
    Term:
    - Origin: caDSR
      Code: '14616426'
      Value: Imaging Technique Diffusion Directionality Type
      Version: '1.00'
  MRImageAcquisitionProtocolElement_magneticFieldStrength:
    Desc: "A vector quantity indicating the ability of a magnetic field to exert a force on moving electric charges. [The American Heritage\xAE Science Dictionary]. The units are of magnetic flux density, e.g. tesla."
    Type: string
    Term:
    - Origin: caDSR
      Code: '14607707'
      Value: Imaging Technique Magnetic Field Strength Number
      Version: '1.00'
  MRImageAcquisitionProtocolElement_resonantNucleusCode:
    Desc: A coded value specifying the atomic nucleus that is the target of the acquisition
    Enum:
    - 1H
    - 3HE
    - 7LI
    - 13C
    - 19F
    - 23NA
    - 31P
    - 129XE
    Term:
    - Origin: caDSR
      Code: '14616427'
      Value: Image Acquisition Resonant Nucleus Type
      Version: '1.00'
  MRImageAcquisitionProtocolElement_acquisitionContrastCode:
    Desc: A coded value specifying the inherent (as opposed to exogenous) contrast in the acquisition.
    Enum:
    - DIFFUSION
    - FLOW_ENCODED_Flow Encoded contrast
    - FLUID_ATTENUATED_Fluid Attenuated T2 weighted contrast
    - PERFUSION_Perfusion weighted contrast
    - PROTON_DENSITY_Proton Density weighted contrast
    - STIR_Short Tau Inversion Recovery
    - TAGGING_Superposition of thin saturation bands onto image
    - T1_T1 weighted contrast
    - T2_T2 weighted contrast
    - T2_STAR_T2* weighted contrast
    - TOF_Time Of Flight weighted contrast
    Term:
    - Origin: caDSR
      Code: '14616428'
      Value: Image Acquisition Contrast Type
      Version: '1.00'
  MRImageAcquisitionProtocolElement_inversionRecoveryIndicator:
    Desc: Specifies whether an inversion recovery preparatory sequence is used in the acquisition.
    Type: string
    Term:
    - Origin: caDSR
      Code: '14607722'
      Value: Image Acquisition Inversion Recovery Indicator
      Version: '1.00'
  MRImageAcquisitionProtocolElement_pulseSequenceName:
    Desc: Name of the pulse sequence that is used for the acquisition. This is usually a vendor-specific name.
    Type: string
    Term:
    - Origin: caDSR
      Code: '14608594'
      Value: Image Acquisition Pulse Sequence Name Text
      Version: '1.00'
  MRImageAcquisitionProtocolElement_multipleSpinEchoIndicator:
    Desc: Specifies whether different lines in k-space are collected for a single frame.
    Type: string
    Term:
    - Origin: caDSR
      Code: '14608595'
      Value: Imaging Technique Multiple Spin Echo Indicator
      Version: '1.00'
  MRImageAcquisitionProtocolElement_phaseContrastIndicator:
    Desc: Specifies whether this is a pulse sequence in which the flowing spins are velocity encoded in phase.
    Type: string
    Term:
    - Origin: caDSR
      Code: '14608601'
      Value: Image Phase Contrast Indicator
      Version: '1.00'
  MRImageAcquisitionProtocolElement_timeOfFlightContrastIndicator:
    Desc: Specifies whether contrast is created by the inflow of blood in the saturated plane.
    Type: string
    Term:
    - Origin: caDSR
      Code: '14608649'
      Value: Imaging Technique Time of Flight Contrast Indicator
      Version: '1.00'
  MRImageAcquisitionProtocolElement_arterialSpinLabelingContrastCode:
    Desc: A coded value specifying how arterial water is used as a diffusable tracer.
    Type: string
    Term:
    - Origin: caDSR
      Code: '14616429'
      Value: Imaging Technique Arterial Spin Labeling Contrast Name
      Version: '1.00'
  MRImageAcquisitionProtocolElement_steadyStatePulseSequenceCode:
    Desc: A coded value specifying how residual transverse magnetization is maintained during the acquisition.
    Enum:
    - FREE PRECESSION
    - TRANSVERSE
    - TIME REVERSED
    - LONGITUDINAL
    - NONE
    Term:
    - Origin: caDSR
      Code: '14616430'
      Value: Image Acquisition Steady State Pulse Sequence Type
      Version: '1.00'
  MRImageAcquisitionProtocolElement_echoPlanarPulseSequenceIndicator:
    Desc: Specifies whether multiple echos of different phase steps are acquired using rephasing gradients instead of repeated 180-degree pulses.
    Type: string
    Term:
    - Origin: caDSR
      Code: '14612651'
      Value: Image Acquisition Echo Planar Pulse Sequence Indicator
      Version: '1.00'
  MRImageAcquisitionProtocolElement_saturationRecoveryIndicator:
    Desc: Specifies whether a saturation recovery pulse sequence is used
    Type: string
    Term:
    - Origin: caDSR
      Code: '14612652'
      Value: Imaging Technique Saturation Recovery Indicator
      Version: '1.00'
  MRImageAcquisitionProtocolElement_spectrallySelectedSuppressionCode:
    Desc: A coded value specifying the type of substance-specific signal suppression is used.
    Enum:
    - FAT
    - WATER
    - FAT AND WATER
    - SILICON GEL
    - NONE
    Term:
    - Origin: caDSR
      Code: '14616431'
      Value: Imaging Technique Spectrally Selected Suppression Type
      Version: '1.00'
  MRImageReconstructionProtocolElement_complexImageComponentCode:
    Desc: A coded value specifying the channel of the quadrature detected data, or the combination derived from those channels, used to reconstruct the image
    Enum:
    - REAL
    - IMAGINARY
    - PHASE
    - MAGNITUDE
    Term:
    - Origin: caDSR
      Code: '14616432'
      Value: Imaging Technique Complex Image Component Type
      Version: '1.00'
  PETImagingAcquisitionProtocolElement_gantryDetectorTilt:
    Desc: Nominal angle of tilt in degrees of the scanning gantry. The units are of plane angle , e.g. degrees.  Zero degrees means the gantry is not tilted, negative degrees are when the top of the gantry is tilted away from where the table enters the gantry.
    Type: string
    Term:
    - Origin: caDSR
      Code: '2656117'
      Value: Image Gantry Detector Tilt 16 Character Number
      Version: '1.00'
  Radiopharmaceutical_radionuclideCode:
    Desc: A coded value that specifies the radioactive isotope in the radiophamaceutical.
    Type: string
    Term:
    - Origin: caDSR
      Code: '14612653'
      Value: Imaging Technique Radionuclide Code Text
      Version: '1.00'
  acquisition_method_type:
    Desc: Records the method of acquisition or source for the specimen under consideration
    Type: string
    Term:
    - Origin: caDSR
      Original Source: MCL/HTAN
      Code: '6626651'
      Value: Biospecimen Acquisition Method Type
      Version: '2.00'
  tumor_tissue_type:
    Desc: Text that describes the kind of disease present in the tumor specimen as related to a specific timepoint (add rows to select multiple values along with timepoints)
    Type: string
    Term:
    - Origin: caDSR
      Original Source: HTAN
      Code: '3288124'
      Value: Tumor Tissue Disease Description Type
      Version: '1.00'
  tissue_fixative:
    Desc: A compound that preserves tissues and cells for microscopic study.
    Req: true
    Enum:
    - Acetone
    - Alcohol
    - Formalin
    - Glutaraldehyde
    - OCT media
    - RNAlater
    - Saline
    - 95% Ethanol
    - Dimidoester
    - Carbodiimide
    - Dimethylacetamide
    - Para-benzoquinone
    - PAXgene tissue
    - TCL lysis buffer
    - NP40 lysis buffer
    - Methacarn
    - Cryo-store
    - Carnoy's Fixative
    - Polaxamer
    - Other
    - None
    - unknown
    Term:
    - Origin: caDSR
      Original Source: NCI Standard
      Code: '65078'
      Value: Specimen Fixative Type
      Version: '4.00'
  embedding_medium:
    Desc: A material that infiltrates and supports a specimen and preserves its shape and structure for sectioning and microscopy.
    Req: true
    Enum:
    - Paraffin wax
    - Carbowax
    - Methacrylate
    - Epoxy Resin (Araldite)
    - Agar embedding
    - Celloidin media
    - Gelatin
    - Other
    - None
    - Unknown
    Term:
    - Origin: caDSR
      Original Source: HTAN
      Code: '8037927'
      Value: Biospecimen Collection Medium Type
      Version: '1.00'
  staining_method:
    Desc: Any of the various methods that use a dye, reagent, or other material for producing coloration in tissues or microorganisms for microscopic examination.
    Req: true
    Type: string
    Term:
    - Origin: caDSR
      Original Source: HTAN
      Code: '7789196'
      Value: Imaging Assay Technology Type
      Version: '1.00'
  objective:
    Desc: "An\_objective\_is an optical element that gathers light from an object being observed and\_focuses\_the\_light rays\_from it to produce a\_real image\_of the object."
    Type: string
    Term:
    - Origin: caDSR
      Code: '7788935'
      Value: Microscope Device Objective Lens Text
      Version: '1.00'
  nominal_magnification:
    Desc: The magnification of the lens as specified by the manufacturer - i.e. '60' is a 60X lens. floating point value > 1(no units)
    Type: string
    Term:
    - Origin: caDSR
      Original Source: HTAN
      Code: '7788940'
      Value: Microscope Device Nominal Magnification Float Value
      Version: '1.00'
  immersion:
    Desc: Immersion medium
    Type: string
    Term:
    - Origin: caDSR
      Original Source: HTAN
      Code: '8058286'
      Value: Microscope Device Immersion Medium Type
      Version: '1.00'
  lens_numerical_aperture:
    Desc: The numerical aperture of the lens. Floating point value > 0.
    Type: string
    Term:
    - Origin: caDSR
      Original Source: HTAN
      Code: '7788942'
      Value: Microscope Device Lens Numerical Aperture Float Value
      Version: '1.00'
  working_distance:
    Desc: The working distance of the lens, expressed as a floating point number. Floating point > 0. Size needs to be specified in microns (um)
    Type: string
    Term:
    - Origin: caDSR
      Original Source: HTAN
      Code: '7788943'
      Value: Microscope Device Working Distance Float Value
      Version: '1.00'
  imaging_assay_type:
    Desc: Type of imaging assay
    Req: true
    Type: string
    Term:
    - Origin: caDSR
      Original Source: HTAN
      Code: '7789196'
      Value: Imaging Assay Technology Type
      Version: '1.00'
  pyramid:
    Desc: The data file contains an image pyramid
    Type: string
    Term:
    - Origin: caDSR
      Original Source: HTAN
      Code: '7788945'
      Value: Image Processing Pyramid Representation True False Indicator
      Version: '1.00'
  physical_size_x:
    Desc: Physical size (X-dimension) of a pixel. Floating point value > 0. Size needs to be specified in microns (um)
    Type: string
    Term:
    - Origin: caDSR
      Original Source: HTAN
      Code: '7786584'
      Value: Image Processing Pyramid Representation True False Indicator
      Version: '1.00'
  physical_size_y:
    Desc: Physical size (Y-dimension) of a pixel. Floating point value > 0. Size needs to be specified in microns (um)
    Type: string
    Term:
    - Origin: caDSR
      Original Source: HTAN
      Code: '7786585'
      Value: Pixel Y-Dimension Float Value
      Version: '1.00'
  physical_size_z:
    Desc: Physical size (Z-dimension) of a pixel. Floating point value > 0. Size needs to be specified in microns (um)
    Type: string
    Term:
    - Origin: caDSR
      Original Source: HTAN
      Code: '7786586'
      Value: Pixel Z-Dimension Float Value
      Version: '1.00'
  size_c:
    Desc: Number of channels. Integer >= 1
    Type: string
    Term:
    - Origin: caDSR
      Code: '7794859'
      Value: OME TIFF Channel Count
      Version: '1.00'
  size_t:
    Desc: Number of time points. Integer >= 1
    Type: string
    Term:
    - Origin: caDSR
      Code: '7794860'
      Value: OME TIFF Timepoint Count
      Version: '1.00'
  size_x:
    Desc: 'Size of image: X dimension (in pixels). Integer >= 1'
    Type: string
    Term:
    - Origin: caDSR
      Code: '7788567'
      Value: OME TIFF X-Dimension Pixel Measurement
      Version: '1.00'
  size_y:
    Desc: 'Size of image: Y dimension (in pixels). Integer >= 1'
    Type: string
    Term:
    - Origin: caDSR
      Code: '7788568'
      Value: OME TIFF Y-Dimension Pixel Measurement
      Version: '1.00'
  size_z:
    Desc: 'Size of image: Z dimension (in pixels). Integer >= 1'
    Type: string
    Term:
    - Origin: caDSR
      Code: '7788569'
      Value: OME TIFF Z-Dimension Pixel Measurement
      Version: '1.00'
  channel_metadata_filename:
    Desc: File name of uploaded companion CSV file containing channel-level metadata details
    Req: true
    Type: string
    Term:
    - Origin: caDSR
      Original Source: HTAN
      Code: '7787678'
      Value: Channel Analysis Metadata Electronic File Name Text
      Version: '1.00'
  channel_metadata_file_url_in_cds:
    Desc: ''
    Req: true
    Type: string
    Term:
    - Origin: caDSR
      Original Source: CDS
      Code: '11556141'
      Value: Electronic File Pathname Text
      Version: '1.00'
  channel_id:
    Desc: The unique channel identifier for each channel in this image must match the corresponding field in the OME-TIFF header
    Req: true
    Type: string
    Term:
    - Origin: caDSR
      Code: Pending
      Version: '1.00'
  channel_name:
    Desc: Channel label for each channel in this image must match the corresponding field in the OME-TIFF header
    Req: true
    Type: string
    Term:
    - Origin: caDSR
      Code: Pending
      Version: '1.00'
  cycle_number:
    Desc: 'the cycle # in which the co-listed reagent(s) was(were) used'
    Type: string
    Term:
    - Origin: caDSR
      Code: Pending
      Version: '1.00'
  sub_cycle_number:
    Desc: 'sub-cycle #'
    Type: string
    Term:
    - Origin: caDSR
      Code: Pending
      Version: '1.00'
  target_name:
    Desc: short descriptive name (abbreviation) for this target (antigen)
    Type: string
    Term:
    - Origin: caDSR
      Code: Pending
      Version: '1.00'
  antibody_name:
    Desc: short descriptive name for this antibody
    Type: string
    Term:
    - Origin: caDSR
      Code: '4588605'
      Value: Tissue Slide IHC Antibody Used Type
      Version: '1.00'
  rrid_identifier:
    Desc: Research Resource Identifier
    Type: string
    Term:
    - Origin: caDSR
      Code: Pending
      Version: '1.00'
  fluorophore:
    Desc: Fluorescent dye label
    Type: string
    Term:
    - Origin: caDSR
      Code: Pending
      Version: '1.00'
  clone:
    Desc: Unique clone identifier
    Type: string
    Term:
    - Origin: caDSR
      Code: Pending
      Version: '1.00'
  lot:
    Desc: lot number from vendor
    Type: string
    Term:
    - Origin: caDSR
      Code: Pending
      Version: '1.00'
  vendor:
    Desc: Vendor name
    Type: string
    Term:
    - Origin: caDSR
      Code: Pending
      Version: '1.00'
  catalog_number:
    Desc: catalog number from vendor
    Type: string
    Term:
    - Origin: caDSR
      Code: Pending
      Version: '1.00'
  excitation_wavelength:
    Desc: center/peak of the excitation spectrum (nm)
    Type: string
    Term:
    - Origin: caDSR
      Code: Pending
      Version: '1.00'
  emission_wavelength:
    Desc: center/peak of the emission spectrum (nm)
    Type: string
    Term:
    - Origin: caDSR
      Code: Pending
      Version: '1.00'
  excitation_bandwidth:
    Desc: nominal width of excitation spectrum (nm)
    Type: string
    Term:
    - Origin: caDSR
      Code: Pending
      Version: '1.00'
  emission_bandwidth:
    Desc: nominal width of emission spectrum (nm)
    Type: string
    Term:
    - Origin: caDSR
      Code: Pending
      Version: '1.00'
  metal_isotope_element:
    Desc: Element mass number
    Type: string
    Term:
    - Origin: caDSR
      Code: Pending
      Version: '1.00'
  oligo_barcode_upper_strand:
    Desc: DNA barcode used for labeling
    Type: string
    Term:
    - Origin: caDSR
      Code: Pending
      Version: '1.00'
  oligo_barcode_lower_strand:
    Desc: DNA barcode used for labeling
    Type: string
    Term:
    - Origin: caDSR
      Code: Pending
      Version: '1.00'
  diluation:
    Desc: Final dilution ratio used in experiment
    Type: string
    Term:
    - Origin: caDSR
      Code: Pending
      Version: '1.00'
  concentration:
    Desc: Final concentration used in experiment
    Type: string
    Term:
    - Origin: caDSR
      Code: Pending
      Version: '1.00'
  passes_qc:
    Desc: Identify stains that did not pass QC but are included in the dataset.
    Type: string
    Term:
    - Origin: caDSR
      Code: Pending
      Version: '1.00'
  # file
  checksum_value:
    Desc: checksum (hash) for file (using checksum_algorithm) - if you want to use a checksum other than md5
    Type: string
  checksum_algorithm:
    Desc: The method by which the file checksum was calculated.
    Type: string
  file_mapping_level:
    Desc: Describes if the file belongs to a Participant, a Sample, or a Study
    Enum:
    - Participiant
    - Sample
    - Study
  submission_version:
    Desc: The version of the metadata file submitted to CDS
    Type: string
    Req: true
  file_id:
    Desc: File identifier
    Type: string
    Req: true
    Key: true
  file_url_in_cds:
    Desc: Location of the file on the CDS cloud, using AWS S3 protocol
    Type: string
    Req: Preferred
    Term:
    - Origin: caDSR
      Original Source: CDS
      Code: '11556141'
      Value: Electronic File Pathname Text
      Version: '1.00'
  file_description:
    Desc: Human-readable description of file
    Type: string
    Term:
    - Origin: caDSR
      Original Source: DSS
      Code: '11280338'
      Value: Electronic Data File Description Text
      Version: '1.00'
  file_name:
    Desc: Name of file
    Type: string
    Req: true
    Term:
    - Origin: caDSR
      Original Source: DSS
      Code: '11284037'
      Value: Electronic Data File Name
      Version: '1.00'
  file_size:
    Desc: File size in bytes
    Type: integer
    Req: false
    Term:
    - Origin: caDSR
      Original Source: DSS
      Code: '11479876'
      Value: Electronic Data File Size Integer
      Version: '1.00'
  file_type:
    Desc: File type from enumerated list
    Enum:
    - BAI
    - BAM
    - BW
    - CRAI
    - CRAM
    - FASTQ
    - HTML
    - IDAT
    - JSON
    - MAF
    - PDF
    - TSV
    - TXT
    - VCF
    - XLSX
    - NIFTI
    - PED
    - BED
    - SEG
    - TAR
    - CSV
    - GVCF
    - TIFF
    - PNG
    - CNS
    - SVG
    - DICT
    Req: true
    Term:
    - Origin: caDSR
      Original Source: DSS
      Code: '11416926'
      Value: Electronic Data File Format Type
      Version: '1.00'
  file_access:
    Desc: File access
    Enum:
    - Open
    - Controlled
    - Not specified in data
  md5sum:
    Desc: MD5 hex digest for this file
    Type:
      pattern: ^[0-9a-fA-F]{32}$
    Req: true
  experimental_strategy_and_data_subtypes:
    Desc: 'What is the experimental strategy used for the study (or what

      type of data subtypes exist in the study)?

      '
    Req: 'Yes'
    Type:
      value_type: list
      item_type: string
      Enum:
      - Amplicon
      - Archer Fusion
      - Bisulfite-Seq
      - Methylation Array
      - OTHER
      - RNA-Seq
      - Targeted Sequencing
      - Targeted-Capture
      - WGA
      - WGS
      - WXS
      - DNA-Seq
      - Pathological
      - Radiological
      - scRNA-Seq
      - Not specified in data
  # participant
  ethnicity:
    Desc: OMB Ethinicity designator
    Enum:
    - Hispanic or Latino
    - Not Hispanic or Latino
    - Unknown
    - Not Reported
    - Not Allowed to Collect
    Req: Preferred
    Term:
    - Origin: caDSR
      Original Source: NCI Std
      Code: '2192217'
      Value: Ethnic Group Category Text
      Version: '2.00'
  gender:
    Desc: Biological gender at birth
    Enum:
    - Female
    - Male
    - Unknown
    - Unspecified
    - Not Reported
    - Not specified in data
    Req: true
    Term:
    - Origin: caDSR
      Original Source: NCI Std
      Code: '2200604'
      Value: Person Gender Text Type
      Version: '3.00'
  race:
    Desc: OMB Race designator
    Enum:
    - White
    - American Indian or Alaska Native
    - Black or African American
    - Asian
    - Native Hawaiian or Other Pacific Islander
    - Unknown
    - Not Reported
    - Not Allowed to Collect
    Req: Preferred
    Term:
    - Origin: caDSR
      Original Source: NCI Std
      Code: '2192199'
      Value: Race Category Text
      Version: '1.00'
  participant_id:
    Desc: 'A number or a string that may contain metadata information, for a participant

      who has taken part in the investigation or study.

      '
    Type: string
    Req: true
    Term:
    - Origin: caDSR
      Original Source: CDS
      Code: '12220014'
      Value: Subject Data Origin Identifier
      Version: '1.00'
  study_participant_id:
    Desc: 'The property study_participant_id is a compound property, combining the property participant_id and the parent property study.phs_accession.

      It is the ID property for the node participant. The reason why we are doing that is because is some cases, there are same participant id in different studies repersent different participants.

      '
    Type: string
    Req: true
    Key: true
  vital_status:
    Desc: Vital status as of last known follow up
    Enum:
    - Alive
    - Dead
    - Unknown
    - Not Reported
    Term:
    - Origin: caDSR
      Original Source: NCI Std
      Code: '2847330'
      Value: Participant Vital Status Type
      Version: '1.00'
  dbGaP_subject_id:
    Desc: Identifier for the participant as assigned by dbGaP
    Type: string
    Req: Preferred
    Term:
    - Origin: caDSR
      Original Source: CDS
      Code: '11524544'
      Value: Research Activity dbGaP Accession Number Identifier
      Version: '1.00'
  # diagnosis
  tissue_or_organ_of_origin:
    Desc: The text term used to describe the anatomic site of origin, of the patient's malignant disease, as described by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O).
    Enum:
    - Abdomen
    - Abdominal Esophagus
    - Adrenal Cortex
    - Adrenal Gland
    - Adrenal Medulla
    - Ampulla of Vater
    - Anal Canal
    - Anal Transitional Zone
    - Anterior Mediastinum
    - Anterior Surface of the Epiglottis
    - Anterior Wall of the Bladder
    - Anterior Wall of the Nasopharynx
    - Antrum Pylori
    - Anus
    - Appendage of the Uterus
    - Appendix
    - Ascending Colon
    - Autonomic Nervous System
    - Axillary Lymph Node
    - Axillary Tail of the Breast
    - Base of the Tongue
    - Biliary Tract
    - Bladder Neck
    - Bladder Trigone
    - Bladder
    - Blood
    - Body of Stomach
    - Body of the Pancreas
    - Body of the Penis
    - Bone Marrow
    - Bone of the Extremity
    - Bone
    - Brain Stem
    - Brain Ventricle
    - Brain
    - Branchial Cleft Remnant
    - Breast
    - Broad Ligament
    - Buccal Mucosa
    - Carotid Body
    - Cauda Equina
    - Cecum
    - Central Portion of the Breast
    - Cerebellum
    - Cerebral Hemisphere
    - Cerebral Meninges
    - Cervical Esophagus
    - Cervix Uteri
    - Choroid
    - Ciliary Body
    - Clitoris
    - Cochlear Nerve
    - Colon
    - Commissure of the Lip
    - Conjunctiva
    - Cornea
    - Corpus Uteri
    - Cranial Nerve
    - Craniopharyngeal Duct
    - Descending Colon
    - Dome of the Bladder
    - Duodenum
    - Ectocervix
    - Endocervix
    - Endocrine Gland
    - Endometrium
    - Epididymis
    - Esophagus
    - Ethmoid Sinus
    - External Ear
    - External Lip
    - External Lower Lip
    - External Upper Lip
    - Extrahepatic Bile Duct
    - Eyelid
    - Eye
    - Fallopian Tube
    - Female Genitalia
    - Floor of Mouth
    - Frontal Lobe
    - Frontal Sinus
    - Fundus of the Stomach
    - Fundus Uteri
    - Gallbladder
    - Gastric Cardia
    - Gastrointestinal Tract
    - Gingiva
    - Glans Penis
    - Glottis
    - Greater Curvature of the Stomach
    - Hard Palate
    - Head and Neck Lymph Node
    - Head of the Pancreas
    - Heart
    - Hematopoietic System
    - Hepatic Flexure
    - Hypopharynx
    - Ileum
    - Ill-Defined Anatomic Site
    - Intestine
    - Intra-Abdominal Lymph Node
    - Intrahepatic Bile Duct
    - Intrathoracic Lymph Node
    - Islet of Langerhans
    - Isthmus Uteri
    - Jejunum
    - Kidney
    - Labium Majus
    - Labium Minus
    - Lacrimal Gland
    - Laryngeal Cartilage
    - Larynx
    - Lateral Wall of the Bladder
    - Lateral Wall of the Nasopharynx
    - Lateral Wall of the Oropharynx
    - Lesser Curvature of the Stomach
    - Lingual Tonsil
    - Lip
    - Liver
    - Lower Extremity
    - Lower Gingiva
    - Lower Lobe of the Lung
    - Lower Third of the Esophagus
    - Lower-Inner Quadrant of the Breast
    - Lower-Outer Quadrant of the Breast
    - Lung
    - Lymph Node of Inguinal Region or Leg
    - Lymph Node
    - Main Bronchus
    - Male Genitalia
    - Mandible
    - Maxillary Sinus
    - Meckel Diverticulum
    - Mediastinum
    - Meninges
    - Middle Ear
    - Middle Lobe of the Right Lung
    - Middle Third of the Esophagus
    - Mucosa of the Lip
    - Mucosa of the Lower Lip
    - Mucosa of the Upper Lip
    - Myometrium
    - Nasal Cavity
    - Nasopharynx
    - Nervous System
    - Nipple
    - Not Reported
    - Occipital Lobe
    - Olfactory Nerve
    - Optic Nerve
    - Oral Cavity
    - Orbit
    - Oropharynx
    - Other and Ill-Defined Sites within Respiratory System and Intrathoracic Organs ICD-O-3
    - Other and Unspecified Female Genital Organs ICD-O-3
    - Other and Unspecified Male Genital Organs ICD-O-3
    - Other Specified Parts of Pancreas
    - Ovary
    - Palate
    - Palatine Tonsil
    - Pancreas
    - Pancreatic Duct
    - Parametrium
    - Paranasal Sinus
    - Parathyroid Gland
    - Parietal Lobe
    - Parotid Gland
    - Pelvic Lymph Node
    - Pelvis
    - Penis
    - Peritoneum
    - Pharynx
    - Pineal Gland
    - Pituitary Gland
    - Placenta
    - Pleura
    - Postcricoid Region
    - Posterior Mediastinum
    - Posterior Wall of the Bladder
    - Posterior Wall of the Hypopharynx
    - Posterior Wall of the Nasopharynx
    - Posterior Wall of the Oropharynx
    - Prepuce
    - Primary Site Unknown
    - Prostate Gland
    - Pylorus
    - Pyriform Sinus
    - Rectosigmoid Region
    - Rectum
    - Renal Pelvis
    - Reticuloendothelial System
    - Retina
    - Retromolar Trigone
    - Retroperitoneum
    - Round Ligament
    - Salivary Gland
    - Scrotum
    - Sigmoid Colon
    - Skene Gland
    - Skin of the Face
    - Skin of the Lip
    - Skin of the Lower Limb and Hip
    - Skin of the Scalp and Neck
    - Skin of the Trunk
    - Skin of the Upper Limb and Shoulder
    - Skin
    - Small Intestine
    - Soft Palate
    - Spermatic Cord
    - Sphenoid Sinus
    - Spinal Cord
    - Spinal Meninges
    - Spleen
    - Splenic Flexure
    - Stomach
    - Subglottis
    - Sublingual Salivary Gland
    - Submandibular Gland
    - Superior Wall of the Nasopharynx
    - Supraglottis
    - Tail of the Pancreas
    - Temporal Lobe
    - Testis
    - Thoracic Esophagus
    - Thorax
    - Thymus Gland
    - Thyroid Gland
    - Tongue
    - Tonsillar Fossa
    - Tonsillar Pillar
    - Trachea
    - Transverse Colon
    - Undescended Testes
    - Unknown
    - Upper Extremity
    - Upper Gingiva
    - Upper Lobe of the Lung
    - Upper Respiratory System
    - Upper Third of the Esophagus
    - Upper-Inner Quadrant of the Breast
    - Upper-Outer Quadrant of the Breast
    - Urachus
    - Ureteric Orifice
    - Ureter
    - Urethra
    - Urinary System
    - Uterus
    - Uvula
    - Vagina
    - Vallecula
    - Vertebral Column
    - Vestibule of Mouth
    - Vulva
    - Waldeyer Ring
    - Abdominal Aorta
    - Abdominal Muscle
    - Abdominal Skin
    - Abdominal Wall
    - Abducens Nerve
    - Accessory Nerve
    - Acetabulum
    - Acromioclavicular Joint
    - Adipose Tissue
    - Ankle Joint
    - Ankle Skin
    - Antecubital Region
    - Anterior Cranial Fossa
    - Aorta
    - Aortocaval Lymph Node
    - Apex of the Tongue
    - Aponeurosis
    - Areola
    - Arm Skin
    - Artery
    - Articular Cartilage
    - Aryepiglottic Fold
    - Arytenoid Cartilage
    - Axilla
    - Axillary Artery
    - Back
    - Bartholin Gland
    - Basal Ganglia
    - Biceps
    - Biceps Femoris
    - Bile Canaliculus
    - Bile Duct
    - Blood Vessel
    - Brachial Lymph Node
    - Brachial Plexus
    - Brachialis
    - Brain Dura Mater
    - Bronchial Lymph Node
    - Bronchiole
    - Bronchus
    - Buttock
    - C1 Vertebra
    - C2 Vertebra
    - Calcaneum
    - Calf
    - Cardiac Atrium
    - Cardiac Ventricle
    - Carina
    - Carotid Artery
    - Carpal Bone
    - Carpal Region
    - Cartilage
    - Celiac Artery
    - Celiac Lymph Node
    - Central Nervous System
    - Cerebellopontine Angle
    - Cerebral Cortex
    - Cerebral Peduncle
    - Cerebral White Matter
    - Ceruminous Gland
    - Cervical Gland
    - Cervical Lymph Node
    - Cheek
    - Chest
    - Chest Wall
    - Choroid Plexus
    - Choroid Plexus of the Fourth Ventricle
    - Choroid Plexus of the Lateral Ventricle
    - Choroid Plexus of the Third Ventricle
    - Coccyx
    - Common Bile Duct
    - Concha
    - Connective Tissue
    - Conus Medullaris
    - Coracobrachialis
    - Corneoscleral Limbus
    - Corpus Callosum
    - Corpus Striatum
    - Costal Cartilage
    - Costovertebral Joint
    - Cowper Gland
    - Cricoid Cartilage
    - Cul-de-sac
    - Cuneiform Cartilage
    - Cystic Duct
    - Diaphragm
    - Diaphragmatic Lymph Node
    - Duct of Gartner
    - Ductus Santorini
    - Dura Mater
    - Ear
    - Ear Skin
    - Elbow Joint
    - Elbow Skin
    - Endocardium
    - Endometrial Stroma
    - Ependyma
    - Epicardium
    - Epidural Spinal Canal Space
    - Epiglottis
    - Epitrochlear Lymph Node
    - Ethmoid Bone
    - Eustachian Tube
    - External Acoustic Meatus
    - External Nose
    - Eyebrow
    - Facial Bone
    - Facial Nerve
    - False Vocal Cord
    - Falx Cerebelli
    - Falx Cerebri
    - Fascia
    - Femoral Artery
    - Femoral Lymph Node
    - Femoral Nerve
    - Femur
    - Fibrous Tissue
    - Fibula
    - Finger
    - Fingernail
    - Flank
    - Foot
    - Foot Bone
    - Foot Phalanx
    - Foot Skin
    - Forearm
    - Forehead
    - Fourth Ventricle
    - Frontal Bone
    - Frontal Pole
    - Gastric Lymph Node
    - Gastrocnemius Muscle
    - Gastroesophageal Junction
    - Gland of Littre
    - Globus Pallidus
    - Glossopharyngeal Nerve
    - Gluteus Maximus
    - Hand
    - Hand Digit 1
    - Hand Phalanx
    - Hand Skin
    - Head Skin
    - Helix
    - Hepatic
    - Hepatic Duct
    - Hepatic Lymph Node
    - Hip
    - Hip Joint
    - Hippocampus
    - Humerus
    - Hymen
    - Hyoid Bone
    - Hypoglossal Nerve
    - Hypothalamus
    - Ileocecal Valve
    - Iliac Artery
    - Iliac Lymph Node
    - Iliac Vein
    - Iliopsoas Muscle
    - Ilium
    - Inferior Vena Cava
    - Infraclavicular Lymph Node
    - Infraclavicular Region
    - Infratentorial Brain
    - Inguinal Lymph Node
    - Inguinal Region
    - Inner Canthus
    - Inner Ear
    - Intercostal Lymph Node
    - Intercostal Muscle
    - Intercostal Nerve
    - Internal Capsule
    - Internal Iliac Lymph Node
    - Internal Mammary Artery
    - Internal Mammary Lymph Node
    - Internal Nare
    - Intervertebral Disc
    - Intraocular Route of Administration
    - Iris
    - Ischiorectal Fossa
    - Ischium
    - Jaw Bone
    - Jaw Joint
    - Joint
    - Knee Joint
    - Knee Skin
    - Labium
    - Lacrimal Sac
    - Large Intestine
    - Lateral Ventricle
    - Lateral Wall of the Pharynx
    - Leg Skin
    - Lens
    - Ligament
    - Lingula of the Lung
    - Lobule of the Auricle
    - Lumbar Nerve
    - Lumbosacral Plexus
    - Lymphatic
    - Male Prepuce
    - Mammary Gland
    - Masseter Muscle
    - Maxilla
    - Median Nerve
    - Mediastinal Lymph Node
    - Medulla Oblongata
    - Meibomian Gland
    - Meniscus Lateralis
    - Meniscus Medialis
    - Mentum
    - Mesencephalon
    - Mesenteric Artery
    - Mesenteric Lymph Node
    - Mesentery
    - Mesonephric Duct
    - Mesonephros
    - Mesovarium
    - Metacarpal Bone
    - Metatarsal Bone
    - Middle Cranial Fossa
    - Minor Salivary Gland
    - Mons Pubis
    - Muscle
    - Musculus Latissimus Dorsi
    - Myocardium
    - Nasal Bone
    - Nasal Cartilage
    - Nasal Septum
    - Nasal Turbinate
    - Nasolacrimal Duct
    - Neck Skin
    - Nerve
    - Nose
    - Nostril
    - Obturator Lymph Node
    - Obturator Nerve
    - Occipital Bone
    - Occipital Lymph Node
    - Oculomotor Muscle
    - Oculomotor Nerve
    - Omentum
    - Optic Chiasm
    - Optic Tract
    - Outer Canthus
    - Palmar Fascia
    - Pancreatic Lymph Node
    - Paraaortic Lymph Node
    - Paraganglion
    - Parasympathetic Nervous System
    - Paratracheal Lymph Node
    - Parietal Bone
    - Parietal Pleura
    - Parotid Duct
    - Parotid Gland Lymph Node
    - Patella
    - Pectoral Lymph Node
    - Pectoralis Major
    - Pericardium
    - Perineum
    - Peripheral Nerve
    - Peritoneal Cavity
    - Pharyngeal Tonsil
    - Pia Mater
    - Plantar Fascia
    - Plantar Region
    - Pons Varolii
    - Popliteal Lymph Node
    - Portal Lymph Node
    - Posterior Cranial Fossa
    - Posterior Wall of the Pharynx
    - Preauricular Lymph Node
    - Prostatic Utricle
    - Psoas Muscle
    - Pubic Bone
    - Pubic Symphysis
    - Pulmonary
    - Pulmonary Hilar Lymph Node
    - Putamen
    - Quadriceps Muscle of the Thigh
    - Radial Artery
    - Radial Nerve
    - Radius Bone
    - Rathke Pouch
    - Rectosigmoid Colon
    - Rectus Abdominis
    - Renal
    - Renal Artery
    - Renal Calyx
    - Retroperitoneal Lymph Node
    - Retropharyngeal Lymph Node
    - Round Ligament of the Uterus
    - Sacral Bone
    - Sacral Lymph Node
    - Sacral Nerve
    - Sacral Plexus
    - Scalene Lymph Node
    - Scalp
    - Scapula
    - Sciatic Nerve
    - Sclera
    - Sella Turcica
    - Seminal Vesicle
    - Shoulder
    - Shoulder Girdle
    - Shoulder Joint
    - Skeletal Muscle Tissue
    - Skin Of The Axilla
    - Skull
    - Skullcap
    - Sphenoid Bone
    - Sphincter of Oddi
    - Spinal Cord Dura Mater
    - Spinal Nerve
    - Splenic Hilar Lymph Node
    - Sternocleidomastoid Muscle
    - Sternocostal Joint
    - Subclavian Artery
    - Subcutis
    - Sublingual Lymph Node
    - Submandibular Duct
    - Submandibular Lymph Node
    - Superior Vena Cava
    - Supraclavicular
    - Supraclavicular Lymph Node
    - Suprasellar Region
    - Supratentorial Brain
    - Sympathetic Nervous System
    - Synovial Bursa
    - Synovial Fluid
    - Tarsal Bone
    - Temporal Bone
    - Tendon
    - Tendon Sheath
    - Tentorium Cerebelli
    - Thalamus
    - Thigh
    - Third Ventricle
    - Thoracic Duct
    - Thoracic Lymph Node
    - Thyroglossal Duct
    - Thyroid Cartilage
    - Tibia
    - Toe
    - Toenail
    - Tooth Socket
    - Tracheobronchial Lymph Node
    - Tragus
    - Trapezius Muscle
    - Triceps Brachii
    - Trigeminal Nerve
    - Trochlear Nerve
    - True Vocal Cord
    - Trunk
    - Tunica Vaginalis
    - Ulna
    - Ulnar Artery
    - Ulnar Nerve
    - Umbilicus
    - Uncus
    - Ureteropelvic Junction
    - Uterine Gland
    - Uterine Ligament
    - Uvea
    - Vaginal Fornix
    - Vagus Nerve
    - Vas Deferens
    - Vein
    - Vena Cava
    - Vermis
    - Vertebra
    - Visceral Pleura
    - Vocal Cord
    - Waldeyer's Tonsillar Ring
    - Wall of the Pharynx
    - Wrist Joint
    - Wrist Skin
  site_of_resection_or_biopsy:
    Desc: The organ or part of the body resected or biopsied, as described by the topography codes of the International Classification of Diseases for Oncology, 3rd Edition (ICD-O-3).
    Enum:
    - Abdomen, NOS
    - Abdominal esophagus
    - Accessory sinus, NOS
    - Acoustic nerve
    - Adrenal gland, NOS
    - Ampulla of Vater
    - Anal canal
    - Anterior 2/3 of tongue, NOS
    - Anterior floor of mouth
    - Anterior mediastinum
    - Anterior surface of epiglottis
    - Anterior wall of bladder
    - Anterior wall of nasopharynx
    - Anus, NOS
    - Aortic body and other paraganglia
    - Appendix
    - Ascending colon
    - Autonomic nervous system, NOS
    - Axillary tail of breast
    - Base of tongue, NOS
    - Bladder neck
    - Bladder, NOS
    - Blood
    - Body of pancreas
    - Body of penis
    - Body of stomach
    - Bone marrow
    - Bone of limb, NOS
    - Bone, NOS
    - Bones of skull and face and associated joints
    - Border of tongue
    - Brain stem
    - Brain, NOS
    - Branchial cleft
    - Breast, NOS
    - Broad ligament
    - Cardia, NOS
    - Carotid body
    - Cauda equina
    - Cecum
    - Central portion of breast
    - Cerebellum, NOS
    - Cerebral meninges
    - Cerebrum
    - Cervical esophagus
    - Cervix uteri
    - Choroid
    - Ciliary body
    - Cloacogenic zone
    - Colon, NOS
    - Commissure of lip
    - Conjunctiva
    - Connective, subcutaneous and other soft tissues of abdomen
    - Connective, subcutaneous and other soft tissues of head, face, and neck
    - Connective, subcutaneous and other soft tissues of lower limb and hip
    - Connective, subcutaneous and other soft tissues of pelvis
    - Connective, subcutaneous and other soft tissues of thorax
    - Connective, subcutaneous and other soft tissues of trunk, NOS
    - Connective, subcutaneous and other soft tissues of upper limb and shoulder
    - Connective, subcutaneous and other soft tissues, NOS
    - Cornea, NOS
    - Corpus uteri
    - Cortex of adrenal gland
    - Cranial nerve, NOS
    - Craniopharyngeal duct
    - Descended testis
    - Descending colon
    - Dome of bladder
    - Dorsal surface of tongue, NOS
    - Duodenum
    - Endocervix
    - Endocrine gland, NOS
    - Endometrium
    - Epididymis
    - Esophagus, NOS
    - Ethmoid sinus
    - Exocervix
    - External ear
    - External lip, NOS
    - External lower lip
    - External upper lip
    - Extrahepatic bile duct
    - Eye, NOS
    - Eyelid
    - Fallopian tube
    - Female genital tract, NOS
    - Floor of mouth, NOS
    - Frontal lobe
    - Frontal sinus
    - Fundus of stomach
    - Fundus uteri
    - Gallbladder
    - Gastric antrum
    - Gastrointestinal tract, NOS
    - Glans penis
    - Glottis
    - Greater curvature of stomach, NOS
    - Gum, NOS
    - Hard palate
    - Head of pancreas
    - Head, face or neck, NOS
    - Heart
    - Hematopoietic system, NOS
    - Hepatic flexure of colon
    - Hypopharyngeal aspect of aryepiglottic fold
    - Hypopharynx, NOS
    - Ileum
    - Ill-defined sites within respiratory system
    - Intestinal tract, NOS
    - Intra-abdominal lymph nodes
    - Intrahepatic bile duct
    - Intrathoracic lymph nodes
    - Islets of Langerhans
    - Isthmus uteri
    - Jejunum
    - Kidney, NOS
    - Labium majus
    - Labium minus
    - Lacrimal gland
    - Laryngeal cartilage
    - Larynx, NOS
    - Lateral floor of mouth
    - Lateral wall of bladder
    - Lateral wall of nasopharynx
    - Lateral wall of oropharynx
    - Lesser curvature of stomach, NOS
    - Lingual tonsil
    - Lip, NOS
    - Liver
    - Long bones of lower limb and associated joints
    - Long bones of upper limb, scapula and associated joints
    - Lower gum
    - Lower limb, NOS
    - Lower lobe, lung
    - Lower third of esophagus
    - Lower-inner quadrant of breast
    - Lower-outer quadrant of breast
    - Lung, NOS
    - Lymph node, NOS
    - Lymph nodes of axilla or arm
    - Lymph nodes of head, face and neck
    - Lymph nodes of inguinal region or leg
    - Lymph nodes of multiple regions
    - Main bronchus
    - Major salivary gland, NOS
    - Male genital organs, NOS
    - Mandible
    - Maxillary sinus
    - Meckel diverticulum
    - Mediastinum, NOS
    - Medulla of adrenal gland
    - Meninges, NOS
    - Middle ear
    - Middle lobe, lung
    - Middle third of esophagus
    - Mouth, NOS
    - Mucosa of lip, NOS
    - Mucosa of lower lip
    - Mucosa of upper lip
    - Myometrium
    - Nasal cavity
    - Nasopharynx, NOS
    - Nervous system, NOS
    - Nipple
    - Occipital lobe
    - Olfactory nerve
    - Optic nerve
    - Orbit, NOS
    - Oropharynx, NOS
    - Other ill-defined sites
    - Other specified parts of female genital organs
    - Other specified parts of male genital organs
    - Other specified parts of pancreas
    - Ovary
    - Overlapping lesion of accessory sinuses
    - Overlapping lesion of bladder
    - Overlapping lesion of bones, joints and articular cartilage
    - Overlapping lesion of bones, joints and articular cartilage of limbs
    - Overlapping lesion of brain
    - Overlapping lesion of brain and central nervous system
    - Overlapping lesion of breast
    - Overlapping lesion of cervix uteri
    - Overlapping lesion of colon
    - Overlapping lesion of connective, subcutaneous and other soft tissues
    - Overlapping lesion of corpus uteri
    - Overlapping lesion of digestive system
    - Overlapping lesion of endocrine glands and related structures
    - Overlapping lesion of esophagus
    - Overlapping lesion of eye and adnexa
    - Overlapping lesion of female genital organs
    - Overlapping lesion of floor of mouth
    - Overlapping lesion of heart, mediastinum and pleura
    - Overlapping lesion of hypopharynx
    - Overlapping lesion of ill-defined sites
    - Overlapping lesion of larynx
    - Overlapping lesion of lip
    - Overlapping lesion of lip, oral cavity and pharynx
    - Overlapping lesion of lung
    - Overlapping lesion of major salivary glands
    - Overlapping lesion of male genital organs
    - Overlapping lesion of nasopharynx
    - Overlapping lesion of other and unspecified parts of mouth
    - Overlapping lesion of palate
    - Overlapping lesion of pancreas
    - Overlapping lesion of penis
    - Overlapping lesion of peripheral nerves and autonomic nervous system
    - Overlapping lesion of rectum, anus and anal canal
    - Overlapping lesion of respiratory system and intrathoracic organs
    - Overlapping lesion of retroperitoneum and peritoneum
    - Overlapping lesion of skin
    - Overlapping lesion of small intestine
    - Overlapping lesion of stomach
    - Overlapping lesion of tongue
    - Overlapping lesion of tonsil
    - Overlapping lesion of urinary organs
    - Overlapping lesion of vulva
    - Overlapping lesions of oropharynx
    - Palate, NOS
    - Pancreas, NOS
    - Pancreatic duct
    - Parametrium
    - Parathyroid gland
    - Paraurethral gland
    - Parietal lobe
    - Parotid gland
    - Pelvic bones, sacrum, coccyx and associated joints
    - Pelvic lymph nodes
    - Pelvis, NOS
    - Penis, NOS
    - Peripheral nerves and autonomic nervous system of abdomen
    - Peripheral nerves and autonomic nervous system of head, face, and neck
    - Peripheral nerves and autonomic nervous system of lower limb and hip
    - Peripheral nerves and autonomic nervous system of pelvis
    - Peripheral nerves and autonomic nervous system of thorax
    - Peripheral nerves and autonomic nervous system of trunk, NOS
    - Peripheral nerves and autonomic nervous system of upper limb and shoulder
    - Peritoneum, NOS
    - Pharynx, NOS
    - Pineal gland
    - Pituitary gland
    - Placenta
    - Pleura, NOS
    - Postcricoid region
    - Posterior mediastinum
    - Posterior wall of bladder
    - Posterior wall of hypopharynx
    - Posterior wall of nasopharynx
    - Posterior wall of oropharynx
    - Prepuce
    - Prostate gland
    - Pylorus
    - Pyriform sinus
    - Rectosigmoid junction
    - Rectum, NOS
    - Renal pelvis
    - Reticuloendothelial system, NOS
    - Retina
    - Retromolar area
    - Retroperitoneum
    - Rib, sternum, clavicle and associated joints
    - Round ligament
    - Scrotum, NOS
    - Short bones of lower limb and associated joints
    - Short bones of upper limb and associated joints
    - Sigmoid colon
    - Skin of lip, NOS
    - Skin of lower limb and hip
    - Skin of other and unspecified parts of face
    - Skin of scalp and neck
    - Skin of trunk
    - Skin of upper limb and shoulder
    - Skin, NOS
    - Small intestine, NOS
    - Soft palate, NOS
    - Specified parts of peritoneum
    - Spermatic cord
    - Sphenoid sinus
    - Spinal cord
    - Spinal meninges
    - Spleen
    - Splenic flexure of colon
    - Stomach, NOS
    - Subglottis
    - Sublingual gland
    - Submandibular gland
    - Superior wall of nasopharynx
    - Supraglottis
    - Tail of pancreas
    - Temporal lobe
    - Testis, NOS
    - Thoracic esophagus
    - Thorax, NOS
    - Thymus
    - Thyroid gland
    - Tongue, NOS
    - Tonsil, NOS
    - Tonsillar fossa
    - Tonsillar pillar
    - Trachea
    - Transverse colon
    - Trigone of bladder
    - Undescended testis
    - Unknown primary site
    - Upper gum
    - Upper limb, NOS
    - Upper lobe, lung
    - Upper respiratory tract, NOS
    - Upper third of esophagus
    - Upper-inner quadrant of breast
    - Upper-outer quadrant of breast
    - Urachus
    - Ureter
    - Ureteric orifice
    - Urethra
    - Urinary system, NOS
    - Uterine adnexa
    - Uterus, NOS
    - Uvula
    - Vagina, NOS
    - Vallecula
    - Ventral surface of tongue, NOS
    - Ventricle, NOS
    - Vertebral column
    - Vestibule of mouth
    - Vulva, NOS
    - Waldeyer ring
    - Biliary tract, NOS
    - Cheek mucosa
    - Clitoris
    - Overlapping lesion of biliary tract
    - Unknown
    - Not Reported
  days_to_last_known_disease_status:
    Desc: The number of days from the date of the initial cancer diagnosis to the date of last known disease status.
    Type: number
  diagnosis_id:
    Desc: Internal identifier
    Type: string
  study_diagnosis_id:
    Desc: The property study_diagnosis_id is a compound property, combining the property diagnosis_id and the parent property participant.study_participant_id. It is the ID property for the node diagnosis.
    Type: string
    Req: true
    Key: true
  disease_type:
    Desc: Type of disease [?]
    Enum:
    - Acinar Cell Neoplasm
    - Basal Cell Neoplasm
    - Blood Vessel Neoplasm
    - Bone Neoplasm
    - Complex Epithelial Neoplasm
    - Epithelial Neoplasm
    - Fibroepithelial Neoplasm
    - Germ Cell Tumor
    - Giant Cell Tumor
    - Glioma
    - Hodgkin Lymphoma
    - Leukemia
    - Lipomatous Neoplasm
    - Lymphatic Vessel Neoplasm
    - Lymphoblastic Lymphoma
    - Lymphoid Leukemia
    - Lymphoma
    - Mast Cell Neoplasm
    - Mature B-Cell Non-Hodgkin Lymphoma
    - Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
    - Meningioma
    - Mesothelial Neoplasm
    - Myelodysplastic Syndrome
    - Myeloid Leukemia
    - Myeloproliferative Neoplasm
    - Myomatous Neoplasm
    - Neoplasm
    - Nerve Sheath Neoplasm
    - Neuroepithelial Neoplasm
    - Not Applicable
    - Not Reported
    - Odontogenic Neoplasm
    - Plasma Cell Neoplasm
    - Skin Appendage Neoplasm
    - Squamous Cell Neoplasm
    - Thymoma
    - Trophoblastic Tumor
    - Unknown
    - Wolffian Tumor
    - Carcinoma NOS
    - Melanoma
    - Adenocarcinoma
    Term:
    - Origin: caDSR
      Original Source: CDS
      Code: '13471160'
      Value: Diagnosis Disease or Disorder Morphology Disease
      Version: '1.00'
  age_at_diagnosis:
    Desc: Participant age at relevant diagnosis
    Type: integer
    Term:
    - Origin: caDSR
      Original Source: DSS
      Code: '10609539'
      Value: Subject Age at Diagnosis Integer
      Version: '1.00'
  days_to_last_known_status:
    Desc: Days to last known status of participant, relative to study index date
    Type: integer
  days_to_last_followup:
    Desc: Days to last participant followup, relative to study index date
    Type: integer
    Term:
    - Origin: caDSR
      Original Source: CDS
      Code: '12426616'
      Value: Subject Initial Cancer Diagnosis To Last Followup Day Count
      Version: '1.00'
  days_to_recurrence:
    Desc: Days to disease recurrence, relative to study index date
    Type: integer
    Term:
    - Origin: caDSR
      Original Source: CDS
      Code: '12432576'
      Value: Subject First Treatment Date To Recurrence Day Count
      Version: '1.00'
  incidence_type:
    Desc: For this diagnosis, disease incidence relative to prior status of subject
    Enum:
    - primary
    - progression
    - recurrence
    - metastasis
    - remission
    - no_disease
  last_known_disease_status:
    Desc: Last known disease incidence for this subject and diagnosis
    Enum:
    - Primary
    - Progression
    - Recurrence
    - Metastasis
    - Remission
    - No_disease
    - Distant met recurrence/progression
    - Loco-regional recurrence/progression
    - Biochemical evidence of disease without structural correlate
    - Tumor free
    Term:
    - Origin: caDSR
      Original Source: DSS
      Code: '12447172'
      Value: Subject Last Known Disease Status
      Version: '1.00'
  primary_diagnosis:
    Desc: Primary disease diagnosed for this diagnosis and subject
    Enum:
    - 4th Ventricular Brain Tumor
    - Acinar Cell Carcinoma
    - Acute megakaryoblastic leukaemia
    - Acute Megakaryoblastic Leukemia
    - Acute Monoblastic and Monocytic Leukemia
    - Acute monoblastic leukemia
    - Acute myeloid leukemia with mutated CEBPA
    - Acute myeloid leukemia with t(9;11)(p22;q23); MLLT3-MLL
    - Acute myeloid leukemia without maturation
    - Acute myeloid leukemia, inv(16)(p13;q22)
    - Acute myeloid leukemia, minimal differentiation
    - Acute Myeloid Leukemia, NOS
    - Acute myeloid leukemia, t(16;16)(p 13;q 11)
    - Acute Myelomonocytic Leukemia
    - Acute promyelocytic leukaemia, t(15;17)(q22;q11-12)
    - Acute Promyelocytic Leukemia
    - Adamantinomatous Craniopharyngioma
    - Adamantinomatous craniopharyngioma with evidence of prior rupture
    - Adamantinomatous craniopharyngioma, WHO grade 1
    - Adenocarcinoma
    - Adrenal Cortical Carcinoma
    - Adrenal cortical neoplasm
    - Adrenal Cortical Tumor
    - Alveolar Rhabdomyosarcoma
    - Alveolar Soft Part Sarcoma
    - Anaplastic Ependymoma
    - Anaplastic Ganglioglioma
    - Anaplastic Large Cell Lymphoma, ALK Positive
    - Anaplastic Medulloblastoma
    - Anaplastic Rhabdomyosarcoma
    - Angiocentric Glioma
    - Angiomatoid Fibrous Histiocytoma
    - Astrocytic Glioma
    - Astrocytic Neoplasm
    - Astrocytic neoplasm with pilocytic/pilomyxoid features
    - Astrocytoma
    - Astrocytoma IDH-mutant, Atrocytoma IDH-mutant
    - Astroglial neoplasm
    - Atypical Cellular Proliferation with Clear Features
    - Atypical Central Neurocytoma
    - Atypical Choroid Plexus Papilloma
    - Atypical Epithelial Neoplasm
    - Atypical Spindle Cell Proliferation
    - Atypical Teratoid/Rhabdoid Tumor
    - Atypical Teratoid/Rhabdoid Tumor (AT/RT)
    - Atypical teratoid/rhabdoid tumor, CNS WHO GRADE 4
    - Atypical teratoid/rhabdoid tumor; CNS WHO grade 4
    - Aytpical teratoid/rhabdoid tumor (AT/RT), WHO grade 4
    - B lymphoblastic leukemia/lymphoma with hyperdiploidy
    - B lymphoblastic leukemia/lymphoma with hypodiploidy (Hypodiploid ALL)
    - B lymphoblastic leukemia/lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1)
    - B lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1)
    - B lymphoblastic leukemia/lymphoma with t(9;22)(q34;q11.2); BCR-ABL1
    - B lymphoblastic leukemia/lymphoma with t(v;11q23); MLL rearranged
    - B Lymphoblastic Leukemia/Lymphoma, NOS
    - B-lymphoblastic leukemia/lymphoma, NOS
    - Biphasic Synovial Sarcoma
    - Brain Mass
    - Brain parenchyma with mild hypercellularity, gliosis and possible cortical dysplasia
    - Brain Tumor
    - Brain tumor with features most suggestive of ependymoma
    - Brain, High Grade Lesion
    - Carcinoma NOS
    - Carcinosarcoma NOS
    - Cellular Ependymoma
    - Cellular Glial Neoplasm
    - Cellular Neoplasm
    - Cellular neoplasm; favor high grade
    - Central Nervous System Tumor with High Grade Histological Features
    - Central Neuroblastoma
    - Central Neurocytoma
    - Cerebellar Mass
    - Cerebellar Tumor
    - 'Cerebellar tumor: High-grade, small blue round cell tumor'
    - Cerebellopontine Angle Tumor
    - Cervical; INI1-Deficient Hematological Malignancy
    - Chondroblastic Osteosarcoma
    - Chondrosarcoma, NOS
    - Chordoma
    - Choroid Plexus Carcinoma
    - Choroid plexus carcinoma, CNS WHO grade 3
    - Choroid Plexus Neoplasm
    - Choroid Plexus Papillary Tumor
    - Choroid Plexus Papilloma
    - Choroid plexus papilloma, WHO grade 1
    - Chronic Myelogenous Leukemia, BCR-ABL Positive
    - Chronic Myeloid Leukemia, BCR-ABL1-Positive
    - Classic Ependymoma, Posterior fossa group A by Immunohistochemistry
    - Classic Medulloblastoma
    - Clear Cell Meningioma
    - Clear Cell Sarcoma
    - CNS Embryonal Tumor
    - CNS primative neuroectodermal tumor (PNET)
    - CNS Primitive Neuroectodermal Tumor (PNET)
    - Compound melanocytic neoplasm
    - Consistent With Oligodendroglioma, IDH Mutant
    - Control
    - Craniopharyngioma
    - Desmoid fibromatosis with CTNNB1 gene mutation
    - Desmoid-type Fibromatosis
    - Desmoid/fibromatosis
    - Desmoplastic Nodular Medulloblastoma
    - Desmoplastic/Nodular Medulloblastoma
    - Desmoplastic/nodular medulloblastoma, CNS WHO grade 4
    - Diffuse astrocytic glioma with mitotic activity and necrosis
    - Diffuse Astrocytoma
    - Diffuse Glioma
    - Diffuse midline glioma, H3 K27-altered
    - Diffuse midline glioma, H3 K27-mutant
    - Diffuse midline glioma, H3K27-altered (WHO grade 4)
    - Diffuse midline glioma, H3K27M altered, CNS WHO grade 4
    - Diffusely infiltrating high grade glioma
    - Ductal Carcinoma NOS
    - Dysembryoplastic Neuroepithelial Tumor
    - Embryonal Neoplasm
    - Embryonal neoplasm most consistent with Medulloblastoma
    - Embryonal Rhabdomyosarcoma
    - Embryonal rhabdomyosarcoma, botryoid type
    - Embryonal rhabdomyosarcoma, minimal focal anaplasia
    - Embryonal Tumor
    - Endometrioid Adenocarcinoma, NOS
    - Endometrioid carcinoma
    - Epdendymoma, Ependymoma
    - Ependymoma NOS
    - Ependymoma, WHO GRADE III
    - Ependymoma-like lesion
    - Epitheliod sarcoma
    - Epitheloid neoplasm
    - Epitheloid Sarcoma
    - Ewing Sarcoma
    - Extrarenal Malignant Rhabdoid Tumor
    - Familial Adenomatous Polyposis
    - Fatty neoplasm with myxoid features, no definitive high grade features, favor lipoblastoma
    - Favor Infiltrating High-Grade Glioma
    - Fibromatosis
    - Fibromatosis Colli
    - Follicular Hyperplasia/Metastatic Papillary Thyroid Cancer
    - Fragments of Schwannoma, CNS WHO GRADE 1, with some mild degenerative changes
    - Frontal tumor, favor infant-type hemispheric glioma
    - Fundic gastrointestinal stromal tumor
    - Fusion negative embryonal rhabdomyosarcoma
    - Ganglioglioma
    - Ganglioneuroblastoma
    - Ganglioneuroma
    - Gastrointestinal stromal tumor (GIST)
    - Gastrointestinal stromal tumor (GIST) epithelioid type, high grade
    - Germinoma
    - Giant Cell Glioblastoma
    - Glial Neoplasm
    - Glial neoplasm favor optic glioma
    - Glial Tumor
    - Glial-neuronal neoplasm
    - Glioblastoma
    - Glioma
    - Glioma, histologically consistent with pilocytic astrocytoma, CNS WHO grade 1
    - Glioma, most consistent with astrocytoma with worrisome features in clinical context
    - Glioneuronal Lesion
    - Glioneuronal Neoplasm
    - Glioneuronal Tumor
    - Granulosa cell tumor
    - Hemangioblastoma
    - Hemangioblastoma, WHO Grade 1
    - Hepatoblastoma
    - Hepatocellular Carcinoma, Fibrolamellar
    - High grade cellular, malignant neoplasm with necrosis and cellular pleomorphism R/O Medulloblastoma
    - High Grade Diffuse Glioma
    - High Grade Ependymal Tumor
    - High Grade Glioma  with H3 K27M and BRAF V600E mutations
    - High grade glioma, NOS, WHO CNS histologic grade 4
    - High Grade Neoplasm
    - High Grade Neuroepithelial Tumor
    - High grade neuroepithelial tumor with glial and neuronal differentiation and focal embryonal morphology.
    - High grade neuroepithelial tumor, favor medulloblastoma
    - High Grade Sarcoma
    - High grade spindle cell sarcoma
    - High Grade Tumor
    - High grade tumor consistent with embryonal tumor
    - High-grade Angiosarcoma
    - High-grade astrocytic neoplasm
    - High-grade Astrocytoma
    - High-grade blue cell tumor
    - High-grade Central Nervous System Neoplasm Favor Embryonal
    - High-grade CNS embryonal tissue
    - High-grade CNS Neoplasm
    - High-grade Ependymal Neoplasm
    - High-grade Ependymal Tumor
    - High-grade glioma with DICER1 and other mutations
    - High-grade glioma, favor ependymoma, WHO GRADE III
    - High-grade infiltrating glioma
    - High-grade Malignant Neoplasm
    - High-grade malignant neoplasm with mesenchymal phenotype
    - High-grade malignant neoplasm, small round blue cell category.
    - High-grade neoplasm, favor embryonal tumor
    - High-grade neoplasm, favor high-grade glioma
    - High-grade neuroepithelial neoplasm
    - High-grade neuroepithelial tumor
    - High-grade neuroepithelial tumor, consistent with supratentorial ependymoma
    - High-grade pleomorphic sarcoma
    - High-grade primary CNS neoplasia
    - High-grade primitive appearing neoplasm
    - High-grade rhabdomyosarcoma with pleomorphic features
    - High-grade sarcoma with myogenic differentiation
    - High-grade serous carcinoma
    - High-grade spindle cell sarcoma compatible with high grade malignant peripheral nerve sheath tumor
    - High-grade Synovial Sarcoma
    - High-grade tumor
    - High-grade undifferentiated sarcoma
    - High-grade, primitive neuroepithelial neoplasm
    - Histiocytic Malignancy
    - Histologically low-grade glioneuronal tumor
    - Histologically low-grade neuroepithelial tumor
    - Hodgkin Lymphoma, NOS
    - Infant Hemispheric Glioma
    - Infant-type hemispheric glioma
    - Infantile Fibrosarcoma
    - Infiltrating duct and lobular carcinoma
    - Infiltrating duct and mucinous carcinoma
    - Infiltrating duct carcinoma NOS
    - Infiltrating Duct Carcinoma, NOS
    - Infiltrating Glioma
    - Infiltrating high grade neoplasm, favor infiltrating high grade glioma
    - Infiltrating Lobular Carcinoma, NOS
    - Infiltrating Neoplasm
    - Infiltrating neuroepithelial neoplasm
    - Inflammatory Myofibroblastic Tumor
    - INI-Deficient High-grade Malignant Neoplasm
    - Intracerebral schwannoma
    - Intraductal Carcinoma NOS
    - Intraductal papillary carcinoma
    - Intradural tumor with marked atypia c/w malignant lesion, Marked atypia c/w malignant lesion, Marked atypia consistent with malignant lesion
    - Intraventricular Tumor
    - Invasive lobular carcinoma
    - Juvenile Granulosa Cell Tumor
    - Juvenile Myelomonocytic Leukemia
    - Large Cell Medulloblastoma
    - Large cell/anaplastic Medulloblastoma
    - Laryngeal Papilloma
    - Left Biopsy Chest Lesion
    - Left Cp Angle Mass; Schwannoma
    - Left Temporal Tumor
    - Left Thoracic Tumor
    - Lobular Adenocarcinoma
    - Lobular And Ductal Carcinoma
    - Lobular Carcinoma NOS
    - Low Cellularity Glioma
    - Low Grade Astrocytoma
    - Low Grade Fibromyxoid Sarcoma
    - Low Grade Glial Neoplasm
    - Low Grade Glial Tumor
    - Low Grade Glial-Glioneuronal Tumor
    - Low Grade Glioma
    - Low grade glioma which morphologically aligns best with pilocytic astrocytoma, CNS WHO Grade 1
    - Low grade glioma, cannot rule out additional neuronal component
    - Low grade glioma, morphologically aligning best with pilocytic astrocytoma
    - Low Grade Glioneuronal Neoplasm
    - Low Grade Glioneuronal Tumor
    - Low grade mixed glial-neuronal tumor, morphology is consistent with/ aligns with/ favors ganglioglioma
    - Low Grade Neuroepithelial Tumor
    - Low grade neuroepithelial tumor (preliminary path report)
    - Low grade neuroepithelial tumor consistent with polymorphous low grade neuro-epithelial tumor of the young
    - Low Grade Neuroglial Tumor
    - Low Grade Primary CNS Neoplasm
    - Low Grade Spindle Cell Neoplasm
    - Low Grade Tumor
    - Low-cellularity glioma
    - Low-grade astrocytoma
    - Low-grade circumscribed glial/glioneuronal tumor
    - Low-grade fibromyxoid sarcoma
    - Low-grade Glial Neoplasm
    - Low-grade glial neoplasm, favor pilomyxoid/pilocytic actrocytoma
    - Low-grade glial neoplasm, with features most consistent with a pilocytic astrocytoma.
    - Low-grade glial-glioneuronal tumor
    - Low-grade glial/glioneuronal neoplasm
    - Low-grade Glial/Glioneuronal tumor
    - Low-grade glial/glioneuronal tumor with adjacent cortical dysplastic changes.
    - Low-grade Glioma
    - Low-grade glioma, favored to represent a pilocytic astrocytoma
    - Low-grade Glioneuronal Neoplasm
    - Low-grade glioneuronal tumor
    - Low-grade glioneuronal tumor, favor Dysembryoplastic neuroepithelial tumor
    - Low-grade spindle cell neoplasm
    - Low-grade tumor
    - Lymphoma, NOS
    - Malignant embryonal tumor, favor medulloblastoma
    - Malignant epithelioid neoplasm, Malignant epithelioid neoplasm with EWSR1::KLF5 fusion
    - Malignant glioma
    - Malignant Melanoma NOS
    - Malignant melanoma, spitzoid type
    - Malignant myoepithelial of pediatric type
    - Malignant Neoplasm
    - Malignant neoplasm most consistent with embryonal tumor
    - Malignant neoplasm of prostate
    - Malignant neuroepithelial tumor
    - Malignant Pecoma
    - Malignant peripheral nerve sheath tumor
    - Malignant primary brain tumor
    - Malignant Rhabdoid Tumor
    - Malignant small blue cell neoplasm, consistent with rhabdomyosarcoma
    - Malignant small round blue cell neoplasm, favor rhabdomyosarcoma
    - Malignant small round blue cell tumor, most consistent with desmoplastic small round cell tumor
    - Malignant Tumor
    - Mast Cell Leukemia
    - Medullary Carcinoma
    - Medulloblastoma
    - Medulloblastoma (CNS WHO grade 4)
    - Medulloblastoma, anaplastic histology, WHO grade 4
    - Medulloblastoma, anaplastic/large cell histology, Non-WNT NON-SHH (By IHC), WHO grade 4
    - Medulloblastoma, classic
    - Medulloblastoma, classic histologic type, non-WNT/non-SHH molecular group, CNS WHO grade 4
    - Medulloblastoma, classical histology
    - Medulloblastoma, CNS WHO Grade 4
    - Medulloblastoma, desmoplastic/nodular histology, SHH-activated (WHO grade 4)
    - Medulloblastoma, favored
    - Medulloblastoma, non-WNT, non-SHH
    - Medulloblastoma, SHH-activated and TP53-wild type
    - Medulloblastoma, SHH-activated and TP53-wildtype, Medulloblastoma with extensive nodularity (MBEN)
    - Medulloblastoma, WHO Grade 4
    - Medulloblastoma, WHO Grade IV
    - Melanoma
    - Meningioma
    - Merkel Cell Tumor
    - Mesenchymal Chondrosarcoma
    - Mesenchymal Neoplasm
    - Metastatic Alveolar Rhabdomyosarcoma
    - Metastatic Carcinoma
    - Metastatic Embryonal Rhabdomyosarcoma
    - Metastatic embryonal rhabdomyosarcoma in three nodules
    - Metastatic nasopharyngeal carcinoma, nonkeratinizing squamous cell carcinoma subtype
    - Metastatic Papillary Thyroid Carcinoma
    - Metastatic Polyphenotypic Malignant Neoplasm
    - Metastatic Rhabdomyosarcoma
    - Mixed Germ Cell Tumor
    - Mixed germ cell w/ matrue teratoma
    - Mixed malignant germ cell tumor with components of embryonal carcinoma, choriocarcinoma, and mature teratoma
    - Mixed malignant germ cell tumor with yolk sac tumor
    - Mixed-Phenotype Acute Leukemia, B/Myeloid, Not Otherwise Specified
    - Mixed-Phenotype Acute Leukemia, T/Myeloid, Not Otherwise Specified
    - Monophasic Synovial Sarcoma, Intermediate-Grade (FNCLCC Grade 2 Of 3)
    - Most consistent with atypical teratoid/rhabdoid tumor, most consistent with atypical teratoid/rhabdoid tumor
    - Mucinous Carcinoma
    - Mucoepidermoid carcinoma
    - Myelodysplastic Syndrome With Multilineage Dysplasia
    - Myelodysplastic Syndrome With Single Lineage Dysplasia
    - Myeloid leukemia associated with Down Syndrome
    - Myofibroblastic proliferation  suggestive of inflammatory myofibroblastic tumor
    - Myofibroma
    - Myxoid Glioneuronal Tumor
    - Myxoid Liposarcoma
    - Myxoid Neoplasm
    - Myxopapillary Ependymoma
    - Myxopapillary ependymoma, CNS WHO grade 2
    - Nasopharyngeal Carcinoma Metastatic
    - Nasopharyngeal carcinoma, non-keratinizing squamous cell carcinoma type
    - Neoplasm
    - Nephroblastoma (Wilms Tumor)
    - Neuroblastoma
    - Neurocytoma
    - Neuroectodermal Tumor
    - Neuroectodermal tumor, NTRK1 altered, with low-grade morphologic features
    - Neuroendocrine Tumor
    - Neuroepithelial Neoplasm
    - Neuroepithelial neoplasm, Glioma
    - Neuroepithelial Tumor
    - Neurofibromatosis; Moderately cellular neoplasm
    - Non-WNT/non-SHH medulloblastoma
    - Not Reported
    - Optic Pathway Glioma
    - Osteosarcoma, NOS
    - Ovarian Sclerosing Stromal Tumor
    - Pancreatobiliary-Type Carcinoma
    - Papillary Carcinoma
    - Papillary carcinoma of thyroid
    - Papillary Neoplasm, Favor Choroid Plexus Tumor
    - Papillary Thyroid Carcinoma
    - Papillary thyroid carcinoma, classic
    - Papillary Tumor of The Pineal Region
    - Paraganglioma
    - Paratesticular Rhabdomyosarcoma
    - Paratesticular rhabdomyosarcoma, favor embryonal
    - Paratesticular Spindle Cell/Sclerosing Rhabdomyosarcoma
    - Pediatric neuroepithelial tumor with ROS1 fusion
    - Pediatric type diffuse low grad astrocytoma, consistent with methylation array finding suggestive of MYB/MYBL1-altered (CNS WHO grade 1)
    - PFA Ependymoma
    - Pheochromocytoma
    - Pilocytic Astrocytoma
    - Pilocytic astrocytoma (WHO Grade 1)
    - Pilocytic astrocytoma, CNS WHO grade 1
    - Pilocytic astrocytoma, CNS WHO GRADE 1, Pilocytic astrocytoma, CNS WHO grade 1
    - Pilocytic Astrocytoma, CNS WHO Grade I
    - Pilocytic astrocytoma, KIAA1549::BRAF fusion-positive (WHO grade 1)
    - Pilocytic astrocytoma, WHO Grade 1
    - Pilocytic astrocytoma, WHO grade I
    - Piloid Glial Proliferation
    - Pilomyxoid Astrocytoma
    - Pineal Parenchymal Tumor
    - Pineoblastoma
    - Pineoblastoma, WHO grade 4
    - Pituitary Adenoma
    - Pituitary Tumor
    - Pleomorphic Sarcoma
    - Pleomorphic Xanthoastrocytoma
    - Pleuropulmonary Blastoma
    - Plexifrom Fibrohistiocytic Tumor
    - Polymorphous Low Grade Neuroepithelial Tumor
    - Poorly Differentiated Malignant Neoplasm with Sarcomatoid Features
    - Poorly Differentiated Pulmonary Adenocarcinoma
    - Poorly Differentiated Ring Cell Adenocarcinoma
    - Poorly Differentiated Sarcoma
    - Poorly Differentiated Sertoli-Leydig Cell Tumor
    - Positive for lesional tissue, favor low-grade glioma, additional studies pending.
    - Possible Synovial Sarcoma
    - Posterior Fossa Ependymoma
    - Posterior fossa ependymoma, group A
    - Posterior fossa ependymoma, group A (CNS group grade III)
    - Posterior fossa ependymoma, group B
    - Posterior fossa ependymoma, WHO grade 2, with retained H3 K27 tri-methylation
    - Posterior fossa group A (PFA) Ependymoma (WHO GRADE 3)
    - Posterior fossa group A ependymoma
    - Posterior Fossa Tumor
    - Posterior Fossa, Forth Ventricular Tumor, Posterior Fossa, Fourth Ventricular Tumor
    - Precursor B-Cell Acute Lymphoblastic Leukemia with Hyperdiploidy
    - Primary central nervous system neoplasm consistent with high grade glioma
    - Primary mediastinal (thymic) large B-cell lymphoma
    - Primitive malignant neoplasm with mesenchymal features
    - Primitive Neuroectoderma Tumor
    - Primitive Sarcoma
    - Primitive/embryonal tumor with high-grade features; compatible with medulloblastoma
    - Psammomatous Meningioma
    - Pure Germinoma
    - PXA Vs Ganglioglioma
    - Renal Cell Adenocarcinoma
    - Renal cell carcinoma, NOS
    - Renal medullary carcinoma
    - Residual CIC-Rearranged Sarcoma
    - Residual Dermatofibrosarcoma Protuberans
    - Residual High Grade Astrocytoma With Piloid Features
    - Residual High-Grade Sarcoma
    - Residual Malignant Melanoma
    - Residual Papillary Tumor of Pineal Region
    - Residual Pineoblastoma
    - Residual/Recurrent Extraventricular Neurocytoma
    - Retinoblastoma
    - Retinoblastoma, moderately differentiated
    - Rhabdoid Tumor, Malignant
    - Rhabdomyoma NOS
    - Rhabdomyosarcoma
    - Rhabdomyosarcoma strongly suspected
    - Rhabdomyosarcoma, favor embryonal subtype pending molecular studies
    - Right Thigh Mass
    - Round Blue Cell Tumor
    - Round Cell Sarcoma
    - Round To Spindle Cell Sarcoma
    - Sarcoma
    - Schwannoma
    - Sclerosing Stromal Tumor
    - Seroli-leydig cell tumor
    - Serous Adenocarcinoma, NOS
    - Serous Cystadenocarcinoma NOS
    - Serous Surface Papillary Carcinoma
    - Sertoli Leydig Cell Tumor
    - Sertoli-Leydig cell tumor, moderately differentiated
    - Sertoli-Leydig cell tumor, poorly differentiated
    - Sertolig Leydig Cell Tumor
    - Signet Ring Cell Carcinoma
    - Small Blue Cell Tumor
    - Small Cell Neuroendocrine Carcinoma
    - Small Round Blue Cell Sarcoma
    - Small Round Blue Cell Tumor
    - Small round blue cell tumor consistent with rhabdomyosarcoma
    - 'Small round blue cell tumor: rhabdomyosarcoma'
    - SMARCB1-deficient undifferentiated round cell sarcoma
    - Spinal Ependymoma Myxopapillary
    - Spinal Tumor
    - Spindle Cell Lesion
    - Spindle Cell Neoplasm
    - Spindle Cell Rhabdomyosarcoma
    - Spindle Cell Sarcoma
    - Squamous Cell Carcinoma NOS
    - Subependymal Giant Cell Astrocytoma
    - Supertentorial Ependymoma
    - Suprasellar Mass
    - Supratentorial Choroid Plexus Papilloma
    - Supratentorial Ependymoma
    - Supratentorial ependymoma, WHO Grade 2
    - Synovial Sarcoma
    - T Lymphoblastic Leukemia/Lymphoma
    - T-lymphoblastic Leukemia
    - T-lymphoblastic Lymphoma
    - Testicular mass
    - Thalamic Brain Tumor
    - Therapy Related Myeloid Neoplasm
    - Therapy-related myeloid neoplasms
    - Unclassified pleomorphic sarcoma
    - Undifferential Small Round Blue Cell Tumor
    - Undifferentiated leukaemia
    - Undifferentiated Leukemia
    - Undifferentiated Malignant Neoplasm with Rhabdoid Morphology And INI1 Loss
    - Undifferentiated Round Cell Sarcoma
    - Undifferentiated sarcoma
    - Undifferentiated small round cell sarcoma
    - Undifferentiated, high-grade neoplasm/sarcoma
    - Unknown
    - Well Differentiated Embryonal Rhabdomyosarcoma
    - Well Differentiated Neuroendocrine Tumor
    - Well To Moderately Differentiated Colonic Adenocarcinoma
    - Yolk Sac Tumor
    - Rasmussen Encephalitis
    - Neoplasm, Nos
    - Atypical Tetroid/Rhabdoid Tumor WHO Grade 4
    - High-grade Small Round Blue Cell Tumor
    - Histologically Low-Grade Glioma With Pilocytic Features, Most Suggestive Of Pilocytic Astrocytoma
    - High-grade Glioneuronal Tumor
    - Aggressive Spindle Cell Neoplasm
    - 'Intraoperative Consultation: Calcified Glial Lesion Dx: Markedly Calcified Lesion'
    - Rhabdoid Tumor, NOS
    - Nodular Spindle Neoplasm
    - '8806/3 : Desmoplastic Small Round Cell Tumor'
    - Favor Pilocytic Astrocytoma
    - Pediatric Type Diffuse Glioma With Angiocentric Pattern
    - Teratoma, malignant, NOS
    - Reactive Connective Tissue
    - Low Grade Glioma Most Consistent With Pilocytic/Pilomyxoid Astrocytoma. WHO Grade 1
    - Adrenalcortical Carcinoma
    - Osteoblastoma
    - High-Grade Infiltrating Astrocytoma
    - '9400/3 : Astrocytoma, NOS'
    - Small Round Cell Sarcoma
    - Desmoplastic Small Round Cell Tumor
    - Compact Neoplasm with MesenchymalFfeatures
    - Meningioangiomatosis
    - Carcinoma, Metastatic, NOS
    - Diffuse Midline Glioma H3 K27 Altered CNS WHO Grade 4
    - Glioneuronal Tumor With BRAF V600E Mutation
    - Clear Cell Sarcoma, NOS
    - Thyroid Carcinoma
    - Lobular and Ossifying Round Cell Neoplasm
    - Malignant Peripheral Nerve Sheath Tumor (Mpnst)
    - Low Grade Glioma, Consistent With Pilocytic Astrocytoma, WHO Grade 1
    - Pilocytic Astrocytoma WHO Grade 1
    - Fibroma
    - Glioma With Low Grade Histologic Features
    - Subependymal Giant Cell Astrocytoma (WHO Grade 1)
    - Rhabdomyosarcoma, Favor Embryonal Subtype
    - Low Grade Glial Neoplasm, Consistent With Pilocytic Astrocytoma
    - Glioneuronal
    - Embryonal Tumor With Multilayered Rosettes, C19MC-Altered
    - Diffuse Midline Glioma, H3K27M Mutated By IHC, WHO Grade IV
    - Pancreatobiliary-Type Carcinoma;Adenocarcinoma, Pancreatobiliary Type
    - High Grade Glioneuronal Tumor
    - Oncocytic Adrenal Cortical Carcinoma
    - Multiple Myeloma
    - High Grade Neoplasm, Consistent With Metastatic Pleuropulmonary Blastoma
    - '9040/3 : Synovial Sarcoma, NOS'
    - Mucoepidermoid Carcinoma Low Grade
    - Endometrioid Carcinoma, NOS
    - Diffuse Astrocytic Neoplasm
    - Oxyphilic Adenocarcinoma
    - Gastrointestinal Stromal Tumor
    - CNS Neuroblastoma
    - Infiltrating Glial Neoplasm
    - Low-Grade Glial/ Glial Neuronal Tumor, Histologic CNS WHO Grade 1
    - Central Primary Primitive Neuroectodermal Tumor
    - Malignant Neoplasm With Primitive Morphology, Favor Medulloblastoma
    - Lung Squamous Cell Carcinoma, NOS
    - Low-grade Glial or Glioneuronal neoplasm
    - Epithelioid Sarcoma
    - '8550/3 : Acinar Cell Carcinoma'
    - Acute Lymphoblastic Leukemia
    - Anaplastic Medulloblastoma WHO Grade 4
    - '9421/1 : Pilocytic Astrocytoma'
    - IDH Mutant Gliomaa
    - Ganglioma, CNS WHO Grade 1
    - Synovial Sarcoma, NOS
    - Cellular Schwannoma
    - Glial/Glioneuronal Neoplasm
    - Atypical Teratoid/ Rhabdoid Tumor, CNS WHO Grade IV
    - Pediatric-Type Glioma, CNS WHO Grade 4
    - Malignant Spindle Cell Neoplasm
    - CNS Neoplasm
    - Diffuse Leptomeningeal Melanocytic Neoplasm
    - Mucous Adenocarcinoma
    - Glioma Subependymal Giant Cell Astrocytoma CNS WHO Grade 1
    - Leiomyosarcoma, NOS
    - Synovial sarcoma, NOS
    - Pancreatobiliary-Type Carcinoma;Mixed Adenocarcinoma And Squamous Cell Carcinoma
    - Aggressive Fibromatosis
    - Bronchio-alveolar Carcinoma
    - Acute Myeloid Leukemia
    - Probable Pilocytic Astrocytoma
    - '9413/0 : Dysembryoplastic Neuroepithelial Tumor'
    - Fibroblastic Spindle Cell Lesion
    - Diffuse Glioma High-grade
    - Ductal Carcinoma, NOS
    - '9400/0 : Astrocytoma, Benign'
    - Choroid Plexus Carcinoma, TP53 Mutant
    - Medulloblastoma, Classic Histologic Type, Non-WNT/Non-SHH Molecular Subtype, WHO Grade 4
    - Atypical Lymphoid Infiltrate
    - Liposarcoma
    - Malignant Melanocytic Neoplasm
    - Low-grade Glial/Glioneuronal Tumor
    - Myofibroblastic Tumor
    - Mucinous Adenocarcinoma
    - Omentum; Pancreatic Acinar Cell Carcinoma
    - '9380/3 : Glioma, Malignant'
    - Embryonal Tumor With Multilayered Rosettes, CNS WHO Grade 4
    - Diffuse Hemispheric Glioma
    - Dermatofibrosarcoma Protuberans
    - Parosteal Osteosarcoma
    - Ependymoma, NOS
    - Follicular Carcinoma
    - NTRK-1 Altered Mesenchymal Tumor
    - Myxopapillary Ependymoma WHO Grade 2
    - Small Cell Squamous Cell Carcinoma
    - '9192/3 : Parosteal Osteosarcoma'
    - Basaloid Squamous Cell Carcinoma
    - Cervical Thoracic Spinal Cord Tumor.Ependymoma With High-Grade Features
    - Malignant Somatic Neoplasm With Multiphase Sarcomatous Components Consistent With Embryonal-Type Sarcoma
    - Pseudomyogenic Hemangioendothelioma
    - Hemangioma
    - Low-grade Astrocytic tumor
    - '8171/3 : Hepatocellular Carcinoma, Fibrolamellar'
    - Medulloblastoma Classic Type CNS Who Grade 4
    - Precursor T-Cell Lymphoblastic Leukemia
    - Metastatic Secondary Tumors
    - Adenocarcinoma In Situ, Non-Mucinous
    - Diffuse Hemispheric Glioma CNS WHO Grade 4
    - '9478/3 : Embryonal Tumor With Multilayered Rosettes With C19MC Alteration'
    - Ossifying Fibroma
    - '8910/3 : Embryonal Rhabdomyosarcoma, NOS'
    - Small Cell Carcinoma of Ovary
    - Langerhans Cell Histiocytosis
    - Low Grade Glioma With Apparent BRAF V600E Expression
    - Diffuse Midline Glioma
    - Pilocytic Astrocytoma, CNS WHO Grade 1
    - Meningioma, WHO Grade 2
    - Schwannoma, Benign Conventional Type WHO Grade 1
    - Teratoma, Malignant, NOS
    - Metastatic Adrenal Cortical Carcinoma
    - Oligodendroglioma
    - Fibroblastic/Myofibroblastic Lesion
    - Metaplastic Carcinoma
    - Dysplasia
    - Adenocarcinoma In Villous Adenoma
    - Ganglioneuroblastoma, Nodular; Unfavorable Histology
    - Diffuse Midline Glioma H3K27-Altered WHO Grade 4
    - Inflammatory Carcinoma
    - Lobular carcinoma NOS
    - Low Grade Glial Neoplasm, Histologically Most Consistent With Pilocytic Astrosytoma, CNS WHO Grade 1
    - Epithelioid Hemangioendothelioma, NOS
    - '8805/3 : Undifferentiated Sarcoma'
    - Dermoid Cyst
    - '9181/3 : Chondroblastic Osteosarcoma'
    - Perineuroma
    - Ulcerated Nodular Melanoma
    - Choroid Plexus Carcinoma TP53 Altered CNS WHO Grade 3
    - Residual Pilocytic Astrocytoma (WHO Grade 1)
    - Morphologically Consistent With Low Grade Glial Neoplasm
    - '8991/3 : Embryonal Sarcoma'
    - Embryonal Neoplasm With Focal Dystrophic Calcifications And Microvascular Proliferation
    - Carcinoma
    - Atypical Teratoid/ Rhabdoid Tumor, CNS WHO Grade 4
    - Polymorphous Low-Grade Neuroepithelial Tumor Of The Young, CNS WHO Grade 1
    - '9392/3 : Ependymoma, Anaplastic'
    - '9080/3 : Teratoma, Malignant, NOS'
    - Favor Low Grade Glioma
    - High-grade Carcinoma
    - Epitheloid Neoplasm
    - Adrenal Cortical Neoplasm
    - '9071/3 : Yolk Sac Tumor, NOS'
    - Epithelial - Myoepithelial Carcinoma
    - Embryonal CNS Tumor
    - Chronic Myelogenous Leukemia
    - '8170/3 : Hepatocellular Carcinoma, NOS'
    - Low Grade Glioneuronal Neoplasm, Including Ganglioglioma
    - Low-Grade Glioma Histologically, Favor Pilocytic Astrocytoma
    - Dysembryoplastic Neuroepithelial Tumor (DNET; WHO Grade 1)
    - High Grade Neuroepithelial Tumor, With Features Aligning Best With A CNS Embryonal Tumor, CNS WHO Grade 4
    - Precursor T-cell lymphoblastic Leukemia
    - Neuroepithelial Tumor Of Pineal Region With Papillary Features
    - Invasive Carcinoma
    - Atypical Meningioma
    - High-grade Serous Carcinoma
    - Adenocarcinoma, Metastatic, NOS
    - '8430/3 : Mucoepidermoid Carcinoma'
    - '8072/3 : Squamous Cell Carcinoma, Large Cell, Nonkeratinizing, NOS'
    - Medulloblastoma, Classic Histology, SHH Activated And TP53 Wild-Type, CNS WHO Grade 4
    - Rhabdomyosarcoma With Diffuse Anaplasia
    - Hypercellular Cortical Parenchyma, Features Suggestive Of Diffuse Glioma
    - Neuroglial Neoplasm
    - Lymphoepithelial Carcinoma
    - High Grade Malignant Neoplasm
    - Papillary Serous Adenocarcinoma
    - Diffuse Midline Glioma H3 K27-altered WHO Grade 4
    - Immature Teratoma
    - Not Specified in Data
    - Malignant Peripheral Nerve Sheath Tumor, High Grade
    - Intraventricular Thalamopeduncular Resection :Diffuse Midline Glioma, H3 K27M Altered WHO Grade 4
    - Myxoid Spindle Cell Tumor
    - Neurofibroma
    - Cystosarcoma Phyllodes, NOS
    - Rhabdoid Tumor
    - Malignant Neoplasia
    - Thyroid Papillary Carcinoma
    - Lung Adenocarcinoma, NOS
    - '9384/1 : Subependymal Giant Cell Astrocytoma'
    - Glioneuronal Tumor NOS
    - Consistent With Meningioma
    - Clear Cell Adenocarcinoma
    - '9473/3 : CNS Embryonal Tumor, NOS'
    - High-grade Fibrosarcoma
    - Metastatic Signet Ring Cell Carcinoma
    - Periosteal osteosarcoma
    - Papillary Tumor
    - Adenocarcinoma, NOS
    - Micropapillary Carcinoma
    - Tumor
    - Thymoma
    - '8370/3 : Adrenal Cortical Carcinoma'
    - Lesional Tissue Present. Cannot Rule Out High Grade Neoplasm
    - Brain Neoplasm
    - Tubular Adenocarcinoma
    - Pineoblastoma, CNS WHO Grade 4
    - Consistent With Neoplasm, Morphologically Favor Low Grade Astrocytoma
    - '8814/3 : Infantile Fibrosarcoma'
    - Malignant Neoplasm, Most Consistent With Atypical Teratoid/Rhabdoid Tumor, WHO Grade IV
    - '8912/3 : Spindle Cell Rhabdomyosarcoma'
    - Malignant Small Blue Cell Tumor With Necrosis
    - Adenosquamous Carcinoma
    - Low Grade Spindle Cell Tumor, Favor Mesenchymal. Differential Chiefly Include STF, Meningiom, Schwannoma And Other Rare Mesenchymal Tumor
    - Invasive Mammary Carcinoma
    - Metastatic Undifferentiated Carcinoma
    - Malignant Meoplasm
    - Mixed Malignant Germ Cell Tumor
    - Acute Leukemia, B/myeloid, NOS
    - Ependymoma, Anaplastic
    - Atypical Mixed Glioneuronal Lesion
    - BRAF V600E Mutant Low Grade Glial Or Glioneuronal Tumor, Ganglioglioma Favored
    - Thymic Carcinoma
    - Ependymoma, WHO Grade II
    - Blue Cell Tumor
    - Atypical Choroid Plexus Papilloma WHO Grade 2
    - High-grade Glial or Glioneuronal Neoplasm
    - Squamous Cell Carcinoma Nos
    - Nasopharyngeal Carcinoma
    - '8821/1 : Aggressive Fibromatosis'
    - Medulloblastoma, Desmoplastic/Nodular Variant (WHO Grade 4).
    - '9540/3 : Malignant Peripheral Nerve Sheath Tumor, NOS'
    - Undifferentiated Round Cell Malignancy
    - Leomorphic Xanthoastrocytoma
    - Epithelioid Cell Tumor
    - Hamartomatous Lesion
    - Xanthogranuloma
    - Sertoli-Leydig Cell Tumor, Moderately Differentiated. Pathologic Stage PT1A, FIGO Stage 1A
    - Medulloblastoma, Classic Histology Type, WNT-Activated Molecular Group, CNS WHO Grade 4
    - '9364/3 : Ewing Sarcoma'
    - High-grade Glioma
    - Retinoblastoma, Poorly Differentiated
    - Acute Leukemia, T/myeloid, NOS
    - Embryonal Tumor With Multilayered Rosettes CNS WHO Grade 4
    - Papillary Neoplasm
    - Adenocarcinoma In Situ, NOS
    - Hamartoma
    - Choroid Plexus Papilloma, Negative For Atypia And Malignancy
    - '9183/3 : Telangiectatic Osteosarcoma'
    - Leydig Cell Tumor
    - Rhabdomyosarcoma With Focal Anaplasia
    - High Grade Mesenchymal Neoplasm
    - High-Grade Malignancy With Rhabdomyoblastic Differentiation
    - Gastrointestinal Stromal Tumor (GIST)
    - Juvenile Myelomonocytic Leukemia, NOS
    - Glial Neoplasm, Appearing Pilocytic
    - Signet-ring Cell Carcinoma
    - Astrocytoma with Pilomyxoid Features
    - Myoepithelial Carcinoma
    - '8720/3 : Malignant Melanoma, NOS'
    - '8920/3 : Alveolar Rhabdomyosarcoma'
    - Telangiectatic Osteosarcoma
    - Small Cell Carcinoma
    - Combined Small Cell Large Carcinoma
    - Medulloblastoma, CNS-WHO Grade 4
    - Telangiectatic osteosarcoma
    - Choroid Plexus Carcinoma CNS WHO Grade 3
    - Supratentorial Ependymoma, ZFTA-Altered, WHO Grade 2
    - Arteriovenous Malformation
    - Non-Germinomatous Germ Cell Tumor
    - Low-grade Glial/Neuronal Tumor
    - Pleuropulmonary Blastoma, Type 1
    - Small Cell Carcinoma, NOS
    - Low Grade Glioma, Favor Pilocytic Astrocytoma, Preliminary WHO Grade 1
    - Morphologically Low Grade Glial Lesion Suggestive Of Pilocytic Astrocytoma
    - Primary CNS Neoplasm
    - Low-Grade Glioma With Piloid Features.
    - Combined Small Cell Adenocarcinoma
    - Renal Cell Carcinoma
    - Glioblastoma Multiforme
    - Hepatocellular Carcinoma, NOS
    - Ganglioglioma, WHO Grade I
    - Periosteal Osteosarcoma
    - '9193/3 : Periosteal Osteosarcoma'
    - '9385/3 : Diffuse Midline Glioma, H3 K27M-Mutant'
    - Infiltrative Fibromatosis
    - Papillary Carcinoma Diffuse Sclerosing Variant With Left Lobe Dominant Nodule And Diffuse Bilateral Intraglandular Spread
    - Prostate Cancer
    - Lymph Node With Metastatic Melanoma
    - EBV-Related Squamous Cell Carcinoma
    - 'High Grade Spindle Cell Sarcoma (Clinical: Neurofibromatosis Type 1 (NF-1).'
    - Glial/glioneuronal Neoplasm
    - Abdominal desmoid
    - Abdominal fibromatosis
    - Achromic nevus
    - Acidophil adenocarcinoma
    - Acidophil adenoma
    - Acidophil carcinoma
    - Acinar adenocarcinoma
    - Acinar adenocarcinoma, sarcomatoid
    - Acinar adenoma
    - Acinar carcinoma
    - Acinar cell adenoma
    - Acinar cell carcinoma
    - Acinar cell cystadenocarcinoma
    - Acinar cell tumor
    - Acinic cell adenocarcinoma
    - Acinic cell adenoma
    - Acinic cell tumor
    - Acoustic neuroma
    - Acquired cystic disease-associated renal cell carcinoma (RCC)
    - Acquired tufted hemangioma
    - Acral lentiginous melanoma, malignant
    - ACTH-producing tumor
    - Acute basophilic leukaemia
    - Acute bilineal leukemia
    - Acute biphenotypic leukemia
    - Acute erythremia
    - Acute erythremic myelosis
    - Acute erythroid leukaemia
    - Acute granulocytic leukemia
    - Acute leukemia, Burkitt type
    - Acute leukemia, NOS
    - Acute lymphatic leukemia
    - Acute lymphoblastic leukemia-lymphoma, NOS
    - Acute lymphoblastic leukemia, L2 type, NOS
    - Acute lymphoblastic leukemia, mature B-cell type
    - Acute lymphoblastic leukemia, NOS
    - Acute lymphoblastic leukemia, precursor cell type
    - Acute lymphocytic leukemia
    - Acute lymphoid leukemia
    - Acute mixed lineage leukemia
    - Acute monoblastic and monocytic leukemia
    - Acute monocytic leukemia
    - Acute myeloblastic leukemia
    - Acute myelocytic leukemia
    - Acute myelofibrosis
    - Acute myelogenous leukemia
    - Acute myeloid leukaemia, t(8;21)(q22;q22)
    - Acute myeloid leukemia (megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1
    - Acute myeloid leukemia with abnormal marrow eosinophils (includes all variants)
    - Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1
    - Acute myeloid leukemia with maturation
    - Acute myeloid leukemia with multilineage dysplasia
    - Acute myeloid leukemia with mutated NPM1
    - Acute myeloid leukemia with myelodysplasia-related changes
    - Acute myeloid leukemia with prior myelodysplastic syndrome
    - Acute myeloid leukemia with t(6;9)(p23;q34); DEK-NUP214
    - Acute myeloid leukemia with t(8;21)(q22;q22); RUNX1-RUNX1T1
    - Acute myeloid leukemia without prior myelodysplastic syndrome
    - Acute myeloid leukemia, AML1(CBF-alpha)/ETO
    - Acute myeloid leukemia, CBF-beta/MYH11
    - Acute myeloid leukemia, M6 type
    - Acute myeloid leukemia, MLL
    - Acute myeloid leukemia, NOS
    - Acute myeloid leukemia, PML/RAR-alpha
    - Acute myeloid leukemia, t(15:17)(g22;q11-12)
    - Acute myelomonocytic leukemia
    - Acute myelomonocytic leukemia with abnormal eosinophils
    - Acute myelosclerosis, NOS
    - Acute myloid leukemia, 11q23 abnormalities
    - Acute non-lymphocytic leukemia
    - Acute panmyelosis with myelofibrosis
    - Acute panmyelosis, NOS
    - Acute progressive histiocytosis X
    - Acute promyelocytic leukaemia, PML-RAR-alpha
    - Acute promyelocytic leukemia, NOS
    - Adamantinoma of long bones
    - Adamantinoma, malignant
    - Adamantinoma, NOS
    - Adenoacanthoma
    - Adenoameloblastoma
    - Adenocarcinoid tumor
    - Adenocarcinoma admixed with neuroendocrine carcinoma
    - Adenocarcinoma combined with other types of carcinoma
    - Adenocarcinoma in a polyp, NOS
    - Adenocarcinoma in adenomatous polyp
    - Adenocarcinoma in adenomatous polyposis coli
    - Adenocarcinoma in multiple adenomatous polyps
    - Adenocarcinoma in polypoid adenoma
    - Adenocarcinoma in situ in a polyp, NOS
    - Adenocarcinoma in situ in adenomatous polyp
    - Adenocarcinoma in situ in polypoid adenoma
    - Adenocarcinoma in situ in tubular adenoma
    - Adenocarcinoma in situ in tubulovillous adenoma
    - Adenocarcinoma in situ in villous adenoma
    - Adenocarcinoma in situ, mucinous
    - Adenocarcinoma in situ, non-mucinous
    - Adenocarcinoma in situ, NOS
    - Adenocarcinoma in tubolovillous adenoma
    - Adenocarcinoma in tubular adenoma
    - Adenocarcinoma in villous adenoma
    - Adenocarcinoma of anal ducts
    - Adenocarcinoma of anal glands
    - Adenocarcinoma of rete ovarii
    - Adenocarcinoma with apocrine metaplasia
    - Adenocarcinoma with cartilaginous and osseous metaplasia
    - Adenocarcinoma with cartilaginous metaplasia
    - Adenocarcinoma with mixed subtypes
    - Adenocarcinoma with neuroendocrine differentiation
    - Adenocarcinoma with osseous metaplasia
    - Adenocarcinoma with spindle cell metaplasia
    - Adenocarcinoma with squamous metaplasia
    - Adenocarcinoma, cribriform comedo-type
    - Adenocarcinoma, cylindroid
    - Adenocarcinoma, diffuse type
    - Adenocarcinoma, endocervical type
    - Adenocarcinoma, intestinal type
    - Adenocarcinoma, metastatic, NOS
    - Adenocarcinoma, pancreatobiliary type
    - Adenocystic carcinoma
    - Adenofibroma, NOS
    - Adenoid basal carcinoma
    - Adenoid cystic carcinoma
    - Adenolipoma
    - Adenolymphoma
    - Adenoma of nipple
    - Adenoma, NOS
    - Adenomatoid odontogenic tumor
    - Adenomatoid tumor, NOS
    - Adenomatosis, NOS
    - Adenomatous polyp, NOS
    - Adenomatous polyposis coli
    - Adenomyoepithelioma
    - Adenomyoepithelioma with carcinoma
    - Adenomyoma
    - Adenosarcoma
    - Adenosquamous carcinoma
    - Adnexal carcinoma
    - Adnexal tumor, benign
    - Adrenal cortical adenocarcinoma
    - Adrenal cortical adenoma, clear cell
    - Adrenal cortical adenoma, compact cell
    - Adrenal cortical adenoma, glomerulosa cell
    - Adrenal cortical adenoma, mixed cell
    - Adrenal cortical adenoma, NOS
    - Adrenal cortical adenoma, pigmented
    - Adrenal cortical carcinoma
    - Adrenal cortical tumor, benign
    - Adrenal cortical tumor, malignant
    - Adrenal cortical tumor, NOS
    - Adrenal medullary paraganglioma
    - Adrenal medullary paraganglioma, malignant
    - Adrenal rest tumor
    - Adult cystic teratoma
    - Adult granulosa cell tumor
    - Adult rhabdomyoma
    - Adult T-cell leukemia
    - Adult T-cell leukemia/lymphoma (HTLV-1 positive) (includes all variants)
    - Adult T-cell lymphoma
    - Adult T-cell lymphoma/leukemia
    - Adult teratoma, NOS
    - Aggressive angiomyxoma
    - Aggressive digital papillary adenoma
    - Aggressive fibromatosis
    - Aggressive NK-cell leukaemia
    - Aggressive osteoblastoma
    - Aggressive systemic mastocytosis
    - Agnogenic myeloid metaplasia
    - AIN III
    - Aleukemic granulocytic leukemia
    - Aleukemic leukemia, NOS
    - Aleukemic lymphatic leukemia
    - Aleukemic lymphocytic leukemia
    - Aleukemic lymphoid leukemia
    - Aleukemic monocytic leukemia
    - Aleukemic myelogenous leukemia
    - Aleukemic myeloid leukemia
    - ALK positive large B-cell lymphoma
    - Alpha cell tumor, malignant
    - Alpha cell tumor, NOS
    - Alpha heavy chain disease
    - Alveolar adenocarcinoma
    - Alveolar adenoma
    - Alveolar carcinoma
    - Alveolar cell carcinoma
    - Alveolar rhabdomyosarcoma
    - Alveolar soft part sarcoma
    - Amelanotic melanoma
    - Ameloblastic carcinoma
    - Ameloblastic fibro-odontoma
    - Ameloblastic fibro-odontosarcoma
    - Ameloblastic fibrodentinoma
    - Ameloblastic fibrodentinosarcoma
    - Ameloblastic fibroma
    - Ameloblastic fibrosarcoma
    - Ameloblastic odontosarcoma
    - Ameloblastic sarcoma
    - Ameloblastoma, malignant
    - Ameloblastoma, NOS
    - AML M6
    - Anal intraepithelial neoplasia, grade III
    - Anal intraepithelial neoplasia, low grade
    - Anaplastic astrocytoma, IDH-mutant
    - Anaplastic astrocytoma, IDH-wildtype
    - Anaplastic large B-cell lymphoma
    - Anaplastic large cell lymphoma, ALK negative
    - Anaplastic large cell lymphoma, ALK positive
    - Anaplastic large cell lymphoma, CD30+
    - Anaplastic large cell lymphoma, NOS
    - Anaplastic large cell lymphoma, T cell and Null cell type
    - Anaplastic medulloblastoma
    - Anaplastic oligoastrocytoma
    - Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted
    - Anaplastic pleomorphic xanthroastrocytoma
    - Ancient schwannoma
    - Androblastoma, benign
    - Androblastoma, malignant
    - Androblastoma, NOS
    - Angioblastic meningioma
    - Angioblastoma
    - Angiocentric glioma
    - Angiocentric immunoproliferative lesion
    - Angiocentric T-cell lymphoma
    - Angioendothelioma
    - Angioendotheliomatosis
    - Angiofibroma, NOS
    - Angioimmunoblastic lymphadenopathy
    - Angioimmunoblastic lymphoma
    - Angioimmunoblastic T-cell lymphoma
    - Angiokeratoma
    - Angioleiomyoma
    - Angiolipoma, NOS
    - Angioma, NOS
    - Angiomatoid fibrous histiocytoma
    - Angiomatous meningioma
    - Angiomyofibroblastoma
    - Angiomyolipoma
    - Angiomyoma
    - Angiomyosarcoma
    - Angiomyxoma
    - Angiosarcoma
    - Angiotropic lymphoma
    - Aortic body paraganglioma
    - Aortic body tumor
    - Aorticopulmonary paraganglioma
    - Apocrine adenocarcinoma
    - Apocrine adenoma
    - Apocrine cystadenoma
    - Apudoma
    - Argentaffinoma, malignant
    - Argentaffinoma, NOS
    - Arrhenoblastoma, benign
    - Arrhenoblastoma, malignant
    - Arrhenoblastoma, NOS
    - Arteriovenous hemangioma
    - Askin tumor
    - Astroblastoma
    - Astrocytic glioma
    - Astrocytoma, anaplastic
    - Astrocytoma, low grade
    - Astrocytoma, NOS
    - Astroglioma
    - Atypical adenoma
    - Atypical carcinoid tumor
    - Atypical choroid plexus papilloma
    - Atypical chronic myeloid leukemia, BCR/ABL negative
    - Atypical chronic myeloid leukemia, Philadelphia chromosome (Ph1) negative
    - Atypical fibrous histiocytoma
    - Atypical fibroxanthoma
    - Atypical follicular adenoma
    - Atypical hyperplasia/Endometrioid intraepithelial neoplasm
    - Atypical leiomyoma
    - Atypical lipoma
    - Atypical medullary carcinoma
    - Atypical meningioma
    - Atypical polypoid adenomyoma
    - Atypical proliferating clear cell tumor
    - Atypical proliferating serous tumor
    - Atypical proliferative endometrioid tumor
    - Atypical proliferative mucinous tumor
    - Atypical proliferative papillary serous tumor
    - Atypical teratoid/rhabdoid tumor
    - B cell lymphoma, NOS
    - B lymphoblastic leukemia/lymphoma with t(5;14)(q31;q32); IL3-IGH
    - B lymphoblastic leukemia/lymphoma, NOS
    - B-ALL
    - B-cell lymphocytic leukemia/small lymphocytic lymphoma
    - B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma
    - B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma
    - Balloon cell melanoma
    - Balloon cell nevus
    - BALT lymphoma
    - Basal cell adenocarcinoma
    - Basal cell adenoma
    - Basal cell carcinoma, desmoplastic type
    - Basal cell carcinoma, fibroepithelial
    - Basal cell carcinoma, micronodular
    - Basal cell carcinoma, morpheic
    - Basal cell carcinoma, nodular
    - Basal cell carcinoma, NOS
    - Basal cell epithelioma
    - Basal cell tumor
    - Basaloid carcinoma
    - Basaloid squamous cell carcinoma
    - Basophil adenocarcinoma
    - Basophil adenoma
    - Basophil carcinoma
    - Basosquamous carcinoma
    - Bednar tumor
    - Bellini duct carcinoma
    - Benign cystic nephroma
    - Benign fibrous histiocytoma
    - Beta cell adenoma
    - Beta cell tumor, malignant
    - Bile duct adenocarcinoma
    - Bile duct adenoma
    - Bile duct carcinoma
    - Bile duct cystadenocarcinoma
    - Bile duct cystadenoma
    - Biliary intraepithelial neoplasia, grade 3
    - Biliary intraepithelial neoplasia, high grade
    - Biliary intraepithelial neoplasia, low grade
    - Biliary papillomatosis
    - Biphenotypic sinonasal sarcoma
    - Bizarre leiomyoma
    - Black adenoma
    - Blast cell leukemia
    - Blastic NK cell lymphoma
    - Blastic plasmacytoid dendritic cell neoplasm
    - Blastoma, NOS
    - Blue nevus, malignant
    - Blue nevus, NOS
    - Botryoid sarcoma
    - Bowen disease
    - Brenner tumor, borderline malignancy
    - Brenner tumor, malignant
    - Brenner tumor, NOS
    - Brenner tumor, proliferating
    - Bronchial adenoma, carcinoid
    - Bronchial adenoma, cylindroid
    - Bronchial adenoma, NOS
    - Bronchial-associated lymphoid tissue lymphoma
    - Bronchio-alveolar carcinoma, mixed mucinous and non-mucinous
    - Bronchio-alveolar carcinoma, mucinous
    - Bronchiolar adenocarcinoma
    - Bronchiolar carcinoma
    - Bronchiolo-alveolar adenocarcinoma, NOS
    - Bronchiolo-alveolar carcinoma, Clara cell
    - Bronchiolo-alveolar carcinoma, Clara cell and goblet cell type
    - Bronchiolo-alveolar carcinoma, goblet cell type
    - Bronchiolo-alveolar carcinoma, indeterminate type
    - Bronchiolo-alveolar carcinoma, non-mucinous
    - Bronchiolo-alveolar carcinoma, NOS
    - Bronchiolo-alveolar carcinoma, type II pneumocyte and goblet cell type
    - Bronchiolo-alveolar carcinoma; type II pneumocyte
    - Brooke tumor
    - Brown fat tumor
    - Burkitt cell leukemia
    - Burkitt lymphoma, NOS (Includes all variants)
    - Burkitt tumor
    - Burkitt-like lymphoma
    - C cell carcinoma
    - c-ALL
    - Calcifying epithelial odontogenic tumor
    - Calcifying epithelioma of Malherbe
    - Calcifying nested epithelial stromal tumor
    - Calcifying odontogenic cyst
    - Canalicular adenoma
    - Cancer
    - Capillary hemangioma
    - Capillary lymphangioma
    - Carcinofibroma
    - Carcinoid tumor of uncertain malignant potential
    - Carcinoid tumor, argentaffin, malignant
    - Carcinoid tumor, argentaffin, NOS
    - Carcinoid tumor, NOS
    - Carcinoid tumor, NOS, of appendix
    - Carcinoid, NOS
    - Carcinoid, NOS, of appendix
    - Carcinoma in a polyp, NOS
    - Carcinoma in adenomatous polyp
    - Carcinoma in pleomorphic adenoma
    - Carcinoma in situ in a polyp, NOS
    - Carcinoma in situ in adenomatous polyp
    - Carcinoma in situ, NOS
    - Carcinoma showing thymus-like differentiation
    - Carcinoma showing thymus-like element
    - Carcinoma simplex
    - Carcinoma with apocrine metaplasia
    - Carcinoma with chondroid differentiation
    - Carcinoma with neuroendocrine differentiation
    - Carcinoma with osseous differentiation
    - Carcinoma with osteoclast-like giant cells
    - Carcinoma with other types mesenchymal differentiation
    - Carcinoma with productive fibrosis
    - Carcinoma, anaplastic, NOS
    - Carcinoma, diffuse type
    - Carcinoma, intestinal type
    - Carcinoma, metastatic, NOS
    - Carcinoma, NOS
    - Carcinoma, undifferentiated, NOS
    - Carcinomatosis
    - Carcinosarcoma, embryonal
    - Carcinosarcoma, NOS
    - Carotid body paraganglioma
    - Carotid body tumor
    - Cartilaginous exostosis
    - CASTLE
    - Cavernous hemangioma
    - Cavernous lymphangioma
    - Cellular angiofibroma
    - Cellular blue nevus
    - Cellular ependymoma
    - Cellular fibroma
    - Cellular leiomyoma
    - Cellular schwannoma
    - Cementifying fibroma
    - Cemento-ossifying fibroma
    - Cementoblastoma, benign
    - Cementoma, NOS
    - Central neuroblastoma
    - Central neurocytoma
    - Central odontogenic fibroma
    - Central osteosarcoma
    - Central primitive neuroectodermal tumor, NOS
    - Cerebellar liponeurocytoma
    - Cerebellar sarcoma, NOS
    - Ceruminous adenocarcinoma
    - Ceruminous adenoma
    - Ceruminous carcinoma
    - Cervical intraepithelial neoplasia, grade III
    - Cervical intraepithelial neoplasia, low grade
    - Chemodectoma
    - Chief cell adenoma
    - Chloroma
    - Cholangiocarcinoma
    - Cholangioma
    - Chondroblastic osteosarcoma
    - Chondroblastoma, malignant
    - Chondroblastoma, NOS
    - Chondroid chordoma
    - Chondroid lipoma
    - Chondroid syringoma
    - Chondroma, NOS
    - Chondromatosis, NOS
    - Chondromatous giant cell tumor
    - Chondromyxoid fibroma
    - Chondrosarcoma grade 2/3
    - Chordoid glioma
    - Chordoid glioma of third ventricle
    - Chordoid meningioma
    - Chordoma, NOS
    - Chorioadenoma
    - Chorioadenoma destruens
    - Chorioangioma
    - Choriocarcinoma combined with embryonal carcinoma
    - Choriocarcinoma combined with other germ cell elements
    - Choriocarcinoma combined with teratorna
    - Choriocarcinoma, NOS
    - Chorioepithelioma
    - Chorionepithelioma
    - Choroid plexus carcinoma
    - Choroid plexus papilloma, anaplastic
    - Choroid plexus papilloma, malignant
    - Choroid plexus papilloma, NOS
    - Chromaffin paraganglioma
    - Chromaffin tumor
    - Chromaffinoma
    - Chromophobe adenocarcinoma
    - Chromophobe adenoma
    - Chromophobe carcinoma
    - Chromophobe cell renal carcinoma
    - Chronic eosinophilic leukemia, NOS
    - Chronic erythremia
    - Chronic granulocytic leukemia, BCR/ABL
    - Chronic granulocytic leukemia, NOS
    - Chronic granulocytic leukemia, Philadelphia chromosome (Ph1) positive
    - Chronic granulocytic leukemia, t(9;22)(q34;q11)
    - Chronic idiopathic myelofibrosis
    - Chronic leukemia, NOS
    - Chronic lymphatic leukemia
    - Chronic lymphocytic leukemia
    - Chronic lymphocytic leukemia, B-cell type (includes all variants of BCLL)
    - Chronic lymphoid leukemia
    - Chronic lymphoproliferative disorder of NK cells
    - Chronic monocytic leukemia
    - Chronic myelocytic leukemia, NOS
    - Chronic myelogenous leukemia, BCR-ABL positive
    - Chronic myelogenous leukemia, Philadelphia chromosome (Ph 1) positive
    - Chronic myelogenous leukemia, t(9;22)(q34;q11)
    - Chronic myeloid leukemia, NOS
    - Chronic myelomonocytic leukemia in transformation
    - Chronic myelomonocytic leukemia, NOS
    - Chronic myelomonocytic leukemia, Type 1
    - Chronic myelomonocytic leukemia, Type II
    - Chronic myeloproliferative disease, NOS
    - Chronic myeloproliferative disorder
    - Chronic neutrophilic leukemia
    - CIN III with severe dysplasia
    - Cin III, NOS
    - Circumscribed arachnoidal cerebellar sarcoma
    - Classical Hodgkin lymphoma, lymphocyte depletion, diffuse fibrosis
    - Classical Hodgkin lymphoma, lymphocyte depletion, NOS
    - Classical Hodgkin lymphoma, lymphocyte depletion, reticular
    - Classical Hodgkin lymphoma, lymphocyte-rich
    - Classical Hodgkin lymphoma, mixed cellularity, NOS
    - Classical Hodgkin lymphoma, nodular sclerosis, cellular phase
    - Classical Hodgkin lymphoma, nodular sclerosis, grade 1
    - Classical Hodgkin lymphoma, nodular sclerosis, grade 2
    - Classical Hodgkin lymphoma, nodular sclerosis, NOS
    - Clear cell (glycogen-rich) urothelial carcinoma
    - Clear cell adenocarcinofibroma
    - Clear cell adenocarcinoma, mesonephroid
    - Clear cell adenocarcinoma, NOS
    - Clear cell adenofibroma
    - Clear cell adenofibroma of borderline malignancy
    - Clear cell adenoma
    - Clear cell carcinoma
    - Clear cell chondrosarcoma
    - Clear cell cystadenocarcinofibroma
    - Clear cell cystadenofibroma
    - Clear cell cystadenofibroma of borderline malignancy
    - Clear cell cystadenoma
    - Clear cell cystic tumor of borderline malignancy
    - Clear cell ependymoma
    - Clear cell hidradenoma
    - Clear cell meningioma
    - Clear cell odontogenic carcinoma
    - Clear cell odontogenic tumor
    - Clear cell sarcoma of kidney
    - Clear cell sarcoma, NOS
    - Clear cell sarcoma, of tendons and aponeuroses
    - Clear cell tumor, NOS
    - Cloacogenic carcinoma
    - CNS Embryonal tumor with rhabdoid features
    - Codman tumor
    - Collecting duct carcinoma
    - Colloid adenocarcinoma
    - Colloid adenoma
    - Colloid carcinoma
    - Columnar cell papilloma
    - Combined carcinoid and adenocarcinoma
    - Combined hepatocellular carcinoma and cholangiocarcinoma
    - Combined large cell neuroendocrine carcinoma
    - Combined small cell carcinoma
    - Combined small cell-adenocarcinoma
    - Combined small cell-large carcinoma
    - Combined small cell-squamous cell carcinoma
    - Combined/mixed carcinoid and adenocarcinoma
    - Comedocarcinoma, noninfiltrating
    - Comedocarcinoma, NOS
    - Common ALL
    - Common precursor B ALL
    - Complete hydatidiform mole
    - Complex odontoma
    - Composite carcinoid
    - Composite Hodgkin and non-Hodgkin lymphoma
    - Compound nevus
    - Compound odontoma
    - Condylomatous carcinoma
    - Congenital fibrosarcoma
    - Congenital generalized fibromatosis
    - Congenital peribronchial myofibroblastic tumor
    - Conventional central osteosarcoma
    - Cortical T ALL
    - CPNET
    - Craniopharyngioma, adamantinomatous
    - Craniopharyngioma, papillary
    - Cribriform carcinoma in situ
    - Cribriform carcinoma, NOS
    - Cribriform comedo-type carcinoma
    - Cutaneous histiocytoma, NOS
    - Cutaneous lymphoma, NOS
    - Cutaneous mastocytosis
    - Cutaneous T-cell lymphoma, NOS
    - Cylindrical cell carcinoma
    - Cylindrical cell papilloma
    - Cylindroma of skin
    - Cylindroma, NOS
    - Cyst-associated renal cell carcinoma
    - Cystadenocarcinoma, NOS
    - Cystadenofibroma, NOS
    - Cystadenoma, NOS
    - Cystic astrocytoma
    - Cystic hygroma
    - Cystic hypersecretory carcinoma
    - Cystic lymphangioma
    - Cystic mesothelioma, benign
    - Cystic mesothelioma, NOS
    - Cystic partially differentiated nephroblastoma
    - Cystic teratoma, NOS
    - Cystic tumor of atrio-ventricular node
    - Cystoma, NOS
    - Cystosarcoma phyllodes, benign
    - Cystosarcoma phyllodes, malignant
    - Cystosarcoma phyllodes, NOS
    - Dabska tumor
    - DCIS, comedo type
    - DCIS, NOS
    - DCIS, papillary
    - Dedifferentiated chondrosarcoma
    - Dedifferentiated chordoma
    - Dedifferentiated liposarcoma
    - Deep histiocytoma
    - Degenerated schwannoma
    - Dendritic cell sarcoma, NOS
    - Dentinoma
    - Dermal and epidermal nevus
    - Dermal nevus
    - Dermatofibroma lenticulare
    - Dermatofibroma, NOS
    - Dermatofibrosarcoma protuberans, NOS
    - Dermatofibrosarcoma, NOS
    - Dermoid cyst with malignant transformation
    - Dermoid cyst with secondary tumor
    - Dermoid cyst, NOS
    - Dermoid, NOS
    - Desmoid, NOS
    - Desmoplastic fibroma
    - Desmoplastic infantile astrocytoma
    - Desmoplastic infantile ganglioglioma
    - Desmoplastic medulloblastoma
    - Desmoplastic melanoma, amelanotic
    - Desmoplastic melanoma, malignant
    - Desmoplastic mesothelioma
    - Desmoplastic nodular medulloblastoma
    - Desmoplastic small round cell tumor
    - Di Guglielmo disease
    - Differentiated penile intraepithelial neoplasia
    - Differentiated-type vulvar intraepithelial neoplasia
    - Diffuse astrocytoma
    - Diffuse astrocytoma, IDH-mutant
    - Diffuse astrocytoma, IDH-wildtype
    - Diffuse astrocytoma, low grade
    - Diffuse cutaneous mastocytosis
    - Diffuse intraductal papillomatosis
    - Diffuse large B-cell lymphoma associated with chronic inflammation
    - Diffuse large B-cell lymphoma, NOS
    - Diffuse leptomeningeal glioneuronal tumor
    - Diffuse melanocytosis
    - Diffuse meningiomatosis
    - Diffuse midline glioma, H3 K27M-mutant
    - Digital papillary adenocarcinoma
    - Diktyoma, benign
    - Diktyoma, malignant
    - DIN 3
    - Duct adenocarcinoma, NOS
    - Duct adenoma, NOS
    - Duct carcinoma, desmoplastic type
    - Duct carcinoma, NOS
    - Duct cell carcinoma
    - Ductal carcinoma in situ, comedo type
    - Ductal carcinoma in situ, cribriform type
    - Ductal carcinoma in situ, micropapillary
    - Ductal carcinoma in situ, NOS
    - Ductal carcinoma in situ, papillary
    - Ductal carcinoma in situ, solid type
    - Ductal carcinoma, cribriform type
    - Ductal carcinoma, NOS
    - Ductal intraepithelial neoplasia 3
    - Ductal papilloma
    - Dysembryoplastic neuroepithelial tumor
    - Dysgerminoma
    - Dysplastic gangliocytoma of cerebellum (Lhermitte-Duclos)
    - Dysplastic nevus
    - EBV positive diffuse large B-cell lymphoma of the elderly
    - EC cell carcinoid
    - Ecchondroma
    - Ecchondrosis
    - Eccrine acrospiroma
    - Eccrine adenocarcinoma
    - Eccrine cystadenoma
    - Eccrine dermal cylindroma
    - Eccrine papillary adenocarcinoma
    - Eccrine papillary adenoma
    - Eccrine poroma
    - Eccrine poroma, malignant
    - Eccrine spiradenoma
    - ECL cell carcinoid, malignant
    - ECL cell carcinoid, NOS
    - Ectomesenchymoma
    - Ectopic hamartomatous thymoma
    - Elastofibroma
    - Embryonal adenocarcinoma
    - Embryonal adenoma
    - Embryonal carcinoma, infantile
    - Embryonal carcinoma, NOS
    - Embryonal carcinoma, polyembryonal type
    - Embryonal hepatoma
    - Embryonal rhabdomyosarcoma, NOS
    - Embryonal rhabdomyosarcoma, pleomorphic
    - Embryonal sarcoma
    - Embryonal teratoma
    - Embryonal tumor with multilayered rosettes C19MC-altered
    - Embryonal tumor with multilayered rosettes, NOS
    - Embryonal tumor with rhabdoid features
    - Encapsulated follicular variant of papillary thyroid carcinoma, NOS (EFVPTC, NOS)
    - Encapsulated papillary carcinoma
    - Encapsulated papillary carcinoma with invasion
    - Enchondroma
    - Endocervical adenocarcinoma usual type
    - Endocrine adenomatosis
    - Endocrine tumor, functioning, NOS
    - Endodermal sinus tumor
    - Endolymphatic stromal myosis
    - Endometrial sarcoma, NOS
    - Endometrial stromal nodule
    - Endometrial stromal sarcoma, high grade
    - Endometrial stromal sarcoma, low grade
    - Endometrial stromal sarcoma, NOS
    - Endometrial stromatosis
    - Endometrioid adenocarcinoma, ciliated cell variant
    - Endometrioid adenocarcinoma, NOS
    - Endometrioid adenocarcinoma, secretory variant
    - Endometrioid adenocarcinoma, villoglandular
    - Endometrioid adenofibroma, borderline malignancy
    - Endometrioid adenofibroma, malignant
    - Endometrioid adenofibroma, NOS
    - Endometrioid adenoma, borderline malignancy
    - Endometrioid adenoma, NOS
    - Endometrioid carcinoma with squamous differentiation
    - Endometrioid carcinoma, NOS
    - Endometrioid cystadenocarcinoma
    - Endometrioid cystadenofibroma, borderline malignancy
    - Endometrioid cystadenofibroma, malignant
    - Endometrioid cystadenofibroma, NOS
    - Endometrioid cystadenoma, borderline malignancy
    - Endometrioid cystadenoma, NOS
    - Endometrioid tumor of low malignant potential
    - Endotheliomatous meningioma
    - Endovascular papillary angioendothelioma
    - Enteric adenocarcinoma
    - Enterochromaffin cell carcinoid
    - Enterochromaffin-like cell carcinoid, NOS
    - Enterochromaffin-like cell tumor, malignant
    - Enteroglucagonoma, malignant
    - Enteroglucagonoma, NOS
    - Enteropathy associated T-cell lymphoma
    - Enteropathy type intestinal T-cell lymphoma
    - Eosinophil adenocarcinoma
    - Eosinophil adenoma
    - Eosinophil carcinoma
    - Eosinophilic granuloma
    - Eosinophilic leukemia
    - Ependymoblastoma
    - Ependymoma, anaplastic
    - Ependymoma, RELA fusion-positive
    - Epidermoid carcinoma in situ with questionable stromal invasion
    - Epidermoid carcinoma in situ, NOS
    - Epidermoid carcinoma, keratinizing
    - Epidermoid carcinoma, large cell, nonkeratinizing
    - Epidermoid carcinoma, NOS
    - Epidermoid carcinoma, small cell, nonkeratinizing
    - Epidermoid carcinoma, spindle cell
    - Epithelial ependymoma
    - Epithelial tumor, benign
    - Epithelial tumor, malignant
    - Epithelial-myoepithelial carcinoma
    - Epithelioid and spindle cell nevus
    - Epithelioid cell melanoma
    - Epithelioid cell nevus
    - Epithelioid cell sarcoma
    - Epithelioid glioblastoma
    - Epithelioid hemangioendothelioma, malignant
    - Epithelioid hemangioendothelioma, NOS
    - Epithelioid hemangioma
    - Epithelioid leiomyoma
    - Epithelioid leiomyosarcoma
    - Epithelioid malignant peripheral nerve sheath tumor
    - Epithelioid mesothelioma, benign
    - Epithelioid mesothelioma, malignant
    - Epithelioid mesothelioma, NOS
    - Epithelioid MPNST
    - Epithelioid sarcoma
    - Epithelioma adenoides cysticum
    - Epithelioma, benign
    - Epithelioma, malignant
    - Epithelioma, NOS
    - Erythremic myelosis, NOS
    - Erythroleukemia
    - Esophageal glandular dysplasia (intraepithelial neoplasia), high grade
    - Esophageal glandular dysplasia (intraepithelial neoplasia), low grade
    - Esophageal intraepithelial neoplasia, high grade
    - Esophageal squamous intraepithelial neoplasia (dysplasia), high grade
    - Esophageal squamous intraepithelial neoplasia (dysplasia), low grade
    - Essential hemorrhagic thrombocythaemia
    - Essential thrombocythemia
    - Esthesioneuroblastoma
    - Esthesioneurocytoma
    - Esthesioneuroepithelioma
    - Ewing sarcoma
    - Ewing tumor
    - Extra-abdominal desmoid
    - Extra-adrenal paraganglioma, malignant
    - Extra-adrenal paraganglioma, NOS
    - Extracutaneous mastocytoma
    - Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue
    - Extranodal NK/T-cell lymphoma, nasal type
    - Extraosseous plasmacytoma
    - Extraventricular neurocytoma
    - FAB L2
    - FAB L3
    - FAB Ll
    - FAB M1
    - FAB M2, AML1(CBF-alpha)/ETO
    - FAB M2, NOS
    - FAB M2, t(8;21)(q22;q22)
    - FAB M3 (includes all variants)
    - FAB M4
    - FAB M4Eo
    - FAB M5 (includes all variants)
    - FAB M6
    - FAB M7
    - FAB MO
    - Familial polyposis coli
    - Fascial fibroma
    - Fascial fibrosarcoma
    - Fetal adenocarcinoma
    - Fetal adenoma
    - Fetal fat cell lipoma
    - Fetal lipoma, NOS
    - Fetal lipomatosis
    - Fetal rhabdomyoma
    - Fibrillary astrocytoma
    - Fibro-osteoma
    - Fibroadenoma, NOS
    - Fibroameloblastic odontoma
    - Fibroblastic liposarcoma
    - Fibroblastic meningioma
    - Fibroblastic osteosarcoma
    - Fibroblastic reticular cell tumor
    - Fibrochondrosarcoma
    - Fibroepithelial basal cell carcinoma, Pinkus type
    - Fibroepithelioma of Pinkus type
    - Fibroepithelioma, NOS
    - Fibrofolliculoma
    - Fibroid uterus
    - Fibrolipoma
    - Fibroliposarcoma
    - Fibroma, NOS
    - Fibromatosis-like metaplastic carcinoma
    - Fibromyoma
    - Fibromyxolipoma
    - Fibromyxoma
    - Fibromyxosarcoma
    - Fibrosarcoma, NOS
    - Fibrosarcomatous dermatofibrosarcoma protuberans
    - Fibrous astrocytoma
    - Fibrous histiocytoma of tendon sheath
    - Fibrous histiocytoma, NOS
    - Fibrous meningioma
    - Fibrous mesothelioma, benign
    - Fibrous mesothelioma, malignant
    - Fibrous mesothelioma, NOS
    - Fibrous papule of nose
    - Fibroxanthoma, malignant
    - Fibroxanthoma, NOS
    - Flat adenoma
    - Flat intraepithelial glandular neoplasia, high grade
    - Flat intraepithelial neoplasia, high grade
    - Florid osseous dysplasia
    - Follicular adenocarcinoma, moderately differentiated
    - Follicular adenocarcinoma, NOS
    - Follicular adenocarcinoma, trabecular
    - Follicular adenocarcinoma, well differentiated
    - Follicular adenoma
    - Follicular adenoma, oxyphilic cell
    - Follicular carcinoma, encapsulated
    - Follicular carcinoma, minimally invasive
    - Follicular carcinoma, moderately differentiated
    - Follicular carcinoma, NOS
    - Follicular carcinoma, oxyphilic cell
    - Follicular carcinoma, trabecular
    - Follicular carcinoma, well differentiated
    - Follicular dendritic cell sarcoma
    - Follicular dendritic cell tumor
    - Follicular fibroma
    - Follicular lymphoma, grade 1
    - Follicular lymphoma, grade 2
    - Follicular lymphoma, grade 3
    - Follicular lymphoma, grade 3A
    - Follicular lymphoma, grade 3B
    - Follicular lymphoma, NOS
    - Follicular lymphoma, small cleaved cell
    - Follicular thyroid carcinoma (FTC), encapsulated angioinvasive
    - Folliculome lipidique
    - Franklin disease
    - G cell tumor, malignant
    - G cell tumor, NOS
    - Gamma heavy chain disease
    - Gangliocytic paraganglioma
    - Gangliocytoma
    - Ganglioglioma, anaplastic
    - Ganglioglioma, NOS
    - Ganglioneuromatosis
    - GANT
    - Gastrin cell tumor
    - Gastrin cell tumor, malignant
    - Gastrinoma, malignant
    - Gastrinoma, NOS
    - Gastrointestinal autonomic nerve tumor
    - Gastrointestinal pacemaker cell tumor
    - Gastrointestinal stromal sarcoma
    - Gastrointestinal stromal tumor, benign
    - Gastrointestinal stromal tumor, malignant
    - Gastrointestinal stromal tumor, NOS
    - Gastrointestinal stromal tumor, uncertain malignant potential
    - Gelatinous adenocarcinoma
    - Gelatinous carcinoma
    - Gemistocytic astrocytoma
    - Gemistocytoma
    - Genital rhabdomyoma
    - Germ cell tumor, nonseminomatous
    - Germ cell tumor, NOS
    - Germ cell tumors with associated hematological malignancy
    - Ghost cell odontogenic carcinoma
    - Giant cell and spindle cell carcinoma
    - Giant cell angiofibroma
    - Giant cell carcinoma
    - Giant cell fibroblastoma
    - Giant cell glioblastoma
    - Giant cell sarcoma
    - Giant cell sarcoma of bone
    - Giant cell tumor of bone, malignant
    - Giant cell tumor of bone, NOS
    - Giant cell tumor of soft parts, NOS
    - Giant cell tumor of tendon sheath
    - Giant cell tumor of tendon sheath, malignant
    - Giant fibroadenoma
    - Giant osteoid osteoma
    - Giant pigmented nevus, NOS
    - Gigantiform cementoma
    - GIST, benign
    - GIST, malignant
    - GIST, NOS
    - Glandular intraepithelial neoplasia, grade I
    - Glandular intraepithelial neoplasia, grade II
    - Glandular intraepithelial neoplasia, grade III
    - Glandular intraepithelial neoplasia, high grade
    - Glandular intraepithelial neoplasia, low grade
    - Glandular papilloma
    - Glassy cell carcinoma
    - Glioblastoma multiforme
    - Glioblastoma with sarcomatous component
    - Glioblastoma, IDH wildtype
    - Glioblastoma, IDH-mutant
    - Gliofibroma
    - Glioma, malignant
    - Glioma, NOS
    - Gliomatosis cerebri
    - Glioneuroma
    - Gliosarcoma
    - Glomangioma
    - Glomangiomyoma
    - Glomangiosarcoma
    - Glomoid sarcoma
    - Glomus jugulare tumor, NOS
    - Glomus tumor, malignant
    - Glomus tumor, NOS
    - Glucagon-like peptide-producing tumor
    - Glucagonoma, malignant
    - Glucagonoma, NOS
    - Glycogen-rich carcinoma
    - Glycogenic rhabdomyoma
    - Goblet cell carcinoid
    - Gonadal stromal tumor, NOS
    - Gonadoblastoma
    - Gonocytoma
    - Granular cell adenocarcinoma
    - Granular cell carcinoma
    - Granular cell myoblastoma, malignant
    - Granular cell myoblastoma, NOS
    - Granular cell tumor of the sellar region
    - Granular cell tumor, malignant
    - Granular cell tumor, NOS
    - Granulocytic leukemia, NOS
    - Granulocytic sarcoma
    - Granulosa cell carcinoma
    - Granulosa cell tumor, adult type
    - Granulosa cell tumor, juvenile
    - Granulosa cell tumor, malignant
    - Granulosa cell tumor, NOS
    - Granulosa cell tumor, sarcomatoid
    - Granulosa cell-theca cell tumor
    - Grawitz tumor
    - Gynandroblastoma
    - Haemangioblastoma
    - Haemangiosarcoma
    - Hairy cell leukaemia variant
    - Hairy cell leukemia
    - Hairy cell leukemia variant
    - Hairy nevus
    - Halo nevus
    - Hand-Schuller-Christian disease
    - Heavy chain disease, NOS
    - Hemangioblastic meningioma
    - Hemangioendothelial sarcoma
    - Hemangioendothelioma, benign
    - Hemangioendothelioma, malignant
    - Hemangioendothelioma, NOS
    - Hemangioma simplex
    - Hemangioma, NOS
    - Hemangiopericytic meningioma
    - Hemangiopericytoma, benign
    - Hemangiopericytoma, malignant
    - Hemangiopericytoma, NOS
    - Hemolymphangioma
    - Hepatoblastoma, epithelioid
    - Hepatoblastoma, mixed epithelial-mesenchymal
    - Hepatocarcinoma
    - Hepatocellular adenoma
    - Hepatocellular carcinoma, clear cell type
    - Hepatocellular carcinoma, fibrolamellar
    - Hepatocellular carcinoma, NOS
    - Hepatocellular carcinoma, pleomorphic type
    - Hepatocellular carcinoma, sarcomatoid
    - Hepatocellular carcinoma, scirrhous
    - Hepatocellular carcinoma, spindle cell variant
    - Hepatocholangiocarcinoma
    - Hepatoid adenocarcinoma
    - Hepatoid carcinoma
    - Hepatoid yolk sac tumor
    - Hepatoma, benign
    - Hepatoma, malignant
    - Hepatoma, NOS
    - Hepatosplenic gamma-delta cell lymphoma
    - Hepatosplenic T-cell lymphoma
    - Hereditary leiomyomatosis & RCC-associated renal cell carcinoma
    - Hibernoma
    - Hidradenocarcinoma
    - Hidradenoma papilliferum
    - Hidradenoma, NOS
    - Hidrocystoma
    - High grade surface osteosarcoma
    - High-grade neuroendocrine carcinoma
    - Hilar cell tumor
    - Hilus cell tumor
    - Histiocyte-rich large B-cell lymphoma
    - Histiocytic medullary reticulosis
    - Histiocytic sarcoma
    - Histiocytoid hemangioma
    - Histiocytoma, NOS
    - Histiocytosis X, NOS
    - Hodgkin disease, lymphocyte predominance, diffuse
    - Hodgkin disease, lymphocyte predominance, NOS
    - Hodgkin disease, lymphocytic-histiocytic predominance
    - Hodgkin disease, nodular sclerosis, lymphocyte depletion
    - Hodgkin disease, nodular sclerosis, lymphocyte predominance
    - Hodgkin disease, nodular sclerosis, mixed cellularity
    - Hodgkin disease, nodular sclerosis, NOS
    - Hodgkin disease, nodular sclerosis, syncytial variant
    - Hodgkin disease, NOS
    - Hodgkin granuloma
    - Hodgkin lymphoma, lymphocyte depletion, diffuse fibrosis
    - Hodgkin lymphoma, lymphocyte depletion, NOS
    - Hodgkin lymphoma, lymphocyte depletion, reticular
    - Hodgkin lymphoma, lymphocyte predominance, nodular
    - Hodgkin lymphoma, lymphocyte-rich
    - Hodgkin lymphoma, mixed cellularity, NOS
    - Hodgkin lymphoma, nodular lymphocyte predominance
    - Hodgkin lymphoma, nodular sclerosis, cellular phase
    - Hodgkin lymphoma, nodular sclerosis, grade 1
    - Hodgkin lymphoma, nodular sclerosis, grade 2
    - Hodgkin lymphoma, nodular sclerosis, NOS
    - Hodgkin lymphoma, NOS
    - Hodgkin paragranuloma, nodular
    - Hodgkin paragranuloma, NOS
    - Hodgkin sarcoma
    - Hurthle cell adenocarcinoma
    - Hurthle cell adenoma
    - Hurthle cell carcinoma
    - Hurthle cell tumor
    - Hutchinson melanotic freckle, NOS
    - Hyalinizing trabecular adenoma
    - Hydatid mole
    - Hydatidiform mole, NOS
    - Hydroa vacciniforme-like lymphoma
    - Hygroma, NOS
    - Hypereosinophilic syndrome
    - Hypernephroid tumor
    - Hypernephroma
    - Idiopathic hemorrhagic thrombocythaemia
    - Idiopathic thrombocythemia
    - Immature teratoma, malignant
    - Immature teratoma, NOS
    - Immunoblastic sarcoma
    - Immunocytoma
    - Immunoglobulin deposition disease
    - Immunoproliferative disease, NOS
    - Immunoproliferative small intestinal disease
    - Indeterminate dendritic cell tumor
    - Indolent systemic mastocytosis
    - Infantile fibrosarcoma
    - Infantile hemangioma
    - Infantile myofibromatosis
    - Infiltrating and papillary adenocarcinoma
    - Infiltrating angiolipoma
    - Infiltrating basal cell carcinoma, non-sclerosing
    - Infiltrating basal cell carcinoma, NOS
    - Infiltrating basal cell carcinoma, sclerosing
    - Infiltrating duct adenocarcinoma
    - Infiltrating duct and colloid carcinoma
    - Infiltrating duct and cribriform carcinoma
    - Infiltrating duct and lobular carcinoma in situ
    - Infiltrating duct and tubular carcinoma
    - Infiltrating duct carcinoma, NOS
    - Infiltrating duct mixed with other types of carcinoma
    - Infiltrating ductular carcinoma
    - Infiltrating lipoma
    - Infiltrating lobular carcinoma and ductal carcinoma in situ
    - Infiltrating lobular carcinoma, NOS
    - Infiltrating lobular mixed with other types of carcinoma
    - Infiltrating papillary adenocarcinoma
    - Inflammatory adenocarcinoma
    - Inflammatory carcinoma
    - Inflammatory liposarcoma
    - Inflammatory myofibroblastic tumor
    - Insular carcinoma
    - Insulinoma, malignant
    - Insulinoma, NOS
    - Interdigitating cell sarcoma
    - Interdigitating dendritic cell sarcoma
    - Intermediate and giant congenital nevus
    - Interstitial cell tumor, benign
    - Interstitial cell tumor, malignant
    - Interstitial cell tumor, NOS
    - Intestinal T-cell lymphoma
    - Intestinal-type adenocarcinoma
    - Intimal sarcoma
    - Intracanalicular fibroadenoma
    - Intracortical osteosarcoma
    - Intracystic carcinoma, NOS
    - Intracystic papillary adenocarcinoma
    - Intracystic papillary adenoma
    - Intracystic papillary neoplasm with associated invasive carcinoma
    - Intracystic papillary neoplasm with high grade intraepithelial neoplasia
    - Intracystic papillary neoplasm with intermediate grade intraepithelial neoplasia
    - Intracystic papillary neoplasm with low grade intraepithelial neoplasia
    - Intracystic papillary tumor with high grade dysplasia
    - Intracystic papillary tumor with high grade entraepithelial neoplasia
    - Intracystic papillary tumor with high grade intraepithelial neoplasia
    - Intracystic papilloma
    - Intradermal nevus
    - Intraductal adenocarcinoma, noninfiltrating, NOS
    - Intraductal and lobular carcinoma
    - Intraductal carcinoma and lobular carcinoma in situ
    - Intraductal carcinoma, clinging
    - Intraductal carcinoma, noninfiltrating, NOS
    - Intraductal carcinoma, NOS
    - Intraductal carcinoma, solid type
    - Intraductal micropapillary carcinoma
    - Intraductal papillary adenocarcinoma with invasion
    - Intraductal papillary adenocarcinoma, NOS
    - Intraductal papillary mucinous neoplasm (IPMN) with an associated invasive carcinoma
    - Intraductal papillary mucinous neoplasm with an associated invasive carcinoma
    - Intraductal papillary mucinous neoplasm with high grade dysplasia
    - Intraductal papillary neoplasm with associated invasive carcinoma
    - Intraductal papillary neoplasm with high grade dysplasia
    - Intraductal papillary neoplasm with high grade intraepithelial neoplasia
    - Intraductal papillary neoplasm with intermediate grade neoplasia
    - Intraductal papillary neoplasm with low grade intraepithelial neoplasia
    - Intraductal papillary neoplasm, NOS
    - Intraductal papillary tumor with high grade dysplasia
    - Intraductal papillary tumor with high grade intraepithelial neoplasia
    - Intraductal papillary-mucinous adenoma
    - Intraductal papillary-mucinous carcinoma, invasive
    - Intraductal papillary-mucinous carcinoma, non-invasive
    - Intraductal papillary-mucinous neoplasm with low grade dysplasia
    - Intraductal papillary-mucinous neoplasm with moderate dysplasia
    - Intraductal papillary-mucinous tumor with intermediate dysplasia
    - Intraductal papillary-mucinous tumor with low grade dysplasia
    - Intraductal papillary-mucinous tumor with moderate dysplasia
    - Intraductal papilloma
    - Intraductal papilloma with ductal carcinoma in situ
    - Intraductal papilloma with lobular carcinoma in situ
    - Intraductal papillomatosis, NOS
    - Intraductal tubular-papillary neoplasm, high grade
    - Intraductal tubular-papillary neoplasm, low grade
    - Intraductal tubulopapillary neoplasm
    - Intraepidermal carcinoma, NOS
    - Intraepidermal epithelioma of Jadassohn
    - Intraepidermal nevus
    - Intraepidermal squamous cell carcinoma, Bowen type
    - Intraepithelial carcinoma, NOS
    - Intraepithelial squamous cell carcinoma
    - Intraglandular papillary neoplasm with low grade intraepithelial neoplasia
    - Intramuscular hemangioma
    - Intramuscular lipoma
    - Intraneural perineurioma
    - Intraosseous low grade osteosarcoma
    - Intraosseous well differentiated osteosarcoma
    - Intratubular germ cell neoplasia
    - Intratubular malignant germ cells
    - Intravascular B-cell lymphoma
    - Intravascular bronchial alveolar tumor
    - Intravascular large B-cell lymphoma
    - Intravascular leiomyomatosis
    - Invasive carcinoma of no special type
    - Invasive carcinoma, NST
    - Invasive encapsulated follicular variant of papillary thyroid carcinoma (invasive EFVPTC)
    - Invasive fibroma
    - Invasive hydatidiform mole
    - Invasive lobular carcinoma, alveolar type
    - Invasive lobular carcinoma, solid type
    - Invasive lobular carcinoma, tubulolobular variant
    - Invasive mammary carcinoma
    - Invasive micropapillary carcinoma
    - Invasive mole, NOS
    - Invasive mucinous adenocarcinoma
    - Involuting nevus
    - Islet cell adenocarcinoma
    - Islet cell adenoma
    - Islet cell adenomatosis
    - Islet cell carcinoma
    - Islet cell tumor, benign
    - Islet cell tumor, NOS
    - Jadassohn blue nevus
    - Jugular paraganglioma
    - Jugulotympanic paraganglioma
    - Junction nevus
    - Junctional nevus, NOS
    - Juvenile angiofibroma
    - Juvenile astrocytoma
    - Juvenile carcinoma of breast
    - Juvenile chronic myelomonocytic leukemia
    - Juvenile fibroadenoma
    - Juvenile hemangioma
    - Juvenile histiocytoma
    - Juvenile melanoma
    - Juvenile myelomonocytic leukemia
    - Juvenile nevus
    - Juxtacortical chondroma
    - Juxtacortical chondrosarcoma
    - Juxtacortical osteosarcoma
    - Juxtaglomerular tumor
    - Kaposi sarcoma
    - Kaposiform hemangioendothelioma
    - Keratotoc papilloma
    - Klatskin tumor
    - Krukenberg tumor
    - Kupffer cell sarcoma
    - L-cell tumor
    - Lactating adenoma
    - Langerhans cell granulomatosis
    - Langerhans cell granulomatosis, unifocal
    - Langerhans cell histiocytosis, disseminated
    - Langerhans cell histiocytosis, generalized
    - Langerhans cell histiocytosis, mono-ostotic
    - Langerhans cell histiocytosis, multifocal
    - Langerhans cell histiocytosis, NOS
    - Langerhans cell histiocytosis, poly-ostotic
    - Langerhans cell histiocytosis, unifocal
    - Langerhans cell sarcoma
    - Large B-cell lymphoma arising in HHV8-associated multicentric Castleman disease
    - Large cell (Ki-1+) lymphoma
    - Large cell calcifying Sertoli cell tumor
    - Large cell carcinoma with rhabdoid phenotype
    - Large cell carcinoma, NOS
    - Large cell medulloblastoma
    - Large cell neuroendocrine carcinoma
    - Large granular lymphocytosis, NOS
    - LCIS, NOS
    - Leiomyoblastoma
    - Leiomyofibroma
    - Leiomyoma, NOS
    - Leiomyomatosis, NOS
    - Lennert lymphoma
    - Lentigo maligna
    - Lentigo maligna melanoma
    - Lepidic adenocarcinoma
    - Lepidic predominant adenocarcinoma
    - Leptomeningeal sarcoma
    - Letterer-Siwe disease
    - Leukemia, NOS
    - Leukemic reticuloendotheliosis
    - Leydig cell tumor, benign
    - Leydig cell tumor, malignant
    - Leydig cell tumor, NOS
    - Linitis plastica
    - Lipid cell tumor of ovary
    - Lipid-rich carcinoma
    - Lipid-rich Sertoli cell tumor
    - Lipid-rich urothelial carcinoma
    - Lipoadenoma
    - Lipoblastoma
    - Lipoblastomatosis
    - Lipoid cell tumor of ovary
    - Lipoleiomyoma
    - Lipoma-like liposarcoma
    - Lipoma, NOS
    - Lipomatous medulloblastoma
    - Liposarcoma, differentiated
    - Liposarcoma, NOS
    - Liposarcoma, well differentiated
    - Liver cell adenoma
    - Liver cell carcinoma
    - Lobular adenocarcinoma
    - Lobular and ductal carcinoma
    - Lobular carcinoma in situ, NOS
    - Lobular carcinoma, noninfiltrating
    - Lobular carcinoma, NOS
    - Localized fibrous tumor
    - Low grade adenosquamous carcinoma
    - Low grade appendiceal mucinous neoplasm
    - Low grade cribriform cystadenocarcinoma (LGCCC)
    - Low-grade central osteosarcoma
    - Low-grade intramedullary osteosarcoma
    - Low-grade myofibroblastic sarcoma
    - Low-grade serous carcinoma
    - Luteinoma
    - Luteoma, NOS
    - Lymphangioendothelial sarcoma
    - Lymphangioendothelioma, malignant
    - Lymphangioendothelioma, NOS
    - Lymphangioleiomyomatosis
    - Lymphangioma, NOS
    - Lymphangiomyoma
    - Lymphangiomyomatosis
    - Lymphangiosarcoma
    - Lymphatic leukemic, NOS
    - Lymphoblastic leukemia, NOS
    - Lymphoblastoma
    - Lymphocytic leukemia, NOS
    - Lymphoepithelial carcinoma
    - Lymphoepithelioid lymphoma
    - Lymphoepithelioma
    - Lymphoepithelioma-like carcinoma
    - Lymphoid leukemia, NOS
    - Lymphomatoid granulomatosis
    - Lymphomatoid papulosis
    - Lymphoplasmacyte-rich meningioma
    - Lymphoproliferative disease, NOS
    - Lymphoproliferative disorder, NOS
    - Lymphosarcoma cell leukemia
    - Lymphosarcoma, diffuse
    - Lymphosarcoma, NOS
    - M6A
    - M6B
    - Macrofollicular adenoma
    - Magnocellular nevus
    - Malignancy
    - Malignant chondroid syringoma
    - Malignant cystic nephroma
    - Malignant eccrine spiradenoma
    - Malignant fibrous histiocytoma
    - Malignant fibrous histiocytoma (MFH) of bone
    - Malignant giant cell tumor of soft parts
    - Malignant histiocytosis
    - Malignant hydatidiform mole
    - Malignant lymphoma, centroblastic, diffuse
    - Malignant lymphoma, centroblastic, follicular
    - Malignant lymphoma, centroblastic, NOS
    - Malignant lymphoma, centroblasticcentrocytic, diffuse
    - Malignant lymphoma, centroblasticcentrocytic, follicular
    - Malignant lymphoma, centroblasticcentrocytic, NOS
    - Malignant lymphoma, centrocytic
    - Malignant lymphoma, cleaved cell, NOS
    - Malignant lymphoma, convoluted cell
    - Malignant lymphoma, diffuse, NOS
    - Malignant lymphoma, follicle center, follicular
    - Malignant lymphoma, follicle center, NOS
    - Malignant lymphoma, follicular, NOS
    - Malignant lymphoma, histiocytic, diffuse
    - Malignant lymphoma, histiocytic, nodular
    - Malignant lymphoma, histiocytic, NOS
    - Malignant lymphoma, Hodgkin
    - Malignant lymphoma, immunoblastic, NOS
    - Malignant lymphoma, large B-cell, diffuse, centroblastic, NOS
    - Malignant lymphoma, large B-cell, diffuse, immunoblastic, NOS
    - Malignant lymphoma, large B-cell, diffuse, NOS
    - Malignant lymphoma, large B-cell, NOS
    - Malignant lymphoma, large cell, cleaved and noncleaved
    - Malignant lymphoma, large cell, cleaved, diffuse
    - Malignant lymphoma, large cell, cleaved, NOS
    - Malignant lymphoma, large cell, diffuse, NOS
    - Malignant lymphoma, large cell, follicular, NOS
    - Malignant lymphoma, large cell, immunoblastic
    - Malignant lymphoma, large cell, noncleaved, diffuse
    - Malignant lymphoma, large cell, noncleaved, follicular
    - Malignant lymphoma, large cell, noncleaved, NOS
    - Malignant lymphoma, large cell, NOS
    - Malignant lymphoma, large cleaved cell, follicular
    - Malignant lymphoma, large cleaved cell, NOS
    - Malignant lymphoma, lymphoblastic, NOS
    - Malignant lymphoma, lymphocytic, diffuse, NOS
    - Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse
    - Malignant lymphoma, lymphocytic, intermediate differentiation, nodular
    - Malignant lymphoma, lymphocytic, nodular, NOS
    - Malignant lymphoma, lymphocytic, NOS
    - Malignant lymphoma, lymphocytic, poorly differentiated, diffuse
    - Malignant lymphoma, lymphocytic, poorly differentiated, nodular
    - Malignant lymphoma, lymphocytic, well differentiated, diffuse
    - Malignant lymphoma, lymphocytic, well differentiated, nodular
    - Malignant lymphoma, lymphoplasmacytic
    - Malignant lymphoma, lymphoplasmacytoid
    - Malignant lymphoma, mixed cell type, diffuse
    - Malignant lymphoma, mixed cell type, follicular
    - Malignant lymphoma, mixed cell type, nodular
    - Malignant lymphoma, mixed lymphocytic-histiocytic, diffuse
    - Malignant lymphoma, mixed lymphocytic-histiocytic, nodular
    - Malignant lymphoma, mixed small and large cell, diffuse
    - Malignant lymphoma, mixed small cleaved and large cell, follicular
    - Malignant lymphoma, nodular, NOS
    - Malignant lymphoma, non-cleaved cell, NOS
    - Malignant lymphoma, non-Hodgkin, NOS
    - Malignant lymphoma, noncleaved cell, follicular, NOS
    - Malignant lymphoma, noncleaved, diffuse, NOS
    - Malignant lymphoma, noncleaved, NOS
    - Malignant lymphoma, NOS
    - Malignant lymphoma, plasmacytoid
    - Malignant lymphoma, small B lymphocytic, NOS
    - Malignant lymphoma, small cell diffuse
    - Malignant lymphoma, small cell, noncleaved, diffuse
    - Malignant lymphoma, small cell, NOS
    - Malignant lymphoma, small cleaved cell, diffuse
    - Malignant lymphoma, small cleaved cell, follicular
    - Malignant lymphoma, small cleaved cell, NOS
    - Malignant lymphoma, small lymphocytic, diffuse
    - Malignant lymphoma, small lymphocytic, NOS
    - Malignant lymphoma, small noncleaved, Burkitt type
    - Malignant lymphoma, undifferentiated cell type, NOS
    - Malignant lymphoma, undifferentiated cell, non-Burkitt
    - Malignant lymphoma, undifferentiated, Burkitt type
    - Malignant lymphomatous polyposis
    - Malignant mast cell tumor
    - Malignant mastocytoma
    - Malignant mastocytosis
    - Malignant melanoma in congenital melanocytic nevus
    - Malignant melanoma in giant pigmented nevus
    - Malignant melanoma in Hutchinson melanotic freckle
    - Malignant melanoma in junctional nevus
    - Malignant melanoma in precancerous melanosis
    - Malignant melanoma, NOS
    - Malignant melanoma, regressing
    - Malignant midline reticulosis
    - Malignant mucinous adenofibroma
    - Malignant mucinous cystadenofibroma
    - Malignant multilocular cystic nephroma
    - Malignant myelosclerosis
    - Malignant myoepithelioma
    - Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation
    - Malignant perivascular epithelial cell tumor
    - Malignant reticulosis, NOS
    - Malignant rhabdoid tumor
    - Malignant schwannoma with rhabdomyoblastic differentiation
    - Malignant schwannoma, NOS
    - Malignant serous adenofibroma
    - Malignant serous cystadenofibroma
    - Malignant tenosynovial giant cell tumor
    - Malignant teratoma, anaplastic
    - Malignant teratoma, intermediate
    - Malignant teratoma, trophoblastic
    - Malignant teratoma, undifferentiated
    - Malignant tumor, clear cell type
    - Malignant tumor, fusiform cell type
    - Malignant tumor, giant cell type
    - Malignant tumor, small cell type
    - Malignant tumor, spindle cell type
    - MALT lymphoma
    - Mammary carcinoma, in situ
    - MANEC
    - Mantle cell lymphoma (Includes all variants blastic, pleomorphic, small cell)
    - Mantle zone lymphoma
    - Marginal zone B-cell lymphoma, NOS
    - Marginal zone lymphoma, NOS
    - Masculinovoblastoma
    - Mast cell leukaemia
    - Mast cell sarcoma
    - Mast cell tumor, NOS
    - Mastocytoma, NOS
    - Matrical carcinoma
    - Mature T ALL
    - Mature T-cell lymphoma, NOS
    - Mature teratoma
    - Mediastinal (thymic) large B-cell lymphoma
    - Mediterranean lymphoma
    - Medullary adenocarcinoma
    - Medullary carcinoma with amyloid stroma
    - Medullary carcinoma with lymphoid stroma
    - Medullary carcinoma, NOS
    - Medullary osteosarcoma
    - Medulloblastoma with extensive nodularity
    - Medulloblastoma, group 3
    - Medulloblastoma, group 4
    - Medulloblastoma, non-WNT/non-SHH
    - Medulloblastoma, NOS
    - Medulloblastoma, SHH-activated and TP53-mutant
    - Medulloblastoma, SHH-activated and TP53-wildtype
    - Medulloblastoma, WNT-activated
    - Medullocytoma
    - Medulloepithelioma, benign
    - Medulloepithelioma, NOS
    - Medullomyoblastoma
    - Megakaryocytic leukemia
    - Megakaryocytic myelosclerosis
    - Melanoameloblastoma
    - Melanocytic nevus
    - Melanocytoma, eyeball
    - Melanocytoma, NOS
    - Melanoma in situ
    - Melanoma, malignant, of soft parts
    - Melanoma, NOS
    - Melanotic medulloblastoma
    - Melanotic MPNST
    - Melanotic neuroectodermal tumor
    - Melanotic neurofibroma
    - Melanotic progonoma
    - Melanotic psammomatous MPNST
    - Melanotic schwannoma
    - Meningeal melanocytoma
    - Meningeal melanoma
    - Meningeal melanomatosis
    - Meningeal sarcoma
    - Meningeal sarcomatosis
    - Meningioma, anaplastic
    - Meningioma, malignant
    - Meningioma, NOS
    - Meningiomatosis, NOS
    - Meningothelial meningioma
    - Meningothelial sarcoma
    - Merkel cell carcinoma
    - Merkel cell tumor
    - Mesenchymal chondrosarcoma
    - Mesenchymal tumor, malignant
    - Mesenchymoma, benign
    - Mesenchymoma, malignant
    - Mesenchymoma, NOS
    - Mesenteric fibromatosis
    - Mesoblastic nephroma
    - Mesodermal mixed tumor
    - Mesonephric adenocarcinoma
    - Mesonephric adenoma
    - Mesonephric tumor, NOS
    - Mesonephroma, benign
    - Mesonephroma, malignant
    - Mesonephroma, NOS
    - Mesothelial papilloma
    - Mesothelioma, benign
    - Mesothelioma, biphasic, malignant
    - Mesothelioma, biphasic, NOS
    - Mesothelioma, malignant
    - Mesothelioma, NOS
    - Metanephric adenoma
    - Metaplastic carcinoma of no special type
    - Metaplastic carcinoma with chondroid differentiation
    - Metaplastic carcinoma with osseous differentiation
    - Metaplastic carcinoma with other types mesenchymal differentiation
    - Metaplastic carcinoma, NOS
    - Metaplastic meningioma
    - Metastasizing leiomyoma
    - Metastatic signet ring cell carcinoma
    - Metatypical carcinoma
    - MGUS
    - Microcystic adenoma
    - Microcystic adnexal carcinoma
    - Microcystic meningioma
    - Microcystic urothelial carcinoma
    - Microfollicular adenoma, NOS
    - Microglioma
    - Micropapillary adenocarcinoma
    - Micropapillary carcinoma, NOS
    - Micropapillary serous carcinoma
    - Midline carcinoma of children and young adults with NUT rearrangement
    - Minimally invasive adenocarcinoma, mucinous
    - Minimally invasive adenocarcinoma, non-mucinous
    - Minimally invasive adenocarcinoma, NOS
    - MiT family translocation renal cell carcinoma
    - Mixed acidophil-basophil adenoma
    - Mixed acidophil-basophil carcinoma
    - Mixed acinar-ductal carcinoma
    - Mixed acinar-endocrine carcinoma
    - Mixed acinar-endocrine-ductal carcinoma
    - Mixed adenocarcinoma and epidermoid carcinoma
    - Mixed adenocarcinoma and squamous cell carcinoma
    - Mixed adenomatous and hyperplastic polyp
    - Mixed adenoneuroendocrine carcinoma
    - Mixed basal-squamous cell carcinoma
    - Mixed carcinoid-adenocarcinoma
    - Mixed cell adenocarcinoma
    - Mixed cell adenoma
    - Mixed ductal-endocrine carcinoma
    - Mixed embryonal carcinoma and teratoma
    - Mixed embryonal rhabdomyosarcoma and alveolar rhabdomyosarcoma
    - Mixed endocrine and exocrine adenocarcinoma
    - Mixed epithelioid and spindle cell melanoma
    - Mixed germ cell sex cord-stromal tumor, unclassified
    - Mixed germ cell tumor
    - Mixed glioma
    - Mixed hepatocellular and bile duct carcinoma
    - Mixed invasive mucinous and non-mucinous adenocarcinoma
    - Mixed islet cell and exocrine adenocarcinoma
    - Mixed liposarcoma
    - Mixed medullary-follicular carcinoma
    - Mixed medullary-papillary carcinoma
    - Mixed meningioma
    - Mixed mesenchymal sarcoma
    - Mixed mesenchymal tumor
    - Mixed pancreatic endocrine and exocrine tumor, malignant
    - Mixed phenotype acute leukemia with t(9;22)(q34;q11.2); BCR-ABL1
    - Mixed phenotype acute leukemia with t(v;11q23); MLL rearranged
    - Mixed phenotype acute leukemia, B/myeloid, NOS
    - Mixed phenotype acute leukemia, T/myeloid, NOS
    - Mixed pineal tumor
    - Mixed pineocytoma-pineoblastoma
    - Mixed small cell carcinoma
    - Mixed squamous cell and glandular papilloma
    - Mixed subependymoma-ependymoma
    - Mixed teratoma and seminoma
    - Mixed tumor, malignant, NOS
    - Mixed tumor, NOS
    - Mixed tumor, salivary gland type, malignant
    - Mixed tumor, salivary gland type, NOS
    - Mixed type rhabdomyosarcoma
    - Monoblastic leukemia, NOS
    - Monoclonal gammopathy of undetermined significance
    - Monoclonal gammopathy, NOS
    - Monocytic leukemia, NOS
    - Monocytoid B-cell lymphoma
    - Monomorphic adenoma
    - Monstrocellular sarcoma
    - MPNST with glandular differentiation
    - MPNST with mesenchymal differentiation
    - MPNST with rhabdomyoblastic differentiation
    - MPNST, NOS
    - Mu heavy chain disease
    - Mucin-producing adenocarcinoma
    - Mucin-producing carcinoma
    - Mucin-secreting adenocarcinoma
    - Mucin-secreting carcinoma
    - Mucinous adenocarcinofibroma
    - Mucinous adenocarcinoma
    - Mucinous adenocarcinoma, endocervical type
    - Mucinous adenofibroma of borderline malignancy
    - Mucinous adenofibroma, NOS
    - Mucinous adenoma
    - Mucinous carcinoid
    - Mucinous carcinoma
    - Mucinous carcinoma, gastric type
    - Mucinous carcinoma, intestinal type
    - Mucinous cystadenocarcinofibroma
    - Mucinous cystadenocarcinoma, non-invasive
    - Mucinous cystadenocarcinoma, NOS
    - Mucinous cystadenofibroma of borderline malignancy
    - Mucinous cystadenofibroma, NOS
    - Mucinous cystadenoma, borderline malignancy
    - Mucinous cystadenoma, NOS
    - Mucinous cystic neoplasm with an associated invasive carcinoma
    - Mucinous cystic neoplasm with high-grade dysplasia
    - Mucinous cystic neoplasm with high-grade intraepithelial neoplasia
    - Mucinous cystic neoplasm with intermediate-grade dysplasia
    - Mucinous cystic neoplasm with intermediate-grade intraepithelial neoplasia
    - Mucinous cystic neoplasm with low-grade dysplasia
    - Mucinous cystic neoplasm with low-grade intraepithelial neoplasia
    - Mucinous cystic tumor of borderline malignancy
    - Mucinous cystic tumor with an associated invasive carcinoma
    - Mucinous cystic tumor with high-grade dysplasia
    - Mucinous cystic tumor with intermediate dysplasia
    - Mucinous cystic tumor with low grade dysplasia
    - Mucinous cystic tumor with moderate dysplasia
    - Mucinous cystoma
    - Mucinous tubular and spindle cell carcinoma
    - Mucinous tumor, NOS, of low malignant potential
    - Mucocarcinoid tumor
    - Mucoepidermoid tumor
    - Mucoid adenocarcinoma
    - Mucoid carcinoma
    - Mucoid cell adenocarcinoma
    - Mucoid cell adenoma
    - Mucosal lentiginous melanoma
    - Mucosal-associated lymphoid tissue lymphoma
    - Mucous adenocarcinoma
    - Mucous carcinoma
    - Mullerian adenosarcoma
    - Mullerian mixed tumor
    - Multicentric basal cell carcinoma
    - Multicystic mesothelioma, benign
    - Multifocal superficial basal cell carcinoma
    - Multiple adenomatous polyps
    - Multiple endocrine adenomas
    - Multiple hemorrhagic sarcoma
    - Multiple meningiomas
    - Multiple myeloma
    - Multiple neurofibromatosis
    - Mycosis fungoides
    - Myelocytic leukemia, NOS
    - Myelodysplastic syndrome with 5q deletion (5q-) syndrome
    - Myelodysplastic syndrome with isolated del (5q)
    - Myelodysplastic syndrome, NOS
    - Myelodysplastic syndrome, unclassifiable
    - Myelodysplastic/myeloproliferative neoplasm, unclassifiable
    - Myelofibrosis as a result of myeloproliferative disease
    - Myelofibrosis with myeloid metaplasia
    - Myelogenous leukemia, NOS
    - Myeloid and lymphoid neoplasms with FGFR1 abnormalities
    - Myeloid and lymphoid neoplasms with PDGFRA rearrangement
    - Myeloid leukemia, NOS
    - Myeloid neoplasms with PDGFRB rearrangement
    - Myeloid sarcoma
    - Myelolipoma
    - Myeloma, NOS
    - Myelomatosis
    - Myelomonocytic leukemia, NOS
    - Myeloproliferative disease, NOS
    - Myeloproliferative neoplasm, NOS
    - Myelosclerosis with myeloid metaplasia
    - Myloproliferative neoplasm, unclassifiable
    - Myoepithelial adenoma
    - Myoepithelial carcinoma
    - Myoepithelial tumor
    - Myoepithelioma
    - Myofibroblastic sarcoma
    - Myofibroblastic tumor, NOS
    - Myofibroblastic tumor, peribronchial
    - Myofibroblastoma
    - Myofibromatosis
    - Myoma
    - Myosarcoma
    - Myxofibroma, NOS
    - Myxoid chondrosarcoma
    - Myxoid fibroma
    - Myxoid leiomyosarcoma
    - Myxoid liposarcoma
    - Myxoinflammatory fibroblastic sarcoma (MIFS)
    - Myxolipoma
    - Myxoliposarcoma
    - Myxoma, NOS
    - Myxopapillary ependymoma
    - Myxosarcoma
    - Neoplasm, benign
    - Neoplasm, malignant
    - Neoplasm, malignant, uncertain whether primary or metastatic
    - Neoplasm, metastatic
    - Neoplasm, NOS
    - Neoplasm, secondary
    - Neoplasm, uncertain whether benign or malignant
    - Nephroblastoma, NOS
    - Nephrogenic adenofibroma
    - Nephroma, NOS
    - Nerve sheath myxoma
    - Nesidioblastoma
    - Nested urothelial carcinoma
    - Neurilemoma, malignant
    - Neurilemoma, NOS
    - Neurilemosarcoma
    - Neurinoma
    - Neurinomatosis
    - Neuroastrocytoma
    - Neuroblastoma, NOS
    - Neuroectodermal tumor, NOS
    - Neuroendocrine carcinoma, low grade
    - Neuroendocrine carcinoma, moderately differentiated
    - Neuroendocrine carcinoma, NOS
    - Neuroendocrine carcinoma, poorly differentiated
    - Neuroendocrine carcinoma, well-differentiated
    - Neuroendocrine tumor, grade 1
    - Neuroendocrine tumor, grade 2
    - Neuroendocrine tumor, well differentiated
    - Neuroepithelioma, NOS
    - Neurofibroma, NOS
    - Neurofibromatosis, NOS
    - Neurofibrosarcoma
    - Neurogenic sarcoma
    - Neurolipocytoma
    - Neuroma, NOS
    - Neuronevus
    - Neurosarcoma
    - Neurothekeoma
    - Neurotropic melanoma, malignant
    - Nevus, NOS
    - NK-cell large granular lymphocytic leukemia
    - NK/T-cell lymphoma, nasal and nasal-type
    - Nodal marginal zone lymphoma
    - Nodular hidradenoma
    - Nodular hidradenoma, malignant
    - Nodular melanoma
    - Non-Hodgkin lymphoma, NOS
    - Non-invasive EFVPTC
    - Non-invasive encapsulated follicular variant of papillary thyroid carcinoma (non-invasive EFVPTC)
    - Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)
    - Non-invasive FTP
    - Non-invasive low grade serous carcinoma
    - Non-invasive mammary carcinoma
    - Non-lymphocytic leukemia, NOS
    - Non-small cell carcinoma
    - Nonchromaffin paraganglioma, malignant
    - Nonchromaffin paraganglioma, NOS
    - Nonencapsulated sclerosing adenocarcinoma
    - Nonencapsulated sclerosing carcinoma
    - Nonencapsulated sclerosing tumor
    - Noninfiltrating intracystic carcinoma
    - Noninfiltrating intraductal papillary adenocarcinoma
    - Noninfiltrating intraductal papillary carcinoma
    - Noninvasive pancreatobiliary papillary neoplasm with high grade dysplasia
    - Noninvasive pancreatobiliary papillary neoplasm with high grade intraepithelial neoplasia
    - Noninvasive pancreatobiliary papillary neoplasm with low grade dysplasia
    - Noninvasive pancreatobiliary papillary neoplasm with low grade intraepithelial neoplasia
    - Nonlipid reticuloendotheliosis
    - Nonpigmented nevus
    - NUT carcinoma
    - NUT midline carcinoma
    - Oat cell carcinoma
    - Odontoameloblastoma
    - Odontogenic carcinoma
    - Odontogenic carcinosarcoma
    - Odontogenic fibroma, NOS
    - Odontogenic fibrosarcoma
    - Odontogenic ghost cell tumor
    - Odontogenic myxofibroma
    - Odontogenic myxoma
    - Odontogenic sarcoma
    - Odontogenic tumor, benign
    - Odontogenic tumor, malignant
    - Odontogenic tumor, NOS
    - Odontoma, NOS
    - Olfactory neuroblastoma
    - Olfactory neurocytoma
    - Olfactory neuroepithelioma
    - Olfactory neurogenic tumor
    - Oligoastrocytoma
    - Oligodendroblastoma
    - Oligodendroglioma, anaplastic
    - Oligodendroglioma, IDH-mutant and 1p/19q-codeleted
    - Oligodendroglioma, NOS
    - Oncocytic adenocarcinoma
    - Oncocytic adenoma
    - Oncocytic carcinoma
    - Oncocytic Schneiderian papilloma
    - Oncocytoma
    - Orchioblastoma
    - Ossifying fibroma
    - Ossifying fibromyxoid tumor
    - Ossifying fibromyxoid tumor, malignant
    - Ossifying renal tumor
    - Osteoblastic sarcoma
    - Osteoblastoma, malignant
    - Osteoblastoma, NOS
    - Osteocartilaginous exostosis
    - Osteochondroma
    - Osteochondromatosis, NOS
    - Osteochondrosarcoma
    - Osteofibroma
    - Osteofibrosarcoma
    - Osteogenic sarcoma, NOS
    - Osteoid osteoma, NOS
    - Osteoma, NOS
    - Osteosarcoma in Paget disease of bone
    - Ovarian stromal tumor
    - Oxyphilic adenocarcinoma
    - Oxyphilic adenoma
    - Pacinian tumor
    - Paget disease and infiltrating duct carcinoma of breast
    - Paget disease and intraductal carcinoma of breast
    - Paget disease of breast
    - Paget disease, extramammary
    - Paget disease, mammary
    - Pagetoid reticulosis
    - Pancreatic endocrine tumor, benign
    - Pancreatic endocrine tumor, malignant
    - Pancreatic endocrine tumor, nonfunctioning
    - Pancreatic endocrine tumor, NOS
    - Pancreatic microadenoma
    - Pancreatic peptide and pancreatic peptide-like peptide within terminal tyrosine amide producing tumor
    - Pancreatobiliary neoplasm, non-invasive
    - Pancreatobiliary-type carcinoma
    - Pancreatoblastoma
    - Papillary adenocarcinoma, follicular variant
    - Papillary adenocarcinoma, NOS
    - Papillary adenofibroma
    - Papillary adenoma, NOS
    - Papillary and follicular adenocarcinoma
    - Papillary and follicular carcinoma
    - Papillary carcinoma in situ
    - Papillary carcinoma, columnar cell
    - Papillary carcinoma, diffuse sclerosing
    - Papillary carcinoma, encapsulated
    - Papillary carcinoma, follicular variant
    - Papillary carcinoma, NOS
    - Papillary carcinoma, oxyphilic cell
    - Papillary carcinoma, tall cell
    - Papillary cystadenocarcinoma, NOS
    - Papillary cystadenoma lymphomatosum
    - Papillary cystadenoma, borderline malignancy
    - Papillary cystadenoma, NOS
    - Papillary cystic tumor
    - Papillary ependymoma
    - Papillary epidermoid carcinoma
    - Papillary glioneuronal tumor
    - Papillary hidradenoma
    - Papillary meningioma
    - Papillary microcarcinoma
    - Papillary mucinous cystadenocarcinoma
    - Papillary mucinous cystadenoma, borderline malignancy
    - Papillary mucinous cystadenoma, NOS
    - Papillary mucinous tumor of low malignant potential
    - Papillary neoplasm, pancreatobiliary-type, with high grade intraepithelial neoplasia
    - Papillary pseudomucinous cystadenocarcinoma
    - Papillary pseudomucinous cystadenoma, borderline malignancy
    - Papillary pseudomucinous cystadenoma, NOS
    - Papillary renal cell carcinoma
    - Papillary serous adenocarcinoma
    - Papillary serous cystadenocarcinoma
    - Papillary serous cystadenoma, borderline malignancy
    - Papillary serous cystadenoma, NOS
    - Papillary serous tumor of low malignant potential
    - Papillary squamous cell carcinoma
    - Papillary squamous cell carcinoma in situ
    - Papillary squamous cell carcinoma, non-invasive
    - Papillary syringadenoma
    - Papillary syringocystadenoma
    - Papillary transitional cell carcinoma
    - Papillary transitional cell carcinoma, non-invasive
    - Papillary transitional cell neoplasm of low malignant potential
    - Papillary tumor of the pineal region
    - Papillary urothelial carcinoma
    - Papillary urothelial carcinoma, non-invasive
    - Papillary urothelial neoplasm of low malignant potential
    - Papillocystic adenocarcinoma
    - Papilloma of bladder
    - Papilloma, NOS
    - Papillomatosis, glandular
    - Papillomatosis, NOS
    - Papillotubular adenocarcinoma
    - Papillotubular adenoma
    - Parachordoma
    - Parafollicular cell carcinoma
    - Paraganglioma, benign
    - Paraganglioma, malignant
    - Paraganglioma, NOS
    - Parasympathetic paraganglioma
    - Parietal cell adenocarcinoma
    - Parietal cell carcinoma
    - Parosteal osteosarcoma
    - Partial hydatidiform mole
    - PEComa, malignant
    - Periapical cemental dysplasia
    - Periapical cemento-osseous dysplasia
    - Pericanalicular fibroadenoma
    - Periductal stromal tumor, low grade
    - Perifollicular fibroma
    - Perineural MPNST
    - Perineurioma, malignant
    - Perineurioma, NOS
    - Periosteal chondroma
    - Periosteal chondrosarcoma
    - Periosteal fibroma
    - Periosteal fibrosarcoma
    - Periosteal sarcoma, NOS
    - Peripheral neuroectodermal tumor
    - Peripheral odontogenic fibroma
    - Peripheral primitive neuroectodermal tumor, NOS
    - Peripheral T-cell lymphoma, AILD (Angioimmunoblastic Lymphadenopathy with Dysproteinemia)
    - Peripheral T-cell lymphoma, large cell
    - Peripheral T-cell lymphoma, NOS
    - Peripheral T-cell lymphoma, pleomorphic medium and large cell
    - Peripheral T-cell lymphoma, pleomorphic small cell
    - Perivascular epithelioid cell tumor, malignant
    - Pheochromoblastoma
    - Pheochromocytoma, malignant
    - Pheochromocytoma, NOS
    - Phosphaturic mesenchymal tumor, malignant
    - Phyllodes tumor, benign
    - Phyllodes tumor, borderline
    - Phyllodes tumor, malignant
    - Phyllodes tumor, NOS
    - Pick tubular adenoma
    - Pigmented adenoma
    - Pigmented basal cell carcinoma
    - Pigmented dermatofibrosarcoma protuberans
    - Pigmented nevus, NOS
    - Pigmented schwannoma
    - Pigmented spindle cell nevus of Reed
    - Pilar tumor
    - Pilocytic astrocytoma
    - Piloid astrocytoma
    - Pilomatricoma, malignant
    - Pilomatricoma, NOS
    - Pilomatrix carcinoma
    - Pilomatrixoma, malignant
    - Pilomatrixoma, NOS
    - Pilomyxoid astrocytoma
    - PIN III
    - Pindborg tumor
    - Pineal parenchymal tumor of intermediate differentiation
    - Pinealoma
    - Pineocytoma
    - Pinkus tumor
    - Pituicytoma
    - Pituitary adenoma, NOS
    - Pituitary carcinoma, NOS
    - Placental site trophoblastic tumor
    - Plasma cell leukemia
    - Plasma cell myeloma
    - Plasma cell tumor
    - Plasmablastic lymphoma
    - Plasmacytic leukemia
    - Plasmacytic lymphoma
    - Plasmacytoma of bone
    - Plasmacytoma, extramedullary
    - Plasmacytoma, NOS
    - Pleomorphic adenoma
    - Pleomorphic carcinoma
    - Pleomorphic cell sarcoma
    - Pleomorphic leiomyoma
    - Pleomorphic lipoma
    - Pleomorphic liposarcoma
    - Pleomorphic lobular carcinoma
    - Pleomorphic lobular carcinoma in situ
    - Pleomorphic rhabdomyosarcoma, adult type
    - Pleomorphic rhabdomyosarcoma, NOS
    - Pleomorphic xanthoastrocytoma
    - Pleuropulmonary blastoma
    - Plexiform fibrohistiocytic tumor
    - Plexiform fibromyxoma
    - Plexiform hemangioma
    - Plexiform leiomyoma
    - Plexiform neurofibroma
    - Plexiform neuroma
    - Plexiform schwannoma
    - PNET, NOS
    - Pneumoblastoma
    - Polar spongioblastoma
    - Polycythemia rubra vera
    - Polycythemia vera
    - Polyembryoma
    - Polygonal cell carcinoma
    - Polymorphic post transplant lymphoproliferative disorder
    - Polymorphic reticulosis
    - Polymorphous low grade adenocarcinoma
    - Polypoid adenoma
    - Polyvesicular vitelline tumor
    - Poorly cohesive carcinoma
    - Porocarcinoma
    - Post transplant lymphoproliferative disorder, NOS
    - PP/PYY producing tumor
    - PPNET
    - Pre-B ALL
    - Pre-pre-B ALL
    - Pre-T ALL
    - Precancerous melanosis, NOS
    - Precursor B-cell lymphoblastic leukemia
    - Precursor B-cell lymphoblastic lymphoma
    - Precursor cell lymphoblastic leukemia, NOS
    - Precursor cell lymphoblastic leukemia, not phenotyped
    - Precursor cell lymphoblastic lymphoma, NOS
    - Precursor T-cell lymphoblastic leukemia
    - Precursor T-cell lymphoblastic lymphoma
    - Preleukemia
    - Preleukemic syndrome
    - Primary amyloidosis
    - Primary cutaneous anaplastic large cell lymphoma
    - Primary cutaneous CD30+ large T-cell lymphoma
    - Primary cutaneous CD30+ T-cell lymphoproliferative disorder
    - Primary cutaneous CD4-positive small/medium T-cell lymphoma
    - Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma
    - Primary cutaneous DLBCL, leg type
    - Primary cutaneous follicle centre lymphoma
    - Primary cutaneous gamma-delta T-cell lymphoma
    - Primary cutaneous neuroendocrine carcinoma
    - Primary diffuse large B-cell lymphoma of the CNS
    - Primary effusion lymphoma
    - Primary intraosseous carcinoma
    - Primary myelofibrosis
    - Primary serous papillary carcinoma of peritoneum
    - Primitive neuroectodermal tumor, NOS
    - Primitive polar spongioblastoma
    - Pro-B ALL
    - Pro-T ALL
    - Prolactinoma
    - Proliferating trichilemmal cyst
    - Proliferating trichilemmal tumor
    - Proliferative dermal lesion in congenital nevus
    - Proliferative polycythemia
    - Prolymphocytic leukemia, B-cell type
    - Prolymphocytic leukemia, NOS
    - Prolymphocytic leukemia, T-cell type
    - Prostatic intraepithelial neoplasia, grade III
    - Protoplasmic astrocytoma
    - Psammomatous meningioma
    - Psammomatous schwannoma
    - Pseudomucinous adenocarcinoma
    - Pseudomucinous cystadenocarcinoma, NOS
    - Pseudomucinous cystadenoma, borderline malignancy
    - Pseudomucinous cystadenoma, NOS
    - Pseudomyxoma peritonei
    - Pseudomyxoma peritonei with unknown primary site
    - Pseudosarcomatous carcinoma
    - PTLD, NOS
    - Pulmonary adenomatosis
    - Pulmonary artery intimal sarcoma
    - Pulmonary blastoma
    - Pulmonary myxoid sarcoma with EWSR1-CREB1 translocation
    - Queyrat erythroplasia
    - Racemose hemangioma
    - RAEB
    - RAEB I
    - RAEB II
    - RAEB-T
    - RARS
    - Rathke pouch tumor
    - Recklinghausen disease
    - Refractory anemia
    - Refractory anemia with excess blasts
    - Refractory anemia with excess blasts in transformation
    - Refractory anemia with ring sideroblasts associated with marked thrombocytosis
    - Refractory anemia with ringed sideroblasts
    - Refractory anemia with sideroblasts
    - Refractory anemia without sideroblasts
    - Refractory cytopenia of childhood
    - Refractory cytopenia with multilineage dysplasia
    - Refractory neutropenia
    - Refractory thrombocytopenia
    - Regressing nevus
    - Renal carcinoma, collecting duct type
    - Renal cell adenocarcinoma
    - Renal cell carcinoma, chromophobe type
    - Renal cell carcinoma, sarcomatoid
    - Renal cell carcinoma, spindle cell
    - Renal cell carcinoma, unclassified
    - Reninoma
    - Renomedullary fibroma
    - Renomedullary interstitial cell tumor
    - Reserve cell carcinoma
    - Reticulohistiocytoma
    - Reticulosarcoma, diffuse
    - Reticulosarcoma, NOS
    - Reticulum cell sarcoma, diffuse
    - Reticulum cell sarcoma, NOS
    - Retinal anlage tumor
    - Retinoblastoma, differentiated
    - Retinoblastoma, diffuse
    - Retinoblastoma, NOS
    - Retinoblastoma, spontaneously regressed
    - Retinoblastoma, undifferentiated
    - Retinocytoma
    - Retroperitoneal fibromatosis
    - Rhabdoid meningioma
    - Rhabdoid sarcoma
    - Rhabdoid tumor, NOS
    - Rhabdomyoma, NOS
    - Rhabdomyosarcoma with ganglionic differentiation
    - Rhabdomyosarcoma, NOS
    - Rhabdosarcoma
    - Rodent ulcer
    - Rosette-forming glioneuronal tumor
    - Round cell carcinoma
    - Round cell liposarcoma
    - Round cell osteosarcoma
    - Round cell sarcoma
    - Salivary duct carcinoma
    - SALT lymphoma
    - Sarcoma botryoides
    - Sarcoma, NOS
    - Sarcomatoid carcinoma
    - Sarcomatoid mesothelioma
    - Sarcomatosis, NOS
    - Schmincke tumor
    - Schneiderian carcinoma
    - Schneiderian papilloma, inverted
    - Schneiderian papilloma, NOS
    - Schwannoma, NOS
    - Scirrhous adenocarcinoma
    - Scirrhous carcinoma
    - Sclerosing epithelioid fibrosarcoma
    - Sclerosing hemangioma
    - Sclerosing hepatic carcinoma
    - Sclerosing liposarcoma
    - Sclerosing rhabdomyosarcoma
    - Sclerosing stromal tumor
    - Sclerosing sweat duct carcinoma
    - Sebaceous adenocarcinoma
    - Sebaceous adenoma
    - Sebaceous carcinoma
    - Sebaceous epithelioma
    - Secondary carcinoma
    - Secretory carcinoma of breast
    - Secretory meningioma
    - Seminoma with high mitotic index
    - Seminoma, anaplastic
    - Seminoma, NOS
    - Seromucinous carcinoma
    - Serotonin producing carcinoid
    - Serous adenocarcinofibroma
    - Serous adenocarcinoma, NOS
    - Serous adenofibroma of borderline malignancy
    - Serous adenofibroma, NOS
    - Serous borderline tumor-micropapillary variant
    - Serous carcinoma, NOS
    - Serous cystadenocarcinofibroma
    - Serous cystadenocarcinoma, NOS
    - Serous cystadenofibroma of borderline malignancy
    - Serous cystadenofibroma, NOS
    - Serous cystadenoma, borderline malignancy
    - Serous cystadenoma, NOS
    - Serous cystoma
    - Serous endometrial intraepithelial carcinoma
    - Serous microcystic adenoma
    - Serous papillary cystic tumor of borderline malignancy
    - Serous surface papillary carcinoma
    - Serous surface papillary tumor of borderline malignancy
    - Serous surface papilloma
    - Serous tubal intraepithelial carcinoma
    - Serous tumor, NOS, of low malignant potential
    - Serrated adenocarcinoma
    - Serrated adenoma
    - Sertoli cell adenoma
    - Sertoli cell carcinoma
    - Sertoli cell tumor with lipid storage
    - Sertoli cell tumor, NOS
    - Sertoli-Leydig cell tumor of intermediate differentiation
    - Sertoli-Leydig cell tumor, intermediate differentiation, with heterologous elements
    - Sertoli-Leydig cell tumor, NOS
    - Sertoli-Leydig cell tumor, poorly differentiated, with heterologous elements
    - Sertoli-Leydig cell tumor, retiform
    - Sertoli-Leydig cell tumor, retiform, with heterologous elements
    - Sertoli-Leydig cell tumor, sarcomatoid
    - Sertoli-Leydig cell tumor, well differentiated
    - Sessile serrated adenoma
    - Sessile serrated polyp
    - SETTLE
    - Sex cord tumor with annular tubules
    - Sex cord tumor, NOS
    - Sex cord-gonadal stromal tumor, incompletely differentiated
    - Sex cord-gonadal stromal tumor, mixed forms
    - Sex cord-gonadal stromal tumor, NOS
    - Sezary disease
    - Sezary syndrome
    - Sialoblastoma
    - Signet ring cell adenocarcinoma
    - Signet ring cell carcinoma
    - Sinonasal papilloma, exophytic
    - Sinonasal papilloma, fungiform
    - Sinonasal papilloma, NOS
    - Skin appendage adenoma
    - Skin appendage carcinoma
    - Skin appendage tumor, benign
    - Skin-associated lymphoid tissue lymphoma
    - Small cell carcinoma pulmonary type
    - Small cell carcinoma, fusiform cell
    - Small cell carcinoma, hypercalcemic type
    - Small cell carcinoma, intermediate cell
    - Small cell carcinoma, NOS
    - Small cell neuroendocrine carcinoma
    - Small cell osteosarcoma
    - Small cell sarcoma
    - Small congenital nevus
    - Smooth muscle tumor of uncertain malignant potential
    - Smooth muscle tumor, NOS
    - Soft tissue perineurioma
    - Soft tissue sarcoma
    - Soft tissue tumor, benign
    - Soft tissue tumor, malignant
    - Solid adenocarcinoma with mucin formation
    - Solid and cystic tumor
    - Solid and papillary epithelial neoplasm
    - Solid carcinoma with mucin formation
    - Solid carcinoma, NOS
    - Solid papillary carcinoma in situ
    - Solid papillary carcinoma with invasion
    - Solid pseudopapillary carcinoma
    - Solid pseudopapillary tumor
    - Solid teratoma
    - Solitary fibrous tumor
    - Solitary fibrous tumor, malignant
    - Solitary fibrous tumor/hemangiopericytoma Grade 1 (CNS)
    - Solitary fibrous tumor/hemangiopericytoma Grade 2 (CNS)
    - Solitary fibrous tumor/hemangiopericytoma Grade 3 (CNS)
    - Solitary mastocytoma of skin
    - Solitary myeloma
    - Solitary plasmacytoma
    - Somatostatin cell tumor, malignant
    - Somatostatin cell tumor, NOS
    - Somatostatinoma, malignant
    - Somatostatinoma, NOS
    - Spermatocytic seminoma
    - Spermatocytoma
    - Spindle cell angioendothelioma
    - Spindle cell carcinoma, NOS
    - Spindle cell hemangioendothelioma
    - Spindle cell lipoma
    - Spindle cell melanoma, NOS
    - Spindle cell melanoma, type A
    - Spindle cell melanoma, type B
    - Spindle cell nevus, NOS
    - Spindle cell oncocytoma
    - Spindle cell rhabdomyosarcoma
    - Spindle cell sarcoma
    - Spindle epithelial tumor with thymus-like differentiation
    - Spindle epithelial tumor with thymus-like element
    - Spindled mesothelioma
    - Spiradenoma, NOS
    - Spitz nevus
    - Splenic B-cell lymphoma/leukemia, unclassifiable
    - Splenic diffuse red pulp small B-cell lymphoma
    - Splenic lymphoma with villous lymphocytes
    - Splenic marginal zone B-cell lymphoma
    - Splenic marginal zone lymphoma, NOS
    - Spongioblastoma multiforme
    - Spongioblastoma polare
    - Spongioblastoma, NOS
    - Spongioneuroblastoma
    - Squamotransitional cell carcinoma
    - Squamous carcinoma
    - Squamous cell carcinoma in situ with questionable stromal invasion
    - Squamous cell carcinoma in situ, NOS
    - Squamous cell carcinoma with horn formation
    - Squamous cell carcinoma, acantholytic
    - Squamous cell carcinoma, adenoid
    - Squamous cell carcinoma, clear cell type
    - Squamous cell carcinoma, HPV-negative
    - Squamous cell carcinoma, HPV-positive
    - Squamous cell carcinoma, keratinizing, NOS
    - Squamous cell carcinoma, large cell, keratinizing
    - Squamous cell carcinoma, large cell, nonkeratinizing, NOS
    - Squamous cell carcinoma, metastatic, NOS
    - Squamous cell carcinoma, microinvasive
    - Squamous cell carcinoma, nonkeratinizing, NOS
    - Squamous cell carcinoma, NOS
    - Squamous cell carcinoma, pseudoglandular
    - Squamous cell carcinoma, sarcomatoid
    - Squamous cell carcinoma, small cell, nonkeratinizing
    - Squamous cell carcinoma, spindle cell
    - Squamous cell epithelioma
    - Squamous cell papilloma, inverted
    - Squamous cell papilloma, NOS
    - Squamous intraepithelial neoplasia, grade I
    - Squamous intraepithelial neoplasia, grade II
    - Squamous intraepithelial neoplasia, grade III
    - Squamous intraepithelial neoplasia, high grade
    - Squamous intraepithelial neoplasia, low grade
    - Squamous odontogenic tumor
    - Squamous papilloma
    - Squamous papillomatosis
    - Stem cell leukemia
    - Steroid cell tumor, malignant
    - Steroid cell tumor, NOS
    - Stromal endometriosis
    - Stromal myosis, NOS
    - Stromal sarcoma, NOS
    - Stromal tumor with minor sex cord elements
    - Stromal tumor, benign
    - Stromal tumor, NOS
    - Struma ovarii and carcinoid
    - Struma ovarii, malignant
    - Struma ovarii, NOS
    - Strumal carcinoid
    - Subacute granulocytic leukemia
    - Subacute leukemia, NOS
    - Subacute lymphatic leukemia
    - Subacute lymphocytic leukemia
    - Subacute lymphoid leukemia
    - Subacute monocytic leukemia
    - Subacute myelogenous leukemia
    - Subacute myeloid leukemia
    - Subareolar duct papillomatosis
    - Subcutaneous panniculitis-like T-cell lymphoma
    - Subependymal astrocytoma, NOS
    - Subependymal giant cell astrocytoma
    - Subependymal glioma
    - Subependymoma
    - Subepidermal nodular fibrosis
    - Superficial spreading adenocarcinoma
    - Superficial spreading melanoma
    - Superficial well differentiated liposarcoma
    - Supratentorial PNET
    - Sweat gland adenocarcinoma
    - Sweat gland adenoma
    - Sweat gland carcinoma
    - Sweat gland tumor, benign
    - Sweat gland tumor, malignant
    - Sweat gland tumor, NOS
    - Sympathetic paraganglioma
    - Sympathicoblastoma
    - Symplastic leiomyoma
    - Syncytial meningioma
    - Synovial sarcoma, biphasic
    - Synovial sarcoma, epithelioid cell
    - Synovial sarcoma, monophasic fibrous
    - Synovial sarcoma, spindle cell
    - Synovioma, benign
    - Synovioma, malignant
    - Synovioma, NOS
    - Syringadenoma, NOS
    - Syringocystadenoma papilliferum
    - Syringofibroadenoma
    - Syringoma, NOS
    - Syringomatous carcinoma
    - Systemic EBV positive T-cell lymphoproliferative disease of childhood
    - Systemic light chain disease
    - Systemic mastocytosis with AHNMD
    - Systemic mastocytosis with associated hematological clonal non-mast cell disorder
    - Systemic tissue mast cell disease
    - T lymphoblastic leukemia/lymphoma
    - T-cell large granular lymphocytic leukemia
    - T-cell large granular lymphocytosis
    - T-cell lymphoma, NOS
    - T-cell rich large B-cell lymphoma
    - T-cell rich/histiocyte-rich large B-cell lymphoma
    - T-gamma lymphoproliferative disease
    - T-zone lymphoma
    - T/NK-cell lymphoma
    - Tanycytic ependymoma
    - Tenosynovial giant cell tumor
    - Teratoblastoma, malignant
    - Teratocarcinoma
    - Teratoid medulloepithelioma
    - Teratoid medulloepithelioma, benign
    - Teratoma with malignant transformation
    - Teratoma, benign
    - Teratoma, differentiated
    - Teratoma, NOS
    - Terminal duct adenocarcinoma
    - Testicular adenoma
    - Testicular stromal tumor
    - Theca cell tumor
    - Theca cell-granulosa cell tumor
    - Thecoma, luteinized
    - Thecoma, malignant
    - Thecoma, NOS
    - Therapy related myeloid neoplasm
    - Therapy-related acute myeloid leukemia, alkylating agent related
    - Therapy-related acute myeloid leukemia, epipodophyllotoxin-related
    - Therapy-related acute myeloid leukemia, NOS
    - Therapy-related myelodysplastic syndrome, alkylating agent related
    - Therapy-related myelodysplastic syndrome, epipodophyllotoxin-related
    - Therapy-related myelodysplastic syndrome, NOS
    - Thymic carcinoma with adenoid cystic carcinoma-like features
    - Thymic carcinoma, NOS
    - Thymic large B-cell lymphoma
    - Thymoma, atypical, malignant
    - Thymoma, atypical, NOS
    - Thymoma, benign
    - Thymoma, cortical, malignant
    - Thymoma, cortical, NOS
    - Thymoma, epithelial, malignant
    - Thymoma, epithelial, NOS
    - Thymoma, lymphocyte-rich, malignant
    - Thymoma, lymphocyte-rich, NOS
    - Thymoma, lymphocytic, malignant
    - Thymoma, lymphocytic, NOS
    - Thymoma, malignant, NOS
    - Thymoma, medullary, malignant
    - Thymoma, medullary, NOS
    - Thymoma, mixed type, malignant
    - Thymoma, mixed type, NOS
    - Thymoma, NOS
    - Thymoma, organoid, malignant
    - Thymoma, organoid, NOS
    - Thymoma, predominantly cortical, malignant
    - Thymoma, predominantly cortical, NOS
    - Thymoma, spindle cell, malignant
    - Thymoma, spindle cell, NOS
    - Thymoma, type A, malignant
    - Thymoma, type A, NOS
    - Thymoma, type AB, malignant
    - Thymoma, type AB, NOS
    - Thymoma, type B1, malignant
    - Thymoma, type B1, NOS
    - Thymoma, type B2, malignant
    - Thymoma, type B2, NOS
    - Thymoma, type B3, malignant
    - Thymoma, type B3, NOS
    - Thymoma, type C
    - Tibial adamantinoma
    - Trabecular adenocarcinoma
    - Trabecular adenoma
    - Trabecular carcinoma
    - Traditional serrated adenoma
    - Traditional sessile serrated adenoma
    - Transient abnormal myelopoiesis
    - Transitional carcinoma
    - Transitional cell carcinoma
    - Transitional cell carcinoma in situ
    - Transitional cell carcinoma, micropapillary
    - Transitional cell carcinoma, sarcomatoid
    - Transitional cell carcinoma, spindle cell
    - Transitional cell papilloma, benign
    - Transitional cell papilloma, inverted, benign
    - Transitional cell papilloma, inverted, NOS
    - Transitional cell papilloma, NOS
    - Transitional meningioma
    - Transitional papilloma
    - Transitional papilloma, inverted, benign
    - Transitional papilloma, inverted, NOS
    - Transitional pineal tumor
    - Trichilemmal carcinoma
    - Trichilemmocarcinoma
    - Trichilemmoma
    - Trichodiscoma
    - Trichoepithelioma
    - Trichofolliculoma
    - Triton tumor, malignant
    - Trophoblastic tumor, epithelioid
    - True histiocytic lymphoma
    - Tubular adenocarcinoma
    - Tubular adenoma, NOS
    - Tubular androblastoma with lipid storage
    - Tubular androblastoma, NOS
    - Tubular carcinoid
    - Tubular carcinoma
    - Tubulo-papillary adenoma
    - Tubulocystic renal cell carcinoma
    - Tubulolobular carcinoma
    - Tubulopapillary adenocarcinoma
    - Tubulovillous adenoma, NOS
    - Tumor cells, benign
    - Tumor cells, malignant
    - Tumor cells, NOS
    - Tumor cells, uncertain whether benign or malignant
    - Tumor embolus
    - Tumor, benign
    - Tumor, malignant, NOS
    - Tumor, metastatic
    - Tumor, NOS
    - Tumor, secondary
    - Tumorlet, benign
    - Tumorlet, NOS
    - Turban tumor
    - Typical carcinoid
    - Unclassified tumor, benign
    - Unclassified tumor, borderline malignancy
    - Unclassified tumor, malignant
    - Unclassified tumor, malignant, uncertain whether primary or metastatic
    - Unclassified tumor, uncertain whether benign or malignant
    - Undifferentiated epithelioid sarcoma
    - Undifferentiated high-grade pleomorphic sarcoma
    - Undifferentiated pleomorphic sarcoma
    - Undifferentiated round cell sarcoma
    - Undifferentiated spindle cell sarcoma
    - Undifferentiated uterine sarcoma
    - Urachal carcinoma
    - Urothelial carcinoma in situ
    - Urothelial carcinoma with divergent differentiation
    - Urothelial carcinoma with squamous differentiation
    - Urothelial carcinoma with trophoblastic differentiation
    - Urothelial carcinoma, NOS
    - Urothelial papilloma, NOS
    - Urticaria pigmentosa
    - Vaginal intraepithelial neoplasia, grade III
    - VAIN III
    - Vascular leiomyoma
    - Venous hemangioma
    - Verrucous carcinoma, NOS
    - Verrucous epidermoid carcinoma
    - Verrucous keratotic hemangioma
    - Verrucous papilloma
    - Verrucous squamous cell carcinoma
    - Villoglandular adenoma
    - Villoglandular carcinoma
    - Villous adenocarcinoma
    - Villous adenoma, NOS
    - Villous papilloma
    - VIN III
    - Vipoma, malignant
    - Vipoma, NOS
    - Von Recklinghausen disease
    - Vulvar intraepithelial neoplasia, grade III
    - Waldenstrom macroglobulinemia
    - Warthin tumor
    - Warty carcinoma
    - Water-clear cell adenocarcinoma
    - Water-clear cell adenoma
    - Water-clear cell carcinoma
    - Well differentiated liposarcoma of superficial soft tissue
    - Well differentiated papillary mesothelioma, benign
    - Well differentiated thymic carcinoma
    - Wilms tumor
    - Wolffian duct adenoma
    - Wolffian duct carcinoma
    - Wolffian duct tumor
    - Xanthofibroma
    - Yolk sac tumor
    - 'Source Data Not Available '
    Req: true
    Term:
    - Origin: caDSR
      Original Source: CDS
      Code: 13606067
      Value: ICD Label/Name
      Version: '1.00'
  primary_site:
    Desc: Anatomical site of disease in primary diagnosis for this diagnosis
    Enum:
    - Adrenal Gland
    - Base of the Tongue
    - Bladder
    - Brain
    - Breast
    - Cervix Uteri
    - Colon
    - Corpus Uteri
    - Esophagus
    - Floor of Mouth
    - Gallbladder
    - Gingiva
    - Hypopharynx
    - Kidney
    - Larynx
    - Limb Skeletal System
    - Lip
    - Lung/Bronchus
    - Lymph Node
    - Meninges
    - Nasopharynx
    - Not Reported
    - Oropharynx
    - Other and Ill Defined Digestive Organs ICD-O-3
    - Other and Ill-Defined Sites ICD-O-3
    - Other and Ill-Defined Sites in Lip, Oral Cavity and Pharynx ICD-O-3
    - Other and Ill-Defined Sites within Respiratory System and Intrathoracic Organs ICD-O-3
    - Other and Unspecified Female Genital Organs ICD-O-3
    - Other and Unspecified Major Salivary Glands ICD-O-3
    - Other and Unspecified Male Genital Organs ICD-O-3
    - Other and Unspecified Parts of Biliary Tract ICD-O-3
    - Other and Unspecified Parts of Mouth ICD-O-3
    - Other and Unspecified Parts of Tongue ICD-O-3
    - Other and Unspecified Urinary Organs ICD-O-3
    - Other Endocrine Glands and Related Structures ICD-O-3
    - Ovary
    - Palate
    - Pancreas
    - Paranasal Sinus
    - Parotid Gland
    - Penis
    - Peritoneum and Retroperitoneum
    - Placenta
    - Prostate Gland
    - Pyriform Sinus
    - Rectosigmoid Region
    - Rectum
    - Renal Pelvis
    - Skin
    - Small Intestine
    - Stomach
    - Testis
    - Thymus Gland
    - Thyroid Gland
    - Tonsil
    - Trachea
    - Unknown
    - Ureter
    - Uterus
    - Vagina
    - Vulva
    - Bronchus and Lung
    - Not specified in data
    Term:
    - Origin: caDSR
      Original Source: PCDC
      Code: '13279286'
      Value: Diagnosis Primary Anatomic Site ICD-O-3 Name
      Version: '1.00'
  morphology:
    Desc: ICD-O-3 Morphology term associated with this diagnosis
    Enum:
    - 8000/0
    - 8000/1
    - 8000/3
    - 8000/6
    - 8000/9
    - 8001/0
    - 8001/1
    - 8001/3
    - 8002/3
    - 8003/3
    - 8004/3
    - 8005/0
    - 8005/3
    - 8010/0
    - 8010/2
    - 8010/3
    - 8010/6
    - 8010/9
    - 8011/0
    - 8011/3
    - 8012/3
    - 8013/3
    - 8014/3
    - 8015/3
    - 8020/3
    - 8020/6
    - 8021/3
    - 8022/3
    - 8023/3
    - 8030/3
    - 8031/3
    - 8032/3
    - 8033/3
    - 8034/3
    - 8035/3
    - 8040/0
    - 8040/1
    - 8040/3
    - 8041/3
    - 8041/34
    - 8041/6
    - 8042/3
    - 8043/3
    - 8044/3
    - 8045/3
    - 8046/3
    - 8046/6
    - 8050/0
    - 8050/2
    - 8050/3
    - 8051/0
    - 8051/3
    - 8052/0
    - 8052/2
    - 8052/3
    - 8053/0
    - 8060/0
    - 8070/2
    - 8070/3
    - 8070/33
    - 8070/6
    - 8071/2
    - 8071/3
    - 8072/3
    - 8073/3
    - 8074/3
    - 8075/3
    - 8076/2
    - 8076/3
    - 8077/0
    - 8077/2
    - 8078/3
    - 8080/2
    - 8081/2
    - 8082/3
    - 8083/3
    - 8084/3
    - 8085/3
    - 8086/3
    - 8090/1
    - 8090/3
    - 8091/3
    - 8092/3
    - 8093/3
    - 8094/3
    - 8095/3
    - 8096/0
    - 8097/3
    - 8098/3
    - 8100/0
    - 8101/0
    - 8102/0
    - 8102/3
    - 8103/0
    - 8110/0
    - 8110/3
    - 8120/0
    - 8120/1
    - 8120/2
    - 8120/3
    - 8121/0
    - 8121/1
    - 8121/3
    - 8122/3
    - 8123/3
    - 8124/3
    - 8130/1
    - 8130/2
    - 8130/3
    - 8131/3
    - 8140/0
    - 8140/1
    - 8140/2
    - 8140/3
    - 8140/33
    - 8140/6
    - 8141/3
    - 8142/3
    - 8143/3
    - 8144/3
    - 8145/3
    - 8146/0
    - 8147/0
    - 8147/3
    - 8148/0
    - 8148/2
    - 8149/0
    - 8150/0
    - 8150/1
    - 8150/3
    - 8151/0
    - 8151/3
    - 8152/1
    - 8152/3
    - 8153/1
    - 8153/3
    - 8154/3
    - 8155/1
    - 8155/3
    - 8156/1
    - 8156/3
    - 8158/1
    - 8160/0
    - 8160/3
    - 8161/0
    - 8161/3
    - 8162/3
    - 8163/0
    - 8163/2
    - 8163/3
    - 8170/0
    - 8170/3
    - 8171/3
    - 8172/3
    - 8173/3
    - 8174/3
    - 8175/3
    - 8180/3
    - 8190/0
    - 8190/3
    - 8191/0
    - 8200/0
    - 8200/3
    - 8201/2
    - 8201/3
    - 8202/0
    - 8204/0
    - 8210/0
    - 8210/2
    - 8210/3
    - 8211/0
    - 8211/3
    - 8212/0
    - 8213/0
    - 8213/3
    - 8214/3
    - 8215/3
    - 8220/0
    - 8220/3
    - 8221/0
    - 8221/3
    - 8230/2
    - 8230/3
    - 8231/3
    - 8240/1
    - 8240/3
    - 8240/6
    - 8241/3
    - 8242/1
    - 8242/3
    - 8243/3
    - 8244/3
    - 8245/1
    - 8245/3
    - 8246/3
    - 8246/6
    - 8247/3
    - 8248/1
    - 8249/3
    - 8249/6
    - 8250/1
    - 8250/2
    - 8250/3
    - 8251/0
    - 8251/3
    - 8252/3
    - 8253/3
    - 8254/3
    - 8255/3
    - 8256/3
    - 8257/3
    - 8260/0
    - 8260/3
    - 8261/0
    - 8261/2
    - 8261/3
    - 8262/3
    - 8263/0
    - 8263/2
    - 8263/3
    - 8264/0
    - 8265/3
    - 8270/0
    - 8270/3
    - 8271/0
    - 8272/0
    - 8272/3
    - 8280/0
    - 8280/3
    - 8281/0
    - 8281/3
    - 8290/0
    - 8290/3
    - 8300/0
    - 8300/3
    - 8310/0
    - 8310/3
    - 8310/6
    - 8311/1
    - 8311/3
    - 8311/6
    - 8312/3
    - 8313/0
    - 8313/1
    - 8313/3
    - 8314/3
    - 8315/3
    - 8316/3
    - 8317/3
    - 8318/3
    - 8319/3
    - 8320/3
    - 8321/0
    - 8322/0
    - 8322/3
    - 8323/0
    - 8323/3
    - 8324/0
    - 8325/0
    - 8330/0
    - 8330/1
    - 8330/3
    - 8331/3
    - 8332/3
    - 8333/0
    - 8333/3
    - 8334/0
    - 8335/3
    - 8336/0
    - 8337/3
    - 8339/3
    - 8340/3
    - 8341/3
    - 8342/3
    - 8343/2
    - 8343/3
    - 8344/3
    - 8345/3
    - 8346/3
    - 8347/3
    - 8350/3
    - 8360/1
    - 8361/0
    - 8370/0
    - 8370/1
    - 8370/3
    - 8371/0
    - 8372/0
    - 8373/0
    - 8374/0
    - 8375/0
    - 8380/0
    - 8380/1
    - 8380/2
    - 8380/3
    - 8380/6
    - 8381/0
    - 8381/1
    - 8381/3
    - 8382/3
    - 8383/3
    - 8384/3
    - 8390/0
    - 8390/3
    - 8391/0
    - 8392/0
    - 8400/0
    - 8400/1
    - 8400/3
    - 8401/0
    - 8401/3
    - 8402/0
    - 8402/3
    - 8403/0
    - 8403/3
    - 8404/0
    - 8405/0
    - 8406/0
    - 8407/0
    - 8407/3
    - 8408/0
    - 8408/1
    - 8408/3
    - 8409/0
    - 8409/3
    - 8410/0
    - 8410/3
    - 8413/3
    - 8420/0
    - 8420/3
    - 8430/1
    - 8430/3
    - 8440/0
    - 8440/3
    - 8441/0
    - 8441/2
    - 8441/3
    - 8441/6
    - 8442/1
    - 8443/0
    - 8444/1
    - 8450/0
    - 8450/3
    - 8451/1
    - 8452/1
    - 8452/3
    - 8453/0
    - 8453/2
    - 8453/3
    - 8454/0
    - 8460/0
    - 8460/2
    - 8460/3
    - 8461/0
    - 8461/3
    - 8461/6
    - 8462/1
    - 8463/1
    - 8470/0
    - 8470/2
    - 8470/3
    - 8471/0
    - 8471/1
    - 8471/3
    - 8472/1
    - 8473/1
    - 8474/1
    - 8474/3
    - 8480/0
    - 8480/1
    - 8480/3
    - 8480/6
    - 8481/3
    - 8482/3
    - 8482/6
    - 8490/3
    - 8490/6
    - 8500/2
    - 8500/3
    - 8500/6
    - 8501/2
    - 8501/3
    - 8502/3
    - 8503/0
    - 8503/2
    - 8503/3
    - 8504/0
    - 8504/2
    - 8504/3
    - 8505/0
    - 8506/0
    - 8507/2
    - 8507/3
    - 8508/3
    - 8509/2
    - 8509/3
    - 8510/3
    - 8512/3
    - 8513/3
    - 8514/3
    - 8519/2
    - 8520/2
    - 8520/3
    - 8521/1
    - 8521/3
    - 8522/1
    - 8522/2
    - 8522/3
    - 8522/6
    - 8523/3
    - 8524/3
    - 8525/3
    - 8530/3
    - 8540/3
    - 8541/3
    - 8542/3
    - 8543/3
    - 8550/0
    - 8550/1
    - 8550/3
    - 8551/3
    - 8552/3
    - 8560/0
    - 8560/3
    - 8561/0
    - 8562/3
    - 8570/3
    - 8571/3
    - 8572/3
    - 8573/3
    - 8574/3
    - 8575/3
    - 8576/3
    - 8580/0
    - 8580/1
    - 8580/3
    - 8581/1
    - 8581/3
    - 8582/1
    - 8582/3
    - 8583/1
    - 8583/3
    - 8584/1
    - 8584/3
    - 8585/1
    - 8585/3
    - 8586/3
    - 8587/0
    - 8588/3
    - 8589/3
    - 8590/1
    - 8591/1
    - 8592/1
    - 8593/1
    - 8594/1
    - 8600/0
    - 8600/3
    - 8601/0
    - 8602/0
    - 8610/0
    - 8620/1
    - 8620/3
    - 8621/1
    - 8622/1
    - 8623/1
    - 8630/0
    - 8630/1
    - 8630/3
    - 8631/0
    - 8631/1
    - 8631/3
    - 8632/1
    - 8633/1
    - 8634/1
    - 8634/3
    - 8640/1
    - 8640/3
    - 8641/0
    - 8642/1
    - 8650/0
    - 8650/1
    - 8650/3
    - 8660/0
    - 8670/0
    - 8670/3
    - 8671/0
    - 8680/0
    - 8680/1
    - 8680/3
    - 8681/1
    - 8682/1
    - 8683/0
    - 8690/1
    - 8691/1
    - 8692/1
    - 8693/1
    - 8693/3
    - 8700/0
    - 8700/3
    - 8710/3
    - 8711/0
    - 8711/3
    - 8712/0
    - 8713/0
    - 8714/3
    - 8720/0
    - 8720/2
    - 8720/3
    - 8720/6
    - 8721/3
    - 8722/0
    - 8722/3
    - 8723/0
    - 8723/3
    - 8725/0
    - 8726/0
    - 8727/0
    - 8728/0
    - 8728/1
    - 8728/3
    - 8730/0
    - 8730/3
    - 8740/0
    - 8740/3
    - 8741/2
    - 8741/3
    - 8742/2
    - 8742/3
    - 8743/3
    - 8744/3
    - 8745/3
    - 8746/3
    - 8750/0
    - 8760/0
    - 8761/0
    - 8761/1
    - 8761/3
    - 8762/1
    - 8770/0
    - 8770/3
    - 8771/0
    - 8771/3
    - 8772/0
    - 8772/3
    - 8773/3
    - 8774/3
    - 8780/0
    - 8780/3
    - 8790/0
    - 8800/0
    - 8800/3
    - 8800/6
    - 8800/9
    - 8801/3
    - 8801/6
    - 8802/3
    - 8803/3
    - 8804/3
    - 8804/6
    - 8805/3
    - 8806/3
    - 8806/6
    - 8810/0
    - 8810/1
    - 8810/3
    - 8811/0
    - 8811/1
    - 8811/3
    - 8812/0
    - 8812/3
    - 8813/0
    - 8813/3
    - 8814/3
    - 8815/0
    - 8815/1
    - 8815/3
    - 8820/0
    - 8821/1
    - 8822/1
    - 8823/0
    - 8824/0
    - 8824/1
    - 8825/0
    - 8825/1
    - 8825/3
    - 8826/0
    - 8827/1
    - 8830/0
    - 8830/1
    - 8830/3
    - 8831/0
    - 8832/0
    - 8832/3
    - 8833/3
    - 8834/1
    - 8835/1
    - 8836/1
    - 8840/0
    - 8840/3
    - 8841/1
    - 8842/0
    - 8842/3
    - 8850/0
    - 8850/1
    - 8850/3
    - 8851/0
    - 8851/3
    - 8852/0
    - 8852/3
    - 8853/3
    - 8854/0
    - 8854/3
    - 8855/3
    - 8856/0
    - 8857/0
    - 8857/3
    - 8858/3
    - 8860/0
    - 8861/0
    - 8862/0
    - 8870/0
    - 8880/0
    - 8881/0
    - 8890/0
    - 8890/1
    - 8890/3
    - 8891/0
    - 8891/3
    - 8892/0
    - 8893/0
    - 8894/0
    - 8894/3
    - 8895/0
    - 8895/3
    - 8896/3
    - 8897/1
    - 8898/1
    - 8900/0
    - 8900/3
    - 8901/3
    - 8902/3
    - 8903/0
    - 8904/0
    - 8905/0
    - 8910/3
    - 8912/3
    - 8920/3
    - 8920/6
    - 8921/3
    - 8930/0
    - 8930/3
    - 8931/3
    - 8932/0
    - 8933/3
    - 8934/3
    - 8935/0
    - 8935/1
    - 8935/3
    - 8936/0
    - 8936/1
    - 8936/3
    - 8940/0
    - 8940/3
    - 8941/3
    - 8950/3
    - 8950/6
    - 8951/3
    - 8959/0
    - 8959/1
    - 8959/3
    - 8960/1
    - 8960/3
    - 8963/3
    - 8964/3
    - 8965/0
    - 8966/0
    - 8967/0
    - 8970/3
    - 8971/3
    - 8972/3
    - 8973/3
    - 8974/1
    - 8975/1
    - 8980/3
    - 8981/3
    - 8982/0
    - 8982/3
    - 8983/0
    - 8983/3
    - 8990/0
    - 8990/1
    - 8990/3
    - 8991/3
    - 9000/0
    - 9000/1
    - 9000/3
    - 9010/0
    - 9011/0
    - 9012/0
    - 9013/0
    - 9014/0
    - 9014/1
    - 9014/3
    - 9015/0
    - 9015/1
    - 9015/3
    - 9016/0
    - 9020/0
    - 9020/1
    - 9020/3
    - 9030/0
    - 9040/0
    - 9040/3
    - 9041/3
    - 9042/3
    - 9043/3
    - 9044/3
    - 9045/3
    - 9050/0
    - 9050/3
    - 9051/0
    - 9051/3
    - 9052/0
    - 9052/3
    - 9053/3
    - 9054/0
    - 9055/0
    - 9055/1
    - 9060/3
    - 9061/3
    - 9062/3
    - 9063/3
    - 9064/2
    - 9064/3
    - 9065/3
    - 9070/3
    - 9071/3
    - 9072/3
    - 9073/1
    - 9080/0
    - 9080/1
    - 9080/3
    - 9081/3
    - 9082/3
    - 9083/3
    - 9084/0
    - 9084/3
    - 9085/3
    - 9086/3
    - 9090/0
    - 9090/3
    - 9091/1
    - 9100/0
    - 9100/1
    - 9100/3
    - 9101/3
    - 9102/3
    - 9103/0
    - 9104/1
    - 9105/3
    - 9110/0
    - 9110/1
    - 9110/3
    - 9120/0
    - 9120/3
    - 9121/0
    - 9122/0
    - 9123/0
    - 9124/3
    - 9125/0
    - 9130/0
    - 9130/1
    - 9130/3
    - 9131/0
    - 9132/0
    - 9133/1
    - 9133/3
    - 9135/1
    - 9136/1
    - 9137/3
    - 9140/3
    - 9141/0
    - 9142/0
    - 9150/0
    - 9150/1
    - 9150/3
    - 9160/0
    - 9161/0
    - 9161/1
    - 9170/0
    - 9170/3
    - 9171/0
    - 9172/0
    - 9173/0
    - 9174/0
    - 9174/1
    - 9175/0
    - 9180/0
    - 9180/3
    - 9180/6
    - 9181/3
    - 9182/3
    - 9183/3
    - 9184/3
    - 9185/3
    - 9186/3
    - 9187/3
    - 9191/0
    - 9192/3
    - 9193/3
    - 9194/3
    - 9195/3
    - 9200/0
    - 9200/1
    - 9210/0
    - 9210/1
    - 9220/0
    - 9220/1
    - 9220/3
    - 9221/0
    - 9221/3
    - 9230/0
    - 9230/3
    - 9231/3
    - 9240/3
    - 9241/0
    - 9242/3
    - 9243/3
    - 9250/1
    - 9250/3
    - 9251/1
    - 9251/3
    - 9252/0
    - 9252/3
    - 9260/3
    - 9261/3
    - 9262/0
    - 9270/0
    - 9270/1
    - 9270/3
    - 9271/0
    - 9272/0
    - 9273/0
    - 9274/0
    - 9275/0
    - 9280/0
    - 9281/0
    - 9282/0
    - 9290/0
    - 9290/3
    - 9300/0
    - 9301/0
    - 9302/0
    - 9302/3
    - 9310/0
    - 9310/3
    - 9311/0
    - 9312/0
    - 9320/0
    - 9321/0
    - 9322/0
    - 9330/0
    - 9330/3
    - 9340/0
    - 9341/1
    - 9341/3
    - 9342/3
    - 9350/1
    - 9351/1
    - 9352/1
    - 9360/1
    - 9361/1
    - 9362/3
    - 9363/0
    - 9364/3
    - 9365/3
    - 9370/3
    - 9371/3
    - 9372/3
    - 9373/0
    - 9380/3
    - 9381/3
    - 9382/3
    - 9383/1
    - 9384/1
    - 9385/3
    - 9390/0
    - 9390/1
    - 9390/3
    - 9391/3
    - 9392/3
    - 9393/3
    - 9394/1
    - 9395/3
    - 9396/3
    - 9400/3
    - 9401/3
    - 9410/3
    - 9411/3
    - 9412/1
    - 9413/0
    - 9420/3
    - 9421/1
    - 9423/3
    - 9424/3
    - 9425/3
    - 9430/3
    - 9431/1
    - 9432/1
    - 9440/3
    - 9440/6
    - 9441/3
    - 9442/1
    - 9442/3
    - 9444/1
    - 9445/3
    - 9450/3
    - 9451/3
    - 9460/3
    - 9470/3
    - 9471/3
    - 9472/3
    - 9473/3
    - 9474/3
    - 9475/3
    - 9476/3
    - 9477/3
    - 9478/3
    - 9480/3
    - 9490/0
    - 9490/3
    - 9491/0
    - 9492/0
    - 9493/0
    - 9500/3
    - 9501/0
    - 9501/3
    - 9502/0
    - 9502/3
    - 9503/3
    - 9504/3
    - 9505/1
    - 9505/3
    - 9506/1
    - 9507/0
    - 9508/3
    - 9509/1
    - 9510/0
    - 9510/3
    - 9511/3
    - 9512/3
    - 9513/3
    - 9514/1
    - 9520/3
    - 9521/3
    - 9522/3
    - 9523/3
    - 9530/0
    - 9530/1
    - 9530/3
    - 9531/0
    - 9532/0
    - 9533/0
    - 9534/0
    - 9535/0
    - 9537/0
    - 9538/1
    - 9538/3
    - 9539/1
    - 9539/3
    - 9540/0
    - 9540/1
    - 9540/3
    - 9541/0
    - 9542/3
    - 9550/0
    - 9560/0
    - 9560/1
    - 9560/3
    - 9561/3
    - 9562/0
    - 9570/0
    - 9571/0
    - 9571/3
    - 9580/0
    - 9580/3
    - 9581/3
    - 9582/0
    - 9590/3
    - 9591/3
    - 9596/3
    - 9597/3
    - 9650/3
    - 9651/3
    - 9652/3
    - 9653/3
    - 9654/3
    - 9655/3
    - 9659/3
    - 9661/3
    - 9662/3
    - 9663/3
    - 9664/3
    - 9665/3
    - 9667/3
    - 9670/3
    - 9671/3
    - 9673/3
    - 9675/3
    - 9678/3
    - 9679/3
    - 9680/3
    - 9684/3
    - 9687/3
    - 9688/3
    - 9689/3
    - 9690/3
    - 9691/3
    - 9695/3
    - 9698/3
    - 9699/3
    - 9700/3
    - 9701/3
    - 9702/3
    - 9705/3
    - 9708/3
    - 9709/3
    - 9712/3
    - 9714/3
    - 9716/3
    - 9717/3
    - 9718/3
    - 9719/3
    - 9724/3
    - 9725/3
    - 9726/3
    - 9727/3
    - 9728/3
    - 9729/3
    - 9731/3
    - 9732/3
    - 9733/3
    - 9734/3
    - 9735/3
    - 9737/3
    - 9738/3
    - 9740/1
    - 9740/3
    - 9741/1
    - 9741/3
    - 9742/3
    - 9750/3
    - 9751/1
    - 9751/3
    - 9752/1
    - 9753/1
    - 9754/3
    - 9755/3
    - 9756/3
    - 9757/3
    - 9758/3
    - 9759/3
    - 9760/3
    - 9761/3
    - 9762/3
    - 9764/3
    - 9765/1
    - 9766/1
    - 9767/1
    - 9768/1
    - 9769/1
    - 9800/3
    - 9801/3
    - 9805/3
    - 9806/3
    - 9807/3
    - 9808/3
    - 9809/3
    - 9811/3
    - 9812/3
    - 9813/3
    - 9814/3
    - 9815/3
    - 9816/3
    - 9817/3
    - 9818/3
    - 9820/3
    - 9823/3
    - 9826/3
    - 9827/3
    - 9831/3
    - 9832/3
    - 9833/3
    - 9834/3
    - 9835/3
    - 9836/3
    - 9837/3
    - 9840/3
    - 9860/3
    - 9861/3
    - 9863/3
    - 9865/3
    - 9866/3
    - 9867/3
    - 9869/3
    - 9870/3
    - 9871/3
    - 9872/3
    - 9873/3
    - 9874/3
    - 9875/3
    - 9876/3
    - 9891/3
    - 9895/3
    - 9896/3
    - 9897/3
    - 9898/1
    - 9898/3
    - 9910/3
    - 9911/3
    - 9920/3
    - 9930/3
    - 9931/3
    - 9940/3
    - 9945/3
    - 9946/3
    - 9948/3
    - 9950/3
    - 9960/3
    - 9961/3
    - 9962/3
    - 9963/3
    - 9964/3
    - 9965/3
    - 9966/3
    - 9967/3
    - 9970/1
    - 9971/1
    - 9971/3
    - 9975/3
    - 9980/3
    - 9982/3
    - 9983/3
    - 9984/3
    - 9985/3
    - 9986/3
    - 9987/3
    - 9989/3
    - 9991/3
    - 9992/3
    - Unknown
    - Not Reported
    Term:
    - Origin: caDSR
      Original Source: CCDI (DDE)
      Code: '13594090'
      Value: Disease Morphology ICD-O-3 Code Label Text
      Version: '1.00'
  tumor_grade:
    Desc: Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.
    Enum:
    - G1
    - G2
    - G3
    - G4
    - GX
    - GB
    - High Grade
    - Intermediate Grade
    - Low Grade
    - Unknown
    - Not Reported
    Term:
    - Origin: caDSR
      Original Source: DSS
      Code: '11325685'
      Value: Diagnosis Tumor Grade
      Version: '1.00'
  tumor_stage_clinical_t:
    Desc: Extent of the primary cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.
    Enum:
    - T0
    - T1
    - T1a
    - T1a1
    - T1a2
    - T1b
    - T1b1
    - T1b2
    - T1c
    - T1mi
    - T2
    - T2a
    - T2a1
    - T2a2
    - T2b
    - T2c
    - T2d
    - T3
    - T3a
    - T3b
    - T3c
    - T3d
    - T4
    - T4a
    - T4b
    - T4c
    - T4d
    - T4e
    - TX
    - Ta
    - Tis
    - Tis (DCIS)
    - Tis (LCIS)
    - Tis (Paget's)
    - Unknown
    - Not Reported
    Term:
    - Origin: caDSR
      Original Source: TCGA
      Code: '3440328'
      Value: Neoplasm American Joint Committee on Cancer Clinical Primary Tumor T Stage
      Version: '1.00'
  tumor_stage_clinical_n:
    Desc: Extent of the regional lymph node involvement for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.
    Enum:
    - N0
    - N0 (i+)
    - N0 (i-)
    - N0 (mol+)
    - N0 (mol-)
    - N1
    - N1a
    - N1b
    - N1bI
    - N1bII
    - N1bIII
    - N1bIV
    - N1c
    - N1mi
    - N2
    - N2a
    - N2b
    - N2c
    - N3
    - N3a
    - N3b
    - N3c
    - N4
    - NX
    - Unknown
    - Not Reported
    Term:
    - Origin: caDSR
      Original Source: TCGA
      Code: '3440330'
      Value: Neoplasm American Joint Committee on Cancer Clinical Regional Lymph Node N Stage
      Version: '1.00'
  tumor_stage_clinical_m:
    Desc: Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.
    Enum:
    - M0
    - M1
    - M1a
    - M1b
    - M1c
    - MX
    - cM0 (i+)
    - Unknown
    - Not Reported
    Term:
    - Origin: caDSR
      Original Source: TCGA
      Code: '3440331'
      Value: Neoplasm American Joint Committee on Cancer Clinical Distant Metastasis M Stage
      Version: '1.00'
  progression_or_recurrence:
    Desc: Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.
    Enum:
    - 'Yes'
    - 'No'
    - Unknown
    - Not Reported
    - Not Allowed To Collect
    Term:
    - Origin: caDSR
      Original Source: DSS
      Code: 13529783
      Value: Disease Progression Or Recurrence Indicator
      Version: '1.00'
  # study
  role_or_affiliation:
    Desc: The text that describes the distinguishable characteristics of the action or activity assigned to or required or expected of a person in a formal association with a group or organization.
    Type: string
  title:
    Desc: The abbreviation that represents an affix occurring at or before the beginning of an individual's name.
    Type: String
  first_name:
    Desc: A word or group of words indicating a person's first (personal or given) name; the name that precedes the surname. Synonym = Given Name.
    Type: string
  middle_name:
    Desc: A means of identifying an individual by using a word or group of words indicating a person's middle name.
    Type: string
  last_name:
    Desc: A means of identifying an individual by using a word or group of words indicating a person's last (family) name. Synonym = Last Name, Surname.
    Type: string
  suffix:
    Desc: Text term to represent an individual's position in a family lineage or pedigree.
    Type: string
  email:
    Desc: The string of characters that represents the electronic mail address of a person.
    Type: string
  clinical_trial_repository:
    Desc: The name of the organization that provides the clinical trial identifier.
    Type: string
  study_version:
    Desc: The version of the phs accession
    Type:
      value_type: list
      item_type: string
    Req: true
  bioproject_accession:
    Desc: NCBI BioProject accession ID
    Type:
      pattern: ^PRJNA[0-9]+$
    Req: Preferred
  study_data_types:
    Desc: Types of scientific data in the study
    Enum:
    - Genomic
    - Proteomic
    - Imaging
    Req: 'Yes'
    Term:
    - Origin: caDSR
      Code: '12571096'
      Value: Data Collection Scientific Data Type Category
      Version: '1.00'
  data_access_level:
    Desc: Is data open, controlled, or mixed?
    Enum:
    - open
    - controlled
    - mixed
    Req: Preferred
  index_date:
    Desc: Index date (Day 0) to which all dates are relative, for this study
    Enum:
    - date_of_diagnosis
    - date_of_enrollment
    - date_of_collection
    - date_of_birth
  phs_accession:
    Desc: PHS accession number (a.k.a dbGaP accession)
    Req: true
    Key: true
    Type:
      pattern: ^phs[0-9]+([.]v[0-9]+)*$
    Term:
    - Origin: caDSR
      Original Source: DSS CDE
      Code: '11524544'
      Value: Research Activity dbGaP Accession Number Identifier
      Version: '1.00'
  study_acronym:
    Desc: Short acronym or other study desginator
    Type: string
    Term:
    - Origin: caDSR
      Original Source: DSS
      Code: '11459812'
      Value: Study Short Name Text
      Version: '1.00'
  study_description:
    Desc: Human-readable study description
    Type: string
    Req: Preferred
  study_access:
    Desc: Study access
    Enum:
    - Open
    - Controlled
    Req: true
  short_description:
    Desc: 'Short description that will identify the dataset on public pages

      A clear and concise formula for the title would be like:

      {methodology} of {organism}: {sample info}

      '
    Type: string
    Req: Preferred
  study_external_url:
    Desc: Website or other url relevant to study
    Type: url
    Req: Preferred
  study_name:
    Desc: Official name of study
    Type: string
    Req: 'Yes'
    Term:
    - Origin: caDSR
      Original Source: DSS
      Code: '11459810'
      Value: Study Name
      Version: '1.00'
  primary_investigator_name:
    Desc: Name of principal investigator
    Type: string
    Req: Preferred
  acl:
    Desc: open or restricted access to data
    Type: string
    Term:
    - Origin: caDSR
      Original Source: DSS
      Code: '11555664'
      Value: Electronic Data File Access Level Text
      Version: '1.00'
  primary_investigator_email:
    Desc: Email of principal investigator
    Type: string
    Req: Preferred
  co_investigator_name:
    Desc: Name of co-principal investigator
    Type: string
  co_investigator_email:
    Desc: Email of co-principal investigator
    Type: string
  cds_primary_bucket:
    Desc: The primary bucket for depositing data
    Type: string
    Req: Preferred
  cds_secondary_bucket:
    Desc: Secondary bucket for depositing data (non-sequence files)
    Type: string
  cds_tertiary_bucket:
    Desc: Secondary bucket for depositing data (non-sequence files)
    Type: string
  authz:
    Desc: multifactor authorization
    Type: string
    Term:
    - Origin: caDSR
      Original Source: CDS
      Code: Pending
      Version: '1.00'
  # sample
  sample_description:
    Desc: Text description of a sample or specimen.
    Type: string
  sample_type_category:
    Desc: The kind of material that forms the sample.
    Type: string
  biosample_accession:
    Desc: NCBI BioSample accession ID (SAMN) for this sample
    Type:
      pattern: ^SAMN[0-9]+$
    Req: Preferred
    Term:
    - Origin: caDSR
      Code: '2230047'
      Value: Specimen Accession Number
      Version: '6.00'
  sample_age_at_collection:
    Desc: Number of days to collection, relative to index date
    Type: integer
    Term:
    - Origin: caDSR
      Code: '11253404'
      Value: Days from Specimen Collection To Initial Pathologic Diagnosis Day Count
      Version: '1.00'
  sample_anatomic_site:
    Desc: Anatomic site from which sample was collected
    Enum:
    - Bone marrow
    - post mortem blood
    - post mortem liver
    - Frontal Lobe
    - Peripheral blood
    - Lung
    - tumor
    - post mortem liver tumor
    - Left Bone marrow
    - Right Bone marrow
    - Left thigh
    - Lung/pleura
    - R. femur/rib/verebra
    - Femur
    - Paraspinal mass
    - Abdominal mass
    - Kidney
    - Brain stem
    - Cerebrum
    - Cerebellum
    - R. Buttock
    - Shoulder
    - L. Kidney
    - R. Kidney
    - Ventricular mass
    - Bilateral
    - Retroperitoneal mass
    - Adrenal mass
    - R. Breast metastasis
    - Paracaval Lymph Node metastasis
    - Transverse Colon
    - Lymph Node met
    - Orbit
    - Lung met
    - Liver
    - 4th ventricle
    - L. Occipital mass
    - Posterior mediastil mass (mediastinum)
    - R. Proximal Ulna
    - R. Sylvian Fissure
    - Lung metastasis
    - Liver metastasis
    - R. Parietal Lobe
    - Tibia
    - Humerus
    - Lung mass
    - R. Distal Femur
    - R. Humerus
    - L. Femur
    - Distal femur
    - L. Distal Femur
    - Os frontalis
    - L. Proximal Tibia
    - Arm
    - Perineum
    - Bone Marrow metastasis
    - Paratesticular
    - Cervical node
    - R. Neck mass
    - Pleural effusion met
    - not reported
    - Abdomen
    - Abdominal Wall
    - Acetabulum
    - Adenoid
    - Adipose
    - Adrenal
    - Alveolar Ridge
    - Amniotic Fluid
    - Ampulla Of Vater
    - Anal Sphincter
    - Ankle
    - Anorectum
    - Antecubital Fossa
    - Antrum
    - Anus
    - Aorta
    - Aortic Body
    - Appendix
    - Aqueous Fluid
    - Artery
    - Ascending Colon
    - Ascending Colon Hepatic Flexure
    - Auditory Canal
    - Autonomic Nervous System
    - Axilla
    - Back
    - Bile Duct
    - Bladder
    - Blood
    - Blood Vessel
    - Bone
    - Bone Marrow
    - Bowel
    - Brain
    - Brain Stem
    - Breast
    - Broad Ligament
    - Bronchiole
    - Bronchus
    - Brow
    - Buccal Cavity
    - Buccal Mucosa
    - Buttock
    - Calf
    - Capillary
    - Cardia
    - Carina
    - Carotid Artery
    - Carotid Body
    - Cartilage
    - Cecum
    - Cell-Line
    - Central Nervous System
    - Cerebral Cortex
    - Cerebrospinal Fluid
    - Cervical Spine
    - Cervix
    - Chest
    - Chest Wall
    - Chin
    - Clavicle
    - Clitoris
    - Colon
    - Colon - Mucosa Only
    - Common Duct
    - Conjunctiva
    - Connective Tissue
    - Dermal
    - Descending Colon
    - Diaphragm
    - Duodenum
    - Ear
    - Ear Canal
    - Ear, Pinna (External)
    - Effusion
    - Elbow
    - Endocrine Gland
    - Epididymis
    - Epidural Space
    - Esophageal; Distal
    - Esophageal; Mid
    - Esophageal; Proximal
    - Esophagogastric Junction
    - Esophagus
    - Esophagus - Mucosa Only
    - Eye
    - Fallopian Tube
    - Femoral Artery
    - Femoral Vein
    - Fibroblasts
    - Fibula
    - Finger
    - Floor Of Mouth
    - Fluid
    - Foot
    - Forearm
    - Forehead
    - Foreskin
    - Frontal Cortex
    - Fundus Of Stomach
    - Gallbladder
    - Ganglia
    - Gastroesophageal Junction
    - Gastrointestinal Tract
    - Glottis
    - Groin
    - Gum
    - Hand
    - Hard Palate
    - Head - Face Or Neck, Nos
    - Head & Neck
    - Heart
    - Hepatic
    - Hepatic Duct
    - Hepatic Flexure
    - Hepatic Vein
    - Hip
    - Hippocampus
    - Hypopharynx
    - Ileum
    - Ilium
    - Index Finger
    - Ischium
    - Islet Cells
    - Jaw
    - Jejunum
    - Joint
    - Knee
    - Lacrimal Gland
    - Large Bowel
    - Laryngopharynx
    - Larynx
    - Leg
    - Leptomeninges
    - Ligament
    - Lip
    - Lumbar Spine
    - Lymph Node
    - Lymph Node(s) Axilla
    - Lymph Node(s) Cervical
    - Lymph Node(s) Distant
    - Lymph Node(s) Epitrochlear
    - Lymph Node(s) Femoral
    - Lymph Node(s) Hilar
    - Lymph Node(s) Iliac-Common
    - Lymph Node(s) Iliac-External
    - Lymph Node(s) Inguinal
    - Lymph Node(s) Internal Mammary
    - Lymph Node(s) Mammary
    - Lymph Node(s) Mesenteric
    - Lymph Node(s) Occipital
    - Lymph Node(s) Paraaortic
    - Lymph Node(s) Parotid
    - Lymph Node(s) Pelvic
    - Lymph Node(s) Popliteal
    - Lymph Node(s) Regional
    - Lymph Node(s) Retroperitoneal
    - Lymph Node(s) Scalene
    - Lymph Node(s) Splenic
    - Lymph Node(s) Subclavicular
    - Lymph Node(s) Submandibular
    - Lymph Node(s) Supraclavicular
    - Lymph Nodes(s) Mediastinal
    - Mandible
    - Maxilla
    - Mediastinal Soft Tissue
    - Mediastinum
    - Mesentery
    - Mesothelium
    - Middle Finger
    - Mitochondria
    - Muscle
    - Nails
    - Nasal Cavity
    - Nasal Soft Tissue
    - Nasopharynx
    - Neck
    - Nerve
    - Nerve(s) Cranial
    - Not Allowed To Collect
    - Occipital Cortex
    - Ocular Orbits
    - Omentum
    - Oral Cavity
    - Oral Cavity - Mucosa Only
    - Oropharynx
    - Other
    - Ovary
    - Palate
    - Pancreas
    - Paranasal Sinuses
    - Paraspinal Ganglion
    - Parathyroid
    - Parotid Gland
    - Patella
    - Pelvis
    - Penis
    - Pericardium
    - Periorbital Soft Tissue
    - Peritoneal Cavity
    - Peritoneum
    - Pharynx
    - Pineal
    - Pineal Gland
    - Pituitary Gland
    - Placenta
    - Pleura
    - Popliteal Fossa
    - Prostate
    - Pylorus
    - Rectosigmoid Junction
    - Rectum
    - Retina
    - Retro-Orbital Region
    - Retroperitoneum
    - Rib
    - Ring Finger
    - Round Ligament
    - Sacrum
    - Salivary Gland
    - Scalp
    - Scapula
    - Sciatic Nerve
    - Scrotum
    - Seminal Vesicle
    - Sigmoid Colon
    - Sinus
    - Sinus(es), Maxillary
    - Skeletal Muscle
    - Skin
    - Skull
    - Small Bowel
    - Small Bowel - Mucosa Only
    - Small Finger
    - Soft Tissue
    - Spinal Column
    - Spinal Cord
    - Spleen
    - Splenic Flexure
    - Sternum
    - Stomach
    - Stomach - Mucosa Only
    - Subcutaneous Tissue
    - Subglottis
    - Sublingual Gland
    - Submandibular Gland
    - Supraglottis
    - Synovium
    - Temporal Cortex
    - Tendon
    - Testis
    - Thigh
    - Thoracic Spine
    - Thorax
    - Throat
    - Thumb
    - Thymus
    - Thyroid
    - Tongue
    - Tonsil
    - Tonsil (Pharyngeal)
    - Trachea / Major Bronchi
    - Trunk
    - Umbilical Cord
    - Ureter
    - Urethra
    - Urinary Tract
    - Uterus
    - Uvula
    - Vagina
    - Vas Deferens
    - Vein
    - Venous
    - Vertebra
    - Vulva
    - White Blood Cells
    - Wrist
    - Unknown
    - Not Reported
    - Not specified in data
    - Unknowm
    Term:
    - Origin: caDSR
      Code: '12083894'
      Value: Specimen Original Anatomic Site Uberon Identifier
      Version: '1.00'
  sample_id:
    Desc: Sample identifier as submitted by requestor
    Type: string
    Req: 'Yes'
    Key: true
    Term:
    - Origin: caDSR
      Code: '6921892'
      Value: Biospecimen Source Laboratory Identifier
      Version: '1.00'
  sample_tumor_status:
    Desc: Tumor or normal status
    Enum:
    - Tumor
    - Normal
    - Abnormal
    - Peritumoral
    - Unknown
    - Not specified in data
    Req: 'Yes'
    Term:
    - Origin: caDSR
      Original Source: DSS
      Code: '14688604'
      Value: Specimen Neoplasm Category
      Version: '1.00'
  sample_type:
    Desc: Tissue type of this sample
    Enum:
    - Ascites
    - Blood
    - Blood Derived Normal
    - Bone Marrow
    - Buccal Mucosa
    - Buffy Coat
    - Cell Line Derived Xenograft Tissue
    - DNA
    - Fluids
    - Metastatic
    - Mouthwash
    - Normal
    - Not specified in data
    - Pleural Fluid
    - Primary Tumor
    - Primary Xenograft Tissue
    - RNA
    - Saliva
    - Skin
    - Solid Tissue Normal
    - Tissue
    - Tumor
    - Tumor Adjacent Normal
    - Unknown
    - Unspecified
    - Xenograft Tissue
    - Additional - New Primary
    - Additional Metastatic
    - Benign Neoplasms
    - Blood Derived Cancer - Bone Marrow
    - Blood Derived Cancer - Bone Marrow, Post-treatment
    - Blood Derived Cancer - Peripheral Blood
    - Blood Derived Cancer - Peripheral Blood, Post-treatment
    - Blood Derived Liquid Biopsy
    - Bone Marrow Normal
    - Buccal Cell Normal
    - Cell Lines
    - Control Analyte
    - EBV Immortalized Normal
    - Expanded Next Generation Cancer Model
    - FFPE Recurrent
    - FFPE Scrolls
    - Fibroblasts from Bone Marrow Normal
    - GenomePlex (Rubicon) Amplified DNA
    - Granulocytes
    - Human Tumor Original Cells
    - In Situ Neoplasms
    - Lymphoid Normal
    - Mixed Adherent Suspension
    - Mononuclear Cells from Bone Marrow Normal
    - Neoplasms of Uncertain and Unknown Behavior
    - Next Generation Cancer Model
    - Next Generation Cancer Model Expanded Under Non-conforming Conditions
    - Not Allowed To Collect
    - Pleural Effusion
    - Post neo-adjuvant therapy
    - Primary Blood Derived Cancer - Bone Marrow
    - Primary Blood Derived Cancer - Peripheral Blood
    - Recurrent Blood Derived Cancer - Bone Marrow
    - Recurrent Blood Derived Cancer - Peripheral Blood
    - Recurrent Tumor
    - Repli-G (Qiagen) DNA
    - Repli-G X (Qiagen) DNA
    - Slides
    - Total RNA
    - Tumor Adjacent Normal - Post Neo-adjuvant Therapy
    - Not Reported
    - Not specified in data
    Req: 'Yes'
    Term:
    - Origin: caDSR
      Code: '13255982'
      Value: Specimen Material Type
      Version: '1.00'
  derived_from_specimen:
    Desc: Identier of the parent specimen of this sample
    Type: string
    Term:
    - Origin: caDSR
      Original Source: HTAN
      Code: '5581201'
      Value: Parent Specimen Label Identifier
      Version: '1.00'
  # treatment
  treatment_id:
    Desc: Internal identifier
    Type: string
    Key: true
  days_to_treatment:
    Desc: Days to start of treatment, relative to index date
    Type: integer
    Term:
    - Origin: caDSR
      Original Source: CDS
      Code: '12447194'
      Value: Subject Initial Cancer Diagnosis To Treatment Day Count
      Version: '1.00'
  treatment_outcome:
    Desc: Text term that describes the patient's final outcome after the treatment was administered
    Enum:
    - Complete Response
    - Mixed Response
    - No Measurable Disease
    - No Response
    - Not Reported
    - Partial Response
    - Persistent Disease
    - Progressive Disease
    - Stable Disease
    - Treatment Ongoing
    - Treatment Stopped Due to Toxicity
    - Unknown
    - Very Good Partial Response
    Term:
    - Origin: caDSR
      Original Source: TCGA
      Code: '5102383'
      Value: Treatment Outcome Type
      Version: '1.00'
  treatment_type:
    Desc: Text term that describes the kind of treatment administered
    Enum:
    - Ablation, Cryo
    - Ablation, Ethanol Injection
    - Ablation, Microwave
    - Ablation, NOS
    - Ablation, Radiofrequency
    - Ablation, Radiosurgical
    - Ancillary Treatment
    - Antiseizure Treatment
    - Bisphosphonate Therapy
    - Blinded Study, Treatment Unknown
    - Brachytherapy, High Dose
    - Brachytherapy, Low Dose
    - Brachytherapy, NOS
    - Chemoembolization
    - Chemoprotectant
    - Chemotherapy
    - Concurrent Chemoradiation
    - Cryoablation
    - Embolization
    - Ethanol Injection Ablation
    - External Beam Radiation
    - Hormone Therapy
    - I-131 Radiation Therapy
    - Immunotherapy (Including Vaccines)
    - Internal Radiation
    - Isolated Limb Perfusion (ILP)
    - Organ Transplantation
    - Other
    - Pharmaceutical Therapy, NOS
    - Pleurodesis
    - Pleurodesis, Talc
    - Pleurodesis, NOS
    - Radiation Therapy, NOS
    - Radiation, 2D Conventional
    - Radiation, 3D Conformal
    - Radiation, Combination
    - Radiation, Cyberknife
    - Radiation, External Beam
    - Radiation, Hypofractionated
    - Radiation, Implants
    - Radiation, Intensity-Modulated Radiotherapy
    - Radiation, Internal
    - Radiation, Mixed Photon Beam
    - Radiation, Photon Beam
    - Radiation, Proton Beam
    - Radiation, Radioisotope
    - Radiation, Stereotactic/Gamma Knife/SRS
    - Radiation, Systemic
    - Radioactive Iodine Therapy
    - Radioembolization
    - Radiosensitizing Agent
    - Stem Cell Transplantation, Allogeneic
    - Stem Cell Transplantation, Autologous
    - Stem Cell Transplantation, Double Autologous
    - Stem Cell Transplantation, Haploidentical
    - Stem Cell Transplantation, Non-Myeloablative
    - Stem Cell Transplantation, NOS
    - Stem Cell Transplantation, Syngenic
    - Stem Cell Treatment
    - Stereotactic Radiosurgery
    - Steroid Therapy
    - Surgery
    - Targeted Molecular Therapy
    - Unknown
    - Not Reported
    Term:
    - Origin: caDSR
      Original Source: TCGA
      Code: '14737565'
      Value: Therapeutic Procedure Performed Type
      Version: '1.00'
  therapeutic_agents:
    Desc: Text identification of the individual agent(s) used as part of a treatment regimen.
    Enum:
    - 10-Deacetyltaxol
    - 11C Topotecan
    - 11D10 AluGel Anti-Idiotype Monoclonal Antibody
    - 12-Allyldeoxoartemisinin
    - 13-Deoxydoxorubicin
    - 14C BMS-275183
    - 17beta-Hydroxysteroid Dehydrogenase Type 5 Inhibitor ASP9521
    - 2-Deoxy-D-glucose
    - 2-Ethylhydrazide
    - 2-Fluoroadenine
    - 2-Fluorofucose-containing SGN-2FF
    - 2-Hydroxyestradiol
    - 2-Hydroxyestrone
    - 2-Hydroxyflutamide Depot
    - 2-Hydroxyoleic Acid
    - 2-Methoxyestradiol
    - 2-Methoxyestradiol Nanocrystal Colloidal Dispersion
    - 2-Methoxyestrone
    - 2-O, 3-O Desulfated Heparin
    - 2,6-Diaminopurine
    - 2,6-Dimethoxyquinone
    - 2'-F-ara-deoxyuridine
    - 3'-C-ethynylcytidine
    - 3'-dA Phosphoramidate NUC-7738
    - 4-Nitroestrone 3-Methyl Ether
    - 4-Thio-2-deoxycytidine
    - 4'-Iodo-4'-Deoxydoxorubicin
    - 5-Aza-4'-thio-2'-deoxycytidine
    - 5-Fluoro-2-Deoxycytidine
    - 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatases Isoform 3 Inhibitor ACT-PFK-158
    - 7-Cyanoquinocarcinol
    - 7-Ethyl-10-Hydroxycamptothecin
    - 7-Hydroxystaurosporine
    - 8-Azaguanine
    - 9-Ethyl 6-Mercaptopurine
    - 9H-Purine-6Thio-98D
    - A2A Receptor Antagonist EOS100850
    - Abagovomab
    - Abarelix
    - Abemaciclib
    - Abemaciclib Mesylate
    - Abexinostat
    - Abexinostat Tosylate
    - Abiraterone
    - Abiraterone Acetate
    - Abituzumab
    - Acai Berry Juice
    - Acalabrutinib
    - Acalisib
    - Aceglatone
    - Acetylcysteine
    - Acitretin
    - Acivicin
    - Aclacinomycin B
    - Aclarubicin
    - Acodazole
    - Acodazole Hydrochloride
    - Acolbifene Hydrochloride
    - Acridine
    - Acridine Carboxamide
    - Acronine
    - Actinium Ac 225 Lintuzumab
    - Actinium Ac 225-FPI-1434
    - Actinium Ac-225 Anti-PSMA Monoclonal Antibody J591
    - Actinomycin C2
    - Actinomycin C3
    - Actinomycin F1
    - Activin Type 2B Receptor Fc Fusion Protein STM 434
    - Acyclic Nucleoside Phosphonate Prodrug ABI-1968
    - Ad-RTS-hIL-12
    - Adagloxad Simolenin
    - Adavosertib
    - Adecatumumab
    - Adenosine A2A Receptor Antagonist AZD4635
    - Adenosine A2A Receptor Antagonist CS3005
    - Adenosine A2A Receptor Antagonist NIR178
    - Adenosine A2A Receptor Antagonist/Phosphodiesterase 10A PBF-999
    - Adenosine A2A/A2B Receptor Antagonist AB928
    - Adenosine A2B Receptor Antagonist PBF-1129
    - Adenovector-transduced AP1903-inducible MyD88/CD40-expressing Autologous PSMA-specific Prostate Cancer Vaccine BPX-201
    - Adenoviral Brachyury Vaccine ETBX-051
    - Adenoviral Cancer Vaccine PF-06936308
    - Adenoviral MUC1 Vaccine ETBX-061
    - Adenoviral PSA Vaccine ETBX-071
    - Adenoviral Transduced hIL-12-expressing Autologous Dendritic Cells INXN-3001 Plus Activator Ligand INXN-1001
    - Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP
    - Adenoviral Tumor-specific Neoantigen Priming Vaccine GRT-C901
    - Adenovirus 5/F35-Human Guanylyl Cyclase C-PADRE
    - Adenovirus Serotype 26-expressing HPV16 Vaccine JNJ-63682918
    - Adenovirus Serotype 26-expressing HPV18 Vaccine JNJ-63682931
    - Adenovirus-expressing TLR5/TLR5 Agonist Nanoformulation M-VM3
    - Adenovirus-mediated Human Interleukin-12 INXN-2001 Plus Activator Ligand INXN-1001
    - Aderbasib
    - ADH-1
    - AE37 Peptide/GM-CSF Vaccine
    - AEE788
    - Aerosol Gemcitabine
    - Aerosolized Aldesleukin
    - Aerosolized Liposomal Rubitecan
    - Afatinib
    - Afatinib Dimaleate
    - Afimoxifene
    - Afuresertib
    - Agatolimod Sodium
    - Agerafenib
    - Aglatimagene Besadenovec
    - Agonistic Anti-CD40 Monoclonal Antibody ADC-1013
    - Agonistic Anti-OX40 Monoclonal Antibody INCAGN01949
    - Agonistic Anti-OX40 Monoclonal Antibody MEDI6469
    - AKR1C3-activated Prodrug OBI-3424
    - AKT 1/2 Inhibitor BAY1125976
    - AKT Inhibitor ARQ 092
    - Akt Inhibitor LY2780301
    - Akt Inhibitor MK2206
    - Akt Inhibitor SR13668
    - Akt/ERK Inhibitor ONC201
    - Alacizumab Pegol
    - Alanosine
    - Albumin-binding Cisplatin Prodrug BTP-114
    - Aldesleukin
    - Aldoxorubicin
    - Alectinib
    - Alefacept
    - Alemtuzumab
    - Alestramustine
    - Alflutinib Mesylate
    - Algenpantucel-L
    - Alisertib
    - Alitretinoin
    - ALK Inhibitor
    - ALK Inhibitor ASP3026
    - ALK Inhibitor PLB 1003
    - ALK Inhibitor RO5424802
    - ALK Inhibitor TAE684
    - ALK Inhibitor WX-0593
    - ALK-2 Inhibitor TP-0184
    - ALK-FAK Inhibitor CEP-37440
    - ALK/c-Met Inhibitor TQ-B3139
    - ALK/FAK/Pyk2 Inhibitor CT-707
    - ALK/ROS1/Met Inhibitor TQ-B3101
    - ALK/TRK Inhibitor TSR-011
    - Alkotinib
    - Allodepleted T Cell Immunotherapeutic ATIR101
    - Allogeneic Anti-BCMA CAR-transduced T-cells ALLO-715
    - Allogeneic Anti-BCMA-CAR T-cells PBCAR269A
    - Allogeneic Anti-BCMA/CS1 Bispecific CAR-T Cells
    - Allogeneic Anti-CD19 CAR T-cells ALLO-501A
    - Allogeneic Anti-CD19 Universal CAR-T Cells CTA101
    - Allogeneic Anti-CD19-CAR T-cells PBCAR0191
    - Allogeneic Anti-CD20 CAR T-cells LUCAR-20S
    - Allogeneic Anti-CD20-CAR T-cells PBCAR20A
    - Allogeneic CD22-specific Universal CAR-expressing T-lymphocytes UCART22
    - Allogeneic CD3- CD19- CD57+ NKG2C+ NK Cells FATE-NK100
    - Allogeneic CD56-positive CD3-negative Natural Killer Cells CYNK-001
    - Allogeneic CD8+ Leukemia-associated Antigens Specific T Cells NEXI-001
    - Allogeneic Cellular Vaccine 1650-G
    - Allogeneic CRISPR-Cas9 Engineered Anti-BCMA T Cells CTX120
    - Allogeneic CRISPR-Cas9 Engineered Anti-CD70 CAR-T Cells CTX130
    - Allogeneic CS1-specific Universal CAR-expressing T-lymphocytes UCARTCS1A
    - Allogeneic GM-CSF-secreting Breast Cancer Vaccine SV-BR-1-GM
    - Allogeneic GM-CSF-secreting Lethally Irradiated Prostate Cancer Vaccine
    - Allogeneic GM-CSF-secreting Lethally Irradiated Whole Melanoma Cell Vaccine
    - Allogeneic GM-CSF-secreting Tumor Vaccine PANC 10.05 pcDNA-1/GM-Neo
    - Allogeneic GM-CSF-secreting Tumor Vaccine PANC 6.03 pcDNA-1/GM-Neo
    - Allogeneic IL13-Zetakine/HyTK-Expressing-Glucocorticoid Resistant Cytotoxic T Lymphocytes GRm13Z40-2
    - Allogeneic Irradiated Melanoma Cell Vaccine CSF470
    - Allogeneic Large Multivalent Immunogen Melanoma Vaccine LP2307
    - Allogeneic Melanoma Vaccine AGI-101H
    - Allogeneic Natural Killer Cell Line MG4101
    - Allogeneic Natural Killer Cell Line NK-92
    - Allogeneic Plasmacytoid Dendritic Cells Expressing Lung Tumor Antigens PDC*lung01
    - Allogeneic Renal Cell Carcinoma Vaccine MGN1601
    - Allogeneic Third-party Suicide Gene-transduced Anti-HLA-DPB1*0401 CD4+ T-cells CTL 19
    - Allosteric ErbB Inhibitor BDTX-189
    - Allovectin-7
    - Almurtide
    - Alobresib
    - Alofanib
    - Alpelisib
    - Alpha Galactosylceramide
    - Alpha V Beta 1 Inhibitor ATN-161
    - Alpha V Beta 8 Antagonist PF-06940434
    - alpha-Folate Receptor-targeting Thymidylate Synthase Inhibitor ONX-0801
    - Alpha-Gal AGI-134
    - Alpha-lactalbumin-derived Synthetic Peptide-lipid Complex Alpha1H
    - Alpha-Thioguanine Deoxyriboside
    - Alpha-tocopheryloxyacetic Acid
    - Alsevalimab
    - Altiratinib
    - Altretamine
    - Alvespimycin
    - Alvespimycin Hydrochloride
    - Alvocidib
    - Alvocidib Hydrochloride
    - Alvocidib Prodrug TP-1287
    - Amatuximab
    - Ambamustine
    - Ambazone
    - Amblyomin-X
    - Amcasertib
    - Ametantrone
    - Amifostine
    - Amino Acid Injection
    - Aminocamptothecin
    - Aminocamptothecin Colloidal Dispersion
    - Aminoflavone Prodrug AFP464
    - Aminopterin
    - Aminopterin Sodium
    - Amivantamab
    - Amolimogene Bepiplasmid
    - Amonafide L-Malate
    - Amrubicin
    - Amrubicin Hydrochloride
    - Amsacrine
    - Amsacrine Lactate
    - Amsilarotene
    - Amustaline
    - Amustaline Dihydrochloride
    - Amuvatinib
    - Amuvatinib Hydrochloride
    - Anakinra
    - Anastrozole
    - Anaxirone
    - Ancitabine
    - Ancitabine Hydrochloride
    - Andecaliximab
    - Androgen Antagonist APC-100
    - Androgen Receptor Antagonist BAY 1161116
    - Androgen Receptor Antagonist SHR3680
    - Androgen Receptor Antagonist TAS3681
    - Androgen Receptor Antagonist TRC253
    - Androgen Receptor Antisense Oligonucleotide AZD5312
    - Androgen Receptor Antisense Oligonucleotide EZN-4176
    - Androgen Receptor Degrader ARV-110
    - Androgen Receptor Degrader CC-94676
    - Androgen Receptor Downregulator AZD3514
    - Androgen Receptor Inhibitor EPI-7386
    - Androgen Receptor Ligand-binding Domain-encoding Plasmid DNA Vaccine MVI-118
    - Androgen Receptor/Glucocorticoid Receptor Antagonist CB-03-10
    - Andrographolide
    - Androstane Steroid HE3235
    - Anetumab Ravtansine
    - Ang2/VEGF-Binding Peptides-Antibody Fusion Protein CVX-241
    - Angiogenesis Inhibitor GT-111
    - Angiogenesis Inhibitor JI-101
    - Angiogenesis/Heparanase Inhibitor PG545
    - Angiopoietin-2-specific Fusion Protein PF-04856884
    - Anhydrous Enol-oxaloacetate
    - Anhydrovinblastine
    - Aniline Mustard
    - Anlotinib Hydrochloride
    - Annamycin
    - Annamycin Liposomal
    - Annonaceous Acetogenins
    - Ansamitomicin P-3
    - Anthramycin
    - Anthrapyrazole
    - Anti c-KIT Antibody-drug Conjugate LOP628
    - Anti-5T4 Antibody-drug Conjugate ASN004
    - Anti-5T4 Antibody-Drug Conjugate PF-06263507
    - Anti-5T4 Antibody-drug Conjugate SYD1875
    - Anti-A33 Monoclonal Antibody KRN330
    - Anti-A5B1 Integrin Monoclonal Antibody PF-04605412
    - Anti-ACTR/4-1BB/CD3zeta-Viral Vector-transduced Autologous T-Lymphocytes ACTR087
    - Anti-AG7 Antibody Drug Conjugate AbGn-107
    - Anti-AGS-16 Monoclonal Antibody AGS-16M18
    - Anti-AGS-5 Antibody-Drug Conjugate ASG-5ME
    - Anti-AGS-8 Monoclonal Antibody AGS-8M4
    - Anti-alpha BCMA/Anti-alpha CD3 T-cell Engaging Bispecific Antibody TNB-383B
    - Anti-alpha5beta1 Integrin Antibody MINT1526A
    - Anti-ANG2 Monoclonal Antibody MEDI-3617
    - Anti-angiopoietin Monoclonal Antibody AMG 780
    - Anti-APRIL Monoclonal Antibody BION-1301
    - Anti-AXL Fusion Protein AVB-S6-500
    - Anti-AXL/PBD Antibody-drug Conjugate ADCT-601
    - Anti-B7-H3 Antibody DS-5573a
    - Anti-B7-H3/DXd Antibody-drug Conjugate DS-7300a
    - Anti-B7-H4 Monoclonal Antibody FPA150
    - Anti-B7H3 Antibody-drug Conjugate MGC018
    - Anti-BCMA Antibody SEA-BCMA
    - Anti-BCMA Antibody-drug Conjugate AMG 224
    - Anti-BCMA Antibody-drug Conjugate CC-99712
    - Anti-BCMA Antibody-drug Conjugate GSK2857916
    - Anti-BCMA SparX Protein Plus BCMA-directed Anti-TAAG ARC T-cells CART-ddBCMA
    - Anti-BCMA/Anti-CD3 Bispecific Antibody REGN5459
    - Anti-BCMA/CD3 BiTE Antibody AMG 420
    - Anti-BCMA/CD3 BiTE Antibody AMG 701
    - Anti-BCMA/CD3 BiTE Antibody REGN5458
    - Anti-BCMA/PBD ADC MEDI2228
    - Anti-BTLA Monoclonal Antibody TAB004
    - Anti-BTN3A Agonistic Monoclonal Antibody ICT01
    - Anti-c-fms Monoclonal Antibody AMG 820
    - Anti-c-KIT Monoclonal Antibody CDX 0158
    - Anti-c-Met Antibody-drug Conjugate HTI-1066
    - Anti-c-Met Antibody-drug Conjugate TR1801
    - Anti-c-Met Monoclonal Antibody ABT-700
    - Anti-c-Met Monoclonal Antibody ARGX-111
    - Anti-c-Met Monoclonal Antibody HLX55
    - Anti-c-MET Monoclonal Antibody LY2875358
    - Anti-C-met Monoclonal Antibody SAIT301
    - Anti-C4.4a Antibody-Drug Conjugate BAY1129980
    - Anti-C5aR Monoclonal Antibody IPH5401
    - Anti-CA19-9 Monoclonal Antibody 5B1
    - Anti-CA6-DM4 Immunoconjugate SAR566658
    - Anti-CCR7 Antibody-drug Conjugate JBH492
    - Anti-CD117 Monoclonal Antibody JSP191
    - Anti-CD122 Humanized Monoclonal Antibody Mik-Beta-1
    - Anti-CD123 ADC IMGN632
    - Anti-CD123 Monoclonal Antibody CSL360
    - Anti-CD123 Monoclonal Antibody KHK2823
    - Anti-CD123 x Anti-CD3 Bispecific Antibody XmAb1404
    - Anti-CD123-Pyrrolobenzodiazepine Dimer Antibody Drug Conjugate SGN-CD123A
    - Anti-CD123/CD3 Bispecific Antibody APVO436
    - Anti-CD123/CD3 Bispecific Antibody JNJ-63709178
    - Anti-CD123/CD3 BiTE Antibody SAR440234
    - Anti-CD137 Agonistic Monoclonal Antibody ADG106
    - Anti-CD137 Agonistic Monoclonal Antibody AGEN2373
    - Anti-CD137 Agonistic Monoclonal Antibody ATOR-1017
    - Anti-CD137 Agonistic Monoclonal Antibody CTX-471
    - Anti-CD137 Agonistic Monoclonal Antibody LVGN6051
    - Anti-CD157 Monoclonal Antibody MEN1112
    - Anti-CD166 Probody-drug Conjugate CX-2009
    - Anti-CD19 Antibody-drug Conjugate SGN-CD19B
    - Anti-CD19 Antibody-T-cell Receptor-expressing T-cells ET019003
    - Anti-CD19 iCAR NK Cells
    - Anti-CD19 Monoclonal Antibody DI-B4
    - Anti-CD19 Monoclonal Antibody MDX-1342
    - Anti-CD19 Monoclonal Antibody MEDI-551
    - Anti-CD19 Monoclonal Antibody XmAb5574
    - Anti-CD19-DM4 Immunoconjugate SAR3419
    - Anti-CD19/Anti-CD22 Bispecific Immunotoxin DT2219ARL
    - Anti-CD19/CD22 CAR NK Cells
    - Anti-CD19/CD3 BiTE Antibody AMG 562
    - Anti-CD19/CD3 Tetravalent Antibody AFM11
    - Anti-CD20 Monoclonal Antibody B001
    - Anti-CD20 Monoclonal Antibody BAT4306F
    - Anti-CD20 Monoclonal Antibody MIL62
    - Anti-CD20 Monoclonal Antibody PRO131921
    - Anti-CD20 Monoclonal Antibody SCT400
    - Anti-CD20 Monoclonal Antibody TL011
    - Anti-CD20 Monoclonal Antibody-Interferon-alpha Fusion Protein IGN002
    - Anti-CD20-engineered Toxin Body MT-3724
    - Anti-CD20/Anti-CD3 Bispecific IgM Antibody IGM2323
    - Anti-CD20/CD3 Monoclonal Antibody REGN1979
    - Anti-CD20/CD3 Monoclonal Antibody XmAb13676
    - Anti-CD205 Antibody-drug Conjugate OBT076
    - Anti-CD22 ADC TRPH-222
    - Anti-CD22 Monoclonal Antibody-MMAE Conjugate DCDT2980S
    - Anti-CD228/MMAE Antibody-drug Conjugate SGN-CD228A
    - Anti-CD25 Monoclonal Antibody RO7296682
    - Anti-CD25-PBD Antibody-drug Conjugate ADCT-301
    - Anti-CD26 Monoclonal Antibody YS110
    - Anti-CD27 Agonistic Monoclonal Antibody MK-5890
    - Anti-CD27L Antibody-Drug Conjugate AMG 172
    - Anti-CD3 Immunotoxin A-dmDT390-bisFv(UCHT1)
    - Anti-CD3/Anti-5T4 Bispecific Antibody GEN1044
    - Anti-CD3/Anti-BCMA Bispecific Monoclonal Antibody JNJ-64007957
    - Anti-CD3/Anti-BCMA Bispecific Monoclonal Antibody PF-06863135
    - Anti-CD3/Anti-CD20 Trifunctional Bispecific Monoclonal Antibody FBTA05
    - Anti-CD3/Anti-GPRC5D Bispecific Monoclonal Antibody JNJ-64407564
    - Anti-CD3/Anti-GUCY2C Bispecific Antibody PF-07062119
    - Anti-CD3/CD20 Bispecific Antibody GEN3013
    - Anti-CD3/CD38 Bispecific Monoclonal Antibody AMG 424
    - Anti-CD3/CD7-Ricin Toxin A Immunotoxin
    - Anti-CD30 Monoclonal Antibody MDX-1401
    - Anti-CD30 Monoclonal Antibody XmAb2513
    - Anti-CD30/CD16A Monoclonal Antibody AFM13
    - Anti-CD30/DM1 Antibody-drug Conjugate F0002
    - Anti-CD32B Monoclonal Antibody BI-1206
    - Anti-CD33 Antibody-drug Conjugate IMGN779
    - Anti-CD33 Antigen/CD3 Receptor Bispecific Monoclonal Antibody AMV564
    - Anti-CD33 Monoclonal Antibody BI 836858
    - Anti-CD33 Monoclonal Antibody-DM4 Conjugate AVE9633
    - Anti-CD33/CD3 Bispecific Antibody GEM 333
    - Anti-CD33/CD3 Bispecific Antibody JNJ-67571244
    - Anti-CD33/CD3 BiTE Antibody AMG 330
    - Anti-CD33/CD3 BiTE Antibody AMG 673
    - Anti-CD352 Antibody-drug Conjugate SGN-CD352A
    - Anti-CD37 Antibody-Drug Conjugate IMGN529
    - Anti-CD37 Bispecific Monoclonal Antibody GEN3009
    - Anti-CD37 MMAE Antibody-drug Conjugate AGS67E
    - Anti-CD37 Monoclonal Antibody BI 836826
    - Anti-CD38 Antibody-drug Conjugate STI-6129
    - Anti-CD38 Monoclonal Antibody MOR03087
    - Anti-CD38 Monoclonal Antibody SAR442085
    - Anti-CD38 Monoclonal Antibody TAK-079
    - Anti-CD38-targeted IgG4-attenuated IFNa TAK-573
    - Anti-CD38/CD28xCD3 Tri-specific Monoclonal Antibody SAR442257
    - Anti-CD38/CD3 Bispecific Monoclonal Antibody GBR 1342
    - Anti-CD39 Monoclonal Antibody SRF617
    - Anti-CD39 Monoclonal Antibody TTX-030
    - Anti-CD40 Agonist Monoclonal Antibody ABBV-927
    - Anti-CD40 Agonist Monoclonal Antibody CDX-1140
    - Anti-CD40 Monoclonal Antibody Chi Lob 7/4
    - Anti-CD40 Monoclonal Antibody SEA-CD40
    - Anti-CD40/Anti-4-1BB Bispecific Agonist Monoclonal Antibody GEN1042
    - Anti-CD40/Anti-TAA Bispecific Monoclonal Antibody ABBV-428
    - Anti-CD40L Fc-Fusion Protein BMS-986004
    - Anti-CD44 Monoclonal Antibody RO5429083
    - Anti-CD45 Monoclonal Antibody AHN-12
    - Anti-CD46 Antibody-drug Conjugate FOR46
    - Anti-CD47 ADC SGN-CD47M
    - Anti-CD47 Monoclonal Antibody AO-176
    - Anti-CD47 Monoclonal Antibody CC-90002
    - Anti-CD47 Monoclonal Antibody Hu5F9-G4
    - Anti-CD47 Monoclonal Antibody IBI188
    - Anti-CD47 Monoclonal Antibody IMC-002
    - Anti-CD47 Monoclonal Antibody SHR-1603
    - Anti-CD47 Monoclonal Antibody SRF231
    - Anti-CD47 Monoclonal Antibody TJC4
    - Anti-CD47/CD19 Bispecific Monoclonal Antibody TG-1801
    - Anti-CD48/MMAE Antibody-drug Conjugate SGN-CD48A
    - Anti-CD52 Monoclonal Antibody ALLO-647
    - Anti-CD70 Antibody-Drug Conjugate MDX-1203
    - Anti-CD70 Antibody-drug Conjugate SGN-CD70A
    - Anti-CD70 CAR-expressing T Lymphocytes
    - Anti-CD70 Monoclonal Antibody MDX-1411
    - Anti-CD71/vcMMAE Probody-drug Conjugate CX-2029
    - Anti-CD73 Monoclonal Antibody BMS-986179
    - Anti-CD73 Monoclonal Antibody CPI-006
    - Anti-CD73 Monoclonal Antibody NZV930
    - Anti-CD73 Monoclonal Antibody TJ4309
    - Anti-CD74 Antibody-drug Conjugate STRO-001
    - Anti-CD98 Monoclonal Antibody IGN523
    - Anti-CDH6 Antibody-drug Conjugate HKT288
    - Anti-CEA BiTE Monoclonal Antibody AMG211
    - Anti-CEA/Anti-DTPA-In (F6-734) Bispecific Antibody
    - Anti-CEA/Anti-HSG Bispecific Monoclonal Antibody TF2
    - Anti-CEACAM1 Monoclonal Antibody CM-24
    - Anti-CEACAM5 Antibody-Drug Conjugate SAR408701
    - Anti-CEACAM6 AFAIKL2 Antibody Fragment/Jack Bean Urease Immunoconjugate L-DOS47
    - Anti-CEACAM6 Antibody BAY1834942
    - Anti-claudin18.2 Monoclonal Antibody AB011
    - Anti-Claudin18.2 Monoclonal Antibody TST001
    - Anti-CLDN6 Monoclonal Antibody ASP1650
    - Anti-CLEC12A/CD3 Bispecific Antibody MCLA117
    - Anti-CLEVER-1 Monoclonal Antibody FP-1305
    - Anti-CSF1 Monoclonal Antibody PD-0360324
    - Anti-CSF1R Monoclonal Antibody IMC-CS4
    - Anti-CSF1R Monoclonal Antibody SNDX-6352
    - Anti-CTGF Monoclonal Antibody FG-3019
    - Anti-CTLA-4 Monoclonal Antibody ADG116
    - Anti-CTLA-4 Monoclonal Antibody ADU-1604
    - Anti-CTLA-4 Monoclonal Antibody AGEN1181
    - Anti-CTLA-4 Monoclonal Antibody BCD-145
    - Anti-CTLA-4 Monoclonal Antibody HBM4003
    - Anti-CTLA-4 Monoclonal Antibody MK-1308
    - Anti-CTLA-4 Monoclonal Antibody ONC-392
    - Anti-CTLA-4 Monoclonal Antibody REGN4659
    - Anti-CTLA-4 Probody BMS-986288
    - Anti-CTLA-4/Anti-PD-1 Monoclonal Antibody Combination BCD-217
    - Anti-CTLA-4/LAG-3 Bispecific Antibody XmAb22841
    - Anti-CTLA-4/OX40 Bispecific Antibody ATOR-1015
    - Anti-CTLA4 Antibody Fc Fusion Protein KN044
    - Anti-CTLA4 Monoclonal Antibody BMS-986218
    - Anti-CXCR4 Monoclonal Antibody PF-06747143
    - Anti-Denatured Collagen Monoclonal Antibody TRC093
    - Anti-DKK-1 Monoclonal Antibody LY2812176
    - Anti-DKK1 Monoclonal Antibody BHQ880
    - Anti-DLL3/CD3 BiTE Antibody AMG 757
    - Anti-DLL4 Monoclonal Antibody MEDI0639
    - Anti-DLL4/VEGF Bispecific Monoclonal Antibody OMP-305B83
    - Anti-DR5 Agonist Monoclonal Antibody TRA-8
    - Anti-DR5 Agonistic Antibody DS-8273a
    - Anti-DR5 Agonistic Monoclonal Antibody INBRX-109
    - Anti-EGFR Monoclonal Antibody CPGJ 602
    - Anti-EGFR Monoclonal Antibody EMD 55900
    - Anti-EGFR Monoclonal Antibody GC1118
    - Anti-EGFR Monoclonal Antibody GT-MAB 5.2-GEX
    - Anti-EGFR Monoclonal Antibody HLX-07
    - Anti-EGFR Monoclonal Antibody Mixture MM-151
    - Anti-EGFR Monoclonal Antibody RO5083945
    - Anti-EGFR Monoclonal Antibody SCT200
    - Anti-EGFR Monoclonal Antibody SYN004
    - Anti-EGFR TAP Antibody-drug Conjugate IMGN289
    - Anti-EGFR/c-Met Bispecific Antibody EMB-01
    - Anti-EGFR/c-Met Bispecific Antibody JNJ-61186372
    - Anti-EGFR/CD16A Bispecific Antibody AFM24
    - Anti-EGFR/DM1 Antibody-drug Conjugate AVID100
    - Anti-EGFR/HER2/HER3 Monoclonal Antibody Mixture Sym013
    - Anti-EGFR/PBD Antibody-drug Conjugate ABBV-321
    - Anti-EGFRvIII Antibody Drug Conjugate AMG 595
    - Anti-EGFRvIII Immunotoxin MR1-1
    - Anti-EGFRvIII/CD3 BiTE Antibody AMG 596
    - Anti-EGP-2 Immunotoxin MOC31-PE
    - Anti-ENPP3 Antibody-Drug Conjugate AGS-16C3F
    - Anti-ENPP3/MMAF Antibody-Drug Conjugate AGS-16M8F
    - Anti-Ep-CAM Monoclonal Antibody ING-1
    - Anti-EphA2 Antibody-directed Liposomal Docetaxel Prodrug MM-310
    - Anti-EphA2 Monoclonal Antibody DS-8895a
    - Anti-EphA2 Monoclonal Antibody-MMAF Immunoconjugate MEDI-547
    - Anti-ErbB2/Anti-ErbB3 Bispecific Monoclonal Antibody MM-111
    - Anti-ErbB3 Antibody ISU104
    - Anti-ErbB3 Monoclonal Antibody AV-203
    - Anti-ErbB3 Monoclonal Antibody CDX-3379
    - Anti-ErbB3 Monoclonal Antibody REGN1400
    - Anti-ErbB3/Anti-IGF-1R Bispecific Monoclonal Antibody MM-141
    - Anti-ETBR/MMAE Antibody-Drug Conjugate DEDN6526A
    - Anti-FAP/Interleukin-2 Fusion Protein RO6874281
    - Anti-FCRH5/CD3 BiTE Antibody BFCR4350A
    - Anti-FGFR2 Antibody BAY1179470
    - Anti-FGFR3 Antibody-drug Conjugate LY3076226
    - Anti-FGFR4 Monoclonal Antibody U3-1784
    - Anti-FLT3 Antibody-drug Conjugate AGS62P1
    - Anti-FLT3 Monoclonal Antibody 4G8-SDIEM
    - Anti-FLT3 Monoclonal Antibody IMC-EB10
    - Anti-FLT3/CD3 BiTE Antibody AMG 427
    - Anti-Folate Receptor-alpha Antibody Drug Conjugate STRO-002
    - Anti-FRA/Eribulin Antibody-drug Conjugate MORAb-202
    - Anti-fucosyl-GM1 Monoclonal Antibody BMS-986012
    - Anti-Ganglioside GM2 Monoclonal Antibody BIW-8962
    - Anti-GARP Monoclonal Antibody ABBV-151
    - Anti-GCC Antibody-Drug Conjugate MLN0264
    - Anti-GCC Antibody-Drug Conjugate TAK-164
    - Anti-GD2 hu3F8/Anti-CD3 huOKT3 Bispecific Antibody
    - Anti-GD2 Monoclonal Antibody hu14.18K322A
    - Anti-GD2 Monoclonal Antibody MORAb-028
    - Anti-GD3 Antibody-drug Conjugate PF-06688992
    - Anti-GITR Agonistic Monoclonal Antibody ASP1951
    - Anti-GITR Agonistic Monoclonal Antibody BMS-986156
    - Anti-GITR Agonistic Monoclonal Antibody INCAGN01876
    - Anti-GITR Monoclonal Antibody GWN 323
    - Anti-GITR Monoclonal Antibody MK-4166
    - Anti-Globo H Monoclonal Antibody OBI-888
    - Anti-Globo H/MMAE Antibody-drug Conjugate OBI 999
    - Anti-Glypican 3/CD3 Bispecific Antibody ERY974
    - Anti-GnRH Vaccine PEP223
    - Anti-gpA33/CD3 Monoclonal Antibody MGD007
    - Anti-GPR20/DXd Antibody-drug Conjugate DS-6157a
    - Anti-gremlin-1 Monoclonal Antibody UCB6114
    - Anti-GRP78 Monoclonal Antibody PAT-SM6
    - Anti-HA Epitope Monoclonal Antibody MEDI8852
    - Anti-HB-EGF Monoclonal Antibody KHK2866
    - Anti-HBEGF Monoclonal Antibody U3-1565
    - Anti-hepcidin Monoclonal Antibody LY2787106
    - Anti-HER-2 Bispecific Antibody KN026
    - Anti-HER2 ADC DS-8201a
    - Anti-HER2 Antibody Conjugated Natural Killer Cells ACE1702
    - Anti-HER2 Antibody-drug Conjugate A166
    - Anti-HER2 Antibody-drug Conjugate ARX788
    - Anti-HER2 Antibody-drug Conjugate BAT8001
    - Anti-HER2 Antibody-drug Conjugate DP303c
    - Anti-HER2 Antibody-drug Conjugate MEDI4276
    - Anti-HER2 Antibody-drug Conjugate RC48
    - Anti-HER2 Bi-specific Monoclonal Antibody ZW25
    - Anti-HER2 Bispecific Antibody-drug Conjugate ZW49
    - Anti-HER2 Immune Stimulator-antibody Conjugate NJH395
    - Anti-HER2 Monoclonal Antibody B002
    - Anti-HER2 Monoclonal Antibody CT-P6
    - Anti-HER2 Monoclonal Antibody HLX22
    - Anti-HER2 Monoclonal Antibody/Anti-CD137Anticalin Bispecific Fusion Protein PRS-343
    - Anti-HER2-DM1 ADC B003
    - Anti-HER2-DM1 Antibody-drug Conjugate GQ1001
    - Anti-HER2-vc0101 ADC PF-06804103
    - Anti-HER2/Anti-CD3 Bispecific Monoclonal Antibody BTRC 4017A
    - Anti-HER2/Anti-CD3 Bispecific Monoclonal Antibody GBR 1302
    - Anti-HER2/Anti-HER3 Bispecific Monoclonal Antibody MCLA-128
    - Anti-HER2/Auristatin Payload Antibody-drug Conjugate XMT-1522
    - Anti-HER2/MMAE Antibody-drug Conjugate MRG002
    - Anti-HER2/PBD-MA Antibody-drug Conjugate DHES0815A
    - Anti-HER3 Antibody-drug Conjugate U3 1402
    - Anti-HER3 Monoclonal Antibody GSK2849330
    - Anti-HGF Monoclonal Antibody TAK-701
    - Anti-HIF-1alpha LNA Antisense Oligonucleotide EZN-2968
    - Anti-HIV-1 Lentiviral Vector-expressing sh5/C46 Cal-1
    - Anti-HLA-DR Monoclonal Antibody IMMU-114
    - Anti-HLA-G Antibody TTX-080
    - Anti-human GITR Monoclonal Antibody AMG 228
    - Anti-human GITR Monoclonal Antibody TRX518
    - Anti-ICAM-1 Monoclonal Antibody BI-505
    - Anti-ICOS Agonist Antibody GSK3359609
    - Anti-ICOS Agonist Monoclonal Antibody BMS-986226
    - Anti-ICOS Monoclonal Antibody KY1044
    - Anti-ICOS Monoclonal Antibody MEDI-570
    - Anti-IGF-1R Monoclonal Antibody AVE1642
    - Anti-IGF-1R Recombinant Monoclonal Antibody BIIB022
    - Anti-IL-1 alpha Monoclonal Antibody MABp1
    - Anti-IL-13 Humanized Monoclonal Antibody TNX-650
    - Anti-IL-15 Monoclonal Antibody AMG 714
    - Anti-IL-8 Monoclonal Antibody BMS-986253
    - Anti-IL-8 Monoclonal Antibody HuMax-IL8
    - Anti-ILDR2 Monoclonal Antibody BAY 1905254
    - Anti-ILT4 Monoclonal Antibody MK-4830
    - Anti-integrin Beta-6/MMAE Antibody-drug Conjugate SGN-B6A
    - Anti-Integrin Monoclonal Antibody-DM4 Immunoconjugate IMGN388
    - Anti-IRF4 Antisense Oligonucleotide ION251
    - Anti-KIR Monoclonal Antibody IPH 2101
    - Anti-KSP/Anti-VEGF siRNAs ALN-VSP02
    - Anti-LAG-3 Monoclonal Antibody IBI-110
    - Anti-LAG-3 Monoclonal Antibody INCAGN02385
    - Anti-LAG-3 Monoclonal Antibody LAG525
    - Anti-LAG-3 Monoclonal Antibody REGN3767
    - Anti-LAG-3/PD-L1 Bispecific Antibody FS118
    - Anti-LAG3 Monoclonal Antibody BI 754111
    - Anti-LAG3 Monoclonal Antibody MK-4280
    - Anti-LAG3 Monoclonal Antibody TSR-033
    - Anti-LAMP1 Antibody-drug Conjugate SAR428926
    - Anti-latent TGF-beta 1 Monoclonal Antibody SRK-181
    - Anti-Lewis B/Lewis Y Monoclonal Antibody GNX102
    - Anti-LGR5 Monoclonal Antibody BNC101
    - Anti-LIF Monoclonal Antibody MSC-1
    - Anti-LILRB4 Monoclonal Antibody IO-202
    - Anti-LIV-1 Monoclonal Antibody-MMAE Conjugate SGN-LIV1A
    - Anti-Ly6E Antibody-Drug Conjugate RG 7841
    - Anti-MAGE-A4 T-cell Receptor/Anti-CD3 scFv Fusion Protein IMC-C103C
    - Anti-Melanin Monoclonal Antibody PTI-6D2
    - Anti-mesothelin Antibody-drug Conjugate BMS-986148
    - Anti-mesothelin-Pseudomonas Exotoxin 24 Cytolytic Fusion Protein LMB-100
    - Anti-mesothelin/MMAE Antibody-Drug Conjugate DMOT4039A
    - Anti-mesothelin/MMAE Antibody-drug Conjugate RC88
    - Anti-Met Monoclonal Antibody Mixture Sym015
    - Anti-Met/EGFR Monoclonal Antibody LY3164530
    - Anti-MMP-9 Monoclonal Antibody GS-5745
    - Anti-MUC1 Monoclonal Antibody BTH1704
    - Anti-MUC16/CD3 Bispecific Antibody REGN4018
    - Anti-MUC16/CD3 BiTE Antibody REGN4018
    - Anti-MUC16/MMAE Antibody-Drug Conjugate DMUC4064A
    - Anti-MUC17/CD3 BiTE Antibody AMG 199
    - Anti-Myeloma Monoclonal Antibody-DM4 Immunoconjugate BT-062
    - Anti-myostatin Monoclonal Antibody LY2495655
    - Anti-NaPi2b Antibody-drug Conjugate XMT-1592
    - Anti-NaPi2b Monoclonal Antibody XMT-1535
    - Anti-nectin-4 Monoclonal Antibody-Drug Conjugate AGS-22M6E
    - Anti-Neuropilin-1 Monoclonal Antibody MNRP1685A
    - Anti-nf-P2X7 Antibody Ointment BIL-010t
    - Anti-NRP1 Antibody ASP1948
    - Anti-Nucleolin Aptamer AS1411
    - Anti-NY-ESO-1 Immunotherapeutic GSK-2241658A
    - Anti-NY-ESO1/LAGE-1A TCR/scFv Anti-CD3 IMCnyeso
    - Anti-OFA Immunotherapeutic BB-MPI-03
    - Anti-OX40 Agonist Monoclonal Antibody ABBV-368
    - Anti-OX40 Agonist Monoclonal Antibody BGB-A445
    - Anti-OX40 Agonist Monoclonal Antibody PF-04518600
    - Anti-OX40 Antibody BMS 986178
    - Anti-OX40 Hexavalent Agonist Antibody INBRX-106
    - Anti-OX40 Monoclonal Antibody GSK3174998
    - Anti-OX40 Monoclonal Antibody IBI101
    - Anti-PD-1 Antibody-interleukin-21 Mutein Fusion Protein AMG 256
    - Anti-PD-1 Checkpoint Inhibitor PF-06801591
    - Anti-PD-1 Fusion Protein AMP-224
    - Anti-PD-1 Monoclonal Antibody 609A
    - Anti-PD-1 Monoclonal Antibody AK105
    - Anti-PD-1 Monoclonal Antibody AMG 404
    - Anti-PD-1 Monoclonal Antibody BAT1306
    - Anti-PD-1 Monoclonal Antibody BCD-100
    - Anti-PD-1 Monoclonal Antibody BI 754091
    - Anti-PD-1 Monoclonal Antibody CS1003
    - Anti-PD-1 Monoclonal Antibody F520
    - Anti-PD-1 Monoclonal Antibody GLS-010
    - Anti-PD-1 Monoclonal Antibody HLX10
    - Anti-PD-1 Monoclonal Antibody HX008
    - Anti-PD-1 Monoclonal Antibody JTX-4014
    - Anti-PD-1 Monoclonal Antibody LZM009
    - Anti-PD-1 Monoclonal Antibody MEDI0680
    - Anti-PD-1 Monoclonal Antibody MGA012
    - Anti-PD-1 Monoclonal Antibody SCT-I10A
    - Anti-PD-1 Monoclonal Antibody Sym021
    - Anti-PD-1 Monoclonal Antibody TSR-042
    - Anti-PD-1/Anti-CTLA4 DART Protein MGD019
    - Anti-PD-1/Anti-HER2 Bispecific Antibody IBI315
    - Anti-PD-1/Anti-LAG-3 Bispecific Antibody RO7247669
    - Anti-PD-1/Anti-LAG-3 DART Protein MGD013
    - Anti-PD-1/Anti-PD-L1 Bispecific Antibody IBI318
    - Anti-PD-1/Anti-PD-L1 Bispecific Antibody LY3434172
    - Anti-PD-1/CD47 Infusion Protein HX009
    - Anti-PD-1/CTLA-4 Bispecific Antibody AK104
    - Anti-PD-1/CTLA-4 Bispecific Antibody MEDI5752
    - Anti-PD-1/TIM-3 Bispecific Antibody RO7121661
    - Anti-PD-1/VEGF Bispecific Antibody AK112
    - Anti-PD-L1 Monoclonal Antibody A167
    - Anti-PD-L1 Monoclonal Antibody BCD-135
    - Anti-PD-L1 Monoclonal Antibody BGB-A333
    - Anti-PD-L1 Monoclonal Antibody CBT-502
    - Anti-PD-L1 Monoclonal Antibody CK-301
    - Anti-PD-L1 Monoclonal Antibody CS1001
    - Anti-PD-L1 Monoclonal Antibody FAZ053
    - Anti-PD-L1 Monoclonal Antibody GR1405
    - Anti-PD-L1 Monoclonal Antibody HLX20
    - Anti-PD-L1 Monoclonal Antibody IMC-001
    - Anti-PD-L1 Monoclonal Antibody LY3300054
    - Anti-PD-L1 Monoclonal Antibody MDX-1105
    - Anti-PD-L1 Monoclonal Antibody MSB2311
    - Anti-PD-L1 Monoclonal Antibody RC98
    - Anti-PD-L1 Monoclonal Antibody SHR-1316
    - Anti-PD-L1 Monoclonal Antibody TG-1501
    - Anti-PD-L1 Monoclonal Antibody ZKAB001
    - Anti-PD-L1/4-1BB Bispecific Antibody INBRX-105
    - Anti-PD-L1/Anti-4-1BB Bispecific Monoclonal Antibody GEN1046
    - Anti-PD-L1/CD137 Bispecific Antibody MCLA-145
    - Anti-PD-L1/IL-15 Fusion Protein KD033
    - Anti-PD-L1/TIM-3 Bispecific Antibody LY3415244
    - Anti-PD1 Monoclonal Antibody AGEN2034
    - Anti-PD1/CTLA4 Bispecific Antibody XmAb20717
    - Anti-PGF Monoclonal Antibody RO5323441
    - Anti-PKN3 siRNA Atu027
    - Anti-PLGF Monoclonal Antibody TB-403
    - Anti-PR1/HLA-A2 Monoclonal Antibody Hu8F4
    - Anti-PRAME Immunotherapeutic GSK2302032A
    - Anti-PRAME T-cell Receptor/Anti-CD3 scFv Fusion Protein IMC-F106C
    - Anti-PRL-3 Monoclonal Antibody PRL3-zumab
    - Anti-prolactin Receptor Antibody LFA102
    - Anti-PSCA Monoclonal Antibody AGS-1C4D4
    - Anti-PSMA Monoclonal Antibody MDX1201-A488
    - Anti-PSMA Monoclonal Antibody MLN591-DM1 Immunoconjugate MLN2704
    - Anti-PSMA Monoclonal Antibody-MMAE Conjugate
    - Anti-PSMA/CD28 Bispecific Antibody REGN5678
    - Anti-PSMA/CD3 Bispecific Antibody CCW702
    - Anti-PSMA/CD3 Bispecific Antibody JNJ-63898081
    - Anti-PSMA/CD3 Monoclonal Antibody MOR209/ES414
    - Anti-PSMA/PBD ADC MEDI3726
    - Anti-PTK7/Auristatin-0101 Antibody-drug Conjugate PF-06647020
    - Anti-PVRIG Monoclonal Antibody COM701
    - Anti-RANKL Monoclonal Antibody GB-223
    - Anti-RANKL Monoclonal Antibody JMT103
    - Anti-Ribonucleoprotein Antibody ATRC-101
    - Anti-ROR1 ADC VLS-101
    - Anti-ROR1/PNU-159682 Derivative Antibody-drug Conjugate NBE-002
    - Anti-S15 Monoclonal Antibody NC318
    - Anti-sCLU Monoclonal Antibody AB-16B5
    - Anti-SIRPa Monoclonal Antibody CC-95251
    - Anti-SLITRK6 Monoclonal Antibody-MMAE Conjugate AGS15E
    - Anti-TAG-72 Monoclonal Antibody scFV CC-49/218
    - Anti-TF Monoclonal Antibody ALT-836
    - Anti-TGF-beta Monoclonal Antibody NIS793
    - Anti-TGF-beta Monoclonal Antibody SAR-439459
    - Anti-TGF-beta RII Monoclonal Antibody IMC-TR1
    - Anti-TIGIT Monoclonal Antibody AB154
    - Anti-TIGIT Monoclonal Antibody BGB-A1217
    - Anti-TIGIT Monoclonal Antibody BMS-986207
    - Anti-TIGIT Monoclonal Antibody COM902
    - Anti-TIGIT Monoclonal Antibody OMP-313M32
    - Anti-TIGIT Monoclonal Antibody SGN-TGT
    - Anti-TIM-3 Antibody BMS-986258
    - Anti-TIM-3 Monoclonal Antibody BGB-A425
    - Anti-TIM-3 Monoclonal Antibody INCAGN02390
    - Anti-TIM-3 Monoclonal Antibody MBG453
    - Anti-TIM-3 Monoclonal Antibody Sym023
    - Anti-TIM-3 Monoclonal Antibody TSR-022
    - Anti-TIM3 Monoclonal Antibody LY3321367
    - Anti-TIM3 Monoclonal Antibody SHR-1702
    - Anti-Tissue Factor Monoclonal Antibody MORAb-066
    - Anti-TRAILR2/CDH17 Tetravalent Bispecific Antibody BI 905711
    - Anti-TROP2 Antibody-drug Conjugate BAT8003
    - Anti-TROP2 Antibody-drug Conjugate SKB264
    - Anti-TROP2/DXd Antibody-drug Conjugate DS-1062a
    - Anti-TWEAK Monoclonal Antibody RG7212
    - Anti-VEGF Anticalin PRS-050-PEG40
    - Anti-VEGF Monoclonal Antibody hPV19
    - Anti-VEGF/ANG2 Nanobody BI 836880
    - Anti-VEGF/TGF-beta 1 Fusion Protein HB-002T
    - Anti-VEGFC Monoclonal Antibody VGX-100
    - Anti-VEGFR2 Monoclonal Antibody HLX06
    - Anti-VEGFR2 Monoclonal Antibody MSB0254
    - Anti-VEGFR3 Monoclonal Antibody IMC-3C5
    - Anti-VISTA Monoclonal Antibody JNJ 61610588
    - Antiangiogenic Drug Combination TL-118
    - Antibody-drug Conjugate ABBV-011
    - Antibody-drug Conjugate ABBV-085
    - Antibody-drug Conjugate ABBV-155
    - Antibody-drug Conjugate ABBV-176
    - Antibody-drug Conjugate ABBV-838
    - Antibody-drug Conjugate ADC XMT-1536
    - Antibody-drug Conjugate Anti-TIM-1-vcMMAE CDX-014
    - Antibody-Drug Conjugate DFRF4539A
    - Antibody-drug Conjugate MEDI7247
    - Antibody-drug Conjugate PF-06647263
    - Antibody-drug Conjugate PF-06664178
    - Antibody-drug Conjugate SC-002
    - Antibody-drug Conjugate SC-003
    - Antibody-drug Conjugate SC-004
    - Antibody-drug Conjugate SC-005
    - Antibody-drug Conjugate SC-006
    - Antibody-drug Conjugate SC-007
    - Antibody-like CD95 Receptor/Fc-fusion Protein CAN-008
    - Antigen-presenting Cells-expressing HPV16 E6/E7 SQZ-PBMC-HPV
    - Antimetabolite FF-10502
    - Antineoplastic Agent Combination SM-88
    - Antineoplastic Vaccine
    - Antineoplastic Vaccine GV-1301
    - Antineoplaston A10
    - Antineoplaston AS2-1
    - Antisense Oligonucleotide GTI-2040
    - Antisense Oligonucleotide QR-313
    - Antitumor B Key Active Component-alpha
    - Antrodia cinnamomea Supplement
    - Antroquinonol Capsule
    - Apalutamide
    - Apatorsen
    - Apaziquone
    - APC8015F
    - APE1/Ref-1 Redox Inhibitor APX3330
    - Aphidicoline Glycinate
    - Apilimod Dimesylate Capsule
    - Apitolisib
    - Apolizumab
    - Apomab
    - Apomine
    - Apoptosis Inducer BZL101
    - Apoptosis Inducer GCS-100
    - Apoptosis Inducer MPC-2130
    - Apricoxib
    - Aprinocarsen
    - Aprutumab
    - Aprutumab Ixadotin
    - AR Antagonist BMS-641988
    - Arabinoxylan Compound MGN3
    - Aranose
    - ARC Fusion Protein SL-279252
    - Archexin
    - Arcitumomab
    - Arfolitixorin
    - Arginase Inhibitor INCB001158
    - Arginine Butyrate
    - Arnebia Indigo Jade Pearl Topical Cream
    - Arsenic Trioxide
    - Arsenic Trioxide Capsule Formulation ORH 2014
    - Artemether Sublingual Spray
    - Artemisinin Dimer
    - Artesunate
    - Arugula Seed Powder
    - Aryl Hydrocarbon Receptor Antagonist BAY2416964
    - Aryl Hydrocarbon Receptor Inhibitor IK-175
    - Asaley
    - Asciminib
    - Ascrinvacumab
    - Ashwagandha Root Powder Extract
    - ASP4132
    - Aspacytarabine
    - Asparaginase
    - Asparaginase Erwinia chrysanthemi
    - Astatine At 211 Anti-CD38 Monoclonal Antibody OKT10-B10
    - Astatine At 211 Anti-CD45 Monoclonal Antibody BC8-B10
    - Astuprotimut-R
    - Asulacrine
    - Asulacrine Isethionate
    - Asunercept
    - At 211 Monoclonal Antibody 81C6
    - Atamestane
    - Atezolizumab
    - Atiprimod
    - Atiprimod Dihydrochloride
    - Atiprimod Dimaleate
    - ATM Inhibitor M 3541
    - ATM Kinase Inhibitor AZD0156
    - ATM Kinase Inhibitor AZD1390
    - Atorvastatin Calcium
    - Atorvastatin Sodium
    - ATR Inhibitor RP-3500
    - ATR Kinase Inhibitor BAY1895344
    - ATR Kinase Inhibitor M1774
    - ATR Kinase Inhibitor M6620
    - ATR Kinase Inhibitor VX-803
    - Atrasentan Hydrochloride
    - Attenuated Listeria monocytogenes CRS-100
    - Attenuated Live Listeria Encoding HPV 16 E7 Vaccine ADXS11-001
    - Attenuated Measles Virus Encoding SCD Transgene TMV-018
    - Atuveciclib
    - Audencel
    - Auranofin
    - Aurora A Kinase Inhibitor LY3295668
    - Aurora A Kinase Inhibitor LY3295668 Erbumine
    - Aurora A Kinase Inhibitor MK5108
    - Aurora A Kinase Inhibitor TAS-119
    - Aurora A Kinase/Tyrosine Kinase Inhibitor ENMD-2076
    - Aurora B Serine/Threonine Kinase Inhibitor TAK-901
    - Aurora B/C Kinase Inhibitor GSK1070916A
    - Aurora kinase A/B inhibitor TT-00420
    - Aurora Kinase Inhibitor AMG 900
    - Aurora Kinase Inhibitor BI 811283
    - Aurora Kinase Inhibitor MLN8054
    - Aurora Kinase Inhibitor PF-03814735
    - Aurora Kinase Inhibitor SNS-314
    - Aurora Kinase Inhibitor TTP607
    - Aurora Kinase/VEGFR2 Inhibitor CYC116
    - Autologous ACTR-CD16-CD28-expressing T-lymphocytes ACTR707
    - Autologous AFP Specific T Cell Receptor Transduced T Cells C-TCR055
    - Autologous Anti-BCMA CAR T-cells PHE885
    - Autologous Anti-BCMA CAR-transduced T-cells KITE-585
    - Autologous Anti-BCMA CD8+ CAR T-cells Descartes-11
    - Autologous Anti-BCMA-CAR Expressing Stem Memory T-cells P-BCMA-101
    - Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-expressing CD4+/CD8+ T-lymphocytes JCARH125
    - Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-expressing Memory T-lymphocytes bb21217
    - Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-expressing T-cells C-CAR088
    - Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-expressing T-cells CT053
    - Autologous Anti-BCMA-CAR-expressing CD4+/CD8+ T-lymphocytes FCARH143
    - Autologous Anti-CD123 CAR-T Cells
    - Autologous Anti-CD19 CAR T-cells 19(T2)28z1xx
    - Autologous Anti-CD19 CAR T-cells IM19
    - Autologous Anti-CD19 CAR TCR-zeta/4-1BB-transduced T-lymphocytes huCART19
    - Autologous Anti-CD19 CAR-4-1BB-CD3zeta-expressing T-cells CNCT19
    - Autologous Anti-CD19 CAR-CD28 T-cells ET019002
    - Autologous Anti-CD19 CAR-CD3zeta-4-1BB-expressing T-cells PZ01
    - Autologous Anti-CD19 CAR-expressing T-lymphocytes CLIC-1901
    - Autologous Anti-CD19 Chimeric Antigen Receptor T-cells AUTO1
    - Autologous Anti-CD19 Chimeric Antigen Receptor T-cells SJCAR19
    - Autologous Anti-CD19 T-cell Receptor T cells ET190L1
    - Autologous Anti-CD19 TAC-T cells TAC01-CD19
    - Autologous Anti-CD19/CD20 Bispecific Nanobody-based CAR-T cells
    - Autologous Anti-CD19/CD22 CAR T-cells AUTO3
    - Autologous Anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing CD4+/CD8+ Central Memory T-lymphocytes JCAR014
    - Autologous Anti-CD19CAR-HER2t/CD22CAR-EGFRt-expressing T-cells
    - Autologous Anti-CD20 CAR Transduced CD4/CD8 Enriched T-cells MB-CART20.1
    - Autologous Anti-CD22 CAR-4-1BB-TCRz-transduced T-lymphocytes CART22-65s
    - Autologous Anti-EGFR CAR-transduced CXCR 5-modified T-lymphocytes
    - Autologous Anti-FLT3 CAR T Cells AMG 553
    - Autologous Anti-HLA-A*02/AFP TCRm-expressing T-cells ET140202
    - Autologous Anti-HLA-A*0201/AFP CAR T-cells ET1402L1
    - Autologous Anti-ICAM-1-CAR-CD28-4-1BB-CD3zeta-expressing T-cells AIC100
    - Autologous Anti-kappa Light Chain CAR-CD28-expressing T-lymphocytes
    - Autologous Anti-NY-ESO-1/LAGE-1 TCR-transduced c259 T Lymphocytes GSK3377794
    - Autologous Anti-PD-1 Antibody-activated Tumor-infiltrating Lymphocytes
    - Autologous Anti-PSMA CAR-T Cells P-PSMA-101
    - Autologous AXL-targeted CAR T-cells CCT301-38
    - Autologous B-cell/Monocyte-presenting HER2/neu Antigen Vaccine BVAC-B
    - Autologous BCMA-targeted CAR T Cells CC-98633
    - Autologous BCMA-targeted CAR T Cells LCAR-B4822M
    - Autologous Bi-epitope BCMA-targeted CAR T-cells JNJ-68284528
    - Autologous Bispecific BCMA/CD19-targeted CAR-T Cells GC012F
    - Autologous Bispecific CD19/CD22-targeted CAR-T Cells GC022
    - Autologous Bone Marrow-derived CD34/CXCR4-positive Stem Cells AMR-001
    - Autologous CAR-mbIL15-Safety Switch T-cells PRGN-3005
    - Autologous CAR-mbIL15-Safety Switch T-cells PRGN-3006
    - Autologous CD123-4SCAR-expressing T-cells 4SCAR123
    - Autologous CD19 CAR-expressing CD4+/CD8+ T-cells MB-CART19.1
    - Autologous CD19-targeted CAR T Cells CC-97540
    - Autologous CD19-targeted CAR T Cells JWCAR029
    - Autologous CD19-targeted CAR-T Cells GC007F
    - Autologous CD19/PD-1 Bispecific CAR-T Cells
    - Autologous CD20-4SCAR-expressing T-cells 4SCAR20
    - Autologous CD22-4SCAR-expressing T-cells 4SCAR22
    - Autologous CD38-4SCAR-expressing T-cells 4SCAR38
    - Autologous Clonal Neoantigen T Cells ATL001
    - Autologous CRISPR-edited Anti-CD19 CAR T Cells XYF19
    - Autologous Deep IL-15 Primed T-cells TRQ15-01
    - Autologous Dendritic Cell Vaccine ACT2001
    - Autologous Dendritic Cell-based Immunotherapeutic AV0113
    - Autologous FRa-4SCAR-expressing T-cells 4SCAR-FRa
    - Autologous Genetically-modified MAGE-A4 C1032 CD8alpha T Cells
    - Autologous Genetically-modified MAGE-A4 C1032 T Cells
    - Autologous Heat-Shock Protein 70 Peptide Vaccine AG-858
    - Autologous HPV16 E7-specific HLA-A*02:01-restricted TCR Gene Engineered Lymphocytes KITE-439
    - Autologous LMP1/LMP2/EBNA1-specific HLA-A02:01/24:02/11:01-restricted TCR-expressing T-lymphocytes YT-E001
    - Autologous MAGE-A3/A6-specific TCR Gene-engineered Lymphocytes KITE-718
    - Autologous MCPyV-specific HLA-A02-restricted TCR-transduced CD4+ and CD8+ T-cells FH-MCVA2TCR
    - Autologous Mesenchymal Stem Cells Apceth_101
    - Autologous Mesothelin-specific Human mRNA CAR-transfected PBMCs MCY-M11
    - Autologous Monocyte-derived Lysate-pulsed Dendritic Cell Vaccine PV-001-DC
    - Autologous Multi-lineage Potential Cells
    - Autologous Nectin-4/FAP-targeted CAR-T Cells
    - Autologous NKG2D CAR T-cells CYAD-02
    - Autologous NKG2D CAR-CD3zeta-DAP10-expressing T-Lymphocytes CYAD-01
    - Autologous Pancreatic Adenocarcinoma Lysate and mRNA-loaded Dendritic Cell Vaccine
    - Autologous Peripheral Blood Lymphocytes from Ibrutinib-treated Chronic Lymphocytic Leukemia Patients IOV-2001
    - Autologous Prostate Cancer Antigen-expressing Dendritic Cell Vaccine BPX-101
    - Autologous Prostate Stem Cell Antigen-specific CAR T Cells BPX-601
    - Autologous Rapamycin-resistant Th1/Tc1 Cells RAPA-201
    - Autologous ROR2-targeted CAR T-cells CCT301-59
    - Autologous TAAs-loaded Autologous Dendritic Cells AV-GBM-1
    - Autologous TCR-engineered T-cells IMA201
    - Autologous TCR-engineered T-cells IMA202
    - Autologous TCR-engineered T-cells IMA203
    - Autologous TCRm-expressing T-cells ET140203
    - Autologous Tetravalent Dendritic Cell Vaccine MIDRIX4-LUNG
    - Autologous Tumor Infiltrating Lymphocytes LN-144
    - Autologous Tumor Infiltrating Lymphocytes LN-145
    - Autologous Tumor Infiltrating Lymphocytes LN-145-S1
    - Autologous Tumor Infiltrating Lymphocytes MDA-TIL
    - Autologous Universal CAR-expressing T-lymphocytes UniCAR02-T
    - Avadomide
    - Avadomide Hydrochloride
    - Avapritinib
    - Avdoralimab
    - Avelumab
    - Aviscumine
    - Avitinib Maleate
    - Axalimogene Filolisbac
    - Axatilimab
    - Axicabtagene Ciloleucel
    - Axitinib
    - AXL Inhibitor DS-1205c
    - AXL Inhibitor SLC-391
    - AXL Receptor Tyrosine Kinase/cMET Inhibitor BPI-9016M
    - AXL/ FLT3/VEGFR2 Inhibitor KC1036
    - Axl/Mer Inhibitor INCB081776
    - Axl/Mer Inhibitor PF-07265807
    - Azacitidine
    - Azapicyl
    - Azaribine
    - Azaserine
    - Azathioprine
    - Azimexon
    - Azintuxizumab Vedotin
    - Aziridinylbenzoquinone RH1
    - Azotomycin
    - Azurin:50-77 Cell Penetrating Peptide p28
    - B-Raf/VEGFR-2 Inhibitor RAF265
    - Babaodan Capsule
    - Bacillus Calmette-Guerin Substrain Connaught Live Antigen
    - Bactobolin
    - Bafetinib
    - Balixafortide
    - Balstilimab
    - Baltaleucel-T
    - Banoxantrone
    - Barasertib
    - Bardoxolone
    - Bardoxolone Methyl
    - Baricitinib
    - Batabulin
    - Batabulin Sodium
    - Batimastat
    - Bavituximab
    - Bazedoxifene
    - Bazlitoran
    - BC-819 Plasmid/Polyethylenimine Complex
    - BCG Solution
    - BCG Tokyo-172 Strain Solution
    - BCG Vaccine
    - Bcl-2 Inhibitor APG 2575
    - Bcl-2 Inhibitor BCL201
    - Bcl-2 Inhibitor BGB-11417
    - Bcl-2 Inhibitor LP-108
    - Bcl-2 Inhibitor S65487
    - Bcl-Xs Adenovirus Vaccine
    - BCMA x CD3 T-cell Engaging Antibody CC-93269
    - BCMA-CD19 Compound CAR T Cells
    - BCMA/CD3e Tri-specific T-cell Activating Construct HPN217
    - Bcr-Abl Kinase Inhibitor K0706
    - Bcr-Abl Kinase Inhibitor PF-114
    - BCR-ABL/KIT/AKT/ERK Inhibitor HQP1351
    - Beauvericin
    - Becatecarin
    - Belagenpumatucel-L
    - Belantamab Mafodotin
    - Belapectin
    - Belimumab
    - Belinostat
    - Belotecan Hydrochloride
    - Belvarafenib
    - Belzutifan
    - Bemarituzumab
    - Bemcentinib
    - Bempegaldesleukin
    - Benaxibine
    - Bendamustine
    - Bendamustine Hydrochloride
    - Bendamustine-containing Nanoparticle-based Formulation RXDX-107
    - Benzaldehyde Dimethane Sulfonate
    - Benzoylphenylurea
    - Berberine Chloride
    - Bermekimab
    - Bersanlimab
    - Berubicin Hydrochloride
    - Berzosertib
    - BET Bromodomain Inhibitor ZEN-3694
    - BET Inhibitor ABBV-744
    - BET Inhibitor BAY1238097
    - BET inhibitor BI 894999
    - BET Inhibitor BMS-986158
    - BET Inhibitor CC-90010
    - BET Inhibitor CPI-0610
    - BET Inhibitor FT-1101
    - BET Inhibitor GS-5829
    - BET Inhibitor GSK2820151
    - BET Inhibitor INCB054329
    - BET Inhibitor INCB057643
    - BET Inhibitor RO6870810
    - BET-bromodomain Inhibitor ODM-207
    - Beta Alethine
    - Beta-Carotene
    - Beta-elemene
    - Beta-Glucan
    - Beta-Glucan MM-10-001
    - Beta-lapachone Prodrug ARQ 761
    - Beta-Thioguanine Deoxyriboside
    - Betaglucin Gel
    - Betulinic Acid
    - Bevacizumab
    - Bexarotene
    - Bexmarilimab
    - BF-200 Gel Formulation
    - BH3 Mimetic ABT-737
    - Bi-functional Alkylating Agent VAL-083
    - Bicalutamide
    - Bimiralisib
    - Binetrakin
    - Binimetinib
    - Bintrafusp Alfa
    - Birabresib
    - Birinapant
    - Bis(choline)tetrathiomolybdate
    - Bisantrene
    - Bisantrene Hydrochloride
    - Bisnafide
    - Bisnafide Dimesylate
    - Bispecific Antibody 2B1
    - Bispecific Antibody AGEN1223
    - Bispecific Antibody AMG 509
    - Bispecific Antibody GS-1423
    - Bispecific Antibody MDX-H210
    - Bispecific Antibody MDX447
    - Bisthianostat
    - BiTE Antibody AMG 910
    - Bivalent BRD4 Inhibitor AZD5153
    - Bizalimogene Ralaplasmid
    - Bizelesin
    - BL22 Immunotoxin
    - Black Cohosh
    - Black Raspberry Nectar
    - Bleomycin
    - Bleomycin A2
    - Bleomycin B2
    - Bleomycin Sulfate
    - Blinatumomab
    - Blueberry Powder Supplement
    - BMI1 Inhibitor PTC596
    - BMS-184476
    - BMS-188797
    - BMS-214662
    - BMS-275183
    - Boanmycin Hydrochloride
    - Bomedemstat
    - Boronophenylalanine-Fructose Complex
    - Bortezomib
    - Bosutinib
    - Bosutinib Monohydrate
    - Botanical Agent BEL-X-HG
    - Botanical Agent LEAC-102
    - Bovine Cartilage
    - Bozitinib
    - BP-Cx1-Platinum Complex BP-C1
    - BR96-Doxorubicin Immunoconjugate
    - Brachyury-expressing Yeast Vaccine GI-6301
    - BRAF Inhibitor
    - BRAF Inhibitor ARQ 736
    - BRAF Inhibitor BGB-3245
    - BRAF Inhibitor PLX8394
    - BRAF(V600E) Kinase Inhibitor ABM-1310
    - BRAF(V600E) Kinase Inhibitor RO5212054
    - BRAF/EGFR Inhibitor BGB-283
    - BRAFV600/PI3K Inhibitor ASN003
    - BRD4 Inhibitor PLX2853
    - BRD4 Inhibitor PLX51107
    - Breflate
    - Brentuximab
    - Brentuximab Vedotin
    - Brequinar
    - Brequinar Sodium
    - Briciclib Sodium
    - Brigatinib
    - Brilanestrant
    - Brimonidine Tartrate Nanoemulsion OCU-300
    - Brivanib
    - Brivanib Alaninate
    - Brivudine
    - Brivudine Phosphoramidate
    - Broad-Spectrum Human Papillomavirus Vaccine V505
    - Broccoli Sprout/Broccoli Seed Extract Supplement
    - Bromacrylide
    - Bromebric Acid
    - Bromocriptine Mesylate
    - Brontictuzumab
    - Brostacillin Hydrochloride
    - Brostallicin
    - Broxuridine
    - Bruceanol A
    - Bruceanol B
    - Bruceanol C
    - Bruceanol D
    - Bruceanol E
    - Bruceanol F
    - Bruceanol G
    - Bruceanol H
    - Bruceantin
    - Bryostatin 1
    - BTK Inhibitor ARQ 531
    - BTK Inhibitor CT-1530
    - BTK Inhibitor DTRMWXHS-12
    - BTK Inhibitor HZ-A-018
    - BTK Inhibitor ICP-022
    - BTK Inhibitor LOXO-305
    - BTK Inhibitor M7583
    - BTK inhibitor TG-1701
    - Budigalimab
    - Budotitane
    - Bufalin
    - Buparlisib
    - Burixafor
    - Burixafor Hydrobromide
    - Burosumab
    - Buserelin
    - Bushen Culuan Decoction
    - Bushen-Jianpi Decoction
    - Busulfan
    - Buthionine Sulfoximine
    - BXQ-350 Nanovesicle Formulation
    - c-Kit Inhibitor PLX9486
    - c-Met Inhibitor ABN401
    - c-Met Inhibitor AL2846
    - c-Met Inhibitor AMG 208
    - c-Met Inhibitor AMG 337
    - c-Met Inhibitor GST-HG161
    - c-Met Inhibitor HS-10241
    - c-Met Inhibitor JNJ-38877605
    - c-Met Inhibitor MK2461
    - c-Met Inhibitor MK8033
    - c-Met Inhibitor MSC2156119J
    - C-myb Antisense Oligonucleotide G4460
    - c-raf Antisense Oligonucleotide ISIS 5132
    - C-VISA BikDD:Liposome
    - C/EBP Beta Antagonist ST101
    - CAB-ROR2-ADC BA3021
    - Cabazitaxel
    - Cabiralizumab
    - Cabozantinib
    - Cabozantinib S-malate
    - Cactinomycin
    - Caffeic Acid Phenethyl Ester
    - CAIX Inhibitor DTP348
    - CAIX Inhibitor SLC-0111
    - Calaspargase Pegol-mknl
    - Calcitriol
    - Calcium Release-activated Channel Inhibitor CM4620
    - Calcium Release-activated Channels Inhibitor RP4010
    - Calcium Saccharate
    - Calculus bovis/Moschus/Olibanum/Myrrha Capsule
    - Calicheamicin Gamma 1I
    - Camidanlumab Tesirine
    - Camptothecin
    - Camptothecin Analogue TLC388
    - Camptothecin Glycoconjugate BAY 38-3441
    - Camptothecin Sodium
    - Camptothecin-20(S)-O-Propionate Hydrate
    - Camrelizumab
    - Camsirubicin
    - Cancell
    - Cancer Peptide Vaccine S-588410
    - Canerpaturev
    - Canertinib Dihydrochloride
    - Canfosfamide
    - Canfosfamide Hydrochloride
    - Cannabidiol
    - Cantrixil
    - Cantuzumab Ravtansine
    - Capecitabine
    - Capecitabine Rapidly Disintegrating Tablet
    - Capivasertib
    - Capmatinib
    - Captopril
    - CAR T-Cells AMG 119
    - Caracemide
    - Carbendazim
    - Carbetimer
    - Carbogen
    - Carbon C 14-pamiparib
    - Carboplatin
    - Carboquone
    - Carboxyamidotriazole
    - Carboxyamidotriazole Orotate
    - Carboxyphenyl Retinamide
    - Carfilzomib
    - Caricotamide/Tretazicar
    - Carlumab
    - Carmofur
    - Carmustine
    - Carmustine Implant
    - Carmustine in Ethanol
    - Carmustine Sustained-Release Implant Wafer
    - Carotuximab
    - Carubicin
    - Carubicin Hydrochloride
    - Carzelesin
    - Carzinophilin
    - Cathelicidin LL-37
    - Cationic Liposome-Encapsulated Paclitaxel
    - Cationic Peptide Cream Cypep-1
    - Catumaxomab
    - CBP/beta-catenin Antagonist PRI-724
    - CBP/beta-catenin Modulator E7386
    - CCR2 Antagonist CCX872-B
    - CCR2 Antagonist PF-04136309
    - CCR2/CCR5 Antagonist BMS-813160
    - CCR4 Inhibitor FLX475
    - CD11b Agonist GB1275
    - CD123-CD33 Compound CAR T Cells
    - CD123-specific Targeting Module TM123
    - CD20-CD19 Compound CAR T Cells
    - CD28/ICOS Antagonist ALPN-101
    - CD4-specific Telomerase Peptide Vaccine UCPVax
    - CD40 Agonist Monoclonal Antibody CP-870,893
    - CD40 Agonistic Monoclonal Antibody APX005M
    - CD44 Targeted Agent SPL-108
    - CD44v6-specific CAR T-cells
    - CD47 Antagonist ALX148
    - CD73 Inhibitor AB680
    - CD73 Inhibitor LY3475070
    - CD80-Fc Fusion Protein ALPN-202
    - CD80-Fc Fusion Protein FPT155
    - CDC7 Inhibitor TAK-931
    - CDC7 Kinase Inhibitor BMS-863233
    - CDC7 Kinase Inhibitor LY3143921 Hydrate
    - CDC7 Kinase Inhibitor NMS-1116354
    - CDK Inhibitor AT7519
    - CDK Inhibitor R547
    - CDK Inhibitor SNS-032
    - CDK/JAK2/FLT3 Inhibitor TG02 Citrate
    - CDK1 Inhibitor BEY1107
    - CDK1/2/4 Inhibitor AG-024322
    - CDK2 Inhibitor PF-07104091
    - CDK2/4/6/FLT3 Inhibitor FN-1501
    - CDK2/5/9 Inhibitor CYC065
    - CDK4 Inhibitor P1446A-05
    - CDK4/6 Inhibitor
    - CDK4/6 Inhibitor BPI-16350
    - CDK4/6 Inhibitor CS3002
    - CDK4/6 Inhibitor FCN-437
    - CDK4/6 Inhibitor G1T38
    - CDK4/6 Inhibitor HS-10342
    - CDK4/6 Inhibitor SHR6390
    - CDK4/6 Inhibitor TQB3616
    - CDK7 Inhibitor CT7001
    - CDK7 Inhibitor SY-1365
    - CDK7 Inhibitor SY-5609
    - CDK8/19 Inhibitor SEL 120
    - CDK9 Inhibitor AZD4573
    - CEA-MUC-1-TRICOM Vaccine CV301
    - CEA-targeting Agent RG6123
    - CEBPA-targeting saRNA MTL-CEBPA Liposome
    - Cedazuridine
    - Cedazuridine/Azacitidine Combination Agent ASTX030
    - Cedazuridine/Decitabine Combination Agent ASTX727
    - Cedefingol
    - Cediranib
    - Cediranib Maleate
    - Celecoxib
    - Cell Cycle Checkpoint/DNA Repair Antagonist IC83
    - Cemadotin
    - Cemadotin Hydrochloride
    - Cemiplimab
    - Cenersen
    - Cenisertib
    - CENP-E Inhibitor GSK-923295
    - Ceralasertib
    - Ceramide Nanoliposome
    - Cerdulatinib
    - Cereblon E3 Ubiquitin Ligase Modulating Agent CC-92480
    - Cereblon E3 Ubiquitin Ligase Modulating Agent CC-99282
    - Cereblon Modulator CC-90009
    - Cergutuzumab Amunaleukin
    - Ceritinib
    - Cesalin
    - cEt KRAS Antisense Oligonucleotide AZD4785
    - Cetrelimab
    - Cetuximab
    - Cetuximab Sarotalocan
    - Cetuximab-IR700 Conjugate RM-1929
    - Cetuximab-loaded Ethylcellulose Polymeric Nanoparticles Decorated with Octreotide (SY)
    - Cevipabulin
    - Cevipabulin Fumarate
    - Cevipabulin Succinate
    - Cevostamab
    - cFMS Tyrosine Kinase Inhibitor ARRY-382
    - Chaparrin
    - Chaparrinone
    - Checkpoint Kinase Inhibitor AZD7762
    - Checkpoint Kinase Inhibitor XL844
    - Chemotherapy
    - Chiauranib
    - Chimeric Monoclonal Antibody 81C6
    - ChiNing Decoction
    - Chk1 Inhibitor CCT245737
    - Chk1 Inhibitor GDC-0425
    - Chk1 Inhibitor GDC-0575
    - CHK1 Inhibitor MK-8776
    - CHK1 Inhibitor PF-477736
    - Chlorambucil
    - Chlorodihydropyrimidine
    - Chloroquine
    - Chloroquinoxaline Sulfonamide
    - Chlorotoxin
    - Chlorotoxin (EQ)-CD28-CD3zeta-CD19t-expressing CAR T-lymphocytes
    - Chlorozotocin
    - Choline Kinase Alpha Inhibitor TCD-717
    - CHP-NY-ESO-1 Peptide Vaccine IMF-001
    - Chromomycin A3
    - Chrysanthemum morifolium/Ganoderma lucidum/Glycyrrhiza glabra/Isatis indigotica/Panax pseudoginseng/Rabdosia rubescens/Scutellaria baicalensis/Serona repens Supplement
    - Cibisatamab
    - Ciclopirox Prodrug CPX-POM
    - Cidan Herbal Capsule
    - Ciforadenant
    - Cilengitide
    - Ciltacabtagene Autoleucel
    - Cimetidine
    - Cinacalcet Hydrochloride
    - Cinobufagin
    - Cinobufotalin
    - Cinrebafusp Alfa
    - Cintirorgon
    - Cintredekin Besudotox
    - Cirmtuzumab
    - cis-Urocanic Acid
    - Cisplatin
    - Cisplatin Liposomal
    - Cisplatin-E Therapeutic Implant
    - Cisplatin/Vinblastine/Cell Penetration Enhancer Formulation INT230-6
    - Citarinostat
    - Citatuzumab Bogatox
    - Cixutumumab
    - CK1alpha/CDK7/CDK9 Inhibitor BTX-A51
    - CK2-targeting Synthetic Peptide CIGB-300
    - CL 246738
    - Cladribine
    - Clanfenur
    - Clarithromycin
    - Class 1/4 Histone Deacetylase Inhibitor OKI-179
    - Clinical Trial
    - Clinical Trial Agent
    - Clioquinol
    - Clivatuzumab
    - Clodronate Disodium
    - Clodronic Acid
    - Clofarabine
    - Clomesone
    - Clomiphene
    - Clomiphene Citrate
    - Clostridium Novyi-NT Spores
    - Cobimetinib
    - Cobolimab
    - Cobomarsen
    - Codrituzumab
    - Coenzyme Q10
    - Cofetuzumab Pelidotin
    - Colchicine-Site Binding Agent ABT-751
    - Cold Contaminant-free Iobenguane I-131
    - Colloidal Gold-Bound Tumor Necrosis Factor
    - Colorectal Cancer Peptide Vaccine PolyPEPI1018
    - Colorectal Tumor-Associated Peptides Vaccine IMA910
    - Coltuximab Ravtansine
    - Combretastatin
    - Combretastatin A-1
    - Combretastatin A1 Diphosphate
    - Commensal Bacterial Strain Formulation VE800
    - Compound Kushen Injection
    - Conatumumab
    - Conbercept
    - Concentrated Lingzhi Mushroom Extract
    - Conditionally Active Biologic Anti-AXL Antibody-drug Conjugate BA3011
    - Copanlisib
    - Copanlisib Hydrochloride
    - Copper Cu 64-ATSM
    - Copper Cu 67 Tyr3-octreotate
    - Copper Gluconate
    - Cord Blood Derived CAR T-Cells
    - Cord Blood-derived Expanded Natural Killer Cells PNK-007
    - Cordycepin
    - Cordycepin Triphosphate
    - Coriolus Versicolor Extract
    - Corticorelin Acetate
    - Cortisone Acetate
    - Cosibelimab
    - Cositecan
    - Coxsackievirus A21
    - Coxsackievirus V937
    - CpG Oligodeoxynucleotide GNKG168
    - Crenolanib
    - Crenolanib Besylate
    - Crizotinib
    - Crolibulin
    - Cryptophycin
    - Cryptophycin 52
    - Crystalline Genistein Formulation AXP107-11
    - CSF-1R Inhibitor BLZ945
    - CSF1R Inhibitor ABSK021
    - CSF1R Inhibitor DCC-3014
    - CSF1R Inhibitor PLX73086
    - CT2584 HMS
    - CTLA-4-directed Probody BMS-986249
    - Curcumin
    - Curcumin/Doxorubicin-encapsulating Nanoparticle IMX-110
    - Cusatuzumab
    - Custirsen Sodium
    - CXC Chemokine Receptor 2 Antagonist AZD5069
    - CXCR1/2 Inhibitor SX-682
    - CXCR2 Antagonist QBM076
    - CXCR4 Antagonist BL-8040
    - CXCR4 Antagonist USL311
    - CXCR4 Inhibitor Q-122
    - CXCR4 Peptide Antagonist LY2510924
    - CXCR4/E-selectin Antagonist GMI-1359
    - Cyclin-dependent Kinase 8/19 Inhibitor BCD 115
    - Cyclin-dependent Kinase Inhibitor PF-06873600
    - Cyclodextrin-Based Polymer-Camptothecin CRLX101
    - Cyclodisone
    - Cycloleucine
    - Cyclopentenyl Cytosine
    - Cyclophosphamide
    - Cyclophosphamide Anhydrous
    - Cyclosporine
    - CYL-02 Plasmid DNA
    - CYP11A1 inhibitor ODM-208
    - CYP11A1 Inhibitor ODM-209
    - CYP17 Inhibitor CFG920
    - CYP17 Lyase Inhibitor ASN001
    - CYP17/Androgen Receptor Inhibitor ODM 204
    - CYP17/CYP11B2 Inhibitor LAE001
    - Cyproterone
    - Cyproterone Acetate
    - Cytarabine
    - Cytarabine Monophosphate Prodrug MB07133
    - Cytarabine-asparagine Prodrug BST-236
    - Cytidine Analog RX-3117
    - Cytochlor
    - Cytokine-based Biologic Agent IRX-2
    - D-methionine Formulation MRX-1024
    - DAB389 Epidermal Growth Factor
    - Dabrafenib
    - Dabrafenib Mesylate
    - Dacarbazine
    - Dacetuzumab
    - DACH Polymer Platinate AP5346
    - DACH-Platin Micelle NC-4016
    - Daclizumab
    - Dacomitinib
    - Dacplatinum
    - Dactinomycin
    - Dactolisib
    - Dactolisib Tosylate
    - Dalantercept
    - Dalotuzumab
    - Daniquidone
    - Danusertib
    - Danvatirsen
    - Daporinad
    - Daratumumab
    - Daratumumab and Hyaluronidase-fihj
    - Daratumumab/rHuPH20
    - Darinaparsin
    - Darleukin
    - Darolutamide
    - Daromun
    - Dasatinib
    - Daunorubicin
    - Daunorubicin Citrate
    - Daunorubicin Hydrochloride
    - DEC-205/NY-ESO-1 Fusion Protein CDX-1401
    - Decitabine
    - Decitabine and Cedazuridine
    - Defactinib
    - Defactinib Hydrochloride
    - Deferoxamine
    - Deferoxamine Mesylate
    - Degarelix
    - Degarelix Acetate
    - Delanzomib
    - Delolimogene Mupadenorepvec
    - Demcizumab
    - Demecolcine
    - Demplatin Pegraglumer
    - Dendrimer-conjugated Bcl-2/Bcl-XL Inhibitor AZD0466
    - Dendritic Cell Vaccine
    - Dendritic Cell-Autologous Lung Tumor Vaccine
    - Dendritic Cell-targeting Lentiviral Vector ID-LV305
    - Denenicokin
    - Dengue Virus Adjuvant PV-001-DV
    - Denibulin
    - Denibulin Hydrochloride
    - Denileukin Diftitox
    - Denintuzumab Mafodotin
    - Denosumab
    - Deoxycytidine Analogue TAS-109
    - Deoxycytidine Analogue TAS-109 Hydrochloride
    - Depatuxizumab
    - Depatuxizumab Mafodotin
    - Derazantinib
    - Deslorelin
    - Deslorelin Acetate
    - Detirelix
    - Detorubicin
    - Deuteporfin
    - Deuterated Enzalutamide
    - Devimistat
    - Dexamethason
    - Dexamethasone
    - Dexamethasone Phosphate
    - Dexamethasone Sodium Phosphate
    - Dexanabinol
    - Dexrazoxane
    - Dexrazoxane Hydrochloride
    - Dezaguanine
    - Dezaguanine Mesylate
    - Dezapelisib
    - DHA-Paclitaxel
    - DHEA Mustard
    - DI-Leu16-IL2 Immunocytokine
    - Dianhydrogalactitol
    - Diarylsulfonylurea Compound ILX-295501
    - Diazepinomicin
    - Diaziquone
    - Diazooxonorleucine
    - Dibrospidium Chloride
    - Dichloroallyl Lawsone
    - Dicycloplatin
    - Didox
    - Dienogest
    - Diethylnorspermine
    - Digitoxin
    - Digoxin
    - Dihydro-5-Azacytidine
    - Dihydrolenperone
    - Dihydroorotate Dehydrogenase Inhibitor AG-636
    - Dihydroorotate Dehydrogenase Inhibitor BAY2402234
    - Diindolylmethane
    - Dilpacimab
    - Dimethylmyleran
    - Dinaciclib
    - Dinutuximab
    - Dioscorea nipponica Makino Extract DNE3
    - Diphencyprone
    - Diphtheria Toxin Fragment-Interleukin-2 Fusion Protein E7777
    - Ditiocarb
    - DKK1-Neutralizing Monoclonal Antibody DKN-01
    - DM-CHOC-PEN
    - DM4-Conjugated Anti-Cripto Monoclonal Antibody BIIB015
    - DNA Interference Oligonucleotide PNT2258
    - DNA Minor Groove Binding Agent SG2000
    - DNA Plasmid Encoding Interleukin-12 INO-9012
    - DNA Plasmid-encoding Interleukin-12 INO-9012/PSA/PSMA DNA Plasmids INO-5150 Formulation INO-5151
    - DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine MEDI0457
    - DNA Vaccine VB10.16
    - DNA-dependent Protein Kinase Inhibitor VX-984
    - DNA-PK inhibitor AZD7648
    - DNA-PK/PI3K-delta Inhibitor BR101801
    - DNA-PK/TOR Kinase Inhibitor CC-115
    - DNMT1 Inhibitor NTX-301
    - DNMT1 Mixed-Backbone Antisense Oligonucleotide MG 98
    - Docetaxel
    - Docetaxel Anhydrous
    - Docetaxel Emulsion ANX-514
    - Docetaxel Formulation CKD-810
    - Docetaxel Lipid Microspheres
    - Docetaxel Nanoparticle CPC634
    - Docetaxel Polymeric Micelles
    - Docetaxel-loaded Nanopharmaceutical CRLX301
    - Docetaxel-PNP
    - Docetaxel/Ritonavir
    - Dociparstat sodium
    - Dolastatin 10
    - Dolastatin 15
    - Domatinostat
    - Donafenib
    - Dopamine-Somatostatin Chimeric Molecule BIM-23A760
    - Dostarlimab
    - Double-armed TMZ-CD40L/4-1BBL Oncolytic Ad5/35 Adenovirus LOAd703
    - Dovitinib
    - Dovitinib Lactate
    - Doxazosin
    - Doxercalciferol
    - Doxifluridine
    - Doxorubicin
    - Doxorubicin Hydrochloride
    - Doxorubicin Prodrug L-377,202
    - Doxorubicin Prodrug/Prodrug-activating Biomaterial SQ3370
    - Doxorubicin-Eluting Beads
    - Doxorubicin-HPMA Conjugate
    - Doxorubicin-loaded EGFR-targeting Nanocells
    - Doxorubicin-Magnetic Targeted Carrier Complex
    - DPT/BCG/Measles/Serratia/Pneumococcus Vaccine
    - DPT/Typhoid/Staphylococcus aureus/Paratyphoid A/Paratyphoid B Vaccine
    - DPX-E7 HPV Vaccine
    - DR5 HexaBody Agonist GEN1029
    - DR5-targeting Tetrameric Nanobody Agonist TAS266
    - Dromostanolone Propionate
    - Drozitumab
    - DTRMWXHS-12/Everolimus/Pomalidomide Combination Agent DTRM-555
    - Dual IGF-1R/InsR Inhibitor BMS-754807
    - Dual Variable Domain Immunoglobulin ABT-165
    - Dual-affinity B7-H3/CD3-targeted Protein MGD009
    - Dubermatinib
    - Duborimycin
    - Dulanermin
    - Duligotuzumab
    - Dupilumab
    - Durvalumab
    - Dusigitumab
    - dUTPase/DPD Inhibitor TAS-114
    - Duvelisib
    - Duvortuxizumab
    - Dynemicin
    - Dynemicin A
    - E2F1 Pathway Activator ARQ 171
    - EBNA-1 inhibitor VK-2019
    - Echinomycin
    - Ecromeximab
    - Edatrexate
    - Edelfosine
    - Edicotinib
    - Edodekin alfa
    - Edotecarin
    - Edrecolomab
    - EED Inhibitor MAK683
    - Efatutazone
    - Efatutazone Dihydrochloride
    - Efizonerimod
    - Eflornithine
    - Eflornithine Hydrochloride
    - Eftilagimod Alpha
    - Eftozanermin Alfa
    - Eg5 Kinesin-Related Motor Protein Inhibitor 4SC-205
    - Eg5 Kinesin-Related Motor Protein Inhibitor ARQ 621
    - EGb761
    - EGFR Antagonist Hemay022
    - EGFR Antisense DNA BB-401
    - EGFR Inhibitor AZD3759
    - EGFR Inhibitor BIBX 1382
    - EGFR Inhibitor DBPR112
    - EGFR Inhibitor PD-168393
    - EGFR Inhibitor TY-9591
    - EGFR Mutant-selective Inhibitor TQB3804
    - EGFR Mutant-specific Inhibitor BPI-7711
    - EGFR Mutant-specific Inhibitor CK-101
    - EGFR Mutant-specific Inhibitor D-0316
    - EGFR Mutant-specific Inhibitor ZN-e4
    - EGFR T790M Antagonist BPI-15086
    - EGFR T790M Inhibitor HS-10296
    - EGFR/EGFRvIII Inhibitor WSD0922-FU
    - EGFR/FLT3/Abl Inhibitor SKLB1028
    - EGFR/HER1/HER2 Inhibitor PKI166
    - EGFR/HER2 Inhibitor AP32788
    - EGFR/HER2 Inhibitor AV-412
    - EGFR/HER2 Inhibitor DZD9008
    - EGFR/HER2 Kinase Inhibitor TAK-285
    - EGFR/TGFb Fusion Monoclonal Antibody BCA101
    - EGFR/VEGFR/RET Inhibitor HA121-28
    - Eicosapentaenoic Acid
    - eIF4E Antisense Oligonucleotide ISIS 183750
    - Elacestrant
    - Elacytarabine
    - Elagolix
    - Elbasvir/Grazoprevir
    - Elesclomol
    - Elesclomol Sodium
    - Elgemtumab
    - Elinafide
    - Elisidepsin
    - Elliptinium
    - Elliptinium Acetate
    - Elmustine
    - Elotuzumab
    - Elpamotide
    - Elsamitrucin
    - Eltanexor
    - Emactuzumab
    - Emapalumab
    - Emepepimut-S
    - Emibetuzumab
    - Emitefur
    - Emofolin Sodium
    - Empesertib
    - Enadenotucirev
    - Enadenotucirev-expressing Anti-CD40 Agonistic Monoclonal Antibody NG-350A
    - Enadenotucirev-expressing FAP/CD3 Bispecific FAP-TAc NG-641
    - Enasidenib
    - Enasidenib Mesylate
    - Enavatuzumab
    - Encapsulated Rapamycin
    - Encelimab
    - Enclomiphene
    - Enclomiphene Citrate
    - Encorafenib
    - Endothelin B Receptor Blocker ENB 003
    - Endothelin Receptor Type A Antagonist YM598
    - Enfortumab Vedotin
    - Engineered Human Umbilical Vein Endothelial Cells AB-205
    - Engineered Red Blood Cells Co-expressing 4-1BBL and IL-15TP RTX-240
    - Engineered Toxin Body Targeting CD38 TAK-169
    - Engineered Toxin Body Targeting HER2 MT-5111
    - Eniluracil/5-FU Combination Tablet
    - Enloplatin
    - Enoblituzumab
    - Enobosarm
    - Enoticumab
    - Enpromate
    - Ensartinib
    - Ensituximab
    - Enteric-Coated TRPM8 Agonist D-3263 Hydrochloride
    - Enterococcus gallinarum Strain MRx0518
    - Entinostat
    - Entolimod
    - Entospletinib
    - Entrectinib
    - Envafolimab
    - Enzalutamide
    - Enzastaurin
    - Enzastaurin Hydrochloride
    - EP2/EP4 Antagonist TPST-1495
    - EP4 Antagonist INV-1120
    - EP4 Antagonist ONO-4578
    - Epacadostat
    - Epcoritamab
    - EphA2-targeting Bicycle Toxin Conjugate BT5528
    - Epipodophyllotoxin Analog GL331
    - Epipropidine
    - Epirubicin
    - Epirubicin Hydrochloride
    - Epitinib Succinate
    - Epitiostanol
    - Epothilone Analog UTD1
    - Epothilone KOS-1584
    - Epratuzumab
    - Epratuzumab-cys-tesirine
    - ER alpha Proteolysis-targeting Chimera Protein Degrader ARV-471
    - ERa36 Modulator Icaritin
    - Erastin Analogue PRLX 93936
    - Erbulozole
    - Erdafitinib
    - Eribulin
    - Eribulin Mesylate
    - ERK 1/2 Inhibitor ASTX029
    - ERK Inhibitor CC-90003
    - ERK Inhibitor GDC-0994
    - ERK Inhibitor LTT462
    - ERK Inhibitor MK-8353
    - ERK1/2 Inhibitor ASN007
    - ERK1/2 Inhibitor HH2710
    - ERK1/2 Inhibitor JSI-1187
    - ERK1/2 Inhibitor KO-947
    - ERK1/2 Inhibitor LY3214996
    - Erlotinib
    - Erlotinib Hydrochloride
    - Ertumaxomab
    - Erythrocyte-encapsulated L-asparaginase Suspension
    - Esorubicin
    - Esorubicin Hydrochloride
    - Esperamicin A1
    - Essiac
    - Esterified Estrogens
    - Estradiol Valerate
    - Estramustine
    - Estramustine Phosphate Sodium
    - Estrogen Receptor Agonist GTx-758
    - Estrogens, Conjugated
    - Etalocib
    - Etanercept
    - Etanidazole
    - Etaracizumab
    - Etarotene
    - Ethaselen
    - Ethinyl Estradiol
    - Ethyleneimine
    - Ethylnitrosourea
    - Etidronate-Cytarabine Conjugate MBC-11
    - Etigilimab
    - Etirinotecan Pegol
    - Etoglucid
    - Etoposide
    - Etoposide Phosphate
    - Etoposide Toniribate
    - Etoprine
    - Etoricoxib
    - Ets-family Transcription Factor Inhibitor TK216
    - Everolimus
    - Everolimus Tablets for Oral Suspension
    - Evofosfamide
    - Ex Vivo-expanded Autologous T Cells IMA101
    - Exatecan Mesylate
    - Exatecan Mesylate Anhydrous
    - Exemestane
    - Exicorilant
    - Exisulind
    - Extended Release Flucytosine
    - Extended Release Metformin Hydrochloride
    - Extended-release Onapristone
    - Ezabenlimab
    - EZH1/2 Inhibitor DS-3201
    - EZH1/2 Inhibitor HH2853
    - EZH2 inhibitor CPI-0209
    - EZH2 Inhibitor CPI-1205
    - EZH2 Inhibitor PF-06821497
    - EZH2 Inhibitor SHR2554
    - F16-IL2 Fusion Protein
    - FACT Complex-targeting Curaxin CBL0137
    - Factor VII-targeting Immunoconjugate Protein ICON-1
    - Factor VIIa Inhibitor PCI-27483
    - Fadraciclib
    - Fadrozole Hydrochloride
    - FAK Inhibitor GSK2256098
    - FAK Inhibitor PF-00562271
    - FAK Inhibitor VS-4718
    - FAK/ALK/ROS1 Inhibitor APG-2449
    - Falimarev
    - Famitinib
    - FAP/4-1BB-targeting DARPin MP0310
    - FAP/4-1BB-targeting Fusion Protein RO7122290
    - Farletuzumab
    - Farnesyltransferase/Geranylgeranyltransferase Inhibitor L-778,123
    - Fas Ligand-treated Allogeneic Mobilized Peripheral Blood Cells
    - Fas Receptor Agonist APO010
    - Fascin Inhibitor NP-G2-044
    - FASN Inhibitor TVB-2640
    - Favezelimab
    - Fazarabine
    - Fc-engineered Anti-CD40 Agonist Antibody 2141-V11
    - Febuxostat
    - Fedratinib
    - Fedratinib Hydrochloride
    - Feladilimab
    - Felzartamab
    - Fenebrutinib
    - Fenretinide
    - Fenretinide Lipid Matrix
    - Fenretinide Phospholipid Suspension ST-001
    - FGF Receptor Antagonist HGS1036
    - FGF/FGFR Pathway Inhibitor E7090
    - FGFR Inhibitor ASP5878
    - FGFR Inhibitor AZD4547
    - FGFR Inhibitor CPL304110
    - FGFR Inhibitor Debio 1347
    - FGFR Inhibitor TAS-120
    - FGFR/CSF-1R Inhibitor 3D185
    - FGFR/VEGFR/PDGFR/FLT3/SRC Inhibitor XL999
    - FGFR1/2/3 Inhibitor HMPL-453
    - FGFR2 Inhibitor RLY-4008
    - FGFR4 Antagonist INCB062079
    - FGFR4 Inhibitor BLU 9931
    - FGFR4 Inhibitor FGF401
    - FGFR4 Inhibitor H3B-6527
    - FGFR4 Inhibitor ICP-105
    - Fianlimab
    - Fibromun
    - Ficlatuzumab
    - Figitumumab
    - Filanesib
    - Filgotinib
    - Filgrastim
    - Fimaporfin A
    - Fimepinostat
    - Firtecan Pegol
    - Fisogatinib
    - Flanvotumab
    - Flotetuzumab
    - Floxuridine
    - FLT3 Inhibitor FF-10101 Succinate
    - FLT3 Inhibitor HM43239
    - FLT3 Inhibitor SKI-G-801
    - Flt3 Ligand/Anti-CTLA-4 Antibody/IL-12 Engineered Oncolytic Vaccinia Virus RIVAL-01
    - FLT3 Tyrosine Kinase Inhibitor TTT-3002
    - FLT3/ABL/Aurora Kinase Inhibitor KW-2449
    - FLT3/CDK4/6 Inhibitor FLX925
    - FLT3/FGFR Dual Kinase Inhibitor MAX-40279
    - FLT3/KIT Kinase Inhibitor AKN-028
    - FLT3/KIT/CSF1R Inhibitor NMS-03592088
    - Flt3/MerTK Inhibitor MRX-2843
    - Fludarabine
    - Fludarabine Phosphate
    - Flumatinib
    - Flumatinib Mesylate
    - Fluorine F 18 Ara-G
    - Fluorodopan
    - Fluorouracil
    - Fluorouracil Implant
    - Fluorouracil-E Therapeutic Implant
    - Fluoxymesterone
    - Flutamide
    - Fluvastatin
    - Fluvastatin Sodium
    - Fluzoparib
    - FMS Inhibitor JNJ-40346527
    - Fms/Trk Tyrosine Kinase Inhibitor PLX7486 Tosylate
    - Folate Receptor Targeted Epothilone BMS753493
    - Folate Receptor-Targeted Tubulysin Conjugate EC1456
    - Folate Receptor-Targeted Vinca Alkaloid EC0489
    - Folate Receptor-Targeted Vinca Alkaloid/Mitomycin C EC0225
    - Folate-FITC
    - Folic Acid
    - Folitixorin
    - Foretinib
    - Foritinib Succinate
    - Formestane
    - Forodesine Hydrochloride
    - Fosaprepitant
    - Fosbretabulin
    - Fosbretabulin Disodium
    - Fosbretabulin Tromethamine
    - Fosgemcitabine Palabenamide
    - Fosifloxuridine Nafalbenamide
    - Foslinanib
    - Foslinanib Disodium
    - Fosquidone
    - Fostriecin
    - Fotemustine
    - Fotretamine
    - FPV Vaccine CV301
    - FPV-Brachyury-TRICOM Vaccine
    - Fresolimumab
    - Fruquintinib
    - Fulvestrant
    - Fumagillin-Derived Polymer Conjugate XMT-1107
    - Fursultiamine
    - Futibatinib
    - Futuximab
    - Futuximab/Modotuximab Mixture
    - G Protein-coupled Estrogen Receptor Agonist LNS8801
    - G-Quadruplex Stabilizer BMVC
    - Galamustine
    - Galarubicin
    - Galectin Inhibitor GR-MD-02
    - Galectin-1 Inhibitor OTX008
    - Galeterone
    - Galiximab
    - Gallium-based Bone Resorption Inhibitor AP-002
    - Galocitabine
    - Galunisertib
    - Gamboge Resin Extract TSB-9-W1
    - Gamma-delta Tocotrienol
    - Gamma-Secretase Inhibitor LY3039478
    - Gamma-Secretase Inhibitor RO4929097
    - Gandotinib
    - Ganetespib
    - Ganglioside GD2
    - Ganglioside GM2
    - Ganitumab
    - Ganoderma lucidum Spores Powder Capsule
    - Garlic
    - Gastrin Immunotoxin
    - Gastrin/cholecystokinin Type B Receptor Inhibitor Z-360
    - Gataparsen Sodium
    - Gatipotuzumab
    - GBM Antigens and Alloantigens Immunotherapeutic Vaccine
    - Gedatolisib
    - Gefitinib
    - Geldanamycin
    - Gelonin
    - Gemcitabine
    - Gemcitabine Elaidate
    - Gemcitabine Hydrochloride
    - Gemcitabine Hydrochloride Emulsion
    - Gemcitabine Prodrug LY2334737
    - Gemcitabine-Phosphoramidate Hydrochloride NUC-1031
    - Gemcitabine-Releasing Intravesical System
    - Gemtuzumab Ozogamicin
    - Genetically Modified Interleukin-12 Transgene-encoding Bifidobacterium longum
    - Genistein
    - Gentuximab
    - Geranylgeranyltransferase I Inhibitor
    - GI-4000 Vaccine
    - Giloralimab
    - Gilteritinib
    - Gilteritinib Fumarate
    - Gimatecan
    - Gimeracil
    - Ginsenoside Rg3 Capsule
    - Giredestrant
    - Girentuximab
    - Girodazole
    - GITR Agonist MEDI1873
    - Givinostat
    - Glasdegib
    - Glasdegib Maleate
    - Glaucarubolone
    - Glecaprevir/Pibrentasvir
    - Glembatumumab Vedotin
    - Glesatinib
    - Glioblastoma Cancer Vaccine ERC1671
    - Glioblastoma Multiforme Multipeptide Vaccine IMA950
    - Glioma Lysate Vaccine GBM6-AD
    - Glioma-associated Peptide-loaded Dendritic Cell Vaccine SL-701
    - Globo H-DT Vaccine OBI-833
    - Glofitamab
    - Glucarpidase
    - Glucocorticoid Receptor Antagonist ORIC-101
    - Glufosfamide
    - Glumetinib
    - Glutaminase Inhibitor CB-839
    - Glutaminase Inhibitor CB-839 Hydrochloride
    - Glutaminase Inhibitor IPN60090
    - Glutamine Antagonist DRP-104
    - Glutathione Pegylated Liposomal Doxorubicin Hydrochloride Formulation 2B3-101
    - Glyco-engineered Anti-CD20 Monoclonal Antibody CHO H01
    - Glycooptimized Trastuzumab-GEX
    - GM-CSF-encoding Oncolytic Adenovirus CGTG-102
    - Gold Sodium Thiomalate
    - Golnerminogene Pradenovec
    - Golotimod
    - Golvatinib
    - Gonadotropin-releasing Hormone Analog
    - Goserelin
    - Goserelin Acetate
    - Goserelin Acetate Extended-release Microspheres LY01005
    - Gossypol
    - Gossypol Acetic Acid
    - Grapiprant
    - Green Tea Extract-based Antioxidant Supplement
    - GS/pan-Notch Inhibitor AL101
    - GS/pan-Notch Inhibitor BMS-986115
    - GSK-3 Inhibitor 9-ING-41
    - GSK-3 Inhibitor LY2090314
    - Guadecitabine
    - Guanabenz Acetate
    - Guselkumab
    - Gusperimus Trihydrochloride
    - Gutolactone
    - H-ras Antisense Oligodeoxynucleotide ISIS 2503
    - H1299 Tumor Cell Lysate Vaccine
    - HAAH Lambda phage Vaccine SNS-301
    - Hafnium Oxide-containing Nanoparticles NBTXR3
    - Halichondrin Analogue E7130
    - Halichondrin B
    - Halofuginone
    - Halofuginone Hydrobromide
    - HCV DNA Vaccine INO-8000
    - HDAC Class I/IIb Inhibitor HG146
    - HDAC Inhibitor AR-42
    - HDAC inhibitor CG200745
    - HDAC Inhibitor CHR-2845
    - HDAC Inhibitor CKD-581
    - HDAC Inhibitor CXD101
    - HDAC Inhibitor MPT0E028
    - HDAC Inhibitor OBP-801
    - HDAC/EGFR/HER2 Inhibitor CUDC-101
    - HDAC6 Inhibitor KA2507
    - HDAC8 Inhibitor NBM-BMX
    - HDM2 Inhibitor HDM201
    - HDM2 Inhibitor MK-8242
    - Hedgehog Inhibitor IPI-609
    - Hematoporphyrin Derivative
    - Hemiasterlin Analog E7974
    - Henatinib Maleate
    - Heparan Sulfate Glycosaminoglycan Mimetic M402
    - Heparin Derivative SST0001
    - HER-2-positive B-cell Peptide Antigen P467-DT-CRM197/Montanide Vaccine IMU-131
    - HER2 ECD+TM Virus-like Replicon Particles Vaccine AVX901
    - HER2 Inhibitor CP-724,714
    - HER2 Inhibitor DZD1516
    - HER2 Inhibitor TAS0728
    - HER2 Tri-specific Natural Killer Cell Engager DF1001
    - HER2-directed TLR8 Agonist SBT6050
    - HER2-targeted DARPin MP0274
    - HER2-targeted Liposomal Doxorubicin Hydrochloride MM-302
    - HER2-targeting Antibody Fc Fragment FS102
    - Herba Scutellaria Barbata
    - Herbimycin
    - Heterodimeric Interleukin-15
    - Hexamethylene Bisacetamide
    - Hexaminolevulinate
    - Hexylresorcinol
    - HIF-1alpha Inhibitor PX-478
    - HIF-2alpha Inhibitor PT2385
    - HIF-2alpha Inhibitor PT2977
    - HIF2a RNAi ARO-HIF2
    - Histone-Lysine N-Methyltransferase EZH2 Inhibitor GSK2816126
    - Histrelin Acetate
    - HLA-A*0201 Restricted TERT(572Y)/TERT(572) Peptides Vaccine Vx-001
    - HLA-A*2402-Restricted Multipeptide Vaccine S-488410
    - HLA-A2-restricted Melanoma-specific Peptides Vaccine GRN-1201
    - HM2/MMAE Antibody-Drug Conjugate ALT-P7
    - Hodgkin's Antigens-GM-CSF-Expressing Cell Vaccine
    - Holmium Ho 166 Poly(L-Lactic Acid) Microspheres
    - Hormone Therapy
    - HPPH
    - HPV 16 E6/E7-encoding Arenavirus Vaccine HB-202
    - HPV 16 E7 Antigen-expressing Lactobacillis casei Vaccine BLS-ILB-E710c
    - HPV DNA Plasmids Therapeutic Vaccine VGX-3100
    - HPV E6/E7 DNA Vaccine GX-188E
    - HPV E6/E7-encoding Arenavirus Vaccine HB-201
    - HPV Types 16/18 E6/E7-Adenoviral Transduced Autologous Lymphocytes/alpha-Galactosylceramide Vaccine BVAC-C
    - HPV-16 E6 Peptides Vaccine/Candida albicans Extract
    - HPV-6-targeting Immunotherapeutic Vaccine INO-3106
    - HPV16 E7-specific HLA-A*02:01-restricted IgG1-Fc Fusion Protein CUE-101
    - HPV16 L2/E6/E7 Fusion Protein Vaccine TA-CIN
    - HPV6/11-targeted DNA Plasmid Vaccine INO-3107
    - Hsp90 Antagonist KW-2478
    - Hsp90 Inhibitor AB-010
    - Hsp90 Inhibitor BIIB021
    - Hsp90 Inhibitor BIIB028
    - Hsp90 Inhibitor Debio 0932
    - Hsp90 Inhibitor DS-2248
    - Hsp90 Inhibitor HSP990
    - Hsp90 Inhibitor MPC-3100
    - Hsp90 Inhibitor PU-H71
    - Hsp90 Inhibitor SNX-5422 Mesylate
    - Hsp90 Inhibitor SNX-5542 Mesylate
    - Hsp90 Inhibitor TQB3474
    - Hsp90 Inhibitor XL888
    - Hsp90-targeted Photosensitizer HS-201
    - HSP90-targeted SN-38 Conjugate PEN-866
    - HSP90alpha/beta Inhibitor TAS-116
    - hTERT Multipeptide/Montanide ISA-51 VG/Imiquimod Vaccine GX 301
    - hTERT Vaccine V934/V935
    - hTERT-encoding DNA Vaccine INVAC-1
    - Hu14.18-IL2 Fusion Protein EMD 273063
    - HuaChanSu
    - Huaier Extract Granule
    - Huang Lian
    - huBC1-huIL12 Fusion Protein AS1409
    - Human Combinatorial Antibody Library-based Monoclonal Antibody VAY736
    - Human MHC Non-Restricted Cytotoxic T-Cell Line TALL-104
    - Human MOAB LICO 28a32
    - Human Monoclonal Antibody 216
    - Human Monoclonal Antibody B11-hCG Beta Fusion Protein CDX-1307
    - Human Papillomavirus 16 E7 Peptide/Padre 965.10
    - Hyaluronidase-zzxf/Pertuzumab/Trastuzumab
    - Hycanthone
    - Hydralazine Hydrochloride
    - Hydrocortisone Sodium Succinate
    - Hydroxychloroquine
    - Hydroxyprogesterone Caproate
    - Hydroxytyrosol
    - Hydroxyurea
    - Hypericin
    - Hypoxia-activated Prodrug TH-4000
    - I 131 Antiferritin Immunoglobulin
    - I 131 Monoclonal Antibody A33
    - I 131 Monoclonal Antibody CC49
    - I 131 Monoclonal Antibody F19
    - I 131 Monoclonal Antibody Lym-1
    - Iadademstat
    - Ianalumab
    - IAP Inhibitor APG-1387
    - IAP Inhibitor AT-406
    - IAP Inhibitor HGS1029
    - Ibandronate Sodium
    - Iberdomide
    - Iboctadekin
    - Ibritumomab Tiuxetan
    - Ibrutinib
    - Icotinib Hydrochloride
    - Icrucumab
    - ICT-121 Dendritic Cell Vaccine
    - Idarubicin
    - Idarubicin Hydrochloride
    - Idarubicin-Eluting Beads
    - Idasanutlin
    - Idecabtagene Vicleucel
    - Idelalisib
    - Idetrexed
    - IDH1 Mutant Inhibitor LY3410738
    - IDH1(R132) Inhibitor IDH305
    - IDH1R132H-Specific Peptide Vaccine PEPIDH1M
    - Idiotype-Pulsed Autologous Dendritic Cell Vaccine APC8020
    - IDO Peptide Vaccine IO102
    - IDO-1 Inhibitor LY3381916
    - IDO/TDO Inhibitor HTI-1090
    - IDO/TDO Inhibitor LY-01013
    - IDO1 Inhibitor KHK2455
    - IDO1 Inhibitor MK-7162
    - IDO1 Inhibitor PF-06840003
    - IDO1/TDO2 Inhibitor DN1406131
    - IDO1/TDO2 Inhibitor M4112
    - Idronoxil
    - Idronoxil Suppository NOX66
    - Ieramilimab
    - Ifabotuzumab
    - Ifetroban
    - Ifosfamide
    - IGF-1R Inhibitor
    - IGF-1R Inhibitor PL225B
    - IGF-1R/IR Inhibitor KW-2450
    - IGF-methotrexate Conjugate
    - IL-10 Immunomodulator MK-1966
    - IL-12-expressing HSV-1 NSC 733972
    - IL-12-expressing Mesenchymal Stem Cell Vaccine GX-051
    - IL-12sc, IL-15sushi, IFNa and GM-CSF mRNA-based Immunotherapeutic Agent SAR441000
    - IL-2 Recombinant Fusion Protein ALT-801
    - IL-2/9/15 Gamma Chain Receptor Inhibitor BNZ-1
    - IL4-Pseudomonas Exotoxin Fusion Protein MDNA55
    - Ilginatinib
    - Ilixadencel
    - Iloprost
    - Ilorasertib
    - Imalumab
    - Imaradenant
    - Imatinib
    - Imatinib Mesylate
    - Imetelstat
    - Imetelstat Sodium
    - Imexon
    - Imgatuzumab
    - Imidazole Mustard
    - Imidazole-Pyrazole
    - Imifoplatin
    - Imipramine Blue
    - Imiquimod
    - Immediate-release Onapristone
    - Immediate-release Tablet Afuresertib
    - Immune Checkpoint Inhibitor ASP8374
    - Immunoconjugate RO5479599
    - Immunocytokine NHS-IL12
    - Immunocytokine NHS-IL2-LT
    - Immunomodulator LAM-003
    - Immunomodulator OHR/AVR118
    - Immunomodulatory Agent CC-11006
    - Immunomodulatory Oligonucleotide HYB2055
    - Immunotherapeutic Combination Product CMB305
    - Immunotherapeutic GSK1572932A
    - Immunotherapy Regimen MKC-1106-MT
    - Immunotoxin CMD-193
    - IMT-1012 Immunotherapeutic Vaccine
    - Inactivated Oncolytic Virus Particle GEN0101
    - Inalimarev
    - Incyclinide
    - Indatuximab Ravtansine
    - Indibulin
    - Indicine-N-Oxide
    - Indisulam
    - Individualized MVA-based Vaccine TG4050
    - Indocyanine Green-labeled Polymeric Micelles ONM-100
    - Indole-3-Carbinol
    - Indomethacin
    - Indoximod
    - Indoximod Prodrug NLG802
    - Indusatumab Vedotin
    - Inebilizumab
    - Inecalcitol
    - Infigratinib
    - Infigratinib Mesylate
    - Infliximab
    - Ingenol Mebutate
    - Ingenol Mebutate Gel
    - Iniparib
    - iNKT Cell Agonist ABX196
    - Innate Immunostimulator rBBX-01
    - INO-1001
    - Inodiftagene Vixteplasmid
    - iNOS Dimerization Inhibitor ASP9853
    - Inosine 5'-monophosphate Dehydrogenase Inhibitor FF-10501-01
    - Inosine Monophosphate Dehydrogenase Inhibitor AVN944
    - Inositol
    - Inotuzumab Ozogamicin
    - Inproquone
    - Integrin alpha-2 Inhibitor E7820
    - Integrin Receptor Antagonist GLPG0187
    - Interferon
    - Interferon Alfa-2B
    - Interferon Alfa-N1
    - Interferon Alfa-N3
    - Interferon Alfacon-1
    - Interferon Beta-1A
    - Interferon Gamma-1b
    - Interferon-gamma-expressing Adenovirus Vaccine ASN-002
    - Interleukin Therapy
    - Interleukin-12-Fc Fusion Protein DF6002
    - Interleukin-15 Agonist Fusion Protein SHR1501
    - Interleukin-15 Fusion Protein BJ-001
    - Interleukin-15/Interleukin-15 Receptor Alpha Complex-Fc Fusion Protein XmAb24306
    - Interleukin-15/Interleukin-15 Receptor Alpha Sushi+ Domain Fusion Protein SO-C101
    - Interleukin-2 Liposome
    - Intermediate-affinity Interleukin-2 Receptor Agonist ALKS 4230
    - Intetumumab
    - Intiquinatine
    - Intoplicine
    - Inulin
    - Iobenguane I-131
    - Iodine I 124 Monoclonal Antibody A33
    - Iodine I 124 Monoclonal Antibody M5A
    - Iodine I 125-Anti-EGFR-425 Monoclonal Antibody
    - Iodine I 131 Anti-Fibronectin Antibody Fragment L19-SIP
    - Iodine I 131 Apamistamab
    - Iodine I 131 Derlotuximab Biotin
    - Iodine I 131 Ethiodized Oil
    - Iodine I 131 IPA
    - Iodine I 131 MIP-1095
    - Iodine I 131 Monoclonal Antibody 81C6
    - Iodine I 131 Monoclonal Antibody BC8
    - Iodine I 131 Monoclonal Antibody CC49-deltaCH2
    - Iodine I 131 Monoclonal Antibody F16SIP
    - Iodine I 131 Monoclonal Antibody G-250
    - Iodine I 131 Monoclonal Antibody muJ591
    - Iodine I 131 Omburtamab
    - Iodine I 131 Rituximab
    - Iodine I 131 Tenatumomab
    - Iodine I 131 TM-601
    - Iodine I 131 Tositumomab
    - Iodine I-131
    - Ioflubenzamide I-131
    - Ionomycin
    - Ipafricept
    - Ipatasertib
    - Ipilimumab
    - Ipomeanol
    - Iproplatin
    - iPSC-derived CD16-expressing Natural Killer Cells FT516
    - iPSC-derived CD16/IL-15RF-expressing Anti-CD19 CAR-NK Cells FT596
    - iPSC-derived Natural Killer Cells FT500
    - IRAK4 Inhibitor CA-4948
    - Iratumumab
    - Iridium Ir 192
    - Irinotecan
    - Irinotecan Hydrochloride
    - Irinotecan Sucrosofate
    - Irinotecan-Eluting Beads
    - Irinotecan/P-glycoprotein Inhibitor HM30181AK Combination Tablet
    - Irofulven
    - Iroplact
    - Irosustat
    - Irradiated Allogeneic Human Lung Cancer Cells Expressing OX40L-Ig Vaccine HS-130
    - Isatuximab
    - Iso-fludelone
    - Isobrucein B
    - Isocoumarin NM-3
    - Isotretinoin
    - Ispinesib
    - Ispinesib Mesylate
    - ISS 1018 CpG Oligodeoxynucleotide
    - Istiratumab
    - Itacitinib
    - Itacitinib Adipate
    - ITK Inhibitor CPI-818
    - Itraconazole
    - Itraconazole Dispersion In Polymer Matrix
    - Ivaltinostat
    - Ivosidenib
    - Ivuxolimab
    - Ixabepilone
    - Ixazomib
    - Ixazomib Citrate
    - JAK Inhibitor
    - JAK Inhibitor INCB047986
    - JAK1 Inhibitor AZD4205
    - JAK1 Inhibitor INCB052793
    - JAK2 Inhibitor AZD1480
    - JAK2 Inhibitor BMS-911543
    - JAK2 Inhibitor XL019
    - JAK2/Src Inhibitor NS-018
    - Jin Fu Kang
    - JNK Inhibitor CC-401
    - Kanglaite
    - Kanitinib
    - Ketoconazole
    - Ketotrexate
    - KRAS G12C Inhibitor GDC-6036
    - KRAS G12C Inhibitor LY3499446
    - KRAS G12C Inhibitor MRTX849
    - KRAS Mutant-targeting AMG 510
    - KRAS-MAPK Signaling Pathway Inhibitor JAB-3312
    - KRASG12C Inhibitor JNJ-74699157
    - KRN5500
    - KSP Inhibitor AZD4877
    - KSP Inhibitor SB-743921
    - Kunecatechins Ointment
    - L-Gossypol
    - L-methylfolate
    - Labetuzumab Govitecan
    - Lactoferrin-derived Lytic Peptide LTX-315
    - Lacutamab
    - Ladiratuzumab Vedotin
    - Ladirubicin
    - Laetrile
    - LAIR-2 Fusion Protein NC410
    - Landogrozumab
    - Laniquidar
    - Lanreotide Acetate
    - Lapachone
    - Lapatinib
    - Lapatinib Ditosylate
    - Laprituximab Emtansine
    - Lapuleucel-T
    - Laromustine
    - Larotaxel
    - Larotinib Mesylate
    - Larotrectinib
    - Larotrectinib Sulfate
    - Lavendustin A
    - Lazertinib
    - Lead Pb 212 TCMC-trastuzumab
    - Lefitolimod
    - Leflunomide
    - Lenalidomide
    - Lenalidomide Analog KPG-121
    - Lentinan
    - Lenvatinib
    - Lenvatinib Mesylate
    - Lenzilumab
    - Lerociclib
    - Lestaurtinib
    - Letetresgene Autoleucel
    - Letolizumab
    - Letrozole
    - Leucovorin
    - Leucovorin Calcium
    - Leuprolide
    - Leuprolide Acetate
    - Leuprolide Mesylate Injectable Suspension
    - Leurubicin
    - Levetiracetam
    - Levoleucovorin Calcium
    - Levothyroxine
    - Levothyroxine Sodium
    - Lexatumumab
    - Lexibulin
    - Liarozole
    - Liarozole Fumarate
    - Liarozole Hydrochloride
    - Licartin
    - Licorice
    - Lifastuzumab Vedotin
    - Lifileucel
    - Lifirafenib
    - Light-activated AU-011
    - Light-Emitting Oncolytic Vaccinia Virus GL-ONC1
    - Lilotomab
    - Limonene, (+)-
    - Limonene, (+/-)-
    - Linifanib
    - Linoleyl Carbonate-Paclitaxel
    - Linperlisib
    - Linrodostat
    - Linsitinib
    - Lintuzumab
    - Liothyronine I-131
    - Liothyronine Sodium
    - Lipid Encapsulated Anti-PLK1 siRNA TKM-PLK1
    - Lipid Nanoparticle Encapsulated mRNAs Encoding Human IL-12A/IL-12B MEDI-1191
    - Lipid Nanoparticle Encapsulated OX40L mRNA-2416
    - Lipid Nanoparticle Encapsulating Glutathione S-transferase P siRNA NBF-006
    - Lipid Nanoparticle Encapsulating mRNAs Encoding Human OX40L/IL-23/IL-36gamma mRNA-2752
    - Liposomal Bcl-2 Antisense Oligonucleotide BP1002
    - Liposomal c-raf Antisense Oligonucleotide
    - Liposomal Curcumin
    - Liposomal Cytarabine
    - Liposomal Daunorubicin Citrate
    - Liposomal Docetaxel
    - Liposomal Eribulin Mesylate
    - Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101
    - Liposomal Irinotecan
    - Liposomal Mitoxantrone Hydrochloride
    - Liposomal MUC1/PET-lipid A Vaccine ONT-10
    - Liposomal NDDP
    - Liposomal Rhenium Re 186
    - Liposomal SN-38
    - Liposomal Topotecan FF-10850
    - Liposomal Vinorelbine
    - Liposomal Vinorelbine Tartrate
    - Liposome
    - Liposome-encapsulated Daunorubicin-Cytarabine
    - Liposome-Encapsulated Doxorubicin Citrate
    - Liposome-encapsulated miR-34 Mimic MRX34
    - Liposome-encapsulated OSI-7904
    - Liposome-encapsulated RB94 Plasmid DNA Gene Therapy Agent SGT-94
    - Liposome-encapsulated TAAs mRNA Vaccine W_ova1
    - Lirilumab
    - Lisavanbulin
    - Lisocabtagene Maraleucel
    - Listeria monocytogenes-LLO-PSA Vaccine ADXS31-142
    - Litronesib
    - Live-attenuated Double-deleted Listeria monocytogenes Bacteria JNJ-64041809
    - Live-Attenuated Listeria Encoding Human Mesothelin Vaccine CRS-207
    - Live-attenuated Listeria monocytogenes-encoding EGFRvIII-NY-ESO-1 Vaccine ADU-623
    - Liver X Receptor beta Agonist RGX-104
    - Lm-tLLO-neoantigens Vaccine ADXS-NEO
    - LMB-1 Immunotoxin
    - LMB-2 Immunotoxin
    - LMB-7 Immunotoxin
    - LMB-9 Immunotoxin
    - LmddA-LLO-chHER2 Fusion Protein-secreting Live-attenuated Listeria Cancer Vaccine ADXS31-164
    - LMP-2:340-349 Peptide Vaccine
    - LMP-2:419-427 Peptide Vaccine
    - LMP2-specific T Cell Receptor-transduced Autologous T-lymphocytes
    - LMP7 Inhibitor M3258
    - Lobaplatin
    - Lodapolimab
    - Lometrexol
    - Lometrexol Sodium
    - Lomustine
    - Lonafarnib
    - Loncastuximab Tesirine
    - Long Peptide Vaccine 7
    - Long-acting Release Pasireotide
    - Lontucirev
    - Lorlatinib
    - Lorukafusp alfa
    - Lorvotuzumab Mertansine
    - Losatuxizumab Vedotin
    - Losoxantrone
    - Losoxantrone Hydrochloride
    - Lovastatin
    - LOXL2 Inhibitor PAT-1251
    - LRP5 Antagonist BI 905681
    - LRP5/6 Antagonist BI 905677
    - LSD1 Inhibitor CC-90011
    - LSD1 Inhibitor GSK2879552
    - LSD1 Inhibitor IMG-7289
    - LSD1 Inhibitor RO7051790
    - LSD1 Inhibitor SYHA1807
    - Lucanthone
    - Lucatumumab
    - Lucitanib
    - Luminespib
    - Luminespib Mesylate
    - Lumretuzumab
    - Lung-targeted Immunomodulator QBKPN
    - Lupartumab Amadotin
    - Lurbinectedin
    - Lurtotecan
    - Lurtotecan Liposome
    - Lutetium Lu 177 Anti-CA19-9 Monoclonal Antibody 5B1
    - Lutetium Lu 177 DOTA-biotin
    - Lutetium Lu 177 DOTA-N3-CTT1403
    - Lutetium Lu 177 DOTA-Tetulomab
    - Lutetium Lu 177 Dotatate
    - Lutetium Lu 177 Lilotomab-satetraxetan
    - Lutetium Lu 177 Monoclonal Antibody CC49
    - Lutetium Lu 177 Monoclonal Antibody J591
    - Lutetium Lu 177 PP-F11N
    - Lutetium Lu 177 Satoreotide Tetraxetan
    - Lutetium Lu 177-DOTA-EB-TATE
    - Lutetium Lu 177-DTPA-omburtamab
    - Lutetium Lu 177-Edotreotide
    - Lutetium Lu 177-NeoB
    - Lutetium Lu 177-PSMA-617
    - Lutetium Lu-177 Capromab
    - Lutetium Lu-177 Girentuximab
    - Lutetium Lu-177 PSMA-R2
    - Lutetium Lu-177 Rituximab
    - LV.IL-2/B7.1-Transduced AML Blast Vaccine RFUSIN2-AML1
    - Lyophilized Black Raspberry Lozenge
    - Lyophilized Black Raspberry Saliva Substitute
    - Lysine-specific Demethylase 1 Inhibitor INCB059872
    - Lyso-Thermosensitive Liposome Doxorubicin
    - Maackia amurensis Seed Lectin
    - Macimorelin
    - Macitentan
    - Macrocycle-bridged STING Agonist E7766
    - Maekmoondong-tang
    - Mafosfamide
    - MAGE-10.A2
    - MAGE-A1-specific T Cell Receptor-transduced Autologous T-cells
    - MAGE-A3 Multipeptide Vaccine GL-0817
    - MAGE-A3 Peptide Vaccine
    - MAGE-A3-specific Immunotherapeutic GSK 2132231A
    - MAGE-A4-specific TCR Gene-transduced Autologous T Lymphocytes TBI-1201
    - Magnesium Valproate
    - Magrolimab
    - MALT1 Inhibitor JNJ-67856633
    - Manelimab
    - Mannosulfan
    - Mannosylerythritol Lipid
    - Mapatumumab
    - Maraba Oncolytic Virus Expressing Mutant HPV E6/E7
    - Marcellomycin
    - MARCKS Protein Inhibitor BIO-11006
    - Margetuximab
    - Marimastat
    - Marizomib
    - Masitinib Mesylate
    - Masoprocol
    - MAT2A Inhibitor AG-270
    - Matrix Metalloproteinase Inhibitor MMI270
    - Matuzumab
    - Mavelertinib
    - Mavorixafor
    - Maytansine
    - MCL-1 Inhibitor ABBV-467
    - MCL-1 Inhibitor AMG 176
    - MCL-1 inhibitor AMG 397
    - Mcl-1 Inhibitor AZD5991
    - Mcl-1 Inhibitor MIK665
    - MDM2 Antagonist ASTX295
    - MDM2 Antagonist RO5045337
    - MDM2 Antagonist RO6839921
    - MDM2 Inhibitor AMG-232
    - MDM2 Inhibitor AMGMDS3
    - MDM2 Inhibitor BI 907828
    - MDM2 Inhibitor KRT-232
    - MDM2/MDMX Inhibitor ALRN-6924
    - MDR Modulator CBT-1
    - Mechlorethamine
    - Mechlorethamine Hydrochloride
    - Mechlorethamine Hydrochloride Gel
    - Medorubicin
    - Medroxyprogesterone
    - Medroxyprogesterone Acetate
    - Megestrol Acetate
    - MEK 1/2 Inhibitor AS703988/MSC2015103B
    - MEK 1/2 Inhibitor FCN-159
    - MEK Inhibitor AZD8330
    - MEK Inhibitor CI-1040
    - MEK inhibitor CS3006
    - MEK Inhibitor GDC-0623
    - MEK Inhibitor HL-085
    - MEK Inhibitor PD0325901
    - MEK Inhibitor RO4987655
    - MEK Inhibitor SHR 7390
    - MEK Inhibitor TAK-733
    - MEK Inhibitor WX-554
    - MEK-1/MEKK-1 Inhibitor E6201
    - MEK/Aurora Kinase Inhibitor BI 847325
    - Melanoma Monoclonal Antibody hIgG2A
    - Melanoma TRP2 CTL Epitope Vaccine SCIB1
    - Melapuldencel-T
    - MELK Inhibitor OTS167
    - Melphalan
    - Melphalan Flufenamide
    - Melphalan Hydrochloride
    - Melphalan Hydrochloride/Sulfobutyl Ether Beta-Cyclodextrin Complex
    - Membrane-Disrupting Peptide EP-100
    - Menatetrenone
    - Menin-MLL Interaction Inhibitor SNDX-5613
    - Menogaril 
    - Merbarone
    - Mercaptopurine
    - Mercaptopurine Anhydrous
    - Mercaptopurine Oral Suspension
    - Merestinib
    - Mesna
    - Mesothelin/CD3e Tri-specific T-cell Activating Construct HPN536
    - MET Kinase Inhibitor OMO-1
    - MET Tyrosine Kinase Inhibitor BMS-777607
    - MET Tyrosine Kinase Inhibitor EMD 1204831
    - MET Tyrosine Kinase Inhibitor PF-04217903
    - MET Tyrosine Kinase Inhibitor SAR125844
    - MET Tyrosine Kinase Inhibitor SGX523
    - MET x MET Bispecific Antibody REGN5093
    - Metamelfalan
    - MetAP2 Inhibitor APL-1202
    - MetAP2 Inhibitor SDX-7320
    - Metarrestin
    - Metatinib Tromethamine
    - Metformin
    - Metformin Hydrochloride
    - Methanol Extraction Residue of BCG
    - Methazolamide
    - Methionine Aminopeptidase 2 Inhibitor M8891
    - Methionine Aminopeptidase 2 Inhibitor PPI-2458
    - Methotrexate
    - Methotrexate Sodium
    - Methotrexate-E Therapeutic Implant
    - Methotrexate-Encapsulating Autologous Tumor-Derived Microparticles
    - Methoxsalen
    - Methoxyamine
    - Methoxyamine Hydrochloride
    - Methyl-5-Aminolevulinate Hydrochloride Cream
    - Methylcantharidimide
    - Methylmercaptopurine Riboside
    - Methylprednisolone
    - Methylprednisolone Acetate
    - Methylprednisolone Sodium Succinate
    - Methylselenocysteine
    - Methyltestosterone
    - Metoprine
    - Mevociclib
    - Mezagitamab
    - Mibefradil
    - Mibefradil Dihydrochloride
    - Micellar Nanoparticle-encapsulated Epirubicin
    - Micro Needle Array-Doxorubicin
    - Microbiome GEN-001
    - Microbiome-derived Peptide Vaccine EO2401
    - Microparticle-encapsulated CYP1B1-encoding DNA Vaccine ZYC300
    - Microtubule Inhibitor SCB01A
    - Midostaurin
    - Mifamurtide
    - Mifepristone
    - Milademetan Tosylate
    - Milataxel
    - Milatuzumab
    - Milatuzumab-Doxorubicin Antibody-Drug Conjugate IMMU-110
    - Milciclib Maleate
    - Milk Thistle
    - Miltefosine
    - Minretumomab
    - Mipsagargin
    - Miptenalimab
    - Mirabegron
    - Miransertib
    - Mirdametinib
    - Mirvetuximab Soravtansine
    - Mirzotamab Clezutoclax
    - Misonidazole
    - Mistletoe Extract
    - Mitazalimab
    - Mitindomide
    - Mitobronitol
    - Mitochondrial Oxidative Phosphorylation Inhibitor ATR-101
    - Mitoclomine
    - Mitoflaxone
    - Mitoguazone
    - Mitoguazone Dihydrochloride
    - Mitolactol
    - Mitomycin
    - Mitomycin A
    - Mitomycin B
    - Mitomycin C Analog KW-2149
    - Mitosis Inhibitor T 1101 Tosylate
    - Mitotane
    - Mitotenamine
    - Mitoxantrone
    - Mitoxantrone Hydrochloride
    - Mitozolomide
    - Mivavotinib
    - Mivebresib
    - Mivobulin
    - Mivobulin Isethionate
    - Mixed Bacteria Vaccine
    - MK0731
    - MKC-1
    - MKNK1 Inhibitor BAY 1143269
    - MMP Inhibitor S-3304
    - MNK1/2 Inhibitor ETC-1907206
    - Mobocertinib
    - Mocetinostat
    - Modakafusp Alfa
    - Modified Vaccinia Ankara-vectored HPV16/18 Vaccine JNJ-65195208
    - Modified Vitamin D Binding Protein Macrophage Activator EF-022
    - Modotuximab
    - MOF Compound RiMO-301
    - Mofarotene
    - Mogamulizumab
    - Molibresib
    - Molibresib Besylate
    - Momelotinib
    - Monalizumab
    - Monocarboxylate Transporter 1 Inhibitor AZD3965
    - Monoclonal Antibody 105AD7 Anti-idiotype Vaccine
    - Monoclonal Antibody 11D10
    - Monoclonal Antibody 11D10 Anti-Idiotype Vaccine
    - Monoclonal Antibody 14G2A
    - Monoclonal Antibody 1F5
    - Monoclonal Antibody 3622W94
    - Monoclonal Antibody 3F8
    - Monoclonal Antibody 3H1 Anti-Idiotype Vaccine
    - Monoclonal Antibody 4B5 Anti-Idiotype Vaccine
    - Monoclonal Antibody 7C11
    - Monoclonal Antibody 81C6
    - Monoclonal Antibody A1G4 Anti-Idiotype Vaccine
    - Monoclonal Antibody A27.15
    - Monoclonal Antibody A33
    - Monoclonal Antibody AbGn-7
    - Monoclonal Antibody AK002
    - Monoclonal Antibody ASP1948
    - Monoclonal Antibody CAL
    - Monoclonal Antibody CC49-delta CH2
    - Monoclonal Antibody CEP-37250/KHK2804
    - Monoclonal Antibody D6.12
    - Monoclonal Antibody E2.3
    - Monoclonal Antibody F19
    - Monoclonal Antibody GD2 Anti-Idiotype Vaccine
    - Monoclonal Antibody HeFi-1
    - Monoclonal Antibody Hu3S193
    - Monoclonal Antibody HuAFP31
    - Monoclonal Antibody HuHMFG1
    - Monoclonal Antibody huJ591
    - Monoclonal Antibody HuPAM4
    - Monoclonal Antibody IMMU-14
    - Monoclonal Antibody L6
    - Monoclonal Antibody Lym-1
    - Monoclonal Antibody m170
    - Monoclonal Antibody Me1-14 F(ab')2
    - Monoclonal Antibody muJ591
    - Monoclonal Antibody MX35 F(ab')2
    - Monoclonal Antibody NEO-201
    - Monoclonal Antibody R24
    - Monoclonal Antibody RAV12
    - Monoclonal Antibody SGN-14
    - Monoclonal Antibody TRK-950
    - Monoclonal Microbial EDP1503
    - Monoclonal T-cell Receptor Anti-CD3 scFv Fusion Protein IMCgp100
    - Monomethyl Auristatin E
    - Morinda Citrifolia Fruit Extract
    - Morpholinodoxorubicin
    - Mosedipimod
    - Mosunetuzumab
    - Motesanib
    - Motesanib Diphosphate
    - Motexafin Gadolinium
    - Motexafin Lutetium
    - Motixafortide
    - Motolimod
    - MOv-gamma Chimeric Receptor Gene
    - Moxetumomab Pasudotox
    - Mps1 Inhibitor BAY 1217389
    - Mps1 Inhibitor BOS172722
    - mRNA-based Personalized Cancer Vaccine mRNA-4157
    - mRNA-based Personalized Cancer Vaccine NCI-4650
    - mRNA-based TriMix Melanoma Vaccine ECI-006
    - mRNA-based Tumor-specific Neoantigen Boosting Vaccine GRT-R902
    - mRNA-derived KRAS-targeted Vaccine V941
    - mRNA-derived Lung Cancer Vaccine BI 1361849
    - mRNA-Derived Prostate Cancer Vaccine CV9103
    - mRNA-derived Prostate Cancer Vaccine CV9104
    - MTF-1 Inhibitor APTO-253 HCl
    - mTOR Inhibitor GDC-0349
    - mTOR Kinase Inhibitor AZD8055
    - mTOR Kinase Inhibitor CC-223
    - mTOR Kinase Inhibitor OSI-027
    - mTOR Kinase Inhibitor PP242
    - mTOR1/2 Kinase Inhibitor ME-344
    - mTORC 1/2 Inhibitor LXI-15029
    - mTORC1/2 Kinase Inhibitor BI 860585
    - mTORC1/mTORC2/DHFR Inhibitor ABTL0812
    - MUC-1/WT1 Peptide-primed Autologous Dendritic Cells
    - MUC1-targeted Peptide GO-203-2C
    - Mucoadhesive Paclitaxel Formulation
    - Multi-AGC Kinase Inhibitor AT13148
    - Multi-epitope Anti-folate Receptor Peptide Vaccine TPIV 200
    - Multi-epitope HER2 Peptide Vaccine H2NVAC
    - Multi-epitope HER2 Peptide Vaccine TPIV100
    - Multi-glioblastoma-peptide-targeting Autologous Dendritic Cell Vaccine ICT-107
    - Multi-kinase Inhibitor TPX-0022
    - Multi-kinase Inhibitor XL092
    - Multi-mode Kinase Inhibitor EOC317
    - Multi-neo-epitope Vaccine OSE 2101
    - Multifunctional/Multitargeted Anticancer Agent OMN54
    - Multikinase Inhibitor 4SC-203
    - Multikinase Inhibitor AEE788
    - Multikinase Inhibitor AT9283
    - Multikinase Inhibitor SAR103168
    - Multipeptide Vaccine S-588210
    - Multitargeted Tyrosine Kinase Inhibitor JNJ-26483327
    - Muparfostat
    - Mureletecan
    - Murizatoclax
    - Muscadine Grape Extract
    - Mutant IDH1 Inhibitor DS-1001
    - Mutant p53 Activator COTI-2
    - Mutant-selective EGFR Inhibitor PF-06459988
    - MVA Tumor-specific Neoantigen Boosting Vaccine MVA-209-FSP
    - MVA-BN Smallpox Vaccine
    - MVA-FCU1 TG4023
    - MVX-1-loaded Macrocapsule/autologous Tumor Cell Vaccine MVX-ONCO-1
    - MYC-targeting siRNA DCR-MYC
    - Mycobacterium tuberculosis Arabinomannan Z-100
    - Mycobacterium w
    - Mycophenolic Acid
    - N-(5-tert-butyl-3-isoxazolyl)-N-(4-(4-pyridinyl)oxyphenyl) Urea
    - N-dihydrogalactochitosan
    - N-Methylformamide
    - N,N-Dibenzyl Daunomycin
    - NA17-A Antigen
    - NA17.A2 Peptide Vaccine
    - Nab-paclitaxel
    - Nab-paclitaxel/Rituximab-coated Nanoparticle AR160
    - Nadofaragene Firadenovec
    - Nagrestipen
    - Namirotene
    - Namodenoson
    - NAMPT Inhibitor OT-82
    - Nanafrocin
    - Nanatinostat
    - Nanocell-encapsulated miR-16-based microRNA Mimic
    - Nanoparticle Albumin-Bound Docetaxel
    - Nanoparticle Albumin-Bound Rapamycin
    - Nanoparticle Albumin-bound Thiocolchicine Dimer nab-5404
    - Nanoparticle Paclitaxel Ointment SOR007
    - Nanoparticle-based Paclitaxel Suspension
    - Nanoparticle-encapsulated Doxorubicin Hydrochloride
    - Nanoscale Coordination Polymer Nanoparticles CPI-100
    - Nanosomal Docetaxel Lipid Suspension
    - Napabucasin
    - Naphthalimide Analogue UNBS5162
    - Naptumomab Estafenatox
    - Naquotinib
    - Naratuximab Emtansine
    - Narnatumab
    - Natalizumab
    - Natural IFN-alpha OPC-18
    - Natural Killer Cells ZRx101
    - Navarixin
    - Navicixizumab
    - Navitoclax
    - Navoximod
    - Navy Bean Powder
    - Naxitamab
    - Nazartinib
    - ncmtRNA Oligonucleotide Andes-1537
    - Necitumumab
    - Nedaplatin
    - NEDD8 Activating Enzyme E1 Inhibitor TAS4464
    - Nedisertib
    - Nelarabine
    - Nelipepimut-S
    - Nelipepimut-S Plus GM-CSF Vaccine
    - Nemorubicin
    - Nemorubicin Hydrochloride
    - Neoantigen Vaccine GEN-009
    - Neoantigen-based Glioblastoma Vaccine
    - Neoantigen-based Melanoma-Poly-ICLC Vaccine
    - Neoantigen-based Renal Cell Carcinoma-Poly-ICLC Vaccine
    - Neoantigen-based Therapeutic Cancer Vaccine GRT-C903
    - Neoantigen-based Therapeutic Cancer Vaccine GRT-R904
    - Neoantigen-HSP70 Peptide Cancer Vaccine AGEN2017
    - Neratinib
    - Neratinib Maleate
    - Nesvacumab
    - NG-nitro-L-arginine
    - Niacinamide
    - Niclosamide
    - Nicotinamide Riboside
    - Nidanilimab
    - Nifurtimox
    - Nilotinib
    - Nilotinib Hydrochloride Anhydrous
    - Nilotinib Hydrochloride Monohydrate
    - Nilutamide
    - Nimesulide-Hyaluronic Acid Conjugate CA102N
    - Nimodipine
    - Nimotuzumab
    - Nimustine
    - Nimustine Hydrochloride
    - Ningetinib Tosylate
    - Nintedanib
    - Niraparib
    - Niraparib Tosylate Monohydrate
    - Nirogacestat
    - Nitric Oxide-Releasing Acetylsalicylic Acid Derivative
    - Nitrogen Mustard Prodrug PR-104
    - Nitroglycerin Transdermal Patch
    - Nivolumab
    - NLRP3 Agonist BMS-986299
    - Nocodazole
    - Nogalamycin
    - Nogapendekin Alfa
    - Nolatrexed Dihydrochloride
    - Non-Small Cell Lung Cancer mRNA-Derived Vaccine CV9201
    - Norgestrel
    - North American Ginseng Extract AFX-2
    - Nortopixantrone
    - Noscapine
    - Noscapine Hydrochloride
    - Not Otherwise Specified
    - Notch Signaling Inhibitor PF-06650808
    - Notch Signaling Pathway Inhibitor MK0752
    - NTRK/ROS1 Inhibitor DS-6051b
    - Nucleolin Antagonist IPP-204106N
    - Nucleoside Analog DFP-10917
    - Nucleotide Analog Prodrug NUC-3373
    - Nucleotide Analogue GS 9219
    - Numidargistat
    - Nurulimab
    - Nutlin-3a
    - Nutraceutical TBL-12
    - NY-ESO-1 Plasmid DNA Cancer Vaccine pPJV7611
    - NY-ESO-1-specific TCR Gene-transduced T Lymphocytes TBI-1301
    - NY-ESO-1/GLA-SE Vaccine ID-G305
    - NY-ESO-B
    - O-Chloroacetylcarbamoylfumagillol
    - O6-Benzylguanine
    - Obatoclax Mesylate
    - Obinutuzumab
    - Oblimersen Sodium
    - Ocaratuzumab
    - Ocrelizumab
    - Octreotide
    - Octreotide Acetate
    - Octreotide Pamoate
    - Odronextamab
    - Ofatumumab
    - Ofranergene Obadenovec
    - Oglufanide Disodium
    - Olaparib
    - Olaptesed Pegol
    - Olaratumab
    - Oleandrin
    - Oleclumab
    - Oligo-fucoidan
    - Oligonucleotide SPC2996
    - Olinvacimab
    - Olivomycin
    - Olmutinib
    - Oltipraz
    - Olutasidenib
    - Olvimulogene Nanivacirepvec
    - Omacetaxine Mepesuccinate
    - Ombrabulin
    - Omipalisib
    - Onalespib
    - Onalespib Lactate
    - Onartuzumab
    - Onatasertib
    - Oncolytic Adenovirus Ad5-DNX-2401
    - Oncolytic Adenovirus ORCA-010
    - Oncolytic Herpes Simplex Virus-1 ONCR-177
    - Oncolytic HSV-1 C134
    - Oncolytic HSV-1 Expressing IL-12 and Anti-PD-1 Antibody T3011
    - Oncolytic HSV-1 G207
    - Oncolytic HSV-1 NV1020
    - Oncolytic HSV-1 rQNestin34.5v.2
    - Oncolytic HSV-1 rRp450
    - Oncolytic HSV1716
    - Oncolytic Measles Virus Encoding Helicobacter pylori Neutrophil-activating Protein
    - Oncolytic Newcastle Disease Virus MEDI5395
    - Oncolytic Newcastle Disease Virus MTH-68H
    - Oncolytic Newcastle Disease Virus Strain PV701
    - Oncolytic Virus ASP9801
    - Oncolytic Virus RP1
    - Ondansetron Hydrochloride
    - Ontorpacept
    - Ontuxizumab
    - Onvansertib
    - Onvatilimab
    - Opaganib
    - OPCs/Green Tea/Spirullina/Curcumin/Antrodia Camphorate/Fermented Soymilk Extract Capsule
    - Opioid Growth Factor
    - Opolimogene Capmilisbac
    - Oportuzumab Monatox
    - Oprozomib
    - Opucolimab
    - Oral Aminolevulinic Acid Hydrochloride
    - Oral Azacitidine
    - Oral Cancer Vaccine V3-OVA
    - Oral Docetaxel
    - Oral Fludarabine Phosphate
    - Oral Hsp90 Inhibitor IPI-493
    - Oral Ixabepilone
    - Oral Microencapsulated Diindolylmethane
    - Oral Milataxel
    - Oral Myoma Vaccine V3-myoma
    - Oral Pancreatic Cancer Vaccine V3-P
    - Oral Picoplatin
    - Oral Sodium Phenylbutyrate
    - Oral Topotecan Hydrochloride
    - Orantinib
    - Oraxol
    - Oregovomab
    - Orelabrutinib
    - Ormaplatin
    - Ortataxel
    - Orteronel
    - Orvacabtagene Autoleucel
    - Osilodrostat
    - Osimertinib
    - Other
    - Otlertuzumab
    - Ovapuldencel-T
    - Ovarian Cancer Stem Cell/hTERT/Survivin mRNAs-loaded Autologous Dendritic Cell Vaccine DC-006
    - Ovine Submaxillary Mucin
    - OX40L-expressing Oncolytic Adenovirus DNX-2440
    - Oxaliplatin
    - Oxaliplatin Eluting Beads
    - Oxaliplatin-Encapsulated Transferrin-Conjugated N-glutaryl Phosphatidylethanolamine Liposome
    - Oxcarbazepine
    - Oxeclosporin
    - Oxidative Phosphorylation Inhibitor IACS-010759
    - Oxidative Phosphorylation Inhibitor IM156
    - Oxidopamine
    - OxPhos Inhibitor VLX600
    - Ozarelix
    - P-cadherin Antagonist PF-03732010
    - P-cadherin Inhibitor PCA062
    - P-cadherin-targeting Agent PF-06671008
    - P-p68 Inhibitor RX-5902
    - P-TEFb Inhibitor BAY1143572
    - p300/CBP Bromodomain Inhibitor CCS1477
    - p38 MAPK Inhibitor LY3007113
    - p53 Peptide Vaccine MPS-128
    - p53-HDM2 Interaction Inhibitor MI-773
    - p53-HDM2 Protein-protein Interaction Inhibitor APG-115
    - p53/HDM2 Interaction Inhibitor CGM097
    - p70S6K Inhibitor LY2584702
    - p70S6K/Akt Inhibitor MSC2363318A
    - p97 Inhibitor CB-5083
    - p97 Inhibitor CB-5339
    - p97 Inhibitor CB-5339 Tosylate
    - Paclitaxel
    - Paclitaxel Ceribate
    - Paclitaxel Injection Concentrate for Nanodispersion
    - Paclitaxel Liposome
    - Paclitaxel Poliglumex
    - Paclitaxel Polymeric Micelle Formulation NANT-008
    - Paclitaxel PPE Microspheres
    - Paclitaxel Trevatide
    - Paclitaxel Vitamin E-Based Emulsion
    - Paclitaxel-Loaded Polymeric Micelle
    - Pacmilimab
    - Pacritinib
    - Padeliporfin
    - Padoporfin
    - PAK4 Inhibitor PF-03758309
    - PAK4/NAMPT Inhibitor KPT-9274
    - Palbociclib
    - Palbociclib Isethionate
    - Palifosfamide
    - Palifosfamide Tromethamine
    - Palladium Pd-103
    - Palonosetron Hydrochloride
    - Pamidronate Disodium
    - Pamidronic Acid
    - Pamiparib
    - Pamrevlumab
    - pan FGFR Inhibitor PRN1371
    - Pan HER/VEGFR2 Receptor Tyrosine Kinase Inhibitor BMS-690514
    - Pan-AKT Inhibitor ARQ751
    - Pan-AKT Kinase Inhibitor GSK690693
    - Pan-FGFR Inhibitor LY2874455
    - Pan-FLT3/Pan-BTK Multi-kinase Inhibitor CG-806
    - pan-HER Kinase Inhibitor AC480
    - Pan-IDH Mutant Inhibitor AG-881
    - Pan-KRAS Inhibitor BI 1701963
    - Pan-Mutant-IDH1 Inhibitor Bay-1436032
    - Pan-mutation-selective EGFR Inhibitor CLN-081
    - pan-PI3K Inhibitor CLR457
    - pan-PI3K/mTOR Inhibitor SF1126
    - Pan-PIM Inhibitor INCB053914
    - pan-PIM Kinase Inhibitor AZD1208
    - pan-PIM Kinase Inhibitor NVP-LGB-321
    - pan-RAF Inhibitor LXH254
    - Pan-RAF Inhibitor LY3009120
    - pan-RAF Kinase Inhibitor CCT3833
    - pan-RAF Kinase Inhibitor TAK-580
    - Pan-RAR Agonist/AP-1 Inhibitor LGD 1550
    - Pan-TRK Inhibitor NOV1601
    - Pan-TRK Inhibitor ONO-7579
    - Pan-VEGFR/TIE2 Tyrosine Kinase Inhibitor CEP-11981
    - Pancratistatin
    - Panitumumab
    - Panobinostat
    - Panobinostat Nanoparticle Formulation MTX110
    - Panulisib
    - Paricalcitol
    - PARP 1/2 Inhibitor IMP4297
    - PARP 1/2 Inhibitor NOV1401
    - PARP Inhibitor AZD2461
    - PARP Inhibitor CEP-9722
    - PARP Inhibitor E7016
    - PARP Inhibitor NMS-03305293
    - PARP-1/2 Inhibitor ABT-767
    - PARP/Tankyrase Inhibitor 2X-121
    - PARP7 Inhibitor RBN-2397
    - Parsaclisib
    - Parsaclisib Hydrochloride
    - Parsatuzumab
    - Partially Engineered T-regulatory Cell Donor Graft TRGFT-201
    - Parvovirus H-1
    - Pasireotide
    - Pasotuxizumab
    - Patidegib
    - Patidegib Topical Gel
    - Patritumab
    - Patritumab Deruxtecan
    - Patupilone
    - Paxalisib
    - Pazopanib
    - Pazopanib Hydrochloride
    - pbi-shRNA STMN1 Lipoplex
    - PBN Derivative OKN-007
    - PCNU
    - PD-1 Directed Probody CX-188
    - PD-1 Inhibitor
    - PD-L1 Inhibitor GS-4224
    - PD-L1 Inhibitor INCB086550
    - PD-L1/4-1BB/HSA Trispecific Fusion Protein NM21-1480
    - PD-L1/PD-L2/VISTA Antagonist CA-170
    - PDK1 Inhibitor AR-12
    - pDNA-encoding Emm55 Autologous Cancer Cell Vaccine IFx-Hu2.0
    - PE/HPV16 E7/KDEL Fusion Protein/GPI-0100 TVGV-1
    - PEG-interleukin-2
    - PEG-PEI-cholesterol Lipopolymer-encased IL-12 DNA Plasmid Vector GEN-1
    - PEG-Proline-Interferon Alfa-2b
    - Pegargiminase
    - Pegaspargase
    - Pegdinetanib
    - Pegfilgrastim
    - Pegilodecakin
    - Peginterferon Alfa-2a
    - Peginterferon Alfa-2b
    - Pegvisomant
    - Pegvorhyaluronidase Alfa
    - Pegylated Deoxycytidine Analogue DFP-14927
    - Pegylated Interferon Alfa
    - Pegylated Liposomal Belotecan
    - Pegylated Liposomal Doxorubicin Hydrochloride
    - Pegylated Liposomal Irinotecan
    - Pegylated Liposomal Mitomycin C Lipid-based Prodrug
    - Pegylated Liposomal Mitoxantrone Hydrochloride
    - Pegylated Liposomal Nanoparticle-based Docetaxel Prodrug MNK-010
    - Pegylated Paclitaxel
    - Pegylated Recombinant Human Arginase I BCT-100
    - Pegylated Recombinant Human Hyaluronidase PH20
    - Pegylated Recombinant Interleukin-2 THOR-707
    - Pegylated Recombinant L-asparaginase Erwinia chrysanthemi
    - Pegylated SN-38 Conjugate PLX038
    - Pegzilarginase
    - Pelabresib
    - Pelareorep
    - Peldesine
    - Pelitinib
    - Pelitrexol
    - Pembrolizumab
    - Pemetrexed
    - Pemetrexed Disodium
    - Pemigatinib
    - Pemlimogene Merolisbac
    - Penberol
    - Penclomedine
    - Penicillamine
    - Pentamethylmelamine
    - Pentamustine
    - Pentostatin
    - Pentoxifylline
    - PEOX-based Polymer Encapsulated Paclitaxel FID-007
    - PEP-3-KLH Conjugate Vaccine
    - Pepinemab
    - Peplomycin
    - Peplomycin Sulfate
    - Peposertib
    - Peptichemio
    - Peptide 946 Melanoma Vaccine
    - Peptide 946-Tetanus Peptide Conjugate Melanoma Vaccine
    - Peretinoin
    - Perflenapent Emulsion
    - Perfosfamide
    - Perifosine
    - Perillyl Alcohol
    - Personalized ALL-specific Multi-HLA-binding Peptide Vaccine
    - Personalized and Adjusted Neoantigen Peptide Vaccine PANDA-VAC
    - Personalized Cancer Vaccine RO7198457
    - Personalized Neoantigen DNA Vaccine GNOS-PV01
    - Personalized Neoantigen DNA Vaccine GNOS-PVO2
    - Personalized Neoantigen Peptide Vaccine iNeo-Vac-P01
    - Personalized Neoepitope Yeast Vaccine YE-NEO-001
    - Personalized Peptide Cancer Vaccine NEO-PV-01
    - Pertuzumab
    - Pevonedistat
    - Pexastimogene Devacirepvec
    - Pexidartinib
    - Pexmetinib
    - PGG Beta-Glucan
    - PGLA/PEG Copolymer-Based Paclitaxel
    - PH20 Hyaluronidase-expressing Adenovirus VCN-01
    - Phaleria macrocarpa Extract DLBS-1425
    - Pharmacological Ascorbate
    - Phellodendron amurense Bark Extract
    - Phenesterin
    - Phenethyl Isothiocyanate
    - Phenethyl Isothiocyanate-containing Watercress Juice
    - Phenyl Acetate
    - Phenytoin Sodium
    - Phosphaplatin PT-112
    - Phosphatidylcholine-Bound Silybin
    - Phospholipid Ether-drug Conjugate CLR 131
    - Phosphoramide Mustard
    - Phosphorodiamidate Morpholino Oligomer AVI-4126
    - Phosphorus P-32
    - Photodynamic Compound TLD-1433
    - Photosensitizer LUZ 11
    - Phytochlorin Sodium-Polyvinylpyrrolidone Complex
    - PI3K Alpha/Beta Inhibitor BAY1082439
    - PI3K Alpha/mTOR Inhibitor PWT33597 Mesylate
    - PI3K Inhibitor ACP-319
    - PI3K Inhibitor BGT226
    - PI3K Inhibitor GDC-0084
    - PI3K Inhibitor GDC0077
    - PI3K Inhibitor GSK1059615
    - PI3K Inhibitor WX-037
    - PI3K Inhibitor ZSTK474
    - PI3K p110beta/delta Inhibitor KA2237
    - PI3K-alpha Inhibitor MEN1611
    - PI3K-beta Inhibitor GSK2636771
    - PI3K-beta Inhibitor SAR260301
    - PI3K-delta Inhibitor AMG 319
    - PI3K-delta Inhibitor HMPL 689
    - PI3K-delta Inhibitor INCB050465
    - PI3K-delta Inhibitor PWT143
    - PI3K-delta Inhibitor SHC014748M
    - PI3K-delta Inhibitor YY-20394
    - PI3K-gamma Inhibitor IPI-549
    - PI3K/BET Inhibitor LY294002
    - PI3K/mTOR Kinase Inhibitor DS-7423
    - PI3K/mTOR Kinase Inhibitor PF-04691502
    - PI3K/mTOR Kinase Inhibitor VS-5584
    - PI3K/mTOR Kinase Inhibitor WXFL10030390
    - PI3K/mTOR/ALK-1/DNA-PK Inhibitor P7170
    - PI3K/mTORC1/mTORC2 Inhibitor DCBCI0901
    - PI3Ka/mTOR Inhibitor PKI-179
    - PI3Kalpha Inhibitor AZD8835
    - PI3Kbeta Inhibitor AZD8186
    - PI3Kdelta Inhibitor GS-9901
    - Pibenzimol
    - Pibrozelesin
    - Pibrozelesin Hydrobromide
    - Picibanil
    - Picoplatin
    - Picrasinoside H
    - Picropodophyllin
    - Pictilisib
    - Pictilisib Bismesylate
    - Pidilizumab
    - Pilaralisib
    - PIM Kinase Inhibitor LGH447
    - PIM Kinase Inhibitor SGI-1776
    - PIM Kinase Inhibitor TP-3654
    - PIM/FLT3 Kinase Inhibitor SEL24
    - Pimasertib
    - Pimitespib
    - Pimurutamab
    - Pinatuzumab Vedotin
    - Pingyangmycin
    - Pinometostat
    - Pioglitazone
    - Pioglitazone Hydrochloride
    - Pipendoxifene
    - Piperazinedione
    - Piperine Extract (Standardized)
    - Pipobroman
    - Piposulfan
    - Pirarubicin
    - Pirarubicin Hydrochloride
    - Pirfenidone
    - Piritrexim
    - Piritrexim Isethionate
    - Pirotinib
    - Piroxantrone
    - Piroxantrone Hydrochloride
    - Pixantrone
    - Pixantrone Dimaleate
    - Pixatimod
    - PKA Regulatory Subunit RIalpha Mixed-Backbone Antisense Oligonucleotide GEM 231
    - PKC-alpha Antisense Oligodeoxynucleotide ISIS 3521
    - PKC-beta Inhibitor MS-553
    - Placebo
    - Pladienolide Derivative E7107
    - Plamotamab
    - Plasmid DNA Vaccine pING-hHER3FL
    - Platinum
    - Platinum Acetylacetonate-Titanium Dioxide Nanoparticles
    - Platinum Compound
    - Plevitrexed
    - Plicamycin
    - Plinabulin
    - Plitidepsin
    - Plk1 Inhibitor BI 2536
    - PLK1 Inhibitor CYC140
    - PLK1 Inhibitor TAK-960
    - Plocabulin
    - Plozalizumab
    - pNGVL4a-CRT-E6E7L2 DNA Vaccine
    - pNGVL4a-Sig/E7(detox)/HSP70 DNA and HPV16 L2/E6/E7 Fusion Protein TA-CIN Vaccine PVX-2
    - Pol I Inhibitor CX5461
    - Polatuzumab Vedotin
    - Polidocanol
    - Poliglusam
    - Polo-like Kinase 1 Inhibitor GSK461364
    - Polo-like Kinase 1 Inhibitor MK1496
    - Polo-like Kinase 1 Inhibitor NMS-1286937
    - Polo-like Kinase 4 Inhibitor CFI-400945 Fumarate
    - Poly-alendronate Dextran-Guanidine Conjugate
    - Poly-gamma Glutamic Acid
    - Polyamine Analog SL11093
    - Polyamine Analogue PG11047
    - Polyamine Analogue SBP-101
    - Polyamine Transport Inhibitor AMXT-1501 Dicaprate
    - Polyandrol
    - Polyethylene Glycol Recombinant Endostatin
    - Polyethyleneglycol-7-ethyl-10-hydroxycamptothecin DFP-13318
    - Polymer-conjugated IL-15 Receptor Agonist NKTR-255
    - Polymer-encapsulated Luteolin Nanoparticle
    - Polymeric Camptothecin Prodrug XMT-1001
    - Polypodium leucotomos Extract
    - Polysaccharide-K
    - Polysialic Acid
    - Polyunsaturated Fatty Acid
    - Polyvalent Melanoma Vaccine
    - Pomalidomide
    - Pomegranate Juice
    - Pomegranate Liquid Extract
    - Ponatinib
    - Ponatinib Hydrochloride
    - Porcupine Inhibitor CGX1321
    - Porcupine Inhibitor ETC-1922159
    - Porcupine Inhibitor RXC004
    - Porcupine Inhibitor WNT974
    - Porcupine Inhibitor XNW7201
    - Porfimer Sodium
    - Porfiromycin
    - Poziotinib
    - PPAR Alpha Antagonist TPST-1120
    - PR1 Leukemia Peptide Vaccine
    - Pracinostat
    - Pralatrexate
    - Pralsetinib
    - Praluzatamab Ravtansine
    - PRAME-targeting T-cell Receptor/Inducible Caspase 9 BPX-701
    - Pravastatin Sodium
    - Prednimustine
    - Prednisolone
    - Prednisolone Acetate
    - Prednisolone Sodium Phosphate
    - Prednisone
    - Prexasertib
    - Prexigebersen
    - PRIMA-1 Analog APR-246
    - Prime Cancer Vaccine MVA-BN-CV301
    - Prinomastat
    - PRMT1 Inhibitor GSK3368715
    - PRMT5 Inhibitor JNJ-64619178
    - PRMT5 Inhibitor PRT811
    - Proapoptotic Sulindac Analog CP-461
    - Procarbazine
    - Procarbazine Hydrochloride
    - Procaspase Activating Compound-1 VO-100
    - Progestational IUD
    - Prohibitin-Targeting Peptide 1
    - Prolgolimab
    - Prostaglandin E2 EP4 Receptor Inhibitor AN0025
    - Prostaglandin E2 EP4 Receptor Inhibitor E7046
    - Prostate Cancer Vaccine ONY-P1
    - Prostate Health Cocktail Dietary Supplement
    - Prostatic Acid Phosphatase-Sargramostim Fusion Protein PA2024
    - Protease-activated Anti-PD-L1 Antibody Prodrug CX-072
    - Protein Arginine Methyltransferase 5 Inhibitor GSK3326595
    - Protein Arginine Methyltransferase 5 Inhibitor PF-06939999
    - Protein Arginine Methyltransferase 5 Inhibitor PRT543
    - Protein Kinase C Inhibitor IDE196
    - Protein Phosphatase 2A Inhibitor LB-100
    - Protein Stabilized Liposomal Docetaxel Nanoparticles
    - Protein Tyrosine Kinase 2 Inhibitor IN10018
    - Proxalutamide
    - PSA/IL-2/GM-CSF Vaccine
    - PSA/PSMA DNA Plasmid INO-5150
    - Pseudoisocytidine
    - PSMA-targeted Docetaxel Nanoparticles BIND-014
    - PSMA-targeted Tubulysin B-containing Conjugate EC1169
    - PSMA/CD3 Tri-specific T-cell Activating Construct HPN424
    - PTEF-b/CDK9 Inhibitor BAY1251152
    - Pterostilbene
    - Pumitepa
    - Puquitinib
    - Puquitinib Mesylate
    - Puromycin
    - Puromycin Hydrochloride
    - PV-10
    - PVA Microporous Hydrospheres/Doxorubicin Hydrochloride
    - Pyrazinamide
    - Pyrazoloacridine
    - Pyridyl Cyanoguanidine CHS 828
    - Pyrotinib
    - Pyrotinib Dimaleate
    - Pyroxamide
    - Pyruvate Kinase Inhibitor TLN-232
    - Pyruvate Kinase M2 Isoform Activator TP-1454
    - Qilisheng Immunoregulatory Oral Solution
    - Quadrivalent Human Papillomavirus (types 6, 11, 16, 18) Recombinant Vaccine
    - Quarfloxin
    - Quinacrine Hydrochloride
    - Quinine
    - Quisinostat
    - Quizartinib
    - R-(-)-Gossypol Acetic Acid
    - Rabusertib
    - Racemetyrosine/Methoxsalen/Phenytoin/Sirolimus SM-88
    - Racotumomab
    - RAD51 Inhibitor CYT-0851
    - Radgocitabine
    - Radgocitabine Hydrochloride
    - Radioactive Iodine
    - Radiolabeled CC49
    - Radium Ra 223 Dichloride
    - Radium Ra 224-labeled Calcium Carbonate Microparticles
    - Radix Angelicae Sinensis/Radix Astragali Herbal Supplement
    - Radotinib Hydrochloride
    - Raf Kinase Inhibitor HM95573
    - RAF Kinase Inhibitor L-779450
    - RAF Kinase Inhibitor XL281
    - Ragifilimab
    - Ralaniten Acetate
    - Ralimetinib Mesylate
    - Raloxifene
    - Raloxifene Hydrochloride
    - Raltitrexed
    - Ramucirumab
    - Ranibizumab
    - Ranimustine
    - Ranolazine
    - Ranpirnase
    - RARalpha Agonist IRX5183
    - Ras Inhibitor
    - Ras Peptide ASP
    - Ras Peptide CYS
    - Ras Peptide VAL
    - Razoxane
    - Realgar-Indigo naturalis Formulation
    - Rebastinib Tosylate
    - Rebeccamycin
    - Rebimastat
    - Receptor Tyrosine Kinase Inhibitor R1530
    - Recombinant Adenovirus-p53 SCH-58500
    - Recombinant Anti-WT1 Immunotherapeutic GSK2302024A
    - Recombinant Bacterial Minicells VAX014
    - Recombinant Bispecific Single-Chain Antibody rM28
    - Recombinant CD40-Ligand
    - Recombinant Erwinia asparaginase JZP-458
    - Recombinant Erythropoietin
    - Recombinant Fas Ligand
    - Recombinant Fractalkine
    - Recombinant Granulocyte-Macrophage Colony-Stimulating Factor
    - Recombinant Human 6Ckine
    - Recombinant Human Adenovirus Type 5 H101
    - Recombinant Human Angiotensin Converting Enzyme 2 APN01
    - Recombinant Human Apolipoprotein(a) Kringle V MG1102
    - Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine
    - Recombinant Human Endostatin
    - Recombinant Human Hsp110-gp100 Chaperone Complex Vaccine
    - Recombinant Human Papillomavirus 11-valent Vaccine
    - Recombinant Human Papillomavirus Bivalent Vaccine
    - Recombinant Human Papillomavirus Nonavalent Vaccine
    - Recombinant Human Plasminogen Kringle 5 Domain ABT 828
    - Recombinant Human TRAIL-Trimer Fusion Protein SCB-313
    - Recombinant Humanized Anti-HER-2 Bispecific Monoclonal Antibody MBS301
    - Recombinant Interferon
    - Recombinant Interferon Alfa
    - Recombinant Interferon Alfa-1b
    - Recombinant Interferon Alfa-2a
    - Recombinant Interferon Alfa-2b
    - Recombinant Interferon Alpha 2b-like Protein
    - Recombinant Interferon Beta
    - Recombinant Interferon Gamma
    - Recombinant Interleukin-12
    - Recombinant Interleukin-13
    - Recombinant Interleukin-18
    - Recombinant Interleukin-2
    - Recombinant Interleukin-6
    - Recombinant KSA Glycoprotein CO17-1A
    - Recombinant Leukocyte Interleukin
    - Recombinant Leukoregulin
    - Recombinant Luteinizing Hormone
    - Recombinant Macrophage Colony-Stimulating Factor
    - Recombinant MAGE-3.1 Antigen
    - Recombinant MIP1-alpha Variant ECI301
    - Recombinant Modified Vaccinia Ankara-5T4 Vaccine
    - Recombinant Oncolytic Poliovirus PVS-RIPO
    - Recombinant Platelet Factor 4
    - Recombinant PRAME Protein Plus AS15 Adjuvant GSK2302025A
    - Recombinant Saccharomyces Cerevisia-CEA(610D)-Expressing Vaccine GI-6207
    - Recombinant Super-compound Interferon
    - Recombinant Thyroglobulin
    - Recombinant Thyrotropin Alfa
    - Recombinant Transforming Growth Factor-Beta
    - Recombinant Transforming Growth Factor-Beta-2
    - Recombinant Tumor Necrosis Factor-Alpha
    - Recombinant Tyrosinase-Related Protein-2
    - Recombinant Vesicular Stomatitis Virus-expressing Human Interferon Beta and Sodium-Iodide Symporter
    - Redaporfin
    - Refametinib
    - Regorafenib
    - Relacorilant
    - Relatlimab
    - Relugolix
    - Remetinostat
    - Renal Cell Carcinoma Peptides Vaccine IMA901
    - Reparixin
    - Repotrectinib
    - Resiquimod
    - Resiquimod Topical Gel
    - Resistant Starch
    - Resminostat
    - Resveratrol
    - Resveratrol Formulation SRT501
    - RET Inhibitor DS-5010
    - RET Mutation/Fusion Inhibitor BLU-667
    - RET/SRC Inhibitor TPX-0046
    - Retaspimycin
    - Retaspimycin Hydrochloride
    - Retelliptine
    - Retifanlimab
    - Retinoic Acid Agent Ro 16-9100
    - Retinoid 9cUAB30
    - Retinol
    - Retinyl Acetate
    - Retinyl Palmitate
    - Retrovector Encoding Mutant Anti-Cyclin G1
    - Revdofilimab
    - Rexinoid NRX 194204
    - Rezivertinib
    - RFT5-dgA Immunotoxin IMTOX25
    - Rhenium Re 188 BMEDA-labeled Liposomes
    - Rhenium Re-186 Hydroxyethylidene Diphosphonate
    - Rhenium Re-188 Ethiodized Oil
    - Rhenium Re-188 Etidronate
    - Rhizoxin
    - RhoC Peptide Vaccine RV001V
    - Ribociclib
    - Ribociclib/Letrozole
    - Ribonuclease QBI-139
    - Ribosome-Inactivating Protein CY503
    - Ribozyme RPI.4610
    - Rice Bran
    - Ricolinostat
    - Ridaforolimus
    - Rigosertib
    - Rigosertib Sodium
    - Rilimogene Galvacirepvec
    - Rilimogene Galvacirepvec/Rilimogene Glafolivec
    - Rilimogene Glafolivec
    - Rilotumumab
    - Rindopepimut
    - Ripertamab
    - RIPK1 Inhibitor GSK3145095
    - Ripretinib
    - Risperidone Formulation in Rumenic Acid
    - Ritrosulfan
    - Rituximab
    - Rituximab and Hyaluronidase Human
    - Rituximab Conjugate CON-4619
    - Riviciclib
    - Rivoceranib
    - Rivoceranib Mesylate
    - RNR Inhibitor COH29
    - Robatumumab
    - Roblitinib
    - ROBO1-targeted BiCAR-NKT Cells
    - Rocakinogene Sifuplasmid
    - Rocapuldencel-T
    - Rociletinib
    - Rodorubicin
    - Roducitabine
    - Rofecoxib
    - Roflumilast
    - Rogaratinib
    - Rogletimide
    - Rolinsatamab Talirine
    - Romidepsin
    - Roneparstat
    - Roniciclib
    - Ropeginterferon Alfa-2B
    - Ropidoxuridine
    - Ropocamptide
    - Roquinimex
    - RORgamma Agonist LYC-55716
    - Rosabulin
    - Rose Bengal Solution PV-10
    - Rosiglitazone Maleate
    - Rosmantuzumab
    - Rosopatamab
    - Rosuvastatin
    - Rovalpituzumab Tesirine
    - RSK1-4 Inhibitor PMD-026
    - Rubitecan
    - Rucaparib
    - Rucaparib Camsylate
    - Rucaparib Phosphate
    - Ruthenium Ru-106
    - Ruthenium-based Small Molecule Therapeutic BOLD-100
    - Ruthenium-based Transferrin Targeting Agent NKP-1339
    - Ruxolitinib
    - Ruxolitinib Phosphate
    - Ruxotemitide
    - S-Adenosylmethionine
    - S-equol
    - S1P Receptor Agonist KRP203
    - Sabarubicin
    - Sabatolimab
    - Sacituzumab Govitecan
    - Sacubitril/Valsartan
    - Safingol
    - Sagopilone
    - Salirasib
    - Salmonella VNP20009
    - Sam68 Modulator CWP232291
    - Samalizumab
    - Samarium Sm 153-DOTMP
    - Samotolisib
    - Samrotamab Vedotin
    - Samuraciclib
    - Sapacitabine
    - Sapanisertib
    - Sapitinib
    - Saracatinib
    - Saracatinib Difumarate
    - SarCNU
    - Sardomozide
    - Sargramostim
    - Sasanlimab
    - Satraplatin
    - Savolitinib
    - SBIL-2
    - Scopoletin
    - SDF-1 Receptor Antagonist PTX-9908
    - Seclidemstat
    - Sedoxantrone Trihydrochloride
    - Selatinib Ditosilate
    - Selective Androgen Receptor Modulator RAD140
    - Selective Cytokine Inhibitory Drug CC-1088
    - Selective Estrogen Receptor Degrader AZD9496
    - Selective Estrogen Receptor Degrader AZD9833
    - Selective Estrogen Receptor Degrader LSZ102
    - Selective Estrogen Receptor Degrader LX-039
    - Selective Estrogen Receptor Degrader LY3484356
    - Selective Estrogen Receptor Degrader SRN-927
    - Selective Estrogen Receptor Modulator CC-8490
    - Selective Estrogen Receptor Modulator TAS-108
    - Selective Glucocorticoid Receptor Antagonist CORT125281
    - Selective Human Estrogen-receptor Alpha Partial Agonist TTC-352
    - Seliciclib
    - Selicrelumab
    - Selinexor
    - Selitrectinib
    - Selonsertib
    - Selpercatinib
    - Selumetinib
    - Selumetinib Sulfate
    - Semaxanib
    - Semuloparin
    - Semustine
    - Seneca Valley Virus-001
    - Seocalcitol
    - Sepantronium Bromide
    - Serabelisib
    - Serclutamab Talirine
    - SERD D-0502
    - SERD G1T48
    - SERD GDC-9545
    - SERD SAR439859
    - SERD SHR9549
    - SERD ZN-c5
    - Serdemetan
    - Sergiolide
    - Seribantumab
    - Serine/Threonine Kinase Inhibitor CBP501
    - Serine/Threonine Kinase Inhibitor XL418
    - Serplulimab
    - Sevacizumab
    - Seviteronel
    - Shared Anti-Idiotype-AB-S006
    - Shared Anti-Idiotype-AB-S024A
    - Shark Cartilage
    - Shark Cartilage Extract AE-941
    - Shenqi Fuzheng Injection SQ001
    - Sho-Saiko-To
    - Short Chain Fatty Acid HQK-1004
    - SHP-1 Agonist SC-43
    - SHP2 Inhibitor JAB-3068
    - SHP2 Inhibitor RLY-1971
    - SHP2 Inhibitor RMC-4630
    - SHP2 Inhibitor TNO155
    - Shu Yu Wan Formula
    - Sialyl Tn Antigen
    - Sialyl Tn-KLH Vaccine
    - Sibrotuzumab
    - siG12D LODER
    - Silatecan AR-67
    - Silibinin
    - Silicon Phthalocyanine 4
    - Silmitasertib Sodium
    - Siltuximab
    - Simalikalactone D
    - Simeprevir
    - Simlukafusp Alfa
    - Simmitinib
    - Simotaxel
    - Simtuzumab
    - Simurosertib
    - Sintilimab
    - Siplizumab
    - Sipuleucel-T
    - Siremadlin
    - siRNA-transfected Peripheral Blood Mononuclear Cells APN401
    - Sirolimus
    - SIRPa-4-1BBL Fusion Protein DSP107
    - SIRPa-Fc Fusion Protein TTI-621
    - SIRPa-Fc-CD40L Fusion Protein SL-172154
    - SIRPa-IgG4-Fc Fusion Protein TTI-622
    - Sitimagene Ceradenovec
    - Sitravatinib
    - Sivifene
    - Sizofiran
    - SLC6A8 Inhibitor RGX-202
    - SLCT Inhibitor GNS561
    - SMAC Mimetic BI 891065
    - Smac Mimetic GDC-0152
    - Smac Mimetic GDC-0917
    - Smac Mimetic LCL161
    - SMO Protein Inhibitor ZSP1602
    - Smoothened Antagonist BMS-833923
    - Smoothened Antagonist LDE225 Topical
    - Smoothened Antagonist LEQ506
    - Smoothened Antagonist TAK-441
    - SN-38-Loaded Polymeric Micelles NK012
    - SNS01-T Nanoparticles
    - Sobuzoxane
    - Sodium Borocaptate
    - Sodium Butyrate
    - Sodium Dichloroacetate
    - Sodium Iodide I-131
    - Sodium Metaarsenite
    - Sodium Phenylbutyrate
    - Sodium Salicylate
    - Sodium Selenite
    - Sodium Stibogluconate
    - Sodium-Potassium Adenosine Triphosphatase Inhibitor RX108
    - Sofituzumab Vedotin
    - Solitomab
    - Sonepcizumab
    - Sonidegib
    - Sonolisib
    - Sorafenib
    - Sorafenib Tosylate
    - Sorghum bicolor Supplement
    - Sotigalimab
    - Sotorasib
    - Sotrastaurin
    - Sotrastaurin Acetate
    - Soy Isoflavones
    - Soy Protein Isolate
    - Spanlecortemlocel
    - Sparfosate Sodium
    - Sparfosic Acid
    - Spartalizumab
    - Spebrutinib
    - Spherical Nucleic Acid Nanoparticle NU-0129
    - Spirogermanium
    - Spiromustine
    - Spiroplatin
    - Splicing Inhibitor H3B-8800
    - Spongistatin
    - Squalamine Lactate
    - SR-BP1/HSI Inhibitor SR31747A
    - SR-T100 Gel
    - Src Kinase Inhibitor AP 23846
    - Src Kinase Inhibitor KX2-391
    - Src Kinase Inhibitor KX2-391 Ointment
    - Src Kinase Inhibitor M475271
    - Src/Abl Kinase Inhibitor AZD0424
    - Src/tubulin Inhibitor KX02
    - SRPK1/ABCG2 Inhibitor SCO-101
    - ssRNA-based Immunomodulator CV8102
    - SSTR2-targeting Protein/DM1 Conjugate PEN-221
    - St. John's Wort
    - Stallimycin
    - Staphylococcal Enterotoxin A
    - Staphylococcal Enterotoxin B
    - STAT Inhibitor OPB-111077
    - STAT3 Inhibitor DSP-0337
    - STAT3 Inhibitor OPB-31121
    - STAT3 Inhibitor OPB-51602
    - STAT3 Inhibitor TTI-101
    - STAT3 Inhibitor WP1066
    - Staurosporine
    - STING Agonist BMS-986301
    - STING Agonist GSK3745417
    - STING Agonist IMSA101
    - STING Agonist MK-1454
    - STING Agonist SB 11285
    - STING Agonist TAK-676
    - STING-activating Cyclic Dinucleotide Agonist MIW815
    - STING-expressing E. coli SYNB1891
    - Streptonigrin
    - Streptozocin
    - Strontium Chloride Sr-89
    - Submicron Particle Paclitaxel Sterile Suspension
    - Sugemalimab
    - Sulfatinib
    - Sulforaphane
    - Sulindac
    - Sulofenur
    - Sumoylation Inhibitor TAK-981
    - Sunitinib
    - Sunitinib Malate
    - Super Enhancer Inhibitor GZ17-6.02
    - Superagonist Interleukin-15:Interleukin-15 Receptor alphaSu/Fc Fusion Complex ALT-803
    - Superoxide Dismutase Mimetic GC4711
    - Suramin
    - Suramin Sodium
    - Survivin Antigen
    - Survivin Antigen Vaccine DPX-Survivac
    - Survivin mRNA Antagonist EZN-3042
    - Survivin-expressing CVD908ssb-TXSVN Vaccine
    - Sustained-release Lipid Inhaled Cisplatin
    - Sustained-release Mitomycin C Hydrogel Formulation UGN-101
    - Sustained-release Mitomycin C Hydrogel Formulation UGN-102
    - Syk Inhibitor HMPL-523
    - Synchrotope TA2M Plasmid DNA Vaccine
    - Synchrovax SEM Plasmid DNA Vaccine
    - Synthetic Alkaloid PM00104
    - Synthetic Glioblastoma Mutated Tumor-specific Peptides Vaccine Therapy APVAC2
    - Synthetic Glioblastoma Tumor-associated Peptides Vaccine Therapy APVAC1
    - Synthetic hTERT DNA Vaccine INO-1400
    - Synthetic hTERT DNA Vaccine INO-1401
    - Synthetic Hypericin
    - Synthetic Long E6 Peptide-Toll-like Receptor Ligand Conjugate Vaccine ISA201
    - Synthetic Long E6/E7 Peptides Vaccine HPV-01
    - Synthetic Long HPV16 E6/E7 Peptides Vaccine ISA101b
    - Synthetic Plumbagin PCUR-101
    - T900607
    - Tabalumab
    - Tabelecleucel
    - Tacedinaline
    - Tafasitamab
    - Tagraxofusp-erzs
    - Talabostat
    - Talabostat Mesylate
    - Talacotuzumab
    - Talactoferrin Alfa
    - Taladegib
    - Talampanel
    - Talaporfin Sodium
    - Talazoparib
    - Taletrectinib
    - Talimogene Laherparepvec
    - Tallimustine
    - Talmapimod
    - Talotrexin
    - Talotrexin Ammonium
    - Taltobulin
    - TAM/c-Met Inhibitor RXDX-106
    - Tamibarotene
    - Taminadenant
    - Tamoxifen
    - Tamoxifen Citrate
    - Tamrintamab Pamozirine
    - Tandutinib
    - Tanespimycin
    - Tanibirumab
    - Tankyrase Inhibitor STP1002
    - Tanomastat
    - Tapotoclax
    - Tarenflurbil
    - Tarextumab
    - Tariquidar
    - Tasadenoturev
    - Taselisib
    - Tasidotin
    - Tasisulam
    - Tasisulam Sodium
    - Tasquinimod
    - Taurolidine
    - Tauromustine
    - Taurultam
    - Taurultam Analogue GP-2250
    - Tavokinogene Telseplasmid
    - Tavolimab
    - Taxane Analogue TPI 287
    - Taxane Compound
    - Taxol Analogue SID 530
    - Tazarotene
    - Tazemetostat
    - Tebentafusp
    - Teclistamab
    - Tecogalan Sodium
    - Tefinostat
    - Tegafur
    - Tegafur-gimeracil-oteracil Potassium
    - Tegafur-Gimeracil-Oteracil Potassium-Leucovorin Calcium Oral Formulation
    - Tegafur-Uracil
    - Tegavivint
    - Teglarinad
    - Teglarinad Chloride
    - Telaglenastat
    - Telaglenastat Hydrochloride
    - Telapristone
    - Telapristone Acetate
    - Telatinib Mesylate
    - Telisotuzumab
    - Telisotuzumab Vedotin
    - Telomerase Inhibitor FJ5002
    - Telomerase-specific Type 5 Adenovirus OBP-301
    - Teloxantrone
    - Teloxantrone Hydrochloride
    - Telratolimod
    - Temarotene
    - Temoporfin
    - Temozolomide
    - Temsirolimus
    - Tenalisib
    - Tenifatecan
    - Teniposide
    - Tepoditamab
    - Tepotinib
    - Teprotumumab
    - Terameprocol
    - Terfluranol
    - Tergenpumatucel-L
    - Teroxirone
    - Tertomotide
    - Tesetaxel
    - Tesevatinib
    - Tesidolumab
    - Testolactone
    - Testosterone Enanthate
    - Tetanus Toxoid Vaccine
    - Tetradecanoylphorbol Acetate
    - Tetrahydrouridine
    - Tetraphenyl Chlorin Disulfonate
    - Tetrathiomolybdate
    - Tezacitabine
    - Tezacitabine Anhydrous
    - TGF-beta Receptor 1 Inhibitor PF-06952229
    - TGF-beta Receptor 1 Kinase Inhibitor SH3051
    - TGF-beta Receptor 1 Kinase Inhibitor YL-13027
    - TGFa-PE38 Immunotoxin
    - TGFbeta Inhibitor LY3200882
    - TGFbeta Receptor Ectodomain-IgG Fc Fusion Protein AVID200
    - Thalicarpine
    - Thalidomide
    - Theliatinib
    - Theramide
    - Therapeutic Angiotensin-(1-7)
    - Therapeutic Breast/Ovarian/Prostate Peptide Cancer Vaccine DPX-0907
    - Therapeutic Cancer Vaccine ATP128
    - Therapeutic Estradiol
    - Therapeutic Hydrocortisone
    - Therapeutic Liver Cancer Peptide Vaccine IMA970A
    - Thiarabine
    - Thiodiglycol
    - Thioguanine
    - Thioguanine Anhydrous
    - Thioinosine
    - Thioredoxin-1 Inhibitor PX-12
    - Thiotepa
    - Thioureidobutyronitrile
    - THL-P
    - Thorium Th 227 Anetumab
    - Thorium Th 227 Anetumab Corixetan
    - Thorium Th 227 Anti-HER2 Monoclonal Antibody BAY2701439
    - Thorium Th 227 Anti-PSMA Monoclonal Antibody BAY 2315497
    - Threonine Tyrosine Kinase Inhibitor CFI-402257
    - Thymidylate Synthase Inhibitor CX1106
    - Thymidylate Synthase Inhibitor DFP-11207
    - Thymopentin
    - Thyroid Extract
    - Tiazofurin
    - Tidutamab
    - Tigapotide
    - Tigatuzumab
    - TIGIT Inhibitor M6223
    - TIGIT-targeting Agent MK-7684
    - Tilarginine
    - Tilogotamab
    - Tilsotolimod Sodium
    - Timonacic
    - Tin Ethyl Etiopurpurin
    - Tinostamustine
    - Tinzaparin Sodium
    - Tiomolibdate Choline
    - Tiomolibdate Diammonium
    - Tipapkinogene Sovacivec
    - Tipifarnib
    - Tipiracil
    - Tipiracil Hydrochloride
    - Tirabrutinib
    - Tiragolumab
    - Tirapazamine
    - Tirbanibulin
    - Tisagenlecleucel
    - Tislelizumab
    - Tisotumab Vedotin
    - Tivantinib
    - Tivozanib
    - TLC ELL-12
    - TLR Agonist BDB001
    - TLR Agonist BSG-001
    - TLR Agonist CADI-05
    - TLR-Directed Cationic Lipid-DNA Complex JVRS-100
    - TLR7 Agonist 852A
    - TLR7 agonist BNT411
    - TLR7 Agonist LHC165
    - TLR7/8/9 Antagonist IMO-8400
    - TLR8 Agonist DN1508052
    - TLR9 Agonist AST-008
    - TM4SF1-CAR/EpCAM-CAR-expressing Autologous T Cells
    - Tocilizumab
    - Tocladesine
    - Tocotrienol
    - Tocotrienol-rich Fraction
    - Tolebrutinib
    - Toll-like Receptor 7 Agonist DSP-0509
    - Tolnidamine
    - Tomaralimab
    - Tomato-Soy Juice
    - Tomivosertib
    - Topical Betulinic Acid
    - Topical Celecoxib
    - Topical Fluorouracil
    - Topical Gemcitabine Hydrochloride
    - Topical Potassium Dobesilate
    - Topical Trichloroacetic Acid
    - Topixantrone
    - Topoisomerase I Inhibitor Genz-644282
    - Topoisomerase I Inhibitor LMP400
    - Topoisomerase I Inhibitor LMP776
    - Topoisomerase I/II Inhibitor NEV-801
    - Topoisomerase-1 Inhibitor LMP744
    - Topoisomerase-II Inhibitor Racemic XK469
    - Topoisomerase-II-beta Inhibitor Racemic XK469
    - Topotecan
    - Topotecan Hydrochloride
    - Topotecan Hydrochloride Liposomes
    - Topotecan Sustained-release Episcleral Plaque
    - Topsalysin
    - TORC1/2 Kinase Inhibitor DS-3078a
    - Toremifene
    - Toremifene Citrate
    - Toripalimab
    - Tosedostat
    - Tositumomab
    - Total Androgen Blockade
    - Tovetumab
    - Tozasertib Lactate
    - TP40 Immunotoxin
    - Trabectedin
    - Trabedersen
    - TRAIL Receptor Agonist ABBV-621
    - Trametinib
    - Trametinib Dimethyl Sulfoxide
    - Trans Sodium Crocetinate
    - Transdermal 17beta-Estradiol Gel BHR-200
    - Transdermal 4-Hydroxytestosterone
    - Transferrin Receptor-Targeted Anti-RRM2 siRNA CALAA-01
    - Transferrin Receptor-Targeted Liposomal p53 cDNA
    - Transferrin-CRM107
    - Tranylcypromine Sulfate
    - Trapoxin
    - Trastuzumab
    - Trastuzumab Conjugate BI-CON-02
    - Trastuzumab Deruxtecan
    - Trastuzumab Duocarmazine
    - Trastuzumab Emtansine
    - Trastuzumab Monomethyl Auristatin F
    - Trastuzumab-TLR 7/8 Agonist BDC-1001
    - Trastuzumab/Hyaluronidase-oysk
    - Trastuzumab/Tesirine Antibody-drug Conjugate ADCT-502
    - Trebananib
    - Tremelimumab
    - Treosulfan
    - Tretazicar
    - Tretinoin
    - Tretinoin Liposome
    - Triamcinolone Acetonide
    - Triamcinolone Hexacetonide
    - Triapine
    - Triazene Derivative CB10-277
    - Triazene Derivative TriN2755
    - Triazinate
    - Triaziquone
    - Tributyrin
    - Triciribine Phosphate
    - Trientine Hydrochloride
    - Triethylenemelamine
    - Trifluridine
    - Trifluridine and Tipiracil Hydrochloride
    - Trigriluzole
    - Trilaciclib
    - Trimelamol
    - Trimeric GITRL-Fc OMP-336B11
    - Trimethylcolchicinic Acid
    - Trimetrexate
    - Trimetrexate Glucuronate
    - Trioxifene
    - Triplatin Tetranitrate
    - Triptolide Analog
    - Triptorelin
    - Triptorelin Pamoate
    - Tris-acryl Gelatin Microspheres
    - Tritylcysteine
    - TRK Inhibitor AZD6918
    - TRK Inhibitor TQB3558
    - TrkA Inhibitor VMD-928
    - Trodusquemine
    - Trofosfamide
    - Troglitazone
    - Tropomyosin Receptor Kinase Inhibitor AZD7451
    - Troriluzole
    - Troxacitabine
    - Troxacitabine Nucleotide Prodrug MIV-818
    - TRPM8 Agonist D-3263
    - TRPV6 Calcium Channel Inhibitor SOR-C13
    - TSP-1 Mimetic ABT-510
    - TSP-1 Mimetic Fusion Protein CVX-045
    - Tubercidin
    - Tubulin Binding Agent TTI-237
    - Tubulin Inhibitor ALB 109564 Dihydrochloride
    - Tubulin Inhibitor ALB-109564
    - Tubulin Polymerization Inhibitor AEZS 112
    - Tubulin Polymerization Inhibitor CKD-516
    - Tubulin Polymerization Inhibitor VERU-111
    - Tubulin-Binding Agent SSR97225
    - Tucatinib
    - Tucidinostat
    - Tucotuzumab Celmoleukin
    - Tyroserleutide
    - Tyrosinase Peptide
    - Tyrosinase-KLH
    - Tyrosinase:146-156 Peptide
    - Tyrosine Kinase Inhibitor
    - Tyrosine Kinase Inhibitor OSI-930
    - Tyrosine Kinase Inhibitor SU5402
    - Tyrosine Kinase Inhibitor TL-895
    - Tyrosine Kinase Inhibitor XL228
    - UAE Inhibitor TAK-243
    - Ubenimex
    - Ubidecarenone Nanodispersion BPM31510n
    - Ublituximab
    - Ulinastatin
    - Ulixertinib
    - Ulocuplumab
    - Umbralisib
    - Uncaria tomentosa Extract
    - Upamostat
    - Upifitamab
    - Uproleselan
    - Uprosertib
    - Urabrelimab
    - Uracil Ointment
    - Urelumab
    - Uroacitides
    - Urokinase-Derived Peptide A6
    - Ursolic Acid
    - USP14/UCHL5 Inhibitor VLX1570
    - Utomilumab
    - Uzansertib
    - V930 Vaccine
    - Vaccine-Sensitized Draining Lymph Node Cells
    - Vaccinium myrtillus/Macleaya cordata/Echinacea angustifolia Extract Granules
    - Vactosertib
    - Vadacabtagene Leraleucel
    - Vadastuximab Talirine
    - Vadimezan
    - Valecobulin
    - Valemetostat
    - Valproic Acid
    - Valrubicin
    - Valspodar
    - Vandetanib
    - Vandetanib-eluting Radiopaque Bead BTG-002814
    - Vandortuzumab Vedotin
    - Vantictumab
    - Vanucizumab
    - Vapreotide
    - Varlilumab
    - Varlitinib
    - Varlitinib Tosylate
    - Vascular Disrupting Agent BNC105
    - Vascular Disrupting Agent BNC105P
    - Vascular Disrupting Agent ZD6126
    - Vatalanib
    - Vatalanib Succinate
    - Vecabrutinib
    - Vector-peptide Conjugated Paclitaxel
    - Vedolizumab
    - VEGF Inhibitor PTC299
    - VEGF/HGF-targeting DARPin MP0250
    - VEGFR Inhibitor KRN951
    - VEGFR-2 DNA Vaccine VXM01
    - VEGFR/FGFR Inhibitor ODM-203
    - VEGFR/PDGFR Tyrosine Kinase Inhibitor TAK-593
    - VEGFR2 Tyrosine Kinase Inhibitor PF-00337210
    - VEGFR2/PDGFR/c-Kit/Flt-3 Inhibitor SU014813
    - Veliparib
    - Veltuzumab
    - Vemurafenib
    - Venetoclax
    - Verapamil
    - Verpasep Caltespen
    - Verubulin
    - Verubulin Hydrochloride
    - Vesencumab
    - Vesigenurtucel-L
    - VGEF Mixed-Backbone Antisense Oligonucleotide GEM 220
    - VGEFR/c-kit/PDGFR Tyrosine Kinase Inhibitor XL820
    - Viagenpumatucel-L
    - Vibecotamab
    - Vibostolimab
    - Vilaprisan
    - Vinblastine
    - Vinblastine Sulfate
    - Vincristine
    - Vincristine Liposomal
    - Vincristine Sulfate
    - Vincristine Sulfate Liposome
    - Vindesine
    - Vinepidine
    - Vinflunine
    - Vinflunine Ditartrate
    - Vinfosiltine
    - Vinorelbine
    - Vinorelbine Tartrate
    - Vinorelbine Tartrate Emulsion
    - Vinorelbine Tartrate Oral
    - Vintafolide
    - Vinzolidine
    - Vinzolidine Sulfate
    - Virulizin
    - Vismodegib
    - Vistusertib
    - Vitamin D3 Analogue ILX23-7553
    - Vitamin E Compound
    - Vitespen
    - VLP-encapsulated TLR9 Agonist CMP-001
    - Vocimagene Amiretrorepvec
    - Vofatamab
    - Volasertib
    - Volociximab
    - Vonlerolizumab
    - Vopratelimab
    - Vorasidenib
    - Vorinostat
    - Vorolanib
    - Vorsetzumab Mafodotin
    - Vosaroxin
    - Vosilasarm
    - Voxtalisib
    - Vulinacimab
    - Warfarin Sodium
    - Wee1 Inhibitor ZN-c3
    - Wee1 Kinase Inhibitor Debio 0123
    - White Carrot
    - Wnt Signaling Inhibitor SM04755
    - Wnt Signaling Pathway Inhibitor SM08502
    - Wnt-5a Mimic Hexapeptide Foxy-5
    - Wobe-Mugos E
    - WT1 Peptide Vaccine OCV-501
    - WT1 Peptide Vaccine WT2725
    - WT1 Protein-derived Peptide Vaccine DSP-7888
    - WT1-A10/AS01B Immunotherapeutic GSK2130579A
    - WT1/PSMA/hTERT-encoding Plasmid DNA INO-5401
    - Xanthohumol
    - XBP1-US/XBP1-SP/CD138/CS1 Multipeptide Vaccine PVX-410
    - Xeloda
    - Xentuzumab
    - Xevinapant
    - Xiaoai Jiedu Decoction
    - XIAP Antisense Oligonucleotide AEG35156
    - XIAP/cIAP1 Antagonist ASTX660
    - Xiliertinib
    - Xisomab 3G3
    - XPO1 Inhibitor SL-801
    - Y 90 Monoclonal Antibody CC49
    - Y 90 Monoclonal Antibody HMFG1
    - Y 90 Monoclonal Antibody Lym-1
    - Y 90 Monoclonal Antibody m170
    - Y 90 Monoclonal Antibody M195
    - Yang Yin Fu Zheng
    - Yangzheng Xiaoji Extract
    - Yiqi-yangyin-jiedu Herbal Decoction
    - Yttrium Y 90 Anti-CD19 Monoclonal Antibody BU12
    - Yttrium Y 90 Anti-CD45 Monoclonal Antibody AHN-12
    - Yttrium Y 90 Anti-CD45 Monoclonal Antibody BC8
    - Yttrium Y 90 Anti-CDH3 Monoclonal Antibody FF-21101
    - Yttrium Y 90 Anti-CEA Monoclonal Antibody cT84.66
    - Yttrium Y 90 Basiliximab
    - Yttrium Y 90 Colloid
    - Yttrium Y 90 Daclizumab
    - Yttrium Y 90 DOTA Anti-CEA Monoclonal Antibody M5A
    - Yttrium Y 90 Glass Microspheres
    - Yttrium Y 90 Monoclonal Antibody B3
    - Yttrium Y 90 Monoclonal Antibody BrE-3
    - Yttrium Y 90 Monoclonal Antibody Hu3S193
    - Yttrium Y 90 Monoclonal Antibody MN-14
    - Yttrium Y 90 Resin Microspheres
    - Yttrium Y 90 Tabituximab Barzuxetan
    - Yttrium Y 90-DOTA-Biotin
    - Yttrium Y 90-DOTA-di-HSG Peptide IMP-288
    - Yttrium Y 90-Edotreotide
    - Yttrium Y 90-labeled Anti-FZD10 Monoclonal Antibody OTSA101
    - Yttrium Y-90 Clivatuzumab Tetraxetan
    - Yttrium Y-90 Epratuzumab Tetraxetan
    - Yttrium Y-90 Ibritumomab Tiuxetan
    - Yttrium Y-90 Tacatuzumab Tetraxetan
    - Yttrium-90 Polycarbonate Brachytherapy Plaque
    - Z-Endoxifen Hydrochloride
    - Zalcitabine
    - Zalifrelimab
    - Zalutumumab
    - Zandelisib
    - Zanidatamab
    - Zanolimumab
    - Zanubrutinib
    - Zebularine
    - Zelavespib
    - Zibotentan
    - Zinc Finger Nuclease ZFN-603
    - Zinc Finger Nuclease ZFN-758
    - Zinostatin
    - Zinostatin Stimalamer
    - Zirconium Zr 89 Panitumumab
    - Ziv-Aflibercept
    - Zolbetuximab
    - Zoledronic Acid
    - Zoptarelin Doxorubicin
    - Zorifertinib
    - Zorubicin
    - Zorubicin Hydrochloride
    - Zotatifin
    - Zotiraciclib Citrate
    - Zuclomiphene Citrate
    - Unknown
    - Not Reported
    Term:
    - Origin: caDSR
      Original Source: CDS
      Code: '13579886'
      Value: Therapeutic Procedure Agent Name
      Version: '1.00'
  # genomic_info
  reporter_label:
    Desc: The text term used to describe the labeled methyl group used as a molecular tag.
    Type: string
  methylation_platform:
    Desc: The equipment used to detect the presence and/or location of methyl groups during DNA or protein analysis.
    Type: string
  genomic_info_id:
    Desc: Genomic info identifier, the ID property for the ndoe genomic_info.
    Type: string
    Req: true
    Key: true
  reference_genome_assembly:
    Desc: Accession or name of genome reference or assembly used for alignment
    Enum:
    - GRCh37
    - GRCh37-lite
    - GRCh38
    - Not specified in data
    Req: Preferred
    Term:
    - Origin: caDSR
      Code: '11529031'
      Value: Genome Assembly NCBI Genetic Reference Sequence Identifier
      Version: '1.00'
  avg_read_length:
    Desc: Average sequence read length
    Type: number
    Req: Preferred
    Term:
    - Origin: caDSR
      Code: '12426615'
      Value: Nucleotide Sequence Average Read Length Count
      Version: '1.00'
  coverage:
    Desc: Average depth of coverage on reference used
    Type: number
    Req: Preferred
    Term:
    - Origin: caDSR
      Code: '11556322'
      Value: Genome Assembly Sequence Depth of Coverage Number
      Version: '1.00'
  bases:
    Desc: Total number of unique bases read
    Type: integer
    Req: Preferred
    Term:
    - Origin: caDSR
      Code: '12373573'
      Value: Sequencing Library Unique Basecalling Count
      Version: '1.00'
  number_of_reads:
    Desc: Total number of reads performed
    Type: integer
    Req: Preferred
    Term:
    - Origin: caDSR
      Code: '11529035'
      Value: Sequencing Library Sequence Read Count
      Version: '1.00'
  design_description:
    Desc: Human-readable description of methods used to create sequencing library
    Type: string
    Req: Preferred
    Term:
    - Origin: caDSR
      Code: '11529028'
      Value: Sequencing Library Platform Model Name
      Version: '1.00'
  platform:
    Desc: Instrument platform or manufacturer
    Req: Preferred
    Enum:
    - LS454
    - ILLUMINA
    - HELICOS
    - ABI_SOLID
    - PACBIO_SMRT
    - ION_TORRENT
    - CAPILLARY
    - OXFORD_NANOPORE
    - BGISEQ
    - Illumina HiSeq 2500
    - Illumina HiSeq X Ten
    - Illumina Next Seq 500
    - Illumina Next Seq 550
    - Illumina NextSeq
    - Illumina NovaSeq 6000
    - NovaSeqS4
    - Unknown
    Term:
    - Origin: caDSR
      Code: '6347771'
      Value: Sequencing Library Platform Name
      Version: '1.00'
  instrument_model:
    Desc: Instrument model
    Req: Preferred
    Enum:
    - 454 GS
    - 454 GS 20
    - 454 GS FLX
    - 454 GS FLX+
    - 454 GS FLX Titanium
    - 454 GS Junior
    - HiSeq X Five
    - HiSeq X Ten
    - Illumina Genome Analyzer
    - Illumina Genome Analyzer II
    - Illumina Genome Analyzer IIx
    - Illumina HiScanSQ
    - Illumina HiSeq
    - Illumina HiSeq 1000
    - Illumina HiSeq 1500
    - Illumina HiSeq 2000
    - Illumina HiSeq 2500
    - Illumina HiSeq 3000
    - Illumina HiSeq 4000
    - Illumina iSeq 100
    - Illumina NovaSeq 6000
    - llumina NovaSeq
    - Illumina MiniSeq
    - Illumina MiSeq
    - Illumina NextSeq
    - NextSeq 500
    - NextSeq 550
    - Helicos HeliScope
    - AB 5500 Genetic Analyzer
    - AB 5500xl Genetic Analyzer
    - AB 5500x-Wl Genetic Analyzer
    - AB SOLiD 3 Plus System
    - AB SOLiD 4 System
    - AB SOLiD 4hq System
    - AB SOLiD PI System
    - AB SOLiD System
    - AB SOLiD System 2.0
    - AB SOLiD System 3.0
    - Complete Genomics
    - PacBio RS
    - PacBio RS II
    - PacBio Sequel
    - PacBio Sequel II
    - Ion Torrent PGM
    - Ion Torrent Proton
    - Ion Torrent S5 XL
    - Ion Torrent S5
    - AB 310 Genetic Analyzer
    - AB 3130 Genetic Analyzer
    - AB 3130xL Genetic Analyzer
    - AB 3500 Genetic Analyzer
    - AB 3500xL Genetic Analyzer
    - AB 3730 Genetic Analyzer
    - AB 3730xL Genetic Analyzer
    - GridION
    - MinION
    - PromethION
    - BGISEQ-500
    - DNBSEQ-G400
    - DNBSEQ-T7
    - DNBSEQ-G50
    - MGISEQ-2000RS
    Term:
    - Origin: caDSR
      Code: '6352164'
      Value: Sequencing Library Platform Model Name
      Version: '1.00'
  library_id:
    Desc: Library identifier as submitted by requestor
    Type: string
    Term:
    - Origin: caDSR
      Code: '11555660'
      Value: Sequencing Library Unique Identifier Text
      Version: '1.00'
  library_layout:
    Desc: Library layout as submitted by requestor
    Req: Preferred
    Enum:
    - Paired-end
    - Single-end
    - Single-indexed
    - Not Reported
    Term:
    - Origin: caDSR
      Code: '11527735'
      Value: Sequencing Library Read Layout Type
      Version: '1.00'
  library_source:
    Desc: Source material used to create library
    Req: Preferred
    Enum:
    - Genomic
    - Transcriptomic
    - Metagenomic
    - Metatranscriptomic
    - Synthetic
    - Viral RNA
    - Genomic Single Cell
    - Single Nucleus
    - Transcriptomic Single Cell
    - Other
    - Bulk Whole Cell
    - Single Cell
    - GENOMIC
    - GENOMIC SINGLE CELL
    - METAGENOMIC
    - METATRANSCRIPTOMIC
    - OTHER
    - SYNTHETIC
    - TRANSCRIPTOMIC
    - TRANSCRIPTOMIC SINGLE CELL
    - VIRAL RNA
    Term:
    - Origin: caDSR
      Code: '6285979'
      Value: Sequencing Library Specimen Source
      Version: '1.00'
  library_selection:
    Desc: Library selection method
    Req: Preferred
    Enum:
    - Hybrid Selection
    - other
    - PCR
    - Poly-T Enrichment
    - PolyA
    - Random
    - 5-methylcytidine antibody
    - CAGE
    - cDNA
    - cDNA_oligo_dT
    - cDNA_randomPriming
    - CF-H
    - CF-M
    - CF-S
    - CF-T
    - ChIP
    - DNAse
    - HMPR
    - Inverse rRNA
    - MBD2 protein methyl-CpG binding domain
    - MDA
    - MF
    - MNase
    - MSLL
    - Oligo-dT
    - Padlock probes capture method
    - Race
    - Random PCR
    - Reduced Representation
    - repeat fractionation
    - Restriction Digest
    - RT-PCR
    - size fractionation
    - unspecified
    - RACE
    - RANDOM
    - RANDOM PCR
    Term:
    - Origin: caDSR
      Code: '6347743'
      Value: Sequencing Library Creation Method Type
      Version: '1.00'
  library_strategy:
    Desc: Nucleic acid capture or processing strategy for this library
    Req: Preferred
    Enum:
    - AMPLICON
    - ATAC-seq
    - Bisulfite-Seq
    - ChIA-PET
    - ChIP-Seq
    - CLONE
    - CLONEEND
    - CTS
    - DNase-Hypersensitivity
    - EST
    - FAIRE-seq
    - FINISHING
    - FL-cDNA
    - Hi-C
    - MBD-Seq
    - MeDIP-Seq
    - miRNA-Seq
    - MNase-Seq
    - MRE-Seq
    - ncRNA-Seq
    - OTHER
    - POOLCLONE
    - RAD-Seq
    - RIP-Seq
    - RNA-Seq
    - SELEX
    - ssRNA-seq
    - Synthetic-Long-Read
    - Targeted-Capture
    - Tethered Chromatin Conformation Capture
    - Tn-Seq
    - WCS
    - WGA
    - WGS
    - WXS
    - DNA-Seq
    - scMultiome
    - snATAC-Seq
    - Spatial-tx
    - Archer Fusion
    - Amplicon
    - ATAC-Seq
    - Other
    Term:
    - Origin: caDSR
      Code: '6273393'
      Value: Sequencing Library Technique Type
      Version: '1.00'
  sequence_alignment_software:
    Desc: Name of software program used to align nucleotide sequence data
    Type: string
    Req: Preferred
    Term:
    - Origin: caDSR
      Code: '11529072'
      Value: Nucleotide Sequence Alignment Software Name Text
      Version: '1.00'
  custom_assembly_fasta_file_for_alignment:
    Desc: File name of any custom assembly fasta file used during alignment
    Type: string
    Req: Preferred
    Term:
    - Origin: caDSR
      Code: '11636299'
      Value: Genome Assembly Custom FASTA File Name
      Version: '1.00'
  # cds_requestor
  cds_requestor:
    Desc: Identifies the user requesting storage in CDS
    Type: string
  data_types:
    Desc: Data types for storage
    Type:
      value_type: list
      item_type: string
  file_types:
    Desc: File types for storage
    Type:
      value_type: list
      item_type: string
  funding_agency:
    Desc: Funding agency of the requestor study
    Type: string
    Req: Preferred
    Term:
    - Origin: caDSR
      Code: '11524545'
      Value: Funding Agency Organization Name Text
      Version: '1.00'
  funding_source_program_name:
    Desc: The funding source organization/sponsor
    Type: string
    Req: Preferred
    Term:
    - Origin: caDSR
      Code: '11524546'
      Value: Funding Agency Program Name Text
      Version: '1.00'
  grant_id:
    Desc: Grant or contract identifier
    Type: string
    Req: Preferred
    Term:
    - Origin: caDSR
      Code: '3434057'
      Value: Grant Funding Identifier Number
      Version: '2.00'
  clinical_trial_system:
    Desc: 'Organization that provides clinical trial identifier (if study

      is a clinical trial)

      '
    Type: string
  clinical_trial_identifier:
    Desc: 'Study identifier in the given clinical trial system

      '
    Type: string
    Term:
    - Origin: caDSR
      Code: '14673514'
      Value: Clinical Trial Study Protocol Unique Identifier
      Version: '1.00'
  clinical_trial_arm:
    Desc: Arm of clinical trial, if appropriate
    Type: string
    Term:
    - Origin: caDSR
      Code: '11524548'
      Value: Clinical Trial Treatment Arm Text
      Version: '1.00'
  organism_species:
    Desc: Species binomial of study participants
    Type: string
    Req: Preferred
  adult_or_childhood_study:
    Desc: Study participants are adult, pediatric, or other
    Req: Preferred
    Enum:
    - Adult
    - Pediatric
    Term:
    - Origin: caDSR
      Code: '11524549'
      Value: Study Subject Legal Adult Or Pediatric Participant Type
      Version: '1.00'
  specimen_id:
    Desc: Identifier for specimen (parent of sample) as provided by requestor
    Type: string
    Key: true
  number_of_participants:
    Desc: How many participants in the study
    Type: number
    Req: 'Yes'
    Term:
    - Origin: caDSR
      Original Source: CDS
      Code: '11555662'
      Value: Research Activity Unique Subjects Count
      Version: '1.00'
  number_of_samples:
    Desc: How many total samples in the study
    Type: number
    Req: 'Yes'
    Term:
    - Origin: caDSR
      Code: '11555663'
      Value: Research Activity Sample Size Count
      Version: '1.00'
  file_types_and_format:
    Desc: 'Specific kinds of files in the dataset that will be uploaded to CDS

      '
    Type:
      value_type: list
      item_type: string
    Req: 'Yes'
  size_of_data_being_uploaded:
    Desc: Size of the data being uploaded to CDS
    Type:
      value_type: number
      units:
      - GB
      - TB
      - PB
    Req: Preferred
  # program
  program_acronym:
    Desc: The name of the program under which related studies will be grouped, expressed in the form of the acronym by which it will identified within the UI. <br>This property is used as the key via which study records can be associated with the appropriate program during data loading, and to identify the correct records during data updates.
    Src: Internally-curated
    Type: string
    Req: 'Yes'
    Key: true
  program_external_url:
    Desc: The external url to which users should be directed in order to learn more about the program.
    Src: Internally-curated
    Type: string
    Req: Preferred
  program_full_description:
    Desc: A more detailed, multiple sentence description of the program.
    Src: Internally-curated
    Type: string
    Req: Preferred
  program_name:
    Desc: The name of the program under which related studies will be grouped, in full text and unabbreviated form, exactly as it will be displayed within the UI.
    Src: Internally-curated
    Type: string
    Req: 'Yes'
    Term:
    - Origin: caDSR
      Original Source: DSS
      Code: '11444542'
      Value: Program Name Text
      Version: '1.00'
  program_short_description:
    Desc: An abbreviated, single sentence description of the program.
    Src: Internally-curated
    Type: string
    Req: Preferred
  program_sort_order:
    Desc: An arbitrarily-assigned value used to dictate the order in which programs are displayed within the application's UI.
    Src: Internally-curated
    Type: integer
    Req: 'No'
  institution:
    Desc: TBD
    Type: String
    Req: Preferred
